Trait_category,Trait,Protein,Protein_definition,sample_size,Estimated_effect,se,lowerCI,upperCI,Pvalue
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FGFBP1,Fibroblast growth factor-binding protein 1,39913,0.13724374018786,0.00279654321701109,0.131762515482519,0.142724964893202,0
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GCG,Pro-glucagon,39477,-0.468891779018292,0.0109017476095441,-0.490259204332998,-0.447524353703585,0
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MFGE8,Lactadherin,39858,-0.188857346694037,0.00383075151661215,-0.196365619666597,-0.181349073721477,0
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PLA2G7,Platelet-activating factor acetylhydrolase,39858,0.127014410869736,0.00268031934646527,0.121760984950664,0.132267836788808,0
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IGSF9,Protein turtle homolog A,37437,-0.257525058530556,0.00742655180661761,-0.272081100071527,-0.242969016989586,1.56626182509875e-252
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PRAP1,Proline-rich acidic protein 1,37437,-0.125331311931764,0.0036268718724953,-0.132439980801854,-0.118222643061673,7.13352139334938e-251
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PYY,Peptide YY,37021,-0.275952790833994,0.00834452915778324,-0.292308067983249,-0.259597513684738,1.88418551902687e-230
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NPY,Pro-neuropeptide Y,40030,-0.195607938609449,0.00602833507133728,-0.20742347534927,-0.183792401869628,8.12244370858363e-224
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TMPRSS15,Enteropeptidase,39788,-0.261817438034432,0.00811606946317887,-0.277724934182263,-0.245909941886602,3.21578943571714e-221
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,AGRP,Agouti-related protein,40058,-0.154593797554384,0.00487360938202563,-0.164146071943154,-0.145041523165614,2.7426754014807e-214
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MAMDC4,Apical endosomal glycoprotein,37368,-0.152935733957468,0.0050681481901469,-0.162869304410156,-0.14300216350478,1.21589892964439e-193
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,C9,Complement component C9,37445,0.143183792346664,0.00483502579151055,0.133707141795303,0.152660442898025,8.01552190626769e-187
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PON3,Serum paraoxonase/lactonase 3,39931,0.0744880104698718,0.00257588241522466,0.0694392809360315,0.0795367400037121,2.72117223891615e-179
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PRSS8,Prostasin,39805,-0.105167324981839,0.00366546995310488,-0.112351646089925,-0.0979830038737534,1.45078730915897e-176
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IGFBP1,Insulin-like growth factor-binding protein 1,40017,0.299104624252912,0.0113008018368987,0.27695505265259,0.321254195853233,3.7561779155171e-151
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ASGR1,Asialoglycoprotein receptor 1,39749,-0.0679898983160203,0.00267926143414989,-0.0732412507269541,-0.0627385459050865,2.69618820133799e-139
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,OXT,Oxytocin-neurophysin 1,40009,-0.322766225261908,0.0127641166627059,-0.347783893920811,-0.297748556603004,2.15919608908833e-138
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CES1,Liver carboxylesterase 1,39854,-0.184445243400008,0.00733057260147988,-0.198813165698908,-0.170077321101107,4.87762692322653e-137
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LDLR,Low-density lipoprotein receptor,39882,-0.11970018028467,0.00483830745896421,-0.12918326290424,-0.110217097665101,1.20786675412069e-132
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PPY,Pancreatic prohormone,39826,-0.22686182096913,0.00922347847043273,-0.244939838771178,-0.208783803167082,3.79054372670003e-131
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,APOF,Apolipoprotein F,37445,0.0585981691274788,0.00238277564527223,0.0539279288627452,0.0632684093922124,1.07534499131885e-130
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GPR37,Prosaposin receptor GPR37,39585,-0.144283014055475,0.00592493511731145,-0.155895886885406,-0.132670141225545,1.31997671366251e-128
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CCN1,CCN family member 1,39758,-0.167983578287141,0.00705264139790317,-0.181806755427031,-0.154160401147251,3.06536621806148e-123
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SLC39A5,Zinc transporter ZIP5,39866,-0.113483471898946,0.00488520769222513,-0.123058478975707,-0.103908464822185,1.96930378478399e-117
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GIP,Gastric inhibitory polypeptide,37043,-0.0933433766381185,0.0040248166601646,-0.101232017292041,-0.0854547359841959,1.16929161115662e-116
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PTH,Parathyroid hormone,37039,-0.166170088771236,0.00737542913743822,-0.180625929880615,-0.151714247661857,2.51168933508569e-110
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LPL,Lipoprotein lipase,39868,0.0975127629911507,0.00437397559459597,0.0889397708257426,0.106085755156559,1.88559363415166e-108
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ACY1,Aminoacylase-1,39868,-0.12729163665203,0.00571050555145898,-0.13848422753289,-0.116099045771171,2.01523554559599e-108
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CCL27,C-C motif chemokine 27,39868,-0.127082021995974,0.00578533957010129,-0.138421287553372,-0.115742756438575,2.17303052815815e-105
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CA14,Carbonic anhydrase 14,40030,0.0710010024987482,0.00324920452672199,0.0646325616263731,0.0773694433711233,2.40531227422548e-104
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,VMO1,Vitelline membrane outer layer protein 1 homolog,39788,-0.132367215462256,0.00616496407171057,-0.144450545042809,-0.120283885881704,7.79865220410501e-101
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IL17RB,Interleukin-17 receptor B,39644,0.107080135971236,0.0049870526786876,0.0973055127210086,0.116854759221464,7.90729770585253e-101
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MUC13,Mucin-13,39489,-0.0970065983583221,0.00469952472393159,-0.106217666817228,-0.0877955298994162,2.03188010522859e-93
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ACE2,Angiotensin-converting enzyme 2,39585,-0.0951813473553468,0.00462028590232524,-0.104237107723904,-0.0861255869867893,4.56186917663866e-93
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,F7,Coagulation factor VII,39899,-0.0563029653186093,0.0027779520433728,-0.06174775132362,-0.0508581793135986,3.32810320018955e-90
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MVK,Mevalonate kinase,39587,-0.148272279033439,0.00734528148769026,-0.162669030749312,-0.133875527317566,1.76085801226695e-89
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IGFBPL1,Insulin-like growth factor-binding protein-like 1,39868,-0.0612476990617329,0.00305179375682843,-0.0672292148251166,-0.0552661832983492,1.67154171637489e-88
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DEFB4A_DEFB4B,Beta-defensin 4A,39585,-0.269351502492043,0.0134395533829292,-0.295693027122584,-0.243009977861502,3.00797722057507e-88
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LGALS4,Galectin-4,39862,-0.0978622954460268,0.00488869066775928,-0.107444129154835,-0.0882804617372187,4.57413401672868e-88
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NHLRC3,NHL repeat-containing protein 3,36838,-0.059330054920448,0.00296067424056061,-0.0651329764319468,-0.0535271334089492,5.32471741222038e-88
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CCL16,C-C motif chemokine 16,40052,-0.0965597031848212,0.00483956649461687,-0.10604525351427,-0.0870741528553721,1.61429553601303e-87
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TFPI,Tissue factor pathway inhibitor,39843,0.0580060554929323,0.00291872031690326,0.0522853636718019,0.0637267473140627,7.66063473287444e-87
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FURIN,Furin,39913,-0.0617903927272497,0.00314031673123325,-0.0679454135204669,-0.0556353719340325,3.45340122653992e-85
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RARRES2,Retinoic acid receptor responder protein 2,39949,-0.0859492560835668,0.00438529841892796,-0.0945444409846656,-0.077354071182468,1.51236517971928e-84
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FGF21,Fibroblast growth factor 21,40011,-0.216613216627962,0.0110650726652973,-0.238300759051945,-0.194925674203979,2.33575110510594e-84
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CHI3L1,Chitinase-3-like protein 1,39545,-0.134587414249677,0.00699466072372651,-0.148296949268181,-0.120877879231173,1.44743745158444e-81
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,39749,-0.0565304059574318,0.00294433682182859,-0.0623013061282158,-0.0507595057866478,3.09146186581728e-81
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,AMOT,Angiomotin,37124,-0.0735660144598303,0.00383602959579301,-0.0810846324675846,-0.066047396452076,7.05020702225102e-81
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CTSD,Cathepsin D,38721,-0.0699101360183575,0.00365305274293064,-0.0770701193945016,-0.0627501526422135,1.14770867070679e-80
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,INHBC,Inhibin beta C chain,39858,-0.072996548058466,0.0038515910371394,-0.0805456664912592,-0.0654474296256728,3.11512038044591e-79
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CPA2,Carboxypeptidase A2,39933,-0.112880738693939,0.00598775147037428,-0.124616731575873,-0.101144745812005,1.98495029268805e-78
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ANGPTL7,Angiopoietin-related protein 7,40030,-0.0648833175682297,0.0034614830027152,-0.0716678242535514,-0.0580988108829079,1.42755402282663e-77
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MEP1A,Meprin A subunit alpha,37382,-0.124390533553419,0.00664404839722219,-0.137412868411975,-0.111368198694864,3.08952447061475e-77
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CD4,T-cell surface glycoprotein CD4,39839,-0.0502094959020053,0.00268464954109044,-0.0554714090025426,-0.044947582801468,3.15394949420803e-77
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SCG2,Secretogranin-2,39949,-0.0536133241299547,0.00289186616577533,-0.0592813818148743,-0.047945266445035,6.138489834829e-76
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CRELD1,Protein disulfide isomerase CRELD1,37124,-0.0634834407498776,0.00345898044872766,-0.0702630424293838,-0.0567038390703713,2.58020365979936e-74
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,HS6ST1,Heparan-sulfate 6-O-sulfotransferase 1,40030,-0.0575969722064891,0.0031503019164016,-0.0637715639626362,-0.0514223804503419,6.27632806745645e-74
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MME,Neprilysin,39788,-0.133393000544062,0.00732100241445017,-0.147742165276385,-0.11904383581174,1.97180021507792e-73
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PSRC1,Proline/serine-rich coiled-coil protein 1,39477,-0.100276127535024,0.0055040258027464,-0.111064018108406,-0.0894882369616406,2.11010102351114e-73
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GRP,Gastrin-releasing peptide,37043,-0.0883277778818863,0.00484558557106023,-0.0978251256011643,-0.0788304301626082,2.43374738284e-73
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GDF15,Growth/differentiation factor 15,40052,-0.0713880071060939,0.00394507545691839,-0.079120355001654,-0.0636556592105339,1.78968571513302e-72
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FTCD,Formimidoyltransferase-cyclodeaminase,37368,-0.141697523937275,0.00783874290490671,-0.157061460030892,-0.126333587843658,3.45001337095106e-72
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,VWA1,von Willebrand factor A domain-containing protein 1,40011,-0.0714343042141565,0.00397032073639782,-0.0792161328574962,-0.0636524755708167,1.12524400602498e-71
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GUSB,Beta-glucuronidase,39919,-0.0981402856949992,0.00546473020519512,-0.108851156897182,-0.0874294144928167,2.04273837535892e-71
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,VPS37A,Vacuolar protein sorting-associated protein 37A,39788,-0.132682396502047,0.00739334884271509,-0.147173360233769,-0.118191432770326,2.58819314558587e-71
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TNFRSF12A,Tumor necrosis factor receptor superfamily member 12A,39913,-0.0575051572986108,0.00323638229049667,-0.0638484665879843,-0.0511618480092373,5.80960499388604e-70
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SMOC1,SPARC-related modular calcium-binding protein 1,40030,-0.05361873630192,0.00304065138631891,-0.059578413019105,-0.0476590595847349,5.97031743476675e-69
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,39477,-0.102411997166454,0.00580871626950432,-0.113797081054683,-0.0910269132782258,6.64947061890704e-69
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NRP1,Neuropilin-1,39949,0.045464315871149,0.00257933868495257,0.040408812048642,0.0505198196936561,6.86450483286971e-69
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,UPB1,Beta-ureidopropionase,37437,-0.15065056808651,0.0085558025598464,-0.167419941103809,-0.133881195069211,1.23665162794723e-68
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NFASC,Neurofascin,40058,-0.0451523817662361,0.00257807989718223,-0.0502054183647133,-0.0400993451677589,4.74865734419126e-68
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CPM,Carboxypeptidase M,39955,-0.0559116809970657,0.00320580044961489,-0.0621950498783109,-0.0496283121158205,1.68792520982507e-67
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ADH4,All-trans-retinol dehydrogenase [NAD(+)] ADH4,39585,-0.136585487162328,0.00785785855846406,-0.151986889936917,-0.121184084387738,4.77675654677308e-67
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GSTA1,Glutathione S-transferase A1,39841,-0.136784040041097,0.00790424431951227,-0.152276358907341,-0.121291721174853,1.73589134698423e-66
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ADIPOQ,Adiponectin,37453,0.106442248241982,0.0061479320873482,0.0943923013507799,0.118492195133185,1.91724752472526e-66
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SERPINF1,Pigment epithelium-derived factor,37254,-0.040367444235828,0.00238109697798078,-0.0450343943126703,-0.0357004941589857,8.40946325253374e-64
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CCL15,C-C motif chemokine 15,40052,-0.0683048199041102,0.00403816894981431,-0.0762196310457463,-0.0603900087624741,1.23135983456791e-63
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FGFBP3,Fibroblast growth factor-binding protein 3,37388,0.0576446304982762,0.00340819947952616,0.050964559518405,0.0643247014781475,1.60605303534917e-63
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,F9,Coagulation factor IX,39908,-0.0286172392079779,0.00169519112276295,-0.0319398138085933,-0.0252946646073626,2.17133248299236e-63
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,KIT,Mast/stem cell growth factor receptor Kit,39908,0.0451601542367076,0.00268118846930822,0.0399050248368635,0.0504152836365518,4.09036384629315e-63
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FAM3B,Protein FAM3B,39788,-0.0563409630508696,0.00334597691581558,-0.0628990778058682,-0.0497828482958711,4.4796063891272e-63
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CCL23,C-C motif chemokine 23,39931,-0.0639961399823317,0.0038269361365776,-0.0714969348100238,-0.0564953451546396,3.01460740396037e-62
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CXADR,Coxsackievirus and adenovirus receptor,39866,-0.0787778946292264,0.00472200520159286,-0.0880330248243485,-0.0695227644341044,5.7984067905778e-62
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TFF3,Trefoil factor 3,39839,-0.0751079852506738,0.00451755419906798,-0.0839623914808471,-0.0662535790205006,1.49032975969602e-61
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,AMBP,Protein AMBP,40003,-0.0298049464817068,0.00179934679497148,-0.0333316661998509,-0.0262782267635627,4.03099341708368e-61
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NOS3,"Nitric oxide synthase, endothelial",39489,-0.0788328372699641,0.00475915699065352,-0.088160784971645,-0.0695048895682832,4.17655191895118e-61
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IL1RN,Interleukin-1 receptor antagonist protein,39820,-0.0821718473823874,0.00497337096025973,-0.0919196544644965,-0.0724240403002784,8.10069118502393e-61
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MTSS1,Protein MTSS 1,37382,-0.16923838654981,0.0102760063936977,-0.189379359081457,-0.149097414018162,2.35799376225489e-60
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PGF,Placenta growth factor,40058,-0.0389307756961714,0.00239733234458523,-0.0436295470915585,-0.0342320043007844,7.76415073015588e-59
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IGSF8,Immunoglobulin superfamily member 8,39868,-0.0456877209410181,0.00281363252146222,-0.0512024406830841,-0.0401730011989522,8.01793115050582e-59
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ADGRG1,Adhesion G-protein coupled receptor G1,39788,-0.0821365047542413,0.00507117645780867,-0.0920760106115463,-0.0721969988969363,1.56054197913103e-58
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CXCL13,C-X-C motif chemokine 13,40009,-0.0875559060914444,0.00548054838269084,-0.0982977809215184,-0.0768140312613703,5.15491683363812e-57
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MET,Hepatocyte growth factor receptor,39879,0.0290199719546109,0.00182109579780197,0.025450624190919,0.0325893197183027,9.81219422324324e-57
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,HHEX,Hematopoietically-expressed homeobox protein HHEX,37388,-0.113763614461541,0.00714227356373261,-0.127762470646457,-0.0997647582766249,1.31945127545524e-56
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GHR,Growth hormone receptor,37124,-0.0425152231045751,0.00268394655418207,-0.0477757583507719,-0.0372546878583782,5.32310844378653e-56
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SELE,E-selectin,40052,-0.0734667089701673,0.00464285437031233,-0.0825667035359795,-0.0643667144043551,5.61807297784322e-56
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CTSO,Cathepsin O,40058,-0.0440085571941293,0.0027912904941957,-0.0494794865627529,-0.0385376278255057,1.37264550499761e-55
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,APOM,Apolipoprotein M,39908,0.0391645259348728,0.00248549201491577,0.0342929615856379,0.0440360902841077,1.59653823940726e-55
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MAD1L1,Mitotic spindle assembly checkpoint protein MAD1,39683,-0.0679788362254346,0.00433295125292721,-0.0764714206811719,-0.0594862517696972,4.68887968096796e-55
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GLA,Alpha-galactosidase A,37088,-0.0552031152907062,0.00352437527020298,-0.062110890820304,-0.0482953397611083,8.3765392491302e-55
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IGFBP4,Insulin-like growth factor-binding protein 4,39585,-0.057911501708388,0.00370087397450384,-0.0651652146984155,-0.0506577887183605,8.86612339843678e-55
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SMAD1,Mothers against decapentaplegic homolog 1,39477,-0.120391130892503,0.00770426318126841,-0.135491486727789,-0.105290775057217,1.24425854086608e-54
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CPB1,Carboxypeptidase B,40052,-0.0833468858850505,0.00535680209684548,-0.0938462179948676,-0.0728475537752333,3.40755314996267e-54
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,UMOD,Uromodulin,40012,0.07592563178913,0.0049141393696189,0.066293918624677,0.0855573449535831,1.80774260917705e-53
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NTRK3,NT-3 growth factor receptor,40009,0.0306717149059845,0.00198728376757291,0.0267766387215416,0.0345667910904274,2.32491358433508e-53
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GSTA3,Glutathione S-transferase A3,39477,-0.10947547080963,0.00713077592304315,-0.123451791618794,-0.0954991500004653,8.27769262713165e-53
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CDKN1A,Cyclin-dependent kinase inhibitor 1,39788,-0.152441515329526,0.00994262263581074,-0.171929055695715,-0.132953974963337,1.10924483702476e-52
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,AFM,Afamin,37453,-0.027128323311055,0.00176922209094532,-0.0305959986093078,-0.0236606480128021,1.25900629029186e-52
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RTN4R,Reticulon-4 receptor,40030,-0.0473302268196304,0.00308969300359941,-0.0533860251066852,-0.0412744285325755,1.34144485006246e-52
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,AREG,Amphiregulin,39788,-0.0667514159245891,0.00436502174549625,-0.0753068585457618,-0.0581959733034165,2.02685241614089e-52
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LECT2,Leukocyte cell-derived chemotaxin-2,37437,-0.0917108960847548,0.00601545878761823,-0.103501195308486,-0.079920596861023,4.72982844081967e-52
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DSG2,Desmoglein-2,39858,0.0378664222463366,0.00248915153416057,0.0329876852393819,0.0427451592532914,6.73294439363918e-52
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,39749,-0.0765705389245465,0.00504072526287801,-0.0864503604397875,-0.0666907174093056,9.45712334815126e-52
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,EPHA1,Ephrin type-A receptor 1,39904,-0.0471275477274387,0.00310996141673028,-0.05322307210423,-0.0410320233506473,1.62676073045472e-51
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CLUL1,Clusterin-like protein 1,39840,0.0637934583590715,0.00421809459079541,0.0555259929611124,0.0720609237570305,2.5579393289516e-51
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CA5A,"Carbonic anhydrase 5A, mitochondrial",39585,-0.128147857657621,0.00849209233281067,-0.14479235862993,-0.111503356685312,4.27771653852067e-51
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PTPRS,Receptor-type tyrosine-protein phosphatase S,40052,0.0342985347151375,0.00227924994831012,0.0298312048164497,0.0387658646138253,7.831089511734e-51
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,AGR2,Anterior gradient protein 2 homolog,39364,-0.139594422570582,0.00935075415241741,-0.15792190070932,-0.121266944431844,4.77513537799241e-50
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NECTIN2,Nectin-2,39846,-0.0392647832694622,0.00263289516737182,-0.044425257797511,-0.0341043087414134,5.86468013675562e-50
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PVR,Poliovirus receptor,40009,-0.051302679366017,0.00346994955670879,-0.0581037804971662,-0.0445015782348677,3.84466213786867e-49
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DCBLD2,"Discoidin, CUB and LCCL domain-containing protein 2",39913,-0.0475283365336067,0.00322182444810557,-0.0538431124518937,-0.0412135606153198,6.24603375753475e-49
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,OMD,Osteomodulin,39931,0.0597261931377809,0.00405334593143806,0.0517816351121623,0.0676707511633995,7.99616365786979e-49
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,HJV,Hemojuvelin,37411,-0.0610151533876439,0.00414521753153824,-0.0691397797494589,-0.052890527025829,1.14897938452065e-48
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MCAM,Cell surface glycoprotein MUC18,39931,0.0448997555906747,0.00305388044378314,0.0389141499208598,0.0508853612604897,1.28488056102235e-48
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CLEC4M,C-type lectin domain family 4 member M,37410,0.0662451265831269,0.00450837695520208,0.0574087077509308,0.0750815454153229,1.66786752411379e-48
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ELN,Elastin,37437,-0.0459147740890004,0.00313246942203818,-0.0520544141561952,-0.0397751340218056,2.81139342107542e-48
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PRCP,Lysosomal Pro-X carboxypeptidase,39948,-0.0424354513064578,0.00290277719624294,-0.048124894611094,-0.0367460080018217,4.3280660733493e-48
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DNAJB1,DnaJ homolog subfamily B member 1,39788,-0.117567309630716,0.00810933571604921,-0.133461607634172,-0.101673011627259,2.50477010320955e-47
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,AGR3,Anterior gradient protein 3,39464,-0.0795570040241441,0.00550523314819819,-0.0903472609946125,-0.0687667470536757,4.95991829773852e-47
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,KRT18,"Keratin, type I cytoskeletal 18",39788,-0.10966183887317,0.00759674503502521,-0.12455145914182,-0.0947722186045211,6.13150854047759e-47
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NCS1,Neuronal calcium sensor 1,40030,-0.0378616285865217,0.00262348686064742,-0.0430036628333906,-0.0327195943396527,6.38855384839363e-47
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,VAT1,Synaptic vesicle membrane protein VAT-1 homolog,39788,0.0263759663716166,0.00184979397581383,0.0227503701790215,0.0300015625642117,7.56029070432976e-46
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ADAMTSL2,ADAMTS-like protein 2,37437,-0.0421239146058209,0.00296055994427384,-0.0479266120965976,-0.0363212171150442,1.29943364716453e-45
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SCLY,Selenocysteine lyase,39984,-0.0651365456081673,0.00459148096234658,-0.0741358482943666,-0.056137242921968,2.08652560856423e-45
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CTSF,Cathepsin F,39913,-0.0531910621419059,0.0037716531197426,-0.0605835022566014,-0.0457986220272104,6.76075596865564e-45
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,COL18A1,Collagen alpha-1(XVIII) chain,39893,-0.0295848186640565,0.00210713125949639,-0.0337147959326694,-0.0254548413954435,1.62043269082322e-44
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FETUB,Fetuin-B,39908,-0.0439158381941263,0.00314691240818979,-0.0500837865141783,-0.0377478898740744,5.28637968020833e-44
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,POSTN,Periostin,37437,0.0480305507452112,0.00346561526526892,0.0412379448252842,0.0548231566651383,2.20999096707552e-43
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NOMO1,Nodal modulator 1,39858,-0.0306292481321859,0.00221577342662889,-0.0349721640483786,-0.0262863322159933,3.26861144741236e-43
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MXRA8,Matrix remodeling-associated protein 8,37124,0.0388739659787556,0.00281087908096293,0.0333646429800682,0.0443832889774429,3.35827482769377e-43
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IL10RB,Interleukin-10 receptor subunit beta,39931,-0.0360559434896886,0.00261483432703506,-0.0411810187706773,-0.0309308682086999,5.21702829292074e-43
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CGREF1,Cell growth regulator with EF hand domain protein 1,39868,-0.0538070214677871,0.00391084506793848,-0.0614722778009465,-0.0461417651346277,7.94566949393408e-43
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PRSS2,Trypsin-2,39931,-0.0660041916254717,0.00480038925597304,-0.0754129545671788,-0.0565954286837646,8.92372248405763e-43
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CTBS,Di-N-acetylchitobiase,37296,-0.0354066050378202,0.00258027748662845,-0.040463948911612,-0.0303492611640285,1.45096957751931e-42
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,KHK,Ketohexokinase,37043,-0.0828592617978304,0.00605428256214137,-0.0947256556196275,-0.0709928679760334,2.39450943175886e-42
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SPINK1,Serine protease inhibitor Kazal-type 1,39858,-0.0512430572648134,0.0037479350283019,-0.0585890099202852,-0.0438971046093417,2.56838040956731e-42
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NOTCH3,Neurogenic locus notch homolog protein 3,40052,0.0433510276333682,0.00317348880735423,0.0371309895709539,0.0495710656957825,3.00240183416821e-42
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ITIH3,Inter-alpha-trypsin inhibitor heavy chain H3,39931,0.0489644463050566,0.00359423993703487,0.0419197360284682,0.0560091565816449,5.00092993206921e-42
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,EPO,Erythropoietin,39866,-0.0982528007634462,0.00721222662426507,-0.112388764947006,-0.0841168365798867,5.00796000926256e-42
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FAM20A,Pseudokinase FAM20A,37437,-0.0357667055610921,0.00263695574059665,-0.0409351388126616,-0.0305982723095227,1.22838451798616e-41
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,HGF,Hepatocyte growth factor,40058,-0.043002761918911,0.00317380393363411,-0.0492234176288339,-0.0367821062089882,1.34833407477008e-41
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,KITLG,Kit ligand,39868,0.046777530143465,0.00346281311440205,0.039990416439237,0.053564643847693,2.34665433925925e-41
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,HAO1,Hydroxyacid oxidase 1,40030,-0.162658948504198,0.0120418569836527,-0.186260988192158,-0.139056908816239,2.35777392467318e-41
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GAST,Gastrin,37388,-0.146147788048588,0.0108414208125428,-0.167396972841172,-0.124898603256004,3.75500971044773e-41
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ALPI,Intestinal-type alkaline phosphatase,37056,-0.151555907586745,0.0112933080440567,-0.173690791353096,-0.129421023820394,8.54902055649489e-41
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,BCAN,Brevican core protein,39749,0.0416190172849594,0.00311023407901556,0.0355229584900889,0.0477150760798299,1.29016760918177e-40
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,THBS2,Thrombospondin-2,39858,-0.0449845923668028,0.00336619328163024,-0.051582331198798,-0.0383868535348075,1.62641417709836e-40
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CD74,HLA class II histocompatibility antigen gamma chain,40009,-0.0422141617976398,0.00316214449999149,-0.0484119650176231,-0.0360163585776565,1.94425786913213e-40
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SEMA3F,Semaphorin-3F,39868,-0.0318243940613068,0.00238498478427493,-0.0364989642384857,-0.027149823884128,2.12031456102997e-40
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,KLK14,Kallikrein-14,40030,0.0560896219366282,0.00421571705688993,0.047826816505124,0.0643524273681325,3.52667363879929e-40
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TNFSF10,Tumor necrosis factor ligand superfamily member 10,40058,0.0322721373543961,0.00242771828795333,0.0275138095100076,0.0370304651987846,4.1128394413588e-40
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CTSE,Cathepsin E,37124,-0.0655792707759151,0.00493846702475682,-0.0752586661444385,-0.0558998754073917,5.49450789269328e-40
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GGT1,Glutathione hydrolase 1 proenzyme,39826,-0.0615281883545194,0.00464408723614662,-0.0706305993373667,-0.052425777371672,7.45025925109522e-40
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,40058,-0.0448777681580522,0.00339134684235698,-0.0515248079690719,-0.0382307283470326,9.09824363102748e-40
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,INPP5D,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1",37043,-0.0709831700257626,0.00536718061159744,-0.0815028440244936,-0.0604634960270316,1.11982306730154e-39
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DMP1,Dentin matrix acidic phosphoprotein 1,37043,0.0748830488543946,0.00566228562802663,0.0637849690234624,0.0859811286853268,1.12765435353807e-39
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RBP5,Retinol-binding protein 5,39788,-0.0688602707415199,0.00523351636478598,-0.0791179628165004,-0.0586025786665394,2.46983966802245e-39
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IL15,Interleukin-15,39866,-0.0397850433822608,0.0030342299356308,-0.0457321340560972,-0.0338379527084245,4.46497701648296e-39
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RNASET2,Ribonuclease T2,39974,-0.0312234157509953,0.00238271575472738,-0.035893538630261,-0.0265532928717297,4.93716944061029e-39
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NCAN,Neurocan core protein,40009,0.0449174503740876,0.00342868625759241,0.0381972253092065,0.0516376754389688,5.17238336292824e-39
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CTSZ,Cathepsin Z,39865,-0.0379395879328803,0.00290046343096006,-0.043624496257562,-0.0322546796081986,6.73562200123576e-39
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TGFB1,Transforming growth factor beta-1 proprotein,40040,-0.0469741250011688,0.00359697487160319,-0.054024195749511,-0.0399240542528265,8.82903415835379e-39
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CHMP6,Charged multivesicular body protein 6,37437,-0.0691820368405781,0.00529747089276348,-0.0795650797903945,-0.0587989938907616,9.60746587590124e-39
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,F11R,Junctional adhesion molecule A,39858,-0.0689462000740552,0.00528743554675001,-0.0793095737456853,-0.0585828264024252,1.14633307834681e-38
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,39587,-0.0509758708130392,0.00391223045161213,-0.0586438424981989,-0.0433078991278794,1.31109488472222e-38
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IGFBP2,Insulin-like growth factor-binding protein 2,40012,0.0755529089559128,0.00580459357455818,0.0641759055497788,0.0869299123620468,1.54956051690923e-38
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,HEG1,Protein HEG homolog 1,37124,-0.032877291739013,0.00253484315614881,-0.0378455843250646,-0.0279089991529613,3.08566080360179e-38
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IGSF3,Immunoglobulin superfamily member 3,39788,-0.0426503496161622,0.00331395222908916,-0.0491456959851769,-0.0361550032471474,1.02450238803627e-37
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SBSN,Suprabasin,37420,0.0407169191733776,0.00316962510321072,0.0345044539710846,0.0469293843756706,1.49988403010501e-37
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ADGRG2,Adhesion G-protein coupled receptor G2,39868,0.032090666904437,0.0025084381592709,0.0271741281122661,0.037007205696608,2.72905711082137e-37
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NCAM2,Neural cell adhesion molecule 2,39858,0.0319319714424992,0.0024976021060614,0.0270366713146188,0.0368272715703795,3.02392393908048e-37
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FGF23,Fibroblast growth factor 23,40008,-0.0697769690957999,0.00545945246990537,-0.0804774959368145,-0.0590764422547854,3.17385220498749e-37
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CPA1,Carboxypeptidase A1,40052,-0.070663523475769,0.00552971252906378,-0.081501760032734,-0.059825286918804,3.25485771658928e-37
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,S100P,Protein S100-P,39585,-0.0623499878236091,0.00491757766138181,-0.0719884400399175,-0.0527115356073008,1.1685597772352e-36
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PLA2G10,Group 10 secretory phospholipase A2,39749,-0.0698744285855646,0.00551804960775061,-0.0806898058167557,-0.0590590513543734,1.4261524570889e-36
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NPPC,C-type natriuretic peptide,39866,-0.0540738199701343,0.00427306155283845,-0.0624490206136977,-0.0456986193265709,1.57885091765499e-36
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CDH1,Cadherin-1,39315,-0.0477287666334051,0.00377268894076215,-0.0551232369572989,-0.0403342963095112,1.67285698175365e-36
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IFNGR2,Interferon gamma receptor 2,39749,-0.0615159456123555,0.00486676995678669,-0.0710548147276574,-0.0519770764970536,1.90305611520566e-36
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TTR,Transthyretin,37309,-0.0296710152879998,0.00235553381810645,-0.0342878615714884,-0.0250541690045111,3.54105110051638e-36
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ADM,Pro-adrenomedullin,40030,-0.0308625321902136,0.00246010188287196,-0.0356843318806426,-0.0260407324997845,6.20683346303686e-36
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CD209,CD209 antigen,39885,0.0454701847707844,0.00363310237841954,0.0383493041090821,0.0525910654324867,9.02476845424939e-36
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,INSL5,Insulin-like peptide INSL5,37382,-0.112870753302811,0.00905704624017084,-0.130622563933546,-0.0951189426720763,1.87881125590058e-35
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CDH2,Cadherin-2,39868,-0.0408699178349865,0.00328152802882301,-0.0473017127714796,-0.0344381228984934,1.9283178425923e-35
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FGFR2,Fibroblast growth factor receptor 2,39913,-0.0249960348105949,0.0020139406385542,-0.0289433584621611,-0.0210487111590287,3.28350831154592e-35
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ACAN,Aggrecan core protein,39730,0.0326258412543667,0.00263596207032846,0.0274593555965229,0.0377923269122105,5.03766031000086e-35
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RET,Proto-oncogene tyrosine-protein kinase receptor Ret,39788,-0.0451985482625872,0.00366267380097109,-0.0523773889124905,-0.0380197076126838,7.92554495906246e-35
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LRCH4,Leucine-rich repeat and calponin homology domain-containing protein 4,37021,-0.0780743683028279,0.0063899511546583,-0.0905986725659582,-0.0655500640396976,3.79957119407772e-34
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SELPLG,P-selectin glycoprotein ligand 1,39866,-0.031749732513825,0.0026018027501621,-0.0368492659041427,-0.0266501991235073,4.24762074421842e-34
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ENO3,Beta-enolase,37043,-0.0689925134303556,0.00565381042100765,-0.0800739818555306,-0.0579110450051806,4.58230345097949e-34
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CD38,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,39788,-0.0343479373636574,0.00281754688313726,-0.0398703292546064,-0.0288255454727083,4.93853672424031e-34
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LRP11,Low-density lipoprotein receptor-related protein 11,39868,-0.0396690787821945,0.00325613419100794,-0.04605110179657,-0.0332870557678189,5.42345283461977e-34
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GSN,Gelsolin,37383,0.021192388580714,0.00174581647470429,0.0177705882902936,0.0246141888711344,9.8336373535707e-34
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,AP3S2,AP-3 complex subunit sigma-2,37388,-0.053265073561572,0.00440007440674489,-0.061889219398792,-0.044640927724352,1.47261777214877e-33
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SIT1,Signaling threshold-regulating transmembrane adapter 1,39587,-0.0618858064978576,0.00512276026563552,-0.0719264166185033,-0.051845196377212,1.88196970418466e-33
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ASPN,Asporin,37437,0.0303170987347783,0.00252197556399012,0.0253740266293577,0.035260170840199,4.0505958180909e-33
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ENPP7,Ectonucleotide pyrophosphatase/phosphodiesterase family member 7,39429,-0.097479775742355,0.00812824182496122,-0.113411129719279,-0.0815484217654311,5.4214193852312e-33
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,HEPH,Hephaestin,37437,-0.0295180119489087,0.00246159154546776,-0.0343427313780255,-0.0246932925197919,5.78091099093477e-33
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SNAPIN,SNARE-associated protein Snapin,37411,-0.065035950814943,0.00543080270729497,-0.0756803241212412,-0.0543915775086449,7.00697669980361e-33
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,EGFR,Epidermal growth factor receptor,40052,0.0179560685015401,0.00150027855778483,0.0150155225282818,0.0208966144747984,7.15166134629506e-33
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SHBG,Sex hormone-binding globulin,37445,0.0574570192955556,0.00482435236495097,0.0480012886602517,0.0669127499308595,1.52802011240362e-32
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CPE,Carboxypeptidase E,39906,0.0429169152954074,0.00360724591826276,0.0358467132956124,0.0499871172952024,1.67212830320275e-32
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NRP2,Neuropilin-2,39858,0.0317060870515115,0.00266773158959075,0.0264773331359136,0.0369348409671094,1.93867645161732e-32
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PIGR,Polymeric immunoglobulin receptor,39677,-0.0403015441963853,0.00340138721381687,-0.0469682631354663,-0.0336348252573042,2.99699927062806e-32
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GPRC5C,G-protein coupled receptor family C group 5 member C,37368,-0.0631315858372156,0.0053309117106586,-0.0735801727901065,-0.0526829988843248,3.39365123693801e-32
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,OCLN,Occludin,37411,-0.0476025047425108,0.00402120983049864,-0.0554840760102881,-0.0397209334747335,3.58276684974262e-32
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,BTN3A2,Butyrophilin subfamily 3 member A2,39866,-0.0406267905699451,0.00344162504337213,-0.0473723756549545,-0.0338812054849358,5.02137827013429e-32
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,KLRB1,Killer cell lectin-like receptor subfamily B member 1,40058,-0.0398471123400743,0.0033772974781983,-0.046466615397343,-0.0332276092828057,5.37093561825341e-32
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PCBD1,Pterin-4-alpha-carbinolamine dehydratase,37114,-0.0523453104828196,0.00444004577065125,-0.061047800193296,-0.0436428207723431,6.39282932951927e-32
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,EFCAB14,EF-hand calcium-binding domain-containing protein 14,37382,-0.0285637770087755,0.00242488418210617,-0.0333165500057036,-0.0238110040118474,7.13150527284673e-32
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SERPINA5,Plasma serine protease inhibitor,37283,-0.0350031587706333,0.00297779303210671,-0.0408396331135624,-0.0291666844277041,9.55408308731451e-32
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PRKRA,Interferon-inducible double-stranded RNA-dependent protein kinase activator A,39477,-0.0742499235317323,0.00632437642539059,-0.0866457013254979,-0.0618541457379668,1.07668128905892e-31
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ACY3,N-acyl-aromatic-L-amino acid amidohydrolase,37021,-0.0614088243325971,0.00525037839576797,-0.0716995659883024,-0.0511180826768919,1.90980569649581e-31
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CNTN1,Contactin-1,40052,0.0291271561169541,0.00249296750853975,0.0242409398002162,0.034013372433692,2.06367396096797e-31
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SUMF2,Inactive C-alpha-formylglycine-generating enzyme 2,40009,-0.057019415393955,0.0048901410633648,-0.06660409187815,-0.04743473890976,2.72100907623239e-31
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FAM3C,Protein FAM3C,39846,-0.0315916547489496,0.00270961755886567,-0.0369025051643264,-0.0262808043335729,2.76073473847162e-31
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CD300LG,CMRF35-like molecule 9,39858,0.0398331757813377,0.00342756741637178,0.033115143645249,0.0465512079174263,4.27697047377504e-31
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CFHR4,Complement factor H-related protein 4,37409,0.0783327115505218,0.00673793710735121,0.0651263548201135,0.0915390682809302,4.28917810324928e-31
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MEGF9,Multiple epidermal growth factor-like domains protein 9,40002,-0.0230122477123455,0.00198097187123189,-0.02689495257996,-0.019129542844731,4.50878381463094e-31
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ANGPTL1,Angiopoietin-related protein 1,39617,-0.0318021796252892,0.0027398290442149,-0.0371722445519504,-0.026432114698628,5.05633081525238e-31
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DPY30,Protein dpy-30 homolog,39979,-0.0641883105811196,0.00554096328184606,-0.0750485986135379,-0.0533280225487013,6.56006632711388e-31
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CHL1,Neural cell adhesion molecule L1-like protein,39900,0.0338160558026314,0.00291991976054585,0.0280930130719616,0.0395390985333013,6.81409794912212e-31
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ZBTB16,Zinc finger and BTB domain-containing protein 16,39477,-0.076841648135401,0.00664021798205902,-0.0898564753802367,-0.0638268208905654,7.61940810881209e-31
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GPD1,Glycerol-3-phosphate dehydrogenase,37368,-0.056364758102799,0.00489310183641458,-0.0659552377021716,-0.0467742785034264,1.46616817422189e-30
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PTS,6-pyruvoyl tetrahydrobiopterin synthase,39419,-0.0588221402538139,0.00511234618908891,-0.0688423387844282,-0.0488019417231997,1.63700048068082e-30
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CALCA,Calcitonin,39713,-0.0655091506898882,0.00570312429345887,-0.0766872743050676,-0.0543310270747088,2.03402481261306e-30
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RIDA,2-iminobutanoate/2-iminopropanoate deaminase,37124,-0.0524964679497399,0.00458718121307979,-0.0614873431273763,-0.0435055927721035,3.48471742414041e-30
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,KYNU,Kynureninase,40058,-0.0485945255022747,0.00425470688582245,-0.0569337509984867,-0.0402553000060627,4.26432469092945e-30
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,APOD,Apolipoprotein D,36780,0.0463083780116545,0.00406096129824663,0.0383488938670911,0.0542678621562179,5.59926168863131e-30
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SERPIND1,Heparin cofactor 2,37424,-0.0300493361646038,0.00263716209553838,-0.035218173871859,-0.0248804984573486,6.08847255740426e-30
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CD2AP,CD2-associated protein,39868,-0.0672792544964066,0.00592872936817412,-0.0788995640580279,-0.0556589449347854,9.85602262664018e-30
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CKB,Creatine kinase B-type,37437,0.0617075135114087,0.00543611842469894,0.0510527213989988,0.0723623056238186,9.93696433818807e-30
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PLA2G15,Phospholipase A2 group XV,39913,-0.0280385937520345,0.00247275584156319,-0.0328851952014983,-0.0231919923025706,1.09069753954882e-29
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TSPAN8,Tetraspanin-8,37382,-0.103779037142139,0.00916701286878691,-0.121746382364962,-0.085811691919317,1.40454317450103e-29
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NCAM1,Neural cell adhesion molecule 1,39931,0.0316770320691943,0.00280674847872155,0.0261758050509001,0.0371782590874886,1.98521021459551e-29
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SMAD2,Mothers against decapentaplegic homolog 2,37368,-0.0730625427851233,0.00648303171665471,-0.0857692849497665,-0.0603558006204801,2.500163100168e-29
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ACAA1,"3-ketoacyl-CoA thiolase, peroxisomal",39477,-0.0874310652442366,0.00776953246958845,-0.10265934888463,-0.0722027816038432,2.89904153431351e-29
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,HAVCR1,Hepatitis A virus cellular receptor 1,40003,-0.0631321656829797,0.00561097409591346,-0.0741296749109701,-0.0521346564549894,2.92418505664041e-29
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ADGRD1,Adhesion G-protein coupled receptor D1,37124,-0.0407721758844352,0.00364332370814185,-0.0479130903523932,-0.0336312614164772,6.08757308063893e-29
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SULT2A1,Bile salt sulfotransferase,39866,-0.0584346885080261,0.00522828218178527,-0.0686821215843252,-0.048187255431727,6.78739048778299e-29
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FLI1,Friend leukemia integration 1 transcription factor,39477,-0.115178814231013,0.0103076245174442,-0.135381758285203,-0.0949758701768222,7.02350669695546e-29
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PXN,Paxillin,39489,-0.0539689396761174,0.00484259071949649,-0.0634604174863305,-0.0444774618659043,9.75912149746526e-29
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CXCL6,C-X-C motif chemokine 6,40058,-0.0800118830703462,0.00718480763746263,-0.094094106039773,-0.0659296601009195,1.06216441193149e-28
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IL18R1,Interleukin-18 receptor 1,40058,-0.0338273259503074,0.00304629706509862,-0.0397980681979007,-0.0278565837027141,1.51379837059044e-28
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,F10,Coagulation factor X,37445,-0.0275732588355212,0.00248252966107145,-0.0324390169712212,-0.0227075006998211,1.54051666144365e-28
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ITGA11,Integrin alpha-11,39866,0.035339529230579,0.0031836138054591,0.0290996461718792,0.0415794122892788,1.58640281777974e-28
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PTGR1,Prostaglandin reductase 1,37437,-0.0826109534435455,0.00745126207373672,-0.0972154271080695,-0.0680064797790216,1.9248898706819e-28
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,YES1,Tyrosine-protein kinase Yes,39788,-0.11826721606865,0.0106773371807039,-0.139194796942829,-0.0973396351944699,2.07206202765845e-28
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,APLP1,Amyloid-like protein 1,39868,0.0530739930903177,0.00479351771248174,0.0436786983738535,0.0624692878067819,2.17386474452295e-28
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RNASE4,Ribonuclease 4,37051,-0.0269280998891113,0.00243439568736514,-0.031699515436347,-0.0221566843418756,2.56810157143898e-28
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MYH9,Myosin-9,37437,-0.114789384778535,0.0104146676368923,-0.135202133346844,-0.0943766362102261,3.94367502347099e-28
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",37388,-0.0395980992540523,0.00359544871974861,-0.0466451787447596,-0.0325510197633451,4.33480429344965e-28
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TIMD4,T-cell immunoglobulin and mucin domain-containing protein 4,39931,0.04424687385832,0.00403431067462944,0.0363396249360463,0.0521541227805937,6.86610330220797e-28
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PLTP,Phospholipid transfer protein,39976,0.0368377828007116,0.00336091794896211,0.0302503836207459,0.0434251819806773,7.41037481180188e-28
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,S100A14,Protein S100-A14,37411,-0.0523652739695456,0.00478887050115609,-0.0617514601518115,-0.0429790877872796,1.02601672700542e-27
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,VASN,Vasorin,39642,0.027934203611378,0.00256293450856063,0.0229108519745992,0.0329575552481569,1.45616844779666e-27
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LAT2,Linker for activation of T-cells family member 2,39788,-0.127075264093636,0.0116615872989477,-0.149931975199574,-0.104218552987699,1.49162412497768e-27
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,EEF1D,Elongation factor 1-delta,37437,-0.0930641624650967,0.00854097444344598,-0.109804472374251,-0.0763238525559426,1.56228379038704e-27
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,VEGFA,Vascular endothelial growth factor A,39993,-0.0580850566312248,0.00533444972987527,-0.0685405781017803,-0.0476295351606692,1.62723728552386e-27
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ADAMTS15,A disintegrin and metalloproteinase with thrombospondin motifs 15,39788,-0.0444713741879372,0.00408732260972086,-0.0524825265029901,-0.0364602218728843,1.78723132698153e-27
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SLITRK1,SLIT and NTRK-like protein 1,37056,0.0324455631058751,0.00298923623622794,0.0265866600828683,0.0383044661288819,2.48652197589752e-27
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ARF6,ADP-ribosylation factor 6,37382,-0.107738336888497,0.00995712605734119,-0.127254303960886,-0.0882223698161082,3.56747540259686e-27
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,WFIKKN2,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 2",39885,0.0335402142932881,0.00311092382687957,0.0274428035926041,0.039637624993972,5.21474199711426e-27
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LSP1,Lymphocyte-specific protein 1,39866,-0.0407869980421522,0.00378555726765433,-0.0482066902867547,-0.0333673057975497,5.62904006307203e-27
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PSIP1,PC4 and SFRS1-interacting protein,39866,-0.0636898238251617,0.00591852265856354,-0.0752901282359462,-0.0520895194143771,6.49475142235591e-27
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SKAP1,Src kinase-associated phosphoprotein 1,39713,-0.0724836170470869,0.00674224289809406,-0.0856984131273512,-0.0592688209668225,7.28184614345442e-27
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CST3,Cystatin-C,39897,-0.0267214927890682,0.00248863012200938,-0.0315992078282066,-0.0218437777499298,8.37594704202247e-27
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DNER,Delta and Notch-like epidermal growth factor-related receptor,39821,0.0253841333270956,0.00237432548311486,0.0207304553801905,0.0300378112740008,1.37840428790684e-26
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,INPPL1,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2",39788,-0.0972959355945994,0.00914688166605569,-0.115223823660069,-0.0793680475291303,2.45570366374933e-26
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ECHDC3,"Enoyl-CoA hydratase domain-containing protein 3, mitochondrial",37437,-0.0753484313487762,0.00708340812050129,-0.0892319112649588,-0.0614649514325937,2.53646967287389e-26
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CSF1,Macrophage colony-stimulating factor 1,39931,-0.0260303116364965,0.00244984523586253,-0.030832008298787,-0.0212286149742059,2.77867295496161e-26
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SARG,Specifically androgen-regulated gene protein,37390,-0.108963706983424,0.0102542237131099,-0.12906198546112,-0.0888654285057287,2.8562403799171e-26
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CRIP2,Cysteine-rich protein 2,39749,-0.0356984755968557,0.00336055994973762,-0.0422851730983414,-0.02911177809537,2.86049619112671e-26
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TIMP1,Metalloproteinase inhibitor 1,39698,-0.0274135068569029,0.00258249734783362,-0.0324752016586568,-0.022351812055149,3.10534281400304e-26
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,EGLN1,Egl nine homolog 1,39866,-0.0529061961568677,0.00499594413619045,-0.062698246663801,-0.0431141456499345,4.05338793052574e-26
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SPOCK1,Testican-1,39749,0.0251069230375919,0.00237640665441029,0.0204491659949478,0.0297646800802361,5.27651221991205e-26
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SNAP29,Synaptosomal-associated protein 29,39913,-0.090092197439104,0.00853713656959683,-0.106824985115514,-0.0733594097626942,5.98510623690516e-26
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CC2D1A,Coiled-coil and C2 domain-containing protein 1A,39749,-0.073181922038633,0.00693624225303109,-0.0867769568545739,-0.059586887222692,6.14589698137544e-26
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DCTN1,Dynactin subunit 1,40030,-0.0637738170348291,0.00608597961254565,-0.0757023370754186,-0.0518452969942396,1.30577730673324e-25
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CES3,Carboxylesterase 3,39788,-0.0675742486654761,0.00644999502264382,-0.080216238909858,-0.0549322584210943,1.33973445206465e-25
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LATS1,Serine/threonine-protein kinase LATS1,37056,-0.0843993388599227,0.00806386443747714,-0.100204513157378,-0.0685941645624675,1.55202837986369e-25
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SRP14,Signal recognition particle 14 kDa protein,39788,-0.0582353022352598,0.0055903940787453,-0.0691924746296006,-0.047278129840919,2.50050666559309e-25
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,B4GALT1,"Beta-1,4-galactosyltransferase 1",39931,-0.0261568460279691,0.00251342434807835,-0.0310831577502026,-0.0212305343057355,2.77598039701893e-25
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IL1R2,Interleukin-1 receptor type 2,39830,-0.0190761794859998,0.00183315645715855,-0.0226691661420306,-0.0154831928299691,2.79851638826049e-25
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LBR,Delta(14)-sterol reductase LBR,40009,-0.06502681759233,0.00625004076243914,-0.0772768974867108,-0.0527767376979493,2.85074467581324e-25
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TIMM8A,Mitochondrial import inner membrane translocase subunit Tim8 A,37388,-0.0847037716190959,0.00814841244709567,-0.100674660015403,-0.0687328832227884,3.2470150528935e-25
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PDZK1,Na(+)/H(+) exchange regulatory cofactor NHE-RF3,37056,-0.0435838880079899,0.00419561855362052,-0.0518073003730861,-0.0353604756428937,3.51770923576493e-25
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DDAH1,"N(G),N(G)-dimethylarginine dimethylaminohydrolase 1",39788,-0.0427811936042208,0.00412706758596756,-0.0508702460727173,-0.0346921411357244,4.2544411466435e-25
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NUMB,Protein numb homolog,37056,-0.0820885267960358,0.00792499570432238,-0.0976215183765077,-0.066555535215564,4.79201684140961e-25
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,C4BPB,C4b-binding protein beta chain,39913,0.038383026184907,0.00370900160538102,0.0311133830383602,0.0456526693314538,5.08899416763479e-25
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,AGT,Angiotensinogen,37445,-0.0217374283632926,0.00210099750124796,-0.0258553834657386,-0.0176194732608466,5.38917853655458e-25
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NPC2,NPC intracellular cholesterol transporter 2,37268,-0.0287970551191861,0.00278578363517966,-0.0342571910441382,-0.0233369191942339,5.93796954327259e-25
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CHAD,Chondroadherin,37124,0.0488333159583353,0.00472427969739392,0.0395737277514432,0.0580929041652273,5.98133079826249e-25
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PON1,Serum paraoxonase/arylesterase 1,37445,0.0246948706424948,0.00239663153807904,0.0199974728278599,0.0293922684571298,8.34134721184882e-25
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CREG1,Protein CREG1,39660,-0.0361627008650227,0.0035167661919433,-0.0430555626012315,-0.0292698391288138,1.00654487388605e-24
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ADH1B,All-trans-retinol dehydrogenase,37124,-0.0729817625281092,0.00710434141337342,-0.0869062716983211,-0.0590572533578973,1.15558980210168e-24
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IDUA,Alpha-L-iduronidase,40030,-0.0440556828296017,0.00429529690661861,-0.0524744647665742,-0.0356369008926293,1.31312567729167e-24
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ERMAP,Erythroid membrane-associated protein,37056,-0.0428153177630507,0.00417347480077902,-0.0509953283725776,-0.0346353071535239,1.33489880919667e-24
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MTSS2,Protein MTSS 2,37368,-0.0954692133124978,0.00933078306689708,-0.113757548123616,-0.0771808785013795,1.75739574433236e-24
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FCAMR,High affinity immunoglobulin alpha and immunoglobulin mu Fc receptor,37437,-0.0680567832867235,0.00665388157525109,-0.0810983911742156,-0.0550151753992313,1.81981133890327e-24
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SIAE,Sialate O-acetylesterase,39875,-0.0451335637026001,0.00441487849788318,-0.0537867255584511,-0.036480401846749,1.85854023507961e-24
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PTPRF,Receptor-type tyrosine-protein phosphatase F,40052,0.027381541193385,0.00267949786849106,0.0221297253711425,0.0326333570156274,1.93569091635678e-24
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,C1QTNF1,Complement C1q tumor necrosis factor-related protein 1,39931,-0.0397107888778082,0.00388808484247489,-0.047331435169059,-0.0320901425865575,2.04948118869222e-24
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CANT1,Soluble calcium-activated nucleotidase 1,39816,-0.0189975179737552,0.00186610011906674,-0.022655074207126,-0.0153399617403844,2.87939657148161e-24
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PTPRB,Receptor-type tyrosine-protein phosphatase beta,37437,-0.0278402877788862,0.00274130033010726,-0.0332132364258964,-0.022467339131876,3.80590917385826e-24
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MLN,Promotilin,39866,-0.0847102180476837,0.00834346899431304,-0.101063417276537,-0.0683570188188301,3.80763155450622e-24
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TXLNA,Alpha-taxilin,39749,-0.0846058490624391,0.00835313914664779,-0.100978001789869,-0.0682336963350094,4.87874474667783e-24
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,KRT5,"Keratin, type II cytoskeletal 5",39489,-0.0478368985233826,0.00473442980344553,-0.0571163809381358,-0.0385574161086293,6.27837273308765e-24
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NUCB2,Nucleobindin-2,39995,-0.0354046899907532,0.00350980555711486,-0.0422839088826984,-0.0285254710988081,7.39489172896085e-24
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LAMP2,Lysosome-associated membrane glycoprotein 2,39383,-0.0180544115665145,0.00180439729207614,-0.0215910302589838,-0.0145177928740453,1.69353331637732e-23
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,AGXT,Serine--pyruvate aminotransferase,39868,-0.0729264056707617,0.00729536920033206,-0.0872253293034126,-0.0586274820381109,1.85423243038272e-23
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GPKOW,G-patch domain and KOW motifs-containing protein,39489,-0.0254839482383633,0.00255099099359468,-0.0304838905858089,-0.0204840058909178,1.9854366515858e-23
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PNLIPRP1,Inactive pancreatic lipase-related protein 1,37388,-0.0722706567086111,0.00724510291417824,-0.0864710584204005,-0.0580702549968218,2.35875819613348e-23
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,39858,-0.0256466327104857,0.00257233019560454,-0.0306883998938706,-0.0206048655271008,2.40780942088249e-23
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ITGAV,Integrin alpha-V,40030,0.015425999376059,0.00154833914003807,0.0123912546615844,0.0184607440905336,2.58492308135113e-23
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RRM2,Ribonucleoside-diphosphate reductase subunit M2,39477,-0.0474437943590764,0.00476190210378798,-0.0567771224825009,-0.038110466235652,2.59208108118975e-23
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SORD,Sorbitol dehydrogenase,39963,-0.0639137501548384,0.00641563425714237,-0.0764883932988374,-0.0513391070108393,2.60594449256398e-23
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ASAH2,Neutral ceramidase,39749,-0.0488603117887699,0.00490591717561052,-0.0584759094529665,-0.0392447141245733,2.68341575682941e-23
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ITGBL1,Integrin beta-like protein 1,37437,-0.0332259324347941,0.00334126346447434,-0.0397748088251638,-0.0266770560444244,3.21178517139934e-23
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,KRT19,"Keratin, type I cytoskeletal 19",39842,-0.0607050133816757,0.00612539153712823,-0.072710780794447,-0.0486992459689043,4.37352394760438e-23
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CCL25,C-C motif chemokine 25,40058,-0.046170654389706,0.00466953516090692,-0.0553229433050835,-0.0370183654743284,5.47215026466092e-23
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GALNT10,Polypeptide N-acetylgalactosaminyltransferase 10,39788,-0.0259513165921591,0.00262564178772315,-0.0310975744960965,-0.0208050586882217,5.69880959413873e-23
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ABL1,Tyrosine-protein kinase ABL1,39788,-0.0633280303133444,0.00640857665325548,-0.0758888405537251,-0.0507672200729637,5.81516112725667e-23
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,BECN1,Beclin-1,37043,-0.0560739540290226,0.00567925312821258,-0.0672052901603193,-0.044942617897726,6.51477867385507e-23
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PRKAR2A,cAMP-dependent protein kinase type II-alpha regulatory subunit,37366,-0.0756849282624473,0.00768052971770946,-0.0907387665091578,-0.0606310900157368,7.85439069700205e-23
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CDH15,Cadherin-15,39973,-0.0493468107860899,0.00501908932282086,-0.0591842258588188,-0.0395093957133611,9.51557843941706e-23
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,COL3A1,Collagen alpha-1(III) chain,37437,-0.0212903846197563,0.00217529792149759,-0.0255539685458916,-0.017026800693621,1.51505503357343e-22
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FYB1,FYN-binding protein 1,39836,-0.0839069174933813,0.00859490569897704,-0.100752932663376,-0.0670609023233863,1.88627525374065e-22
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,39749,-0.0354798972485673,0.00363484885942707,-0.0426042010130444,-0.0283555934840903,1.91316241346171e-22
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CNTN3,Contactin-3,39858,-0.0297285161529964,0.00305888682668436,-0.0357239343332977,-0.023733097972695,2.89093600022033e-22
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SMNDC1,Survival of motor neuron-related-splicing factor 30,37382,-0.0541372313749438,0.0055902045383065,-0.0650940322700246,-0.0431804304798631,4.14803894471504e-22
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MENT,Protein MENT,37124,0.020184328811452,0.00208426294302014,0.0160991734431325,0.0242694841797715,4.16723505253374e-22
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,REN,Renin,39868,-0.0596718916666,0.00617633882722397,-0.0717775157679589,-0.047566267565241,5.05262996817421e-22
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GRPEL1,"GrpE protein homolog 1, mitochondrial",39788,-0.0555309679051738,0.00575039163019192,-0.06680173550035,-0.0442602003099976,5.28014654310307e-22
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SPARCL1,SPARC-like protein 1,39871,0.0246355679223525,0.00255236872728454,0.0196329252168748,0.0296382106278302,5.53108324284372e-22
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SEL1L,Protein sel-1 homolog 1,37043,-0.0283448634500834,0.00293894710916854,-0.0341051997840537,-0.022584527116113,6.12398826306646e-22
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FSTL3,Follistatin-related protein 3,39803,-0.0270532192116136,0.0028072736076351,-0.0325554754825784,-0.0215509629406488,6.41317667370342e-22
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TNFRSF14,Tumor necrosis factor receptor superfamily member 14,39885,-0.0264611649900712,0.00274588081597242,-0.0318430913893771,-0.0210792385907652,6.41823011593609e-22
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,REG4,Regenerating islet-derived protein 4,39885,-0.0423644651566464,0.00439875147375177,-0.0509860180451999,-0.0337429122680929,6.77940877059707e-22
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ERP44,Endoplasmic reticulum resident protein 44,39758,-0.0234664547108436,0.0024372975652091,-0.0282435579386534,-0.0186893514830337,6.98376527137811e-22
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,AKR7L,Aflatoxin B1 aldehyde reductase member 4,37056,-0.0635774766762224,0.0066144467123639,-0.0765417922324557,-0.0506131611199892,8.39419604933747e-22
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IL16,Pro-interleukin-16,40058,-0.0369483003229674,0.00385813498890818,-0.0445102449012274,-0.0293863557447073,1.1432144951537e-21
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GH1,Somatotropin,39846,0.161965383155011,0.0169164885181734,0.128809065659392,0.195121700650631,1.1710259840278e-21
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SERPINA4,Kallistatin,37241,-0.0210247875176844,0.0021955065968129,-0.0253279804474377,-0.0167215945879311,1.1803537745617e-21
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NFKBIE,NF-kappa-B inhibitor epsilon,39477,-0.0442178593757049,0.00462079434137762,-0.0532746162848051,-0.0351611024666048,1.23364810340822e-21
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TFF2,Trefoil factor 2,39908,-0.0510801969018634,0.00534021422273534,-0.0615470167784247,-0.0406133770253021,1.27885963397473e-21
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ITPR1,"Inositol 1,4,5-trisphosphate receptor type 1",37043,-0.0627252489834622,0.00656923522714038,-0.0756009500286573,-0.049849547938267,1.547195774638e-21
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FUOM,Fucose mutarotase,37124,-0.0568669273102052,0.00595577217348252,-0.068540240770231,-0.0451936138501795,1.54760963788214e-21
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CEP85,Centrosomal protein of 85 kDa,39477,-0.0571320143773234,0.0059854303204533,-0.0688634578054119,-0.0454005709492349,1.55549961175242e-21
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IMMT,MICOS complex subunit MIC60,37368,-0.039172041289389,0.00410834935214371,-0.0472244060195907,-0.0311196765591874,1.75562987622498e-21
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PSME1,Proteasome activator complex subunit 1,39738,-0.0329509118583003,0.00346232817653412,-0.0397370750843072,-0.0261647486322935,2.03339342804366e-21
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TRIM5,Tripartite motif-containing protein 5,39866,-0.076897537528086,0.00808876229999785,-0.0927515116360818,-0.0610435634200903,2.24080190783084e-21
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ARSA,Arylsulfatase A,39858,-0.0398611597209973,0.00421395260247975,-0.0481205068218576,-0.031601812620137,3.52048402208995e-21
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DNAJC6,Putative tyrosine-protein phosphatase auxilin,37043,-0.0753429623637153,0.00796665814361783,-0.0909576123252063,-0.0597283124022244,3.68799253045291e-21
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MFAP5,Microfibrillar-associated protein 5,40052,-0.0356282331045206,0.00376996801897608,-0.0430173704217137,-0.0282390957873275,3.82139900826084e-21
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CDHR2,Cadherin-related family member 2,39788,-0.0646065923809306,0.00683938367558469,-0.0780117843850766,-0.0512014003767846,3.98822856841758e-21
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CNTN5,Contactin-5,39897,0.0318106597331033,0.00336911472306006,0.0252071948759055,0.038414124590301,4.155352867804e-21
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FCN1,Ficolin-1,37430,-0.0496948884639821,0.0052759984947947,-0.0600358455137797,-0.0393539314141845,5.27599942233168e-21
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MAN2B2,Epididymis-specific alpha-mannosidase,37437,-0.0519863521272457,0.00551966009954155,-0.0628048859223471,-0.0411678183321443,5.30822527787278e-21
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TGFA,Protransforming growth factor alpha,39866,-0.0404611349119355,0.00430063737891978,-0.0488903841746183,-0.0320318856492527,5.71868645455061e-21
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CDC27,Cell division cycle protein 27 homolog,39477,-0.0538246145144503,0.0057476830859323,-0.0650900733628776,-0.042559155666023,8.65608309505632e-21
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SPINK4,Serine protease inhibitor Kazal-type 4,39866,-0.0544366449294471,0.0058181300150648,-0.0658401797589741,-0.0430331100999201,9.32184919636926e-21
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RNF149,E3 ubiquitin-protein ligase RNF149,37043,-0.0258715513540944,0.00276437786303431,-0.0312897319656416,-0.0204533707425471,9.34314196730825e-21
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NFKB1,Nuclear factor NF-kappa-B p105 subunit,37021,-0.0655988249333711,0.00701456358016946,-0.0793473695505032,-0.0518502803162389,9.99039285075398e-21
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,EFNA4,Ephrin-A4,39720,-0.0241883721589104,0.0025931025300436,-0.0292708531177959,-0.019105891200025,1.21879798568017e-20
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PAXX,Protein PAXX,37124,-0.0402213718521371,0.00431184128875942,-0.0486725807781055,-0.0317701629261686,1.24623307419775e-20
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IFI30,Gamma-interferon-inducible lysosomal thiol reductase,37085,-0.0337568638743673,0.00361944993981784,-0.0408509857564103,-0.0266627419923243,1.26562280184623e-20
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PBLD,Phenazine biosynthesis-like domain-containing protein,39489,-0.045073462423438,0.00483632845672701,-0.0545526661986229,-0.035594258648253,1.31853213881478e-20
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,AP1G2,AP-1 complex subunit gamma-like 2,37368,-0.0697120104335107,0.00748586438904977,-0.0843843046360483,-0.0550397162309732,1.43895579191276e-20
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IGF2R,Cation-independent mannose-6-phosphate receptor,39858,-0.0204489876528691,0.00220028868886254,-0.0247615534830397,-0.0161364218226985,1.6770315443832e-20
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,VSIR,V-type immunoglobulin domain-containing suppressor of T-cell activation,39841,-0.0534526339570429,0.00575454511217651,-0.0647315423769089,-0.042173725537177,1.75759472992395e-20
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SUOX,"Sulfite oxidase, mitochondrial",37411,-0.0546638199489521,0.00588997071169154,-0.0662081625438675,-0.0431194773540366,1.93325974626418e-20
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,OSM,Oncostatin-M,39785,-0.0621172242248365,0.00669697689369509,-0.0752432989364789,-0.0489911495131941,1.9918409047573e-20
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,YTHDF3,YTH domain-containing family protein 3,39587,-0.0741219045638357,0.0079956399576706,-0.0897933588808701,-0.0584504502468013,2.09242123886051e-20
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,APOA4,Apolipoprotein A-IV,37453,-0.0307141621875921,0.00331770595719943,-0.037216865863703,-0.0242114585114812,2.3982040738433e-20
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LDLRAP1,Low density lipoprotein receptor adapter protein 1,37411,-0.0848078511788714,0.00917528976309371,-0.102791419114535,-0.0668242832432077,2.74752154896444e-20
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ALDH1A1,Retinal dehydrogenase 1,39858,-0.0454887329691193,0.00492531249839337,-0.0551423454659703,-0.0358351204722683,2.88133235861351e-20
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GFER,FAD-linked sulfhydryl oxidase ALR,39477,-0.0560681811257575,0.0060760852482953,-0.0679773082124163,-0.0441590540390987,3.11298353706411e-20
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CD5,T-cell surface glycoprotein CD5,40003,-0.0283438479050024,0.00307888750477504,-0.0343784674143615,-0.0223092283956433,3.79616964647643e-20
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NAGPA,N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase,37124,-0.0186583064045256,0.00202778890462468,-0.02263277265759,-0.0146838401514613,4.05828812030654e-20
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,BACH1,Transcription regulator protein BACH1,39866,-0.0638514778688616,0.00694876800410112,-0.0774710631568997,-0.0502318925808234,4.44650312166731e-20
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TANK,TRAF family member-associated NF-kappa-B activator,39587,-0.0608359199293256,0.00664266129997458,-0.0738555360772757,-0.0478163037813754,5.90564276441158e-20
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,HSD11B1,Corticosteroid 11-beta-dehydrogenase isozyme 1,39866,0.0331881168050505,0.00363836742246253,0.0260569166570239,0.040319316953077,8.25779844133148e-20
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,BMPER,BMP-binding endothelial regulator protein,37124,-0.0191920689693785,0.00210835260654337,-0.0233244400782035,-0.0150596978605535,1.00383097571968e-19
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RNASE6,Ribonuclease K6,37386,-0.0235170995505064,0.00259116856686897,-0.0285957899415696,-0.0184384091594432,1.28166383236742e-19
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,C19orf12,Protein C19orf12,39489,-0.055213130337517,0.00609017297682507,-0.0671498693720942,-0.0432763913029399,1.37941266454112e-19
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IGDCC4,Immunoglobulin superfamily DCC subclass member 4,37437,0.0219416566511193,0.00242051146712988,0.0171974541755447,0.0266858591266939,1.4160430459247e-19
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PLXNB2,Plexin-B2,39984,-0.0200306215034616,0.00221055533789684,-0.0243633099657394,-0.0156979330411838,1.43350691203689e-19
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,EIF2AK2,"Interferon-induced, double-stranded RNA-activated protein kinase",37358,-0.0927112371798795,0.0102322858128566,-0.112766517373078,-0.0726559569866806,1.47275440999374e-19
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ISM1,Isthmin-1,39866,-0.0338542636265847,0.00373732091014638,-0.0411794126104717,-0.0265291146426978,1.47337553282817e-19
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CLEC1B,C-type lectin domain family 1 member B,40009,-0.0816270231214928,0.00902097108609724,-0.0993081264502434,-0.0639459197927422,1.61019769683827e-19
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NAA80,N-alpha-acetyltransferase 80,37039,-0.102552621326724,0.0113453691245112,-0.124789544810766,-0.080315697842682,1.79651231102425e-19
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IPCEF1,Interactor protein for cytohesin exchange factors 1,39720,-0.0757704202774518,0.00839036768468533,-0.0922155409394351,-0.0593252996154686,1.89944376593226e-19
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DPP4,Dipeptidyl peptidase 4,39575,0.0253759725084268,0.00281376860910835,0.0198609860345744,0.0308909589822791,2.12310058993649e-19
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ICAM4,Intercellular adhesion molecule 4,39866,0.0443176939930022,0.00491492284268854,0.0346844452213326,0.0539509427646717,2.14868701497e-19
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TOP2B,DNA topoisomerase 2-beta,37056,-0.0672338470851048,0.0074603426762075,-0.0818561187304715,-0.0526115754397381,2.29501553954854e-19
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TJAP1,Tight junction-associated protein 1,39913,-0.069827531267443,0.00777334289494488,-0.0850632833415349,-0.054591779193351,2.92370997023743e-19
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CEACAM20,Carcinoembryonic antigen-related cell adhesion molecule 20,37169,-0.036487462991041,0.00406399500249875,-0.0444528931959386,-0.0285220327861435,3.1167229904433e-19
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,BTD,Biotinidase,37453,-0.017233764844519,0.00192475764114671,-0.0210062898211666,-0.0134612398678715,3.87735665458099e-19
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SEZ6L2,Seizure 6-like protein 2,39788,0.02014547458817,0.00225231562756205,0.0157309359581484,0.0245600132181916,4.14616403652885e-19
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SERPINH1,Serpin H1,37169,-0.10786013430767,0.0120701176757245,-0.13151756495209,-0.0842027036632497,4.55462908261913e-19
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,A1BG,Alpha-1B-glycoprotein,37453,-0.0142775411554788,0.00160180838718439,-0.0174170855943602,-0.0111379967165974,5.5724989068867e-19
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CD86,T-lymphocyte activation antigen CD86,37382,0.0244840582023762,0.00274703855723505,0.0190998626301955,0.0298682537745569,5.60086107743563e-19
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,HYOU1,Hypoxia up-regulated protein 1,40052,-0.0179182618690505,0.00201353176183151,-0.0218647841222402,-0.0139717396158607,6.22562716593487e-19
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,STC1,Stanniocalcin-1,40009,-0.0349277650831704,0.00392674235262513,-0.0426241800943157,-0.0272313500720252,6.4590058230007e-19
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,APOE,Apolipoprotein E,37453,-0.0604273499931957,0.00679828289314564,-0.0737519844637611,-0.0471027155226302,6.95693620035271e-19
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IL4R,Interleukin-4 receptor subunit alpha,39866,-0.029712515421396,0.00335166304149814,-0.0362817749827323,-0.0231432558600596,8.44255063305051e-19
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CCN4,CCN family member 4,40030,-0.0332212974300247,0.00375329855191965,-0.0405777625917872,-0.0258648322682622,9.53788424795587e-19
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,BLOC1S3,Biogenesis of lysosome-related organelles complex 1 subunit 3,37388,-0.034151391521613,0.00386178415903015,-0.0417204884733121,-0.0265822945699139,1.04191270202054e-18
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TDRKH,Tudor and KH domain-containing protein,39489,-0.0706366980022616,0.0080011190655186,-0.086318891370678,-0.0549545046338451,1.17321366488827e-18
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CD40,Tumor necrosis factor receptor superfamily member 5,39859,-0.041574064872199,0.00471470816124225,-0.0508148928682338,-0.0323332368761641,1.28393691000824e-18
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LRRN1,Leucine-rich repeat neuronal protein 1,39587,0.0323020597127828,0.00366636966355799,0.0251159751722092,0.0394881442533565,1.37568847577404e-18
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CEP20,Centrosomal protein 20,39477,-0.0610130794051317,0.00692539294399002,-0.0745868495753521,-0.0474393092349112,1.38046736868387e-18
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GLB1,Beta-galactosidase,39749,-0.034796787718045,0.00395150894492287,-0.0425417452500938,-0.0270518301859961,1.42926740856293e-18
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PAK4,Serine/threonine-protein kinase PAK 4,39489,-0.0507980223437078,0.00577294388814158,-0.0621129923644654,-0.0394830523229503,1.51816280867319e-18
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NFATC3,"Nuclear factor of activated T-cells, cytoplasmic 3",39587,-0.0492893528614092,0.00560457845350347,-0.060274326630276,-0.0383043790925424,1.58385086978694e-18
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NFX1,Transcriptional repressor NF-X1,37021,-0.055518188670504,0.00631146258214572,-0.0678886553315096,-0.0431477220094984,1.58674470592176e-18
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LAG3,Lymphocyte activation gene 3 protein,39788,0.0335106153405645,0.00381079187125047,0.0260414632729136,0.0409797674082154,1.59416610543974e-18
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SORT1,Sortilin,39846,-0.0307153009028454,0.00349676327651983,-0.0375689569248243,-0.0238616448808665,1.73636225915927e-18
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DTNB,Dystrobrevin beta,37348,-0.0361423402769275,0.00411698217150772,-0.0442116253330826,-0.0280730552207724,1.84831913628447e-18
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ANGPT2,Angiopoietin-2,40030,-0.0312899364526059,0.00356910072604758,-0.0382853738756592,-0.0242944990295527,2.01638603349527e-18
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SERPINE1,Plasminogen activator inhibitor 1,40052,-0.0556023616147836,0.00634361450934184,-0.0680358460530936,-0.0431688771764736,2.04854047006069e-18
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,VSIG2,V-set and immunoglobulin domain-containing protein 2,37368,-0.0437930153886285,0.00499770090019335,-0.0535885091530075,-0.0339975216242496,2.13246429088992e-18
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MMP1,Interstitial collagenase,39314,-0.0754560446596584,0.00861298613883706,-0.092337497491779,-0.0585745918275377,2.13844408798188e-18
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,AIFM1,"Apoptosis-inducing factor 1, mitochondrial",39763,-0.0857837182133323,0.00979631485684202,-0.104984495332743,-0.066582941093922,2.20916385221714e-18
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NFATC1,"Nuclear factor of activated T-cells, cytoplasmic 1",39866,-0.0804480867603549,0.00919790889068603,-0.0984759881860996,-0.0624201853346103,2.41969114065203e-18
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SCAMP3,Secretory carrier-associated membrane protein 3,39788,-0.0692498620329723,0.00792834364566421,-0.0847894155784742,-0.0537103084874705,2.6878287867787e-18
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MAPK9,Mitogen-activated protein kinase 9,39866,-0.0355646227496572,0.0040721755765691,-0.0435460868797326,-0.0275831586195818,2.70797242617935e-18
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CXCL10,C-X-C motif chemokine 10,39931,-0.0538366595437077,0.00616991380093158,-0.0659296905935336,-0.0417436284938817,2.90166890719189e-18
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FGF19,Fibroblast growth factor 19,39931,-0.062377658298649,0.0071639969361634,-0.0764190922935293,-0.0483362243037688,3.41599859377633e-18
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,EZR,Ezrin,40009,-0.0195979827601012,0.00225085333085972,-0.0240096552885863,-0.0151863102316162,3.42020818089371e-18
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CD248,Endosialin,37437,0.0322726863555535,0.00371348515485236,0.0249942554520429,0.0395511172590641,4.01151284432373e-18
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IKBKG,NF-kappa-B essential modulator,39866,-0.0749789367179575,0.00863864188257048,-0.0919106748077956,-0.0580471986281193,4.35320094104875e-18
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CDH17,Cadherin-17,39868,-0.0539140637270979,0.00622754235205563,-0.066120046737127,-0.0417080807170689,5.28176639970796e-18
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IDS,Iduronate 2-sulfatase,40058,0.00730818048883545,0.00084420610198594,0.00565353652894301,0.00896282444872789,5.2988582864944e-18
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CTRB1,Chymotrypsinogen B,39858,-0.0431167682154683,0.00500983734735744,-0.0529360494162889,-0.0332974870146478,8.22919267381424e-18
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FEN1,Flap endonuclease 1,39477,-0.0503100024138404,0.0058478078665632,-0.0617717058323043,-0.0388482989953765,8.47871180047481e-18
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DKK1,Dickkopf-related protein 1,40009,-0.0481078616139216,0.00559396872525348,-0.0590720403154184,-0.0371436829124247,8.69717890755684e-18
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,AMN,Protein amnionless,39587,-0.0384420266445317,0.00447119109495899,-0.0472055611906513,-0.0296784920984121,8.88810964928003e-18
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CFI,Complement factor I,37453,-0.0160992570640654,0.00187243996266932,-0.0197692393908973,-0.0124292747372335,8.98961648520476e-18
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TCTN3,Tectonic-3,37437,-0.0237472995088581,0.0027644863970553,-0.0291656928470865,-0.0183289061706297,9.6255994757445e-18
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ELOA,Elongin-A,39788,-0.0410392669114768,0.0047940609551035,-0.0504356263834797,-0.031642907439474,1.22574210245131e-17
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SCARB2,Lysosome membrane protein 2,39486,-0.0230832652433143,0.00269677057774784,-0.0283689355757001,-0.0177975949109285,1.23675721180517e-17
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TREH,Trehalase,37437,-0.0603910329798363,0.00705736471722246,-0.0742234678255923,-0.0465585981340803,1.27977382012793e-17
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,EPPK1,Epiplakin,37043,-0.0599290660152856,0.00700572576151311,-0.0736602885078513,-0.0461978435227199,1.31575288941727e-17
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CLEC4D,C-type lectin domain family 4 member D,39866,-0.0485748183017118,0.00568103359808142,-0.0597096441539514,-0.0374399924494722,1.33670194658153e-17
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,BANK1,B-cell scaffold protein with ankyrin repeats,39866,-0.0851116184868309,0.00996757943917363,-0.104648074187611,-0.0655751627860505,1.47603131264359e-17
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,BOC,Brother of CDO,39585,0.0187142160568481,0.00219273825193465,0.0144164490830561,0.02301198303064,1.53287376704909e-17
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TAX1BP1,Tax1-binding protein 1,37388,-0.0503785600839547,0.00591480611078856,-0.0619715800611003,-0.0387855401068091,1.80313945229522e-17
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,APEX1,DNA-(apurinic or apyrimidinic site) endonuclease,39979,-0.0458770332669086,0.00539167130075476,-0.0564447090163879,-0.0353093575174293,1.90889802392227e-17
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ANG,Angiogenin,39843,-0.0269459548431732,0.00316735165287904,-0.0331539640828161,-0.0207379456035303,1.93436953774497e-17
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,AXIN1,Axin-1,39866,-0.0760855626082532,0.00894807394787265,-0.0936237875460836,-0.0585473376704228,2.00853463421295e-17
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,COL5A1,Collagen alpha-1(V) chain,37124,-0.0315301547544344,0.0037124167488301,-0.0388064915821414,-0.0242538179267274,2.22331202986238e-17
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NPL,N-acetylneuraminate lyase,37437,-0.0349218015482732,0.00412434599737345,-0.0430055197031252,-0.0268380833934213,2.76866838064901e-17
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,UFD1,Ubiquitin recognition factor in ER-associated degradation protein 1,37382,-0.111536049522735,0.0132138754783043,-0.137435245460211,-0.0856368535852583,3.46892966945449e-17
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DTYMK,Thymidylate kinase,37437,-0.0542610672081016,0.00643658247497647,-0.0668767688590555,-0.0416453655571477,3.79873904515967e-17
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CEBPB,CCAAT/enhancer-binding protein beta,39585,-0.0294459553212174,0.00349756979511388,-0.0363011921196406,-0.0225907185227942,4.12189853889292e-17
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PPP1R9B,Neurabin-2,40058,-0.0746743529060609,0.00887883702622752,-0.0920768734774668,-0.057271832334655,4.42369216488322e-17
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,THOP1,Thimet oligopeptidase,39798,-0.0239890810410512,0.00285374013561518,-0.029582411706857,-0.0183957503752455,4.58955885284165e-17
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,XCL1,Lymphotactin,40030,-0.043200799084756,0.00513939803442146,-0.0532740192322221,-0.0331275789372899,4.59911688743e-17
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ABCA2,ATP-binding cassette sub-family A member 2,37021,-0.0289630936351151,0.00344577282120201,-0.0357168083646711,-0.0222093789055592,4.69910754645319e-17
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CDCP1,CUB domain-containing protein 1,39749,-0.0392099005836164,0.00467678369005849,-0.048376396616131,-0.0300434045511017,5.54287779461169e-17
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ULBP2,UL16-binding protein 2,39749,-0.0286947160304233,0.00342324549335294,-0.0354042771973951,-0.0219851548634516,5.61997655577658e-17
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PLAT,Tissue-type plasminogen activator,40002,-0.0389058880349814,0.00464727235288519,-0.0480145418466364,-0.0297972342233264,6.1364993179548e-17
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CTSC,Dipeptidyl peptidase 1,39856,-0.0335093941051904,0.00400396640961747,-0.0413571682680407,-0.0256616199423402,6.2835580601147e-17
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FUS,RNA-binding protein FUS,39455,-0.0308159016785925,0.00368301761227742,-0.0380346161986562,-0.0235971871585287,6.40482125325446e-17
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LAT,Linker for activation of T-cells family member 1,40058,-0.0594063826628903,0.00711226199870518,-0.0733464161803525,-0.0454663491454282,7.20814181052119e-17
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,YOD1,Ubiquitin thioesterase OTU1,37021,-0.0480385383968757,0.00575225436197139,-0.0593129569463396,-0.0367641198474118,7.425056300091e-17
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,EPCAM,Epithelial cell adhesion molecule,39867,-0.0742809082290196,0.00890866035668162,-0.0917418825281156,-0.0568199339299237,8.16014629068034e-17
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SCPEP1,Retinoid-inducible serine carboxypeptidase,36995,-0.0398413365079168,0.00478219165318792,-0.0492144321481651,-0.0304682408676684,8.7922637582192e-17
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MTHFSD,Methenyltetrahydrofolate synthase domain-containing protein,37169,-0.088684743083105,0.0106526899680856,-0.109564015420553,-0.0678054707456573,9.24206414438891e-17
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ILKAP,Integrin-linked kinase-associated serine/threonine phosphatase 2C,39469,-0.045996138197139,0.00552940086119058,-0.0568337638850725,-0.0351585125092055,9.64007918764473e-17
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FABP2,"Fatty acid-binding protein, intestinal",39868,0.0606224993407404,0.00729820985157952,0.0463180080316446,0.0749269906498363,1.06388138948207e-16
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,VSIG4,V-set and immunoglobulin domain-containing protein 4,39831,-0.0295916855051805,0.00357157495603082,-0.0365919724190009,-0.0225913985913601,1.27039800396741e-16
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ST3GAL1,"CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1",39788,0.0332700303712505,0.00401681706054713,0.0253970689325782,0.0411429918099229,1.29911091820445e-16
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,BPIFB1,BPI fold-containing family B member 1,39786,0.0490578093431959,0.00593706928488234,0.0374211535448265,0.0606944651415652,1.5317652820374e-16
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CEACAM8,Carcinoembryonic antigen-related cell adhesion molecule 8,39585,-0.0372690613153621,0.0045156876201293,-0.0461198090508155,-0.0284183135799086,1.66277290501837e-16
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GPA33,Cell surface A33 antigen,39788,-0.10139583701626,0.0123193756825429,-0.125541813354044,-0.0772498606784763,2.00574227520977e-16
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LEP,Leptin,39868,-0.0522744585410363,0.00635373427275193,-0.0647277777156301,-0.0398211393664425,2.05971230267311e-16
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PALM2,Paralemmin-2,37388,-0.0291523302579133,0.00354753613279327,-0.0361055010781881,-0.0221991594376385,2.26315376041181e-16
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PNLIP,Pancreatic triacylglycerol lipase,37445,-0.0471950819474539,0.00574716195514289,-0.0584595193795339,-0.0359306445153738,2.37249698931169e-16
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SH2D1A,SH2 domain-containing protein 1A,39866,-0.0434704913613732,0.00530513686219692,-0.0538685596112791,-0.0330724231114672,2.71544441748565e-16
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SNAP23,Synaptosomal-associated protein 23,39868,-0.0667330683043904,0.00815647706967223,-0.082719763360948,-0.0507463732478328,3.0095599454383e-16
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CRHBP,Corticotropin-releasing factor-binding protein,39862,-0.0214395071335667,0.00262593803493567,-0.0265863456820406,-0.0162926685850928,3.46581147201445e-16
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TARBP2,RISC-loading complex subunit TARBP2,39489,-0.0609149482891174,0.00747135939330349,-0.0755588126999922,-0.0462710838782425,3.81330178122721e-16
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,KRT8,"Keratin, type II cytoskeletal 8",36991,-0.0498837450797103,0.0061212095569185,-0.0618813158112705,-0.03788617434815,3.98894136101165e-16
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CCL21,C-C motif chemokine 21,39931,-0.0298416411662292,0.00366520672141356,-0.0370254463401998,-0.0226578359922586,4.17526373567526e-16
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PLEKHO1,Pleckstrin homology domain-containing family O member 1,37388,-0.0529434261555462,0.00650745208074903,-0.0656980322338143,-0.0401888200772782,4.44644221984202e-16
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CCN2,CCN family member 2,39880,-0.044561415607843,0.00547993215691987,-0.055302082635406,-0.0338207485802801,4.53876001283364e-16
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ERBB4,Receptor tyrosine-protein kinase erbB-4,39913,0.0181221007584102,0.00222913916321392,0.0137529879985109,0.0224912135183094,4.61728010466646e-16
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SPINT2,Kunitz-type protease inhibitor 2,39931,-0.0312099173606588,0.00384818503103636,-0.03875236002149,-0.0236674746998275,5.41122549545276e-16
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,REG1B,Lithostathine-1-beta,40052,-0.041316930039696,0.00509483237026624,-0.0513028014854178,-0.0313310585939741,5.44042511362779e-16
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LGALS8,Galectin-8,40009,-0.0464645609332279,0.00573217380958379,-0.0576996216000122,-0.0352295002664437,5.60674560959186e-16
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TOMM20,Mitochondrial import receptor subunit TOM20 homolog,37437,-0.0577380768270039,0.00715794357246522,-0.0717676462290357,-0.043708507424972,7.85057460996968e-16
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CTSB,Cathepsin B,39847,0.0387691974797689,0.00481141885114061,0.0293388165315333,0.0481995784280045,8.31612741414407e-16
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DDC,Aromatic-L-amino-acid decarboxylase,39846,-0.0367173290448592,0.00456054640770211,-0.0456560000039553,-0.027778658085763,8.7800058883982e-16
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RBFOX3,RNA binding protein fox-1 homolog 3,37411,-0.0279752914385317,0.00347579184972513,-0.0347878434639929,-0.0211627394130704,9.06728646116788e-16
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SELL,L-selectin,37453,0.0170774765907497,0.00212267551867335,0.0129170325741499,0.0212379206073494,9.31527502509075e-16
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,39998,-0.0227321356720138,0.00282808656962502,-0.0282751853484789,-0.0171890859955488,9.76003666382566e-16
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,VPS53,Vacuolar protein sorting-associated protein 53 homolog,39788,-0.0578444505809669,0.00720219152747025,-0.0719607459748086,-0.0437281551871252,1.02968979287339e-15
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,39585,-0.040990334472317,0.0051116445912893,-0.051009157871244,-0.03097151107339,1.14053865815199e-15
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ATP6V1G1,V-type proton ATPase subunit G 1,37043,-0.0547812275208645,0.00683050815663408,-0.0681690235078673,-0.0413934315338617,1.14548142433948e-15
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,AGRN,Agrin,39931,-0.0244472777844396,0.00305488976909834,-0.0304348617318723,-0.0184596938370069,1.30004486513546e-15
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RELT,Tumor necrosis factor receptor superfamily member 19L,39858,-0.0199566280450165,0.0024938192384493,-0.0248445137523771,-0.0150687423376559,1.30291169990912e-15
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TFF1,Trefoil factor 1,39789,-0.0563826271489233,0.00705302202768009,-0.0702065503231763,-0.0425587039746703,1.39406672276832e-15
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TNIP1,TNFAIP3-interacting protein 1,37388,-0.066125159482371,0.00827040611289261,-0.0823351554636406,-0.0499151635011015,1.39584974895404e-15
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DAAM1,Disheveled-associated activator of morphogenesis 1,37124,-0.0619841558976973,0.00776111737958397,-0.0771959459616819,-0.0467723658337127,1.50209688073362e-15
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,OPTC,Opticin,39788,0.0330190665456727,0.00413934378306352,0.0249059527308682,0.0411321803604772,1.60209833994188e-15
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,HLA_E,,39866,-0.0204767077103702,0.00256827707537169,-0.0255105307780987,-0.0154428846426417,1.65341264809309e-15
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LRTM2,Leucine-rich repeat and transmembrane domain-containing protein 2,37411,0.0192166997991823,0.0024109007616913,0.0144913343062673,0.0239420652920972,1.70255580184691e-15
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TF,Serotransferrin,37453,-0.016322194530459,0.00204849510684408,-0.0203372449398734,-0.0123071441210446,1.7418137507645e-15
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CNST,Consortin,39868,-0.0805324804521993,0.0101309295336041,-0.100389102338063,-0.0606758585663351,2.00205237148515e-15
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,37124,-0.0206993534011911,0.0026039227664769,-0.0258030420234858,-0.0155956647788964,2.02665733206467e-15
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PLIN1,Perilipin-1,39489,-0.0258123597752188,0.00324912148550943,-0.0321806378868173,-0.0194440816636203,2.08331635162539e-15
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ATG16L1,Autophagy-related protein 16-1,37382,-0.0640492861512775,0.00806581896145971,-0.0798582913157385,-0.0482402809868164,2.16605645568241e-15
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CHRDL2,Chordin-like protein 2,39868,-0.0418909108552821,0.00528208995915916,-0.052243807175234,-0.0315380145353301,2.32131002824039e-15
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CCL5,C-C motif chemokine 5,39931,-0.075087794431216,0.00947633660114218,-0.0936614141694547,-0.0565141746929773,2.45530710514525e-15
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,KAZN,Kazrin,37382,-0.077343953951157,0.00976971107906794,-0.0964925876661301,-0.0581953202361838,2.62795236227737e-15
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NXPH3,Neurexophilin-3,37056,0.0219774531224835,0.00278709007816345,0.0165147565692831,0.0274401496756839,3.37938912911117e-15
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CEP43,Centrosomal protein 43,39476,-0.0516454289067455,0.00655626838656862,-0.06449571494442,-0.038795142869071,3.5655871837864e-15
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SHMT1,"Serine hydroxymethyltransferase, cytosolic",39908,-0.0641329340012196,0.00814470382294131,-0.0800965534941846,-0.0481693145082546,3.64769746827271e-15
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LTBP2,Latent-transforming growth factor beta-binding protein 2,40052,0.0227540504102782,0.00289126507098219,0.0170871708711531,0.0284209299494033,3.77151675904143e-15
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,HSPB6,Heat shock protein beta-6,40030,-0.0275334848367069,0.0035135677399786,-0.0344200776070649,-0.0206468920663488,4.92600262303177e-15
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FIS1,Mitochondrial fission 1 protein,39855,-0.0573483386849097,0.00732090909759858,-0.0716973205162029,-0.0429993568536165,5.04119029281446e-15
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PDLIM7,PDZ and LIM domain protein 7,39931,-0.0926319970327066,0.0118302366849171,-0.115819260935144,-0.0694447331302691,5.17717177588213e-15
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ERBIN,Erbin,39788,-0.0754828323887468,0.00964195715882094,-0.0943810684200359,-0.0565845963574578,5.24293702455448e-15
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SSNA1,Sjoegren syndrome nuclear autoantigen 1,37382,-0.0370708800702372,0.00473925209031173,-0.0463598141672481,-0.0277819459732262,5.57877744936757e-15
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SIGLEC7,Sialic acid-binding Ig-like lectin 7,39868,-0.0205635176016849,0.00263347687419914,-0.0257251322751152,-0.0154019029282546,6.14364426266358e-15
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NFE2,Transcription factor NF-E2 45 kDa subunit,37043,-0.0546278763964842,0.00700432915949677,-0.0683563615490978,-0.0408993912438705,6.69894284341083e-15
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TGFBR2,TGF-beta receptor type-2,39913,-0.0217580003477709,0.00279058562696974,-0.0272275481766316,-0.0162884525189102,6.73057681979799e-15
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SLMAP,Sarcolemmal membrane-associated protein,37382,-0.0611828089478761,0.00785765434812965,-0.0765838114702102,-0.045781806425542,7.39451274025794e-15
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,39885,-0.023180350323785,0.00297926751092671,-0.0290197146452014,-0.0173409860023687,7.65887028240332e-15
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ARHGEF12,Rho guanine nucleotide exchange factor 12,39866,-0.0758008392446952,0.00974533234746493,-0.0949016906457265,-0.0566999878436639,7.80459444573211e-15
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SDCCAG8,Serologically defined colon cancer antigen 8,37368,-0.0834491242832729,0.0107287046714688,-0.104477385439352,-0.0624208631271941,7.89300044300437e-15
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ERN1,Serine/threonine-protein kinase/endoribonuclease IRE1,37368,-0.027447058632718,0.0035321534033319,-0.0343700793032486,-0.0205240379621875,8.3716655027493e-15
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LPA,Apolipoprotein(a),37186,0.128188524567906,0.0165177493043149,0.095813735931449,0.160563313204363,9.06271514188322e-15
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TNFSF12,Tumor necrosis factor ligand superfamily member 12,40058,0.0209386251160415,0.00270509297435036,0.0156366428863149,0.0262406073457682,1.04890449166468e-14
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IQGAP2,Ras GTPase-activating-like protein IQGAP2,39788,-0.0396544420575312,0.00513458241044146,-0.0497182235819965,-0.029590660533066,1.20343000798337e-14
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TPP1,Tripeptidyl-peptidase 1,39767,-0.0336813324571726,0.00436204920432932,-0.0422309488976581,-0.0251317160166871,1.21833703452126e-14
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SRPK2,SRSF protein kinase 2,39866,-0.0608472731515155,0.00788793791848619,-0.0763076314717484,-0.0453869148312826,1.29123899141794e-14
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GCC1,GRIP and coiled-coil domain-containing protein 1,37388,-0.0785135378375885,0.0101772555076358,-0.0984609586325546,-0.0585661170426223,1.29821628628032e-14
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,EHBP1,EH domain-binding protein 1,37437,-0.0543101701342632,0.00704058760840826,-0.0681097218467434,-0.040510618421783,1.3054112148407e-14
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TRIM40,E3 ubiquitin ligase TRIM40,37039,-0.0525419208935367,0.00683104609327013,-0.0659307712363462,-0.0391530705507272,1.55552115823967e-14
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GFAP,Glial fibrillary acidic protein,39453,0.0314477559791216,0.00409832794477759,0.0234150332073575,0.0394804787508857,1.77495833054974e-14
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,POF1B,Protein POF1B,37056,-0.0324491272236683,0.00424345852458619,-0.0407663059318572,-0.0241319485154794,2.20171846093885e-14
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RBKS,Ribokinase,39504,-0.0355130370967033,0.00465262021986878,-0.0446321727276461,-0.0263939014657605,2.42719179832649e-14
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NOTCH2,Neurogenic locus notch homolog protein 2,37437,0.0155453342239732,0.00203807484941206,0.0115507075191256,0.0195399609288208,2.55316846515519e-14
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,WWP2,NEDD4-like E3 ubiquitin-protein ligase WWP2,39749,-0.0380834540936597,0.0050112736945153,-0.0479055505349097,-0.0282613576524097,3.13684343907896e-14
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PQBP1,Polyglutamine-binding protein 1,39477,-0.0389851295964513,0.0051313985604508,-0.0490426707749349,-0.0289275884179678,3.1930888041811e-14
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CRELD2,Protein disulfide isomerase CRELD2,39908,-0.0370097595704384,0.00487703340042555,-0.0465687450352725,-0.0274507741056044,3.41141069494006e-14
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IRAK1,Interleukin-1 receptor-associated kinase 1,39587,-0.0501137004103824,0.00660790721891551,-0.0630651985594567,-0.037162202261308,3.540227873917e-14
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FOXO1,Forkhead box protein O1,39866,-0.0610197148095456,0.00806579125704325,-0.0768286656733504,-0.0452107639457409,4.08118107698465e-14
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,USP25,Ubiquitin carboxyl-terminal hydrolase 25,37368,-0.0515972729191052,0.00682083927464852,-0.0649661178974163,-0.0382284279407941,4.14000662313332e-14
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,STAT5B,Signal transducer and activator of transcription 5B,39788,-0.097674574943123,0.0129184663642392,-0.122994769017032,-0.0723543808692141,4.22220977691474e-14
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PILRA,Paired immunoglobulin-like type 2 receptor alpha,39858,-0.0294434405694158,0.00389533034916227,-0.0370782880537738,-0.0218085930850577,4.29293199281331e-14
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,B3GNT7,"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7",37043,-0.0264176905026259,0.00349585172263494,-0.0332695598789903,-0.0195658211262614,4.40095411335757e-14
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PLXNA4,Plexin-A4,39866,-0.057528019067928,0.00761737228288016,-0.0724580687423731,-0.0425979693934829,4.50969301802636e-14
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RFC4,Replication factor C subunit 4,37368,-0.0151222189933365,0.00200340737245143,-0.0190488974433413,-0.0111955405433317,4.69363709835933e-14
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SLA2,Src-like-adapter 2,37411,-0.0747534730443377,0.00990349347542515,-0.094164320256171,-0.0553426258325044,4.69477451238492e-14
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MDK,Midkine,39843,-0.0356556664508452,0.00473932189296629,-0.0449447373610591,-0.0263665955406312,5.6217655686679e-14
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PPP1R12A,Protein phosphatase 1 regulatory subunit 12A,39913,-0.0665006884387855,0.00886676306335927,-0.0838795440429696,-0.0491218328346013,6.71519558443861e-14
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GZMA,Granzyme A,40058,-0.0237692000223609,0.00317128224599383,-0.0299849132245088,-0.017553486820213,6.96457233001573e-14
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,COL6A3,Collagen alpha-3(VI) chain,40052,-0.0224628357465357,0.00300289653158988,-0.0283485129484519,-0.0165771585446195,7.7897574457094e-14
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NELL1,Protein kinase C-binding protein NELL1,39913,0.0284892465922478,0.00382604975709854,0.0209901890683347,0.035988304116161,1.00996597553675e-13
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SERPINA12,Serpin A12,39405,-0.08269719715128,0.0111097208175533,-0.104472249953685,-0.0609221443488755,1.03044856181911e-13
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CD274,Programmed cell death 1 ligand 1,39749,-0.0233945850138009,0.00314690166266369,-0.0295625122726217,-0.01722665775498,1.10589647285328e-13
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PECAM1,Platelet endothelial cell adhesion molecule,39858,-0.0209328925037755,0.00281606195723353,-0.0264523739399532,-0.0154134110675977,1.11198008785013e-13
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DNAJA2,DnaJ homolog subfamily A member 2,40009,-0.0573484942896401,0.00771689435482221,-0.0724736072250916,-0.0422233813541886,1.12699778109536e-13
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,HEXIM1,Protein HEXIM1,39866,-0.056812772061036,0.00765862689505194,-0.0718236807753378,-0.0418018633467342,1.24727325369546e-13
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CMIP,C-Maf-inducing protein,37368,-0.0576260454371206,0.00777514793561323,-0.0728653353909225,-0.0423867554833187,1.32228434936931e-13
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RARRES1,Retinoic acid receptor responder protein 1,39477,-0.023547351207205,0.00317783683190684,-0.0297759113977424,-0.0173187910166676,1.32892297781553e-13
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,EIF4G1,Eukaryotic translation initiation factor 4 gamma 1,40058,-0.0692020751868319,0.00934416631825064,-0.0875166411706032,-0.0508875092030607,1.36656795608098e-13
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FARSA,Phenylalanine--tRNA ligase alpha subunit,37039,-0.0477412364861601,0.00644680152933343,-0.0603769674836536,-0.0351055054886666,1.3868078908893e-13
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SEZ6L,Seizure 6-like protein,39913,0.0186713683270361,0.00252238875152817,0.0137274863740409,0.0236152502800313,1.40520899257927e-13
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,F12,Coagulation factor XII,37453,-0.0287777382447543,0.00389098958016268,-0.0364040778218732,-0.0211513986676355,1.48567797285513e-13
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PLSCR3,Phospholipid scramblase 3,37373,-0.0412876590294209,0.0055831952998407,-0.0522307218171086,-0.0303445962417331,1.49744040182456e-13
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NT5C1A,Cytosolic 5'-nucleotidase 1A,37388,-0.0212489940046349,0.00287377065211219,-0.0268815844827748,-0.015616403526495,1.50715552674336e-13
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,BCR,Breakpoint cluster region protein,39866,-0.0636842146877835,0.00862378770776983,-0.0805868385950124,-0.0467815907805546,1.60297770729878e-13
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,OMG,Oligodendrocyte-myelin glycoprotein,39788,0.044971849218043,0.0060935257435352,0.033028538760714,0.0569151596753719,1.6576493931652e-13
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DAG1,Dystroglycan,39931,-0.0335405731694281,0.00454709257246083,-0.0424528746114513,-0.0246282717274048,1.70728472526564e-13
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SORCS2,VPS10 domain-containing receptor SorCS2,39477,-0.0236617635394726,0.00320788960825762,-0.0299492271716575,-0.0173742999072877,1.7115983520617e-13
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RBP2,Retinol-binding protein 2,39788,0.0527981035124173,0.00717265725880277,0.0387396952851639,0.0668565117396707,1.91413691553056e-13
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ENTPD5,Ectonucleoside triphosphate diphosphohydrolase 5,39585,0.0147880330743374,0.00201095735379408,0.0108465566609011,0.0187295094877738,2.02249750523211e-13
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SNCG,Gamma-synuclein,39749,-0.0447147666018696,0.00609369276992546,-0.0566584044309235,-0.0327711287728157,2.27495380081941e-13
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SERPINA3,Alpha-1-antichymotrypsin,37407,0.00993986880556294,0.0013581604169959,0.00727787438825098,0.0126018632228749,2.64623386989282e-13
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PLAU,Urokinase-type plasminogen activator,39858,0.019617209391015,0.00268275412280573,0.0143590113103158,0.0248754074717142,2.74953270648381e-13
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PDCD5,Programmed cell death protein 5,40009,-0.0396995167326096,0.00543534915694919,-0.05035280108023,-0.0290462323849892,2.92477498584396e-13
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PBXIP1,Pre-B-cell leukemia transcription factor-interacting protein 1,37382,-0.0202928374690294,0.00277880298428102,-0.0257392913182202,-0.0148463836198386,2.97758950636924e-13
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FGR,Tyrosine-protein kinase Fgr,39489,-0.0386561175909588,0.00529445874753114,-0.0490332567361198,-0.0282789784457977,2.988595669623e-13
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,EBAG9,Receptor-binding cancer antigen expressed on SiSo cells,39749,-0.0647774160258655,0.00887308386071966,-0.0821686603928761,-0.047386171658855,3.00406815324452e-13
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SLC51B,Organic solute transporter subunit beta,37021,-0.0517634519074495,0.00710990429996378,-0.0656988643353785,-0.0378280394795205,3.51542456478309e-13
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,STAB2,Stabilin-2,37437,-0.0191155913230241,0.00262711026843021,-0.0242647274491473,-0.0139664551969009,3.61975861219015e-13
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CCL11,Eotaxin,40058,-0.0260345633942619,0.00358054199828925,-0.0330524257109088,-0.019016701077615,3.72793186978848e-13
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,KLB,Beta-klotho,39489,0.0502480180487035,0.00691153848444507,0.0367014026191912,0.0637946334782159,3.76051737983753e-13
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,BRAP,BRCA1-associated protein,37249,-0.0751664612235837,0.0103432037304995,-0.0954391405353628,-0.0548937819118046,3.87246606350864e-13
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ESM1,Endothelial cell-specific molecule 1,39862,0.0231967449898456,0.00319273307539554,0.0169389881620704,0.0294545018176209,3.88846843581793e-13
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,EREG,Proepiregulin,39713,-0.0544081769476825,0.00748855034074746,-0.0690857356155475,-0.0397306182798175,3.8891604824782e-13
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LRRFIP1,Leucine-rich repeat flightless-interacting protein 1,37368,-0.0329446614321199,0.00453604500949985,-0.0418353096507396,-0.0240540132135002,3.9973560896192e-13
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,AZI2,5-azacytidine-induced protein 2,37411,-0.0378168484538803,0.00521117704807089,-0.0480307554680993,-0.0276029414396614,4.17685457820221e-13
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MAP4K5,Mitogen-activated protein kinase kinase kinase kinase 5,39713,-0.0762026670502038,0.0105060009870641,-0.0967944289848494,-0.0556109051155582,4.25694231370772e-13
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SUSD2,Sushi domain-containing protein 2,39858,0.019161004150365,0.0026428484682868,0.0139810211525228,0.0243409871482071,4.35398970539889e-13
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ADAM9,Disintegrin and metalloproteinase domain-containing protein 9,37382,-0.0200459009394799,0.00276655265249936,-0.0254683441383786,-0.0146234577405811,4.53164037093264e-13
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,S100G,Protein S100-G,37411,0.0305874807738461,0.00422184733593784,0.0223126599954079,0.0388623015522843,4.55645678123959e-13
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SERPINA9,Serpin A9,39715,-0.0493572775027178,0.00682127435675002,-0.0627269752419479,-0.0359875797634878,4.84031556510051e-13
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DCXR,L-xylulose reductase,39913,-0.0364571254707278,0.00504751358397631,-0.0463502520953214,-0.0265639988461343,5.32178091971648e-13
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CCL3,C-C motif chemokine 3,39866,-0.0425468404426013,0.00589073558830969,-0.0540926821956882,-0.0310009986895143,5.327102610378e-13
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PFKFB2,"6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 2",39758,-0.0507106675821863,0.00702316579925907,-0.0644760725487341,-0.0369452626156386,5.41472183258563e-13
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PTH1R,Parathyroid hormone/parathyroid hormone-related peptide receptor,39866,-0.0249869800383218,0.00346797479665068,-0.0317842106397572,-0.0181897494368865,6.06025725851709e-13
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SELP,P-selectin,39931,-0.0387622640506015,0.00538676146116325,-0.0493203165144815,-0.0282042115867216,6.48196429090856e-13
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,EGFL7,Epidermal growth factor-like protein 7,39477,-0.0266148610211613,0.00369865339797096,-0.0338642216811844,-0.0193655003611382,6.49074200106573e-13
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TXNRD1,"Thioredoxin reductase 1, cytoplasmic",39858,-0.0313959688101829,0.00436755750131544,-0.0399563815127612,-0.0228355561076046,6.84264102799046e-13
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PLAUR,Urokinase plasminogen activator surface receptor,39757,-0.0180248360520409,0.00250843924069132,-0.0229413769637959,-0.0131082951402859,6.98439667726968e-13
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TRIM24,Transcription intermediary factor 1-alpha,37135,-0.0439864005124657,0.00613101215214579,-0.0560031843306714,-0.0319696166942599,7.64711468002645e-13
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,EIF4G3,Eukaryotic translation initiation factor 4 gamma 3,37411,-0.0443213834819556,0.0061813369335337,-0.0564368038716816,-0.0322059630922295,7.87722415180979e-13
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PILRB,Paired immunoglobulin-like type 2 receptor beta,39868,-0.0381754057675677,0.0053269197615848,-0.0486161685002739,-0.0277346430348615,8.02915040155124e-13
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ESAM,Endothelial cell-selective adhesion molecule,40052,-0.0209878982811264,0.00293293873882533,-0.026736458209224,-0.0152393383530287,8.6670762862961e-13
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CALCOCO1,Calcium-binding and coiled-coil domain-containing protein 1,39977,-0.0691655378889302,0.00966880579590858,-0.088116397248911,-0.0502146785289494,8.82481329841733e-13
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IL1RAP,Interleukin-1 receptor accessory protein,39858,0.0287395776384326,0.00402005092301304,0.020860277829327,0.0366188774475381,9.11519025607185e-13
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CBS,Cystathionine beta-synthase,37043,-0.0341987249036312,0.00479207458572389,-0.04359119109165,-0.0248062587156123,1.0073106312645e-12
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RNF41,E3 ubiquitin-protein ligase NRDP1,39477,-0.0449994627185042,0.00630875730226944,-0.0573646270309523,-0.0326342984060561,1.02622120742579e-12
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NMNAT1,Nicotinamide/nicotinic acid mononucleotide adenylyltransferase 1,39749,-0.0472269262397874,0.00662125826079642,-0.0602045924309484,-0.0342492600486264,1.02722142597936e-12
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PENK,Proenkephalin-A,37124,-0.019401820004441,0.00273665481001097,-0.0247656634320625,-0.0140379765768195,1.4129530873536e-12
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,VSTM2L,V-set and transmembrane domain-containing protein 2-like protein,39585,-0.0375967791210101,0.00530898131109674,-0.0480023824907597,-0.0271911757512605,1.483938912616e-12
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FKBP4,Peptidyl-prolyl cis-trans isomerase FKBP4,39749,-0.0294134236510056,0.00416780431945809,-0.0375823201171434,-0.0212445271848677,1.76792216590424e-12
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,COCH,Cochlin,37437,-0.0301956761687043,0.00428986662915524,-0.0386038147618485,-0.02178753757556,2.03156900713353e-12
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SFRP4,Secreted frizzled-related protein 4,37124,-0.0273804247928292,0.00389909652892649,-0.0350226539895251,-0.0197381955961333,2.28959773371311e-12
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,AP3B1,AP-3 complex subunit beta-1,37382,-0.0505092792041333,0.00720205340001957,-0.0646253038681717,-0.036393254540095,2.44034000636723e-12
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FGD3,"FYVE, RhoGEF and PH domain-containing protein 3",37411,-0.0529780287639861,0.00755410721106503,-0.0677840788976735,-0.0381719786302986,2.44071116695525e-12
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RAPGEF2,Rap guanine nucleotide exchange factor 2,37169,-0.0353114907318286,0.00504603154081585,-0.0452017125518277,-0.0254212689118295,2.72315849095268e-12
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ARHGEF10,Rho guanine nucleotide exchange factor 10,37411,-0.0615947927551829,0.00880528912535148,-0.0788531594408718,-0.044336426069494,2.77301910234807e-12
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TIMP4,Metalloproteinase inhibitor 4,39858,0.0256335548798184,0.00368053023904764,0.018419715611285,0.0328473941483518,3.42071725392933e-12
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,KCTD5,BTB/POZ domain-containing protein KCTD5,37165,-0.028531174243873,0.00410470423414273,-0.0365763945427928,-0.0204859539449532,3.80019520518809e-12
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NCK2,Cytoplasmic protein NCK2,39931,-0.0690997056106578,0.00995276027687072,-0.0886071157533244,-0.0495922954679912,3.99204785391045e-12
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ROBO2,Roundabout homolog 2,40009,0.0147973409945078,0.00213174536471572,0.010619120079665,0.0189755619093506,4.02947510898719e-12
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PARP1,Poly [ADP-ribose] polymerase 1,39866,-0.0356566393948691,0.00513703485046354,-0.0457252277017776,-0.0255880510879605,4.04013089377203e-12
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,HBEGF,Proheparin-binding EGF-like growth factor,39984,-0.0471314852221696,0.00679270980405503,-0.0604451964381174,-0.0338177740062217,4.11248223368451e-12
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,S100A4,Protein S100-A4,39913,-0.0369316158079906,0.00532689021777792,-0.0473723206348353,-0.0264909109811459,4.27543186855338e-12
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,OGA,Protein O-GlcNAcase,37382,-0.0462965288889752,0.00668163419543371,-0.0593925319120253,-0.0332005258659251,4.43251506483882e-12
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RAB27B,Ras-related protein Rab-27B,37437,-0.0532929500460061,0.00769589882096635,-0.0683769117351002,-0.0382089883569121,4.56063154294726e-12
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IL18,Interleukin-18,39795,-0.0294672031051867,0.00426489968599638,-0.0378264064897396,-0.0211079997206338,5.05716312471024e-12
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CBLIF,Cobalamin binding intrinsic factor,39846,-0.0444810044134753,0.00643869069505052,-0.0571008381757743,-0.0318611706511763,5.08665406185531e-12
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PCBP2,Poly(rC)-binding protein 2,37411,-0.047094686779336,0.00681801875440727,-0.0604580035379742,-0.0337313700206977,5.15686592562942e-12
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SH2B3,SH2B adapter protein 3,39477,-0.0638411148673089,0.00924741871694579,-0.0819660555525227,-0.0457161741820952,5.26286172055716e-12
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CD27,CD27 antigen,39913,-0.0251632966041935,0.00364528453763916,-0.0323080542979663,-0.0180185389104208,5.28325889476087e-12
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CAMKK1,Calcium/calmodulin-dependent protein kinase kinase 1,39477,-0.0293456790490595,0.00425290843118693,-0.0376813795741859,-0.0210099785239331,5.39471670297453e-12
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IL18BP,Interleukin-18-binding protein,39931,-0.0191158107413003,0.00277434076652898,-0.0245535186436971,-0.0136781028389035,5.77754491586666e-12
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LYPD8,Ly6/PLAUR domain-containing protein 8,39477,-0.0339039115575034,0.00492606560460162,-0.0435590001425226,-0.0242488229724842,6.10261483083793e-12
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CXCL9,C-X-C motif chemokine 9,39931,-0.0420278838482549,0.00610659131293585,-0.0539968028216092,-0.0300589648749006,6.10360133050014e-12
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FAS,Tumor necrosis factor receptor superfamily member 6,40002,-0.0205913316748895,0.00299195524999068,-0.0264555639648713,-0.0147270993849078,6.10894781873613e-12
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NME3,Nucleoside diphosphate kinase 3,39885,0.0153701714531194,0.00223364335482745,0.0109922304776576,0.0197481124285812,6.15440699725592e-12
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GFRA1,GDNF family receptor alpha-1,40011,-0.0173354447120996,0.00252233859217258,-0.0222792283527579,-0.0123916610714413,6.5271136181386e-12
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CDA,Cytidine deaminase,37422,-0.029914468866931,0.00435379509850006,-0.0384479072599911,-0.0213810304738709,6.65843164607353e-12
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TADA3,Transcriptional adapter 3,37368,-0.0255062459399382,0.00371533870864281,-0.0327883098088781,-0.0182241820709983,6.93363833438699e-12
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RABEP1,Rab GTPase-binding effector protein 1,37124,-0.0502199515867617,0.0073222324602264,-0.0645715272088055,-0.035868375964718,7.26419296324694e-12
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,37056,-0.0233116571606839,0.00340142615679969,-0.0299784524280113,-0.0166448618933565,7.52681587177525e-12
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ANGPT1,Angiopoietin-1,39794,-0.0542428023637136,0.00791650566807633,-0.0697591534731432,-0.038726451254284,7.55648875676504e-12
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GUCA2A,Guanylin,39796,-0.0206939619576322,0.00302428264780813,-0.0266215559473361,-0.0147663679679283,8.06002806753397e-12
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SSC5D,Soluble scavenger receptor cysteine-rich domain-containing protein SSC5D,39931,-0.0273125047218672,0.00399320344053171,-0.0351391834653094,-0.0194858259784251,8.21929607425219e-12
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CCL14,C-C motif chemokine 14,39843,-0.0249521491909071,0.00365033473603533,-0.0321068052735363,-0.0177974931082778,8.46288368743858e-12
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RNASE1,Ribonuclease pancreatic,37445,-0.014364230634796,0.00210272175212057,-0.0184855652689523,-0.0102428960006397,8.77571626819499e-12
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DOK2,Docking protein 2,39868,-0.0785667195749601,0.0115121974784926,-0.101130626632806,-0.0560028125171145,9.13024293805952e-12
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SHISA5,Protein shisa-5,37437,-0.0146289300614745,0.0021480719397516,-0.0188391510633876,-0.0104187090595613,1.01520441362542e-11
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,BST2,Bone marrow stromal antigen 2,40009,-0.033864938475831,0.00499111189359046,-0.0436475177872683,-0.0240823591643937,1.20079575437711e-11
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CD207,C-type lectin domain family 4 member K,39496,-0.0239772964727887,0.00353410717001053,-0.0309041465260094,-0.0170504464195681,1.20636047625746e-11
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PTP4A3,Protein tyrosine phosphatase type IVA 3,37056,-0.0329150712100496,0.004853514279061,-0.0424279591970092,-0.0234021832230901,1.23828934685774e-11
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PDGFB,Platelet-derived growth factor subunit B,39931,-0.0543374655453976,0.0080285787964799,-0.0700734799864982,-0.038601451104297,1.35083758782903e-11
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RASSF2,Ras association domain-containing protein 2,39477,-0.0349849757445596,0.00516961286747691,-0.0451174169648143,-0.0248525345243048,1.35757385306493e-11
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CCL2,C-C motif chemokine 2,39720,-0.0327630871636484,0.00484690225973942,-0.0422630155927376,-0.0232631587345591,1.43204451103326e-11
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CEMIP2,Cell surface hyaluronidase,37056,-0.0202584447936411,0.00300543767563403,-0.0261491026378838,-0.0143677869493984,1.64293087186674e-11
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,OTUD7B,OTU domain-containing protein 7B,37411,-0.0406320905804691,0.00603090296117301,-0.0524526603843682,-0.02881152077657,1.67855075816739e-11
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,HPSE,Heparanase,37306,-0.0594700174449458,0.00882906485960074,-0.0767749845697633,-0.0421650503201284,1.69764584997755e-11
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LCAT,Phosphatidylcholine-sterol acyltransferase,37445,-0.0138296404091158,0.00205346666349659,-0.0178544350695691,-0.00980484574866251,1.70783705384601e-11
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FMNL1,Formin-like protein 1,39489,-0.0384214061321313,0.00572277726653516,-0.0496380495745402,-0.0272047626897223,1.96192643834106e-11
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SYTL4,Synaptotagmin-like protein 4,37437,-0.045512174221729,0.00678116075884356,-0.0588032493090624,-0.0322210991343956,2.00195176611482e-11
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FSHB,Follitropin subunit beta,37043,0.041226010413186,0.00615103600665203,0.0291699798401481,0.053282040986224,2.13526839025077e-11
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CFC1,Cryptic protein,39477,-0.0293331578965366,0.00438028190406534,-0.0379185104285046,-0.0207478053645685,2.20547600055607e-11
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CASP10,Caspase-10,39489,-0.0449121026818616,0.00671078226663338,-0.058065235924463,-0.0317589694392601,2.26807128405608e-11
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,39858,-0.0218460697522915,0.00326610860631741,-0.0282476426206737,-0.0154444968839094,2.32599875740545e-11
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TREM2,Triggering receptor expressed on myeloid cells 2,39862,-0.0323717639830822,0.00483982153041725,-0.0418578141827,-0.0228857137834644,2.32736551341185e-11
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PIBF1,"Progesterone-induced-blocking factor 1, Isoform 4",37411,-0.0486531945925536,0.00728337272952971,-0.0629286051424319,-0.0343777840426754,2.48205460146191e-11
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PGA4,Pepsin A-4,37445,-0.0389556941514562,0.00584121920963529,-0.0504044838023414,-0.027506904500571,2.67324315925637e-11
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NCF2,Neutrophil cytosol factor 2,39843,-0.0519237175946354,0.00779278748817748,-0.0671975810714632,-0.0366498541178075,2.76967915297147e-11
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CNDP1,Beta-Ala-His dipeptidase,39931,-0.0284937037184266,0.00427784260017973,-0.0368782752147789,-0.0201091322220744,2.81243919015295e-11
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CLEC3B,Tetranectin,37138,0.0132576541105679,0.00199172816169615,0.00935386691364347,0.0171614413074924,2.91723781225472e-11
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ATP6AP2,Renin receptor,39477,-0.0254339015420056,0.00382346956004315,-0.0329279018796902,-0.017939901204321,2.98647157977362e-11
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,39862,-0.023484652096655,0.00353460674687067,-0.0304124813205215,-0.0165568228727884,3.14693945878303e-11
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GOLGA3,Golgin subfamily A member 3,37411,-0.0484879721762128,0.00730297260848573,-0.0628017984888449,-0.0341741458635808,3.26772421349018e-11
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CALCOCO2,Calcium-binding and coiled-coil domain-containing protein 2,37043,-0.047986071454083,0.00723259056358517,-0.0621619489587099,-0.033810193949456,3.37862740653749e-11
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,JAM3,Junctional adhesion molecule C,37124,-0.0315382287062649,0.00475483826002309,-0.0408577116959101,-0.0222187457166196,3.41984567048025e-11
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ADD1,Alpha-adducin,37124,-0.0429895636100803,0.00648218975805905,-0.0556946555358761,-0.0302844716842846,3.44116745060863e-11
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GASK1A,Golgi-associated kinase 1A,37021,-0.026632498083344,0.00401685417181998,-0.0345055322601112,-0.0187594639065769,3.48341289537677e-11
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CRTAC1,Cartilage acidic protein 1,40052,0.0187070348590376,0.00282461110195083,0.013170797099214,0.0242432726188612,3.63377129871904e-11
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,WIF1,Wnt inhibitory factor 1,40030,0.0207470543954762,0.00314338397342025,0.0145860218075725,0.0269080869833799,4.23287497770461e-11
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MYBPC1,"Myosin-binding protein C, slow-type",37437,-0.042276300355285,0.00640693939489639,-0.0548339015692819,-0.029718699141288,4.30693137591439e-11
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DCTN2,Dynactin subunit 2,39788,-0.0586081417874363,0.00890523232104776,-0.0760623971366899,-0.0411538864381827,4.80860109757924e-11
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GIGYF2,GRB10-interacting GYF protein 2,37411,-0.0473725557911337,0.00720394942506188,-0.061492296664255,-0.0332528149180125,5.01276268901165e-11
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CD63,CD63 antigen,39720,-0.0317151563133838,0.00482897774973186,-0.0411799527028582,-0.0222503599239093,5.26960270369628e-11
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RBPMS2,RNA-binding protein with multiple splicing 2,37043,-0.0635971962116095,0.00968816309165445,-0.0825859958712522,-0.0446083965519668,5.41903849359376e-11
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CXCL17,C-X-C motif chemokine 17,40058,-0.0263557691249557,0.00402684026423516,-0.0342483760428567,-0.0184631622070548,6.12713881700539e-11
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IL1R1,Interleukin-1 receptor type 1,39826,-0.0137904659202693,0.00210829346394678,-0.017922721109605,-0.00965821073093361,6.29423133321632e-11
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RAB33A,Ras-related protein Rab-33A,37021,-0.0412422711216523,0.00630499071543552,-0.0536000529239059,-0.0288844893193987,6.32792253682115e-11
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CDC42BPB,Serine/threonine-protein kinase MRCK beta,37382,-0.0628228602527386,0.00961365499051995,-0.0816656240341577,-0.0439800964713195,6.59976252913401e-11
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MTDH,Protein LYRIC,37056,-0.0566650707202262,0.00869048360662771,-0.0736984185892165,-0.0396317228512358,7.26932227855992e-11
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,WASHC3,WASH complex subunit 3,37388,-0.04637266449977,0.00711415597906921,-0.0603164102187456,-0.0324289187807944,7.35983188617201e-11
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,COL9A1,Collagen alpha-1(IX) chain,39866,0.026686513104296,0.00410293498881275,0.018644760526223,0.034728265682369,8.03967288733187e-11
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,WFDC2,WAP four-disulfide core domain protein 2,39017,-0.0218333099202183,0.00335987349156915,-0.0284186619636938,-0.0152479578767428,8.37939052048924e-11
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PPBP,Platelet basic protein,37371,-0.0518108473331582,0.00798091356835099,-0.0674534379271261,-0.0361682567391902,8.77540674151809e-11
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,HYAL1,Hyaluronidase-1,39747,-0.0138942899403004,0.00214110807157009,-0.0180908617605777,-0.00969771812002298,8.87890878954377e-11
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,WARS,"Tryptophan--tRNA ligase, cytoplasmic",39858,-0.022898751685067,0.00352896066410401,-0.0298155145867108,-0.0159819887834231,8.90593990619205e-11
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,COL1A1,Collagen alpha-1(I) chain,40052,0.0150693407951858,0.00232303554554902,0.0105161911259098,0.0196224904644619,9.01498260966829e-11
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ITGB1,Integrin beta-1,39862,0.0132234399611834,0.00203930412181009,0.00922640388243566,0.0172204760399312,9.17617132504612e-11
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,USP8,Ubiquitin carboxyl-terminal hydrolase 8,39585,-0.0589262625456722,0.00909132871798225,-0.0767452668329174,-0.041107258258427,9.34626344316449e-11
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TNR,Tenascin-R,39749,0.0254928239790863,0.00393645163433809,0.0177773787757837,0.033208269182389,9.68915817394886e-11
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FABP4,"Fatty acid-binding protein, adipocyte",40052,-0.0294559749237301,0.00455495169878294,-0.0383836802533447,-0.0205282695941155,1.0296434933571e-10
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TXNDC5,Thioredoxin domain-containing protein 5,40009,-0.041559307764215,0.00642717620034712,-0.0541565731168953,-0.0289620424115346,1.03392986008012e-10
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TMPRSS5,Transmembrane protease serine 5,39667,0.0230765722092957,0.0035690454476849,0.0160812431318333,0.0300719012867581,1.03750029590718e-10
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PRSS22,Brain-specific serine protease 4,37056,-0.020416928927903,0.00315814006384212,-0.0266068834530336,-0.0142269744027724,1.04961971462569e-10
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ERBB3,Receptor tyrosine-protein kinase erbB-3,39809,-0.0116701336799079,0.00180635485754587,-0.0152105892006978,-0.00812967815911799,1.07310481907618e-10
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MZB1,Marginal zone B- and B1-cell-specific protein,39908,-0.0297654214809485,0.00460755227528089,-0.038796223940499,-0.0207346190213979,1.07618165511906e-10
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ENTR1,Endosome-associated-trafficking regulator 1,37043,-0.0363388270747897,0.00563053324140223,-0.0473746722279381,-0.0253029819216414,1.12831572364114e-10
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MBL2,Mannose-binding protein C,37257,0.0651958781101353,0.0101019538643633,0.0453960485359832,0.0849957076842874,1.12842768143799e-10
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NBN,Nibrin,39587,-0.0311793219078631,0.00483788741697924,-0.0406615812451424,-0.0216970625705838,1.19103961384738e-10
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,EIF4EBP1,Eukaryotic translation initiation factor 4E-binding protein 1,39868,-0.0384226388563438,0.00596435109044771,-0.0501127669936213,-0.0267325107190663,1.21234635625747e-10
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,C8B,Complement component C8 beta chain,37453,0.0183298531124529,0.00284649008857708,0.0127507325388418,0.023908973686064,1.23932100858991e-10
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,VNN1,Pantetheinase,37445,-0.0438012897527744,0.00680555606669122,-0.0571401796434892,-0.0304623998620596,1.26691356121834e-10
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PLA2G1B,Phospholipase A2,40031,0.0246582794828819,0.00383331393278588,0.0171449841746215,0.0321715747911422,1.28938309251457e-10
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FOLR1,Folate receptor alpha,39809,-0.0165171588087909,0.00256848848104309,-0.0215513962316354,-0.0114829213859465,1.30636549871018e-10
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,HTRA2,"Serine protease HTRA2, mitochondrial",39913,-0.0370504983713523,0.00576425405743043,-0.0483484363239159,-0.0257525604187886,1.33262640323101e-10
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SCGN,Secretagogin,39587,-0.0259556591069929,0.00404605269385211,-0.033885922386943,-0.0180253958270428,1.4479163449718e-10
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LYN,Tyrosine-protein kinase Lyn,39788,-0.050889319333913,0.0079494025940097,-0.066470148418172,-0.035308490249654,1.58002571896134e-10
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IL22RA1,Interleukin-22 receptor subunit alpha-1,39587,-0.025882849161765,0.00404367918971917,-0.0338084603736146,-0.0179572379499154,1.58924534736516e-10
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LARP1,La-related protein 1,37368,-0.0384339929234133,0.00601309369043495,-0.0502196565566658,-0.0266483292901608,1.69421894438371e-10
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,STAT2,Signal transducer and activator of transcription 2,37056,-0.0472255909406395,0.0073975328491027,-0.0617247553248808,-0.0327264265563982,1.78337306295524e-10
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,BSG,Basigin,40040,-0.0116416652959044,0.00182485473644788,-0.0152183805793422,-0.00806495001246656,1.82488652565482e-10
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CTHRC1,Collagen triple helix repeat-containing protein 1,37437,-0.0160581216737461,0.00252005950799034,-0.0209974383094072,-0.011118805038085,1.92451952484346e-10
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,VEGFC,Vascular endothelial growth factor C,39913,-0.0331690237142565,0.00520788454211348,-0.043376477416799,-0.0229615700117141,1.95436989396105e-10
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NBL1,Neuroblastoma suppressor of tumorigenicity 1,39913,-0.0152285503604827,0.00239228557619256,-0.0199174300898201,-0.0105396706311453,1.99688735839988e-10
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,VTI1A,Vesicle transport through interaction with t-SNAREs homolog 1A,37124,-0.034902188351696,0.00548264480802241,-0.0456481721754199,-0.0241562045279721,2.00489052807926e-10
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PDGFA,Platelet-derived growth factor subunit A,40052,-0.0429044070312489,0.00674133599205732,-0.0561174255756812,-0.0296913884868165,2.01354224474666e-10
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,OGFR,Opioid growth factor receptor,39788,-0.019523736490678,0.00306939067940116,-0.0255397422223043,-0.0135077307590517,2.06198132284956e-10
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TRIM25,E3 ubiquitin/ISG15 ligase TRIM25,37382,-0.0645957156332046,0.0101629871902882,-0.0845151705261694,-0.0446762607402397,2.13752522989174e-10
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PTPRZ1,Receptor-type tyrosine-protein phosphatase zeta,37437,0.0193142265794328,0.00304027844154116,0.0133552808340122,0.0252731723248535,2.18200236488256e-10
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CDH5,Cadherin-5,40052,0.0181756165220332,0.00286160573166927,0.0125668692879614,0.023784363756105,2.18847974993982e-10
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,UNC5D,Netrin receptor UNC5D,37056,0.0158512864335606,0.00249764502415641,0.0109559021862141,0.0207466706809072,2.27482691732562e-10
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DNMBP,Dynamin-binding protein,39749,-0.0369053837557493,0.00581936957639029,-0.0483113481254742,-0.0254994193860243,2.33203987190241e-10
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,EVI5,Ecotropic viral integration site 5 protein homolog,37056,-0.0541533128851922,0.00855658787175805,-0.0709242251138379,-0.0373824006565464,2.54993404148902e-10
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FGA,Fibrinogen alpha chain,37149,0.0183041321031021,0.00289762960621049,0.0126247780749296,0.0239834861312747,2.75309955808577e-10
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,BIRC2,Baculoviral IAP repeat-containing protein 2,39477,-0.0377953537550665,0.00598529230130066,-0.0495265266656157,-0.0260641808445172,2.77994498258343e-10
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,EIF4B,Eukaryotic translation initiation factor 4B,39749,-0.0343822525250278,0.00544641170680575,-0.0450572194703671,-0.0237072855796885,2.81253846005892e-10
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,39858,-0.0149972077866187,0.00238123279311358,-0.0196644240611213,-0.0103299915121161,3.09211363699651e-10
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LACRT,Extracellular glycoprotein lacritin,37339,-0.0284184998965127,0.00452352122817453,-0.0372846015037348,-0.0195523982892906,3.43670017549103e-10
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,AP2B1,AP-2 complex subunit beta,37039,-0.0289804367270461,0.00461514123585392,-0.0380261135493197,-0.0199347599047724,3.50495117344569e-10
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,HDGFL2,Hepatoma-derived growth factor-related protein 2,37388,-0.0368832150510663,0.00587973649613595,-0.0484074985834928,-0.0253589315186399,3.65089624292742e-10
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,AKT1S1,Proline-rich AKT1 substrate 1,39489,-0.0396610423783819,0.00632333058230262,-0.052054770319695,-0.0272673144370687,3.65399884886003e-10
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,WASF1,Wiskott-Aldrich syndrome protein family member 1,39585,-0.0553465191883694,0.00882553782534972,-0.0726445733260549,-0.038048465050684,3.67685816275816e-10
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ING1,Inhibitor of growth protein 1,39453,-0.0264736221966296,0.00422796265985048,-0.0347604290099366,-0.0181868153833227,3.9113653801039e-10
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CPXM2,Inactive carboxypeptidase-like protein X2,37437,-0.0140856206266726,0.00225207965960759,-0.0184996967595035,-0.00967154449384173,4.10763899807842e-10
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FUT3_FUT5,3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase FUT3_4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT5,40009,0.0261241571531489,0.00418080735013606,0.0179297747468823,0.0343185395594156,4.24552338580771e-10
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TNFSF14,Tumor necrosis factor ligand superfamily member 14,39749,-0.0336939133659803,0.0053932972464252,-0.0442647759689737,-0.0231230507629869,4.28054605967664e-10
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,WDR46,WD repeat-containing protein 46,37368,-0.02109800367771,0.00338376445422652,-0.0277301820079939,-0.014465825347426,4.65025381360863e-10
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PF4,Platelet factor 4,37385,-0.056466651414944,0.00906565473863735,-0.0742353347026732,-0.0386979681272148,4.84451880585341e-10
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PCDH7,Protocadherin-7,37382,-0.0196403594106434,0.0031534763974753,-0.025821173149695,-0.0134595456715918,4.85916730005691e-10
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CXCL11,C-X-C motif chemokine 11,40009,-0.0453931522299413,0.0072994367344275,-0.0597000482294193,-0.0310862562304634,5.13555613834366e-10
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,OPHN1,Oligophrenin-1,37388,-0.0630271970397058,0.0101352865114133,-0.0828923586020759,-0.0431620354773356,5.16398552715685e-10
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FABP1,"Fatty acid-binding protein, liver",39862,-0.0545312106754331,0.00877716712840001,-0.0717344582470971,-0.0373279631037691,5.33194589531844e-10
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CNP,"2',3'-cyclic-nucleotide 3'-phosphodiesterase",37026,-0.0466181330661478,0.00750758481079641,-0.0613329992953088,-0.0319032668369868,5.47614301766103e-10
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,APP,Amyloid-beta precursor protein,39829,-0.0387561950084593,0.00624705442398699,-0.0510004216794738,-0.0265119683374448,5.64327791522521e-10
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SIRPB1,Signal-regulatory protein beta-1,39835,-0.02573876933613,0.00414906424808098,-0.0338709352623687,-0.0176066034098912,5.65767483542417e-10
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IL6,Interleukin-6,39788,-0.0411564161287754,0.00665026599039726,-0.054190937469954,-0.0281218947875968,6.21518052410473e-10
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CD70,CD70 antigen,39866,0.0244436503943864,0.00396547092561814,0.0166713273801748,0.0322159734085979,7.25736934077926e-10
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,COMMD1,COMM domain-containing protein 1,37043,-0.0359189287508433,0.00583043035702471,-0.0473465722506118,-0.0244912852510749,7.4580421816537e-10
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GRHPR,Glyoxylate reductase/hydroxypyruvate reductase,37437,-0.0369779064072798,0.00600527891967549,-0.0487482530898438,-0.0252075597247159,7.5953579168169e-10
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NUDT5,ADP-sugar pyrophosphatase,39858,-0.0298156388495811,0.0048430308858936,-0.0393079793859326,-0.0203232983132297,7.61926229629266e-10
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ZNRD2,Protein ZNRD2,37382,-0.0392376010952715,0.00637700258189589,-0.0517365261557875,-0.0267386760347556,7.81841150104627e-10
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ANXA2,Annexin A2,36879,-0.0403302766595633,0.00655501249269844,-0.0531781011452523,-0.0274824521738744,7.84648298257934e-10
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,B4GAT1,"Beta-1,4-glucuronyltransferase 1",39858,0.0140575386577112,0.00228724562386964,0.00957453723492675,0.0185405400804957,8.13164938058583e-10
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CCL7,C-C motif chemokine 7,39866,-0.0336123116747275,0.00547093016445131,-0.044335334797052,-0.0228892885524029,8.24754860729309e-10
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,EPHB4,Ephrin type-B receptor 4,40052,-0.013527798982913,0.0022048220332456,-0.0178492501680743,-0.0092063477977516,8.68383569041265e-10
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,39914,0.0173076960716586,0.00282291685283926,0.0117747790400936,0.0228406131032235,8.92934581491867e-10
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,METAP2,Methionine aminopeptidase 2,40011,-0.0332074149532152,0.00541739159633529,-0.0438255024820324,-0.0225893274243981,9.00457163518043e-10
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LTA4H,Leukotriene A-4 hydrolase,40030,0.0336996501854589,0.00549908157342646,0.022921450301543,0.0444778500693747,9.0920832053412e-10
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LGALS9,Galectin-9,39859,-0.0180726613196562,0.00295040217998358,-0.023855449592424,-0.0122898730468884,9.25193333948177e-10
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,HSD17B14,17-beta-hydroxysteroid dehydrogenase 14,37388,-0.035550809958595,0.00580795647996342,-0.0469344046593233,-0.0241672152578667,9.55280611334834e-10
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MOCS2,Molybdopterin synthase catalytic subunit,37124,-0.0390421796419232,0.0063970527394758,-0.0515804030112957,-0.0265039562725506,1.06895800123639e-09
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ARHGEF1,Rho guanine nucleotide exchange factor 1,37388,-0.0519336190919931,0.00851501829548995,-0.0686230549511534,-0.0352441832328328,1.09600202953673e-09
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,EPHA2,Ephrin type-A receptor 2,39248,-0.0168138756692101,0.00276162616582781,-0.0222266629542327,-0.0114010883841876,1.16756239233576e-09
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PTPN1,Tyrosine-protein phosphatase non-receptor type 1,39749,-0.0449192175646651,0.0073796641237167,-0.0593833592471498,-0.0304550758821803,1.17768826368506e-09
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MNDA,Myeloid cell nuclear differentiation antigen,39841,-0.0556594329281874,0.00914537046869346,-0.0735843590468266,-0.0377345068095482,1.1835228628326e-09
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FGFBP2,Fibroblast growth factor-binding protein 2,37437,-0.02831881995579,0.00465569713243233,-0.0374439863353573,-0.0191936535762226,1.21412797183356e-09
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ALPP,"Alkaline phosphatase, placental type",39788,-0.060258447502618,0.00991614752061375,-0.0796940966430209,-0.0408227983622151,1.25396112361251e-09
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FLT4,Vascular endothelial growth factor receptor 3,39913,-0.019364998520257,0.00318774893200382,-0.0256129864269845,-0.0131170106135296,1.2692809509098e-09
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CD36,Platelet glycoprotein 4,37056,-0.0260748644115582,0.00429351778009072,-0.034490159260536,-0.0176595695625804,1.28929658936097e-09
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ZHX2,Zinc fingers and homeoboxes protein 2,37388,-0.0177500394499921,0.00292349561936466,-0.0234800908639468,-0.0120199880360373,1.30102671662977e-09
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SEC31A,Protein transport protein Sec31A,37043,-0.0439206325199843,0.00724571018488822,-0.0581222244823653,-0.0297190405576034,1.38448696660515e-09
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LXN,Latexin,39682,0.0380026533473191,0.0062735480673643,0.0257064991352851,0.0502988075593531,1.41294434962708e-09
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GORASP2,Golgi reassembly-stacking protein 2,37382,-0.0268548891973407,0.00445239777593446,-0.0355815888381722,-0.0181281895565092,1.66624197698158e-09
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ADAMTS4,A disintegrin and metalloproteinase with thrombospondin motifs 4,37056,-0.0206602500925582,0.00342589025533417,-0.0273749949930132,-0.0139455051921033,1.67694269403349e-09
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SPTLC1,Serine palmitoyltransferase 1,37388,-0.0202210569551334,0.00335495243200684,-0.0267967637218668,-0.0136453501884,1.71134714218729e-09
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FAM3D,Protein FAM3D,37382,-0.0471490224089603,0.00783432474568949,-0.0625042989105117,-0.0317937459074089,1.80858631920314e-09
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DAB2,Disabled homolog 2,40030,-0.062899173849029,0.010463074568302,-0.0834068000029009,-0.042391547695157,1.87720823502286e-09
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,HNMT,Histamine N-methyltransferase,39669,-0.0260423791108171,0.00433988660746544,-0.0345485568614494,-0.0175362013601849,2.00752007282544e-09
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ADAMTSL4,ADAMTS-like protein 4,37043,-0.013655669702232,0.00227587105564152,-0.0181163769712894,-0.0091949624331746,2.02248725499396e-09
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PCDH17,Protocadherin-17,39868,-0.0196842804372142,0.00328226941524899,-0.0261175284911022,-0.0132510323833262,2.05122653105927e-09
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NIT2,Omega-amidase NIT2,37377,-0.0424664556040181,0.00708115825213337,-0.0563455257781995,-0.0285873854298367,2.05990173290498e-09
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FGL1,Fibrinogen-like protein 1,37445,-0.0348942607958822,0.00581884571052707,-0.0462991983885153,-0.0234893232032492,2.06393402811685e-09
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DYNLT1,Dynein light chain Tctex-type 1,37039,-0.0450327249203826,0.00751105214065294,-0.0597543871160624,-0.0303110627247029,2.0812883792683e-09
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SKAP2,Src kinase-associated phosphoprotein 2,39931,-0.0583700487174464,0.00975640945672273,-0.0774926112526229,-0.0392474861822698,2.24072968627788e-09
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RPL14,60S ribosomal protein L14,37043,-0.0226893837499622,0.00380501215306809,-0.0301472075699757,-0.0152315599299488,2.5394567144552e-09
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PRDX1,Peroxiredoxin-1,39434,0.0507191218122428,0.00851729364141553,0.0340252262750684,0.0674130173494173,2.65924808329547e-09
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GIT1,ARF GTPase-activating protein GIT1,37056,-0.0545786635951725,0.00917213009856488,-0.0725560385883597,-0.0366012886019854,2.74119001573152e-09
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SPP1,Osteopontin,40012,0.0251166844344936,0.00422324786504885,0.0168391186189978,0.0333942502499893,2.78319784022712e-09
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ZBTB17,Zinc finger and BTB domain-containing protein 17,39585,-0.0226001194530876,0.00380082631332612,-0.0300497390272068,-0.0151504998789684,2.80409480917116e-09
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CTRL,Chymotrypsin-like protease CTRL-1,37388,0.036631292262908,0.00617859036018248,0.0245212551569504,0.0487413293688657,3.12695486898247e-09
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,WFDC1,WAP four-disulfide core domain protein 1,37123,-0.0292279567602613,0.00493344126111359,-0.0388975016320439,-0.0195584118884787,3.21099703339014e-09
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MITD1,MIT domain-containing protein 1,39749,-0.0539941859399587,0.00912066834636371,-0.0718706958988315,-0.0361176759810858,3.2860936558359e-09
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SPARC,SPARC,39913,-0.0390876652048116,0.00661077252586556,-0.0520447793555081,-0.0261305510541151,3.43324036289797e-09
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TNXB,Tenascin-X,39858,0.0142676276160472,0.00241321156774631,0.0095377329432644,0.0189975222888299,3.44231164657087e-09
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,KLF4,Krueppel-like factor 4,36991,-0.0218752741877977,0.00371116643693789,-0.029149160404196,-0.0146013879713994,3.85165490804637e-09
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RETN,Resistin,39790,-0.0225553986201075,0.0038278005976811,-0.0300578877915625,-0.0150529094486526,3.88017196992267e-09
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NTRK2,BDNF/NT-3 growth factors receptor,39868,0.014130987434065,0.00239824240338228,0.0094304323234357,0.0188315425446942,3.88672264333531e-09
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LAYN,Layilin,39713,-0.0178248396442416,0.00302698192586923,-0.0237577242189453,-0.0118919550695379,3.97232431592302e-09
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CD200,OX-2 membrane glycoprotein,39866,0.014200036159948,0.00241496608129441,0.00946670264061097,0.0189333696792851,4.18396003830671e-09
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ECHS1,"Enoyl-CoA hydratase, mitochondrial",37043,-0.0536059531746946,0.00914525035091451,-0.071530643862487,-0.0356812624869022,4.69344395536495e-09
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CD226,CD226 antigen,37056,-0.0230636487251658,0.00393752281801777,-0.0307811934484806,-0.015346104001851,4.81369367997449e-09
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SUGP1,SURP and G-patch domain-containing protein 1,37382,-0.0220219100500641,0.00376951703437228,-0.0294101634374337,-0.0146336566626944,5.27315351694461e-09
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FBP1,"Fructose-1,6-bisphosphatase 1",39868,-0.0398212082729885,0.00682653539655224,-0.0532012176502309,-0.0264411988957461,5.53909758930924e-09
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DDHD2,Phospholipase DDHD2,37411,-0.0366129910042027,0.00627646833306043,-0.0489148689370012,-0.0243111130714043,5.55570748962059e-09
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NGRN,Neugrin,37388,-0.0116732940452245,0.00200203497962683,-0.0155972826052931,-0.00774930548515588,5.6450072387307e-09
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LRP1,Prolow-density lipoprotein receptor-related protein 1,39788,0.0145025916191421,0.00248866587014126,0.00962480651366522,0.0193803767246189,5.7365390560229e-09
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FAM13A,Protein FAM13A,37382,-0.0369800175861237,0.00636364330735452,-0.0494527584685385,-0.0245072767037088,6.3447128715907e-09
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,HGFAC,Hepatocyte growth factor activator,37318,0.0154716436617442,0.00266263252923896,0.0102528839044359,0.0206904034190526,6.36365627146066e-09
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,BGN,Biglycan,39448,0.0650450917568127,0.0111962254792099,0.0431004898175612,0.0869896936960641,6.38603822679373e-09
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,B2M,Beta-2-microglobulin,37453,-0.0167958623283431,0.00289142146321758,-0.0224630483962495,-0.0111286762604366,6.43072138212356e-09
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ATXN3,Ataxin-3,37388,-0.0334256248847717,0.00575561607976285,-0.0447066324011069,-0.0221446173684365,6.48448858122115e-09
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CNTN4,Contactin-4,39858,0.0130027652859177,0.0022393719000304,0.00861359636185807,0.0173919342099772,6.50270667477871e-09
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SERPING1,Plasma protease C1 inhibitor,37424,0.0102608983392082,0.00176719612817862,0.00679719392797815,0.0137246027504383,6.52922611216252e-09
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NADK,NAD kinase,39868,-0.02907251998531,0.00501154869876382,-0.0388951554348871,-0.0192498845357329,6.7122837534915e-09
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FOXO3,Forkhead box protein O3,39477,-0.0531330941396281,0.00916792880873908,-0.0711022346047567,-0.0351639536744995,6.94148026762709e-09
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TRAF2,TNF receptor-associated factor 2,39866,-0.0386440098833888,0.00666976920682427,-0.0517167575287643,-0.0255712622380132,7.00601965679563e-09
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IL12A_IL12B,Interleukin-12,39788,-0.0399644063077523,0.00691796107522582,-0.0535236100151949,-0.0264052026003097,7.75070160327106e-09
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CSPG4,Chondroitin sulfate proteoglycan 4,37437,0.0177782207834443,0.00308080016813354,0.0117398524539025,0.023816589112986,8.06900203387271e-09
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,AKR1C4,Aldo-keto reductase family 1 member C4,39585,-0.0285433856646928,0.00494776809434446,-0.0382410111296079,-0.0188457601997776,8.12708310306853e-09
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IL12B,Interleukin-12 subunit beta,40058,-0.0283319844798723,0.00491258868944655,-0.0379606583111876,-0.0187033106485571,8.20583771888895e-09
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,REEP4,Receptor expression-enhancing protein 4,37411,-0.0337998915546245,0.00586612872405629,-0.0452975038537748,-0.0223022792554741,8.4994003701301e-09
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PDCD6,Programmed cell death protein 6,39868,0.0375933641235877,0.00654102841904747,0.0247729484222547,0.0504137798249208,9.23206525795733e-09
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,VEGFD,Vascular endothelial growth factor D,40024,0.0190463759296816,0.00333488202889085,0.0125100071530555,0.0255827447063076,1.14114945084023e-08
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,BAG6,Large proline-rich protein BAG6,39585,-0.0197827651414062,0.00346511172583751,-0.0265743841240477,-0.0129911461587646,1.15606424643712e-08
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CAMSAP1,Calmodulin-regulated spectrin-associated protein 1,37411,-0.0572881829225619,0.0100338540307442,-0.0769545368228205,-0.0376218290223034,1.15692629329236e-08
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SH3GLB2,Endophilin-B2,37388,-0.0353622764684464,0.00621272078308401,-0.0475392092032911,-0.0231853437336018,1.28230584257726e-08
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IL7R,Interleukin-7 receptor subunit alpha,39858,0.0277506587415145,0.00488608352491924,0.0181739350326728,0.0373273824503562,1.37412978185832e-08
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MOG,Myelin-oligodendrocyte glycoprotein,40030,0.0168857249695118,0.00298235940698699,0.0110403005318173,0.0227311494072063,1.52277706926494e-08
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RRAS,Ras-related protein R-Ras,37039,-0.0701607126132332,0.0123926058489888,-0.0944502200772511,-0.0458712051492152,1.53189206818431e-08
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CXCL5,C-X-C motif chemokine 5,39805,-0.0605220346001628,0.0106961718349413,-0.0814865313966477,-0.0395575378036779,1.55516891018076e-08
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,OPLAH,5-oxoprolinase,37043,-0.0368925329593036,0.00652439674147226,-0.0496803505725893,-0.024104715346018,1.59498948680879e-08
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TSC22D1,TSC22 domain family protein 1,37411,-0.0360081322684516,0.00637567449910296,-0.0485044542866934,-0.0235118102502098,1.65841576420569e-08
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LETM1,Mitochondrial proton/calcium exchanger protein,37411,-0.0278353725014604,0.00492890964434917,-0.0374960354043847,-0.018174709598536,1.6619573847187e-08
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MAVS,Mitochondrial antiviral-signaling protein,39477,-0.049043304843053,0.00869194603168711,-0.0660795190651597,-0.0320070906209463,1.70621747385292e-08
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,USO1,General vesicular transport factor p115,39788,-0.0475135607178087,0.00842927644728807,-0.0640349425544933,-0.030992178881124,1.76246422233301e-08
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RECK,Reversion-inducing cysteine-rich protein with Kazal motifs,37043,0.0110649792777355,0.00196941752613037,0.00720492092651993,0.014925037628951,1.96634374526594e-08
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FCRLB,Fc receptor-like B,39477,-0.0304663217197776,0.00543273211000934,-0.0411144766553959,-0.0198181667841592,2.08243971417158e-08
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FABP3,"Fatty acid-binding protein, heart",37437,-0.0258168997269721,0.00460504220656658,-0.0348427824518426,-0.0167910170021016,2.10818261609267e-08
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SERPINE2,Glia-derived nexin,37437,-0.033957731918836,0.00606263457975563,-0.0458404956951571,-0.022074968142515,2.17068555118522e-08
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DGKA,Diacylglycerol kinase alpha,37056,-0.0288253473455594,0.00514643232163166,-0.0389123546959574,-0.0187383399951613,2.17334106884637e-08
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DNM3,Dynamin-3,37411,-0.0288686739449472,0.00516330688697676,-0.0389887554434217,-0.0187485924464728,2.29967571017326e-08
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,AAMDC,Mth938 domain-containing protein,37043,-0.02808491063623,0.00502921281906684,-0.037942167761601,-0.018227653510859,2.39206938198135e-08
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MPHOSPH8,M-phase phosphoprotein 8,39585,-0.0396904863582843,0.00711772277335333,-0.0536412229940568,-0.0257397497225118,2.49746674593246e-08
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CTSS,Cathepsin S,36543,-0.0128646543368437,0.00230706723598162,-0.0173865061193677,-0.00834280255431974,2.50863105288207e-08
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SOD3,Extracellular superoxide dismutase,37445,0.0318974354521548,0.00572198310157573,0.0206823485730664,0.0431125223312432,2.5291000661413e-08
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GOPC,Golgi-associated PDZ and coiled-coil motif-containing protein,39866,-0.0530807254291374,0.00952670912184144,-0.0717530753079466,-0.0344083755503282,2.56214378918006e-08
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CTRC,Chymotrypsin-C,39856,0.0322306308481295,0.00579414177337139,0.0208741129723216,0.0435871487239375,2.7000718911673e-08
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TSPAN1,Tetraspanin-1,39585,-0.0210456853712679,0.00378368268520572,-0.0284617034342711,-0.0136296673082647,2.70701652047665e-08
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CLEC6A,C-type lectin domain family 6 member A,39477,-0.0242572940253569,0.00436222348198256,-0.0328072520500427,-0.0157073360006711,2.73000509404742e-08
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PACS2,Phosphofurin acidic cluster sorting protein 2,37021,-0.03258705147919,0.00586905881743021,-0.0440904067613532,-0.0210836961970268,2.87317519436611e-08
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SAA4,Serum amyloid A-4 protein,37453,-0.0171991414895987,0.00309929430219622,-0.0232737583219033,-0.0111245246572941,2.92058003770861e-08
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FLT3LG,Fms-related tyrosine kinase 3 ligand,40058,-0.0173507105979746,0.00312716417988317,-0.0234799523905456,-0.0112214688054036,2.9283759467078e-08
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CCL19,C-C motif chemokine 19,40009,-0.0601931268825097,0.0108512078910778,-0.0814614943490222,-0.0389247594159971,2.94946017720045e-08
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SLC16A1,Monocarboxylate transporter 1,39489,-0.0301253888607042,0.00544906954781495,-0.0408055651744215,-0.0194452125469869,3.28081647751577e-08
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CCL4,C-C motif chemokine 4,39882,-0.0322117957897214,0.00583928050977583,-0.0436567855888821,-0.0207668059905608,3.51376476344834e-08
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FOXJ3,Forkhead box protein J3,37056,-0.023250430273086,0.00421497396896739,-0.0315117792522621,-0.01498908129391,3.5302883452407e-08
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DPEP2,Dipeptidase 2,39788,0.015048138451178,0.00273165590145979,0.00969409288431678,0.0204021840180392,3.66891826325572e-08
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,COMT,Catechol O-methyltransferase,39403,-0.0439712586936723,0.00799326561602356,-0.0596380593010784,-0.0283044580862661,3.83524632639457e-08
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FNTA,Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha,37368,-0.0184951669066347,0.00336266479772612,-0.0250859899101779,-0.0119043439030916,3.86362798639268e-08
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,HSPA1A,Heat shock 70 kDa protein 1A,39904,-0.0368048703809374,0.00669641904895243,-0.0499298517168841,-0.0236798890449906,3.93974290104194e-08
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ANKRD54,Ankyrin repeat domain-containing protein 54,39477,-0.0291482810109763,0.00530401203809556,-0.0395441446056436,-0.018752417416309,3.95669822645607e-08
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,STAMBP,STAM-binding protein,39713,-0.0332134198637159,0.00604485790324415,-0.0450613413540745,-0.0213654983733574,3.97876540773118e-08
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CD79B,B-cell antigen receptor complex-associated protein beta chain,40058,-0.0215590010742079,0.00392917002537879,-0.0292601743239503,-0.0138578278244654,4.15161288439526e-08
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MGLL,Monoglyceride lipase,39908,-0.0448981123398751,0.00819272500547503,-0.0609558533506062,-0.028840371329144,4.31145862153805e-08
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CYTL1,Cytokine-like protein 1,37437,0.0117525491923548,0.00214593684513966,0.00754651297588111,0.0159585854088286,4.41157927295973e-08
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DPEP1,Dipeptidase 1,39713,0.0243422749849442,0.00444598579045871,0.0156281428356451,0.0330564071342433,4.43878091049066e-08
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PSME2,Proteasome activator complex subunit 2,39666,-0.0185682767605488,0.00339788594048644,-0.0252281332039022,-0.0119084203171954,4.70824361439211e-08
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CD6,T-cell differentiation antigen CD6,40040,-0.026877790893756,0.00492085332537275,-0.0365226634114866,-0.0172329183760254,4.77696104496708e-08
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CACNB3,Voltage-dependent L-type calcium channel subunit beta-3,37411,-0.0434345628789517,0.00795149729326029,-0.0590194975737419,-0.0278496281841616,4.77923522532858e-08
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,HAVCR2,Hepatitis A virus cellular receptor 2,39858,-0.0172420284243132,0.00315680996533155,-0.0234293759563631,-0.0110546808922634,4.7822297715898e-08
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,BCL2L15,Bcl-2-like protein 15,37056,-0.0289517743412534,0.00531051398705358,-0.0393603817558784,-0.0185431669266283,5.07636926633199e-08
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LAMP1,Lysosome-associated membrane glycoprotein 1,37097,-0.0144754087106568,0.00265643962673329,-0.019682030379054,-0.0092687870422595,5.15088948156155e-08
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,STIP1,Stress-induced-phosphoprotein 1,39826,-0.0330970979125931,0.00607786054938147,-0.0450097045893808,-0.0211844912358054,5.24181191669356e-08
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,HNRNPUL1,Heterogeneous nuclear ribonucleoprotein U-like protein 1,37411,-0.0244304207118036,0.00448752424398132,-0.033225968230007,-0.0156348731936002,5.29817492168819e-08
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,COMP,Cartilage oligomeric matrix protein,39729,0.0171042542303385,0.00314286275021301,0.010944243239921,0.023264265220756,5.33911863215105e-08
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CST7,Cystatin-F,39882,-0.0470284867021561,0.00864385213460112,-0.0639704368859743,-0.0300865365183379,5.38545045168622e-08
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CCL13,C-C motif chemokine 13,40024,-0.0351336848863734,0.00645994088704451,-0.0477951690249806,-0.0224722007477662,5.44499518949118e-08
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IFNG,Interferon gamma,39587,-0.0583569828731977,0.010740351693957,-0.0794080721933533,-0.037305893553042,5.6102121920358e-08
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PTGDS,Prostaglandin-H2 D-isomerase,39762,-0.0144627290807709,0.00266383404939042,-0.0196838438175761,-0.00924161434396565,5.74081464686183e-08
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PDLIM5,PDZ and LIM domain protein 5,37411,-0.0611536422179267,0.0112633678154674,-0.0832298431362427,-0.0390774412996107,5.75089751964732e-08
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DLK1,Protein delta homolog 1,40052,-0.0283493400275154,0.00523494188458425,-0.0386098261213006,-0.0180888539337303,6.20212725351675e-08
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CD34,Hematopoietic progenitor cell antigen CD34,39945,0.0122062470439342,0.00225421643325759,0.00778798283474937,0.0166245112531191,6.22195956635702e-08
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GGT5,Glutathione hydrolase 5 proenzyme,39749,-0.0116713512446286,0.0021558039495936,-0.015896726985832,-0.00744597550342513,6.25544839177357e-08
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PLIN3,Perilipin-3,39868,-0.0217613660055892,0.00403180568038847,-0.0296637051391506,-0.0138590268720277,6.85667430551208e-08
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SLC27A4,Long-chain fatty acid transport protein 4,39489,-0.034307122650411,0.00635747053454805,-0.0467677648981252,-0.0218464804026969,6.90020234223694e-08
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,39477,-0.0396428932169096,0.00734688231130728,-0.0540427825470719,-0.0252430038867473,6.9182641466031e-08
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IL12RB1,Interleukin-12 receptor subunit beta-1,39587,-0.0186646832107085,0.00346364917413414,-0.0254534355920114,-0.0118759308294055,7.19776203709436e-08
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CD69,Early activation antigen CD69,39785,-0.0444268204707676,0.00824627717829273,-0.0605895237402213,-0.0282641172013138,7.24594218273327e-08
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PZP,Pregnancy zone protein,37453,-0.0277874510840663,0.00516945709897432,-0.037919586998056,-0.0176553151700766,7.77122434865344e-08
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CGA,Glycoprotein hormones alpha chain,39858,0.0445869336609644,0.00830373894485373,0.0283116053290511,0.0608622619928777,8.00569823940506e-08
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RABGAP1L,Rab GTPase-activating protein 1-like,39587,-0.030041792311256,0.00559650209341191,-0.0410109364143434,-0.0190726482081687,8.07623651414594e-08
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,XIAP,E3 ubiquitin-protein ligase XIAP,37056,-0.029522891748541,0.00550391532051954,-0.0403105657767593,-0.0187352177203227,8.27817494780554e-08
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ICAM2,Intercellular adhesion molecule 2,40052,-0.0157564753753844,0.0029398173665871,-0.0215185174138951,-0.00999443333687369,8.45118442154827e-08
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CKMT1A_CKMT1B,"Creatine kinase U-type, mitochondrial",39809,-0.0329087460110953,0.00614096477125393,-0.0449450369627531,-0.0208724550594376,8.48989461066672e-08
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CD300A,CMRF35-like molecule 8,37124,-0.0145560910602152,0.00271875946948621,-0.0198848596204082,-0.00922732250002226,8.74908770519614e-08
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CCN5,CCN family member 5,39858,-0.0193156157750942,0.00361205521644966,-0.0263952439993356,-0.0122359875508529,9.03817190403448e-08
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RAB11FIP3,Rab11 family-interacting protein 3,37437,-0.0540700569656627,0.0101104526701458,-0.0738865441991485,-0.0342535697321769,9.04047180462287e-08
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,HIP1R,Huntingtin-interacting protein 1-related protein,37365,-0.021040744437064,0.00393597410686819,-0.0287552536865256,-0.0133262351876023,9.15070013830441e-08
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SEPTIN8,Septin-8,37357,-0.0159686860921721,0.00299232942942497,-0.021833651773845,-0.0101037204104991,9.6268825674738e-08
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IFT20,Intraflagellar transport protein 20 homolog,37039,-0.0218651340412863,0.00409800093793713,-0.0298972158796431,-0.0138330522029295,9.68260860780398e-08
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SH3BP1,SH3 domain-binding protein 1,37382,-0.0239915869590492,0.0045045275082877,-0.032820460875293,-0.0151627130428053,1.01948284373731e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,HCLS1,Hematopoietic lineage cell-specific protein,40058,-0.0279980879712377,0.00525998910982841,-0.0383076666265014,-0.0176885093159741,1.03520041266873e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,AKR1B10,Aldo-keto reductase family 1 member B10,37039,-0.0304545757367531,0.00572322550250579,-0.0416720977216645,-0.0192370537518418,1.0475845142302e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MAP2,Microtubule-associated protein 2,37388,-0.0230031474649799,0.00432329288564257,-0.0314768015208393,-0.0145294934091204,1.04990109883108e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MYOC,Myocilin,39858,0.0229374335698949,0.00431217789797702,0.01448556488986,0.0313893022499299,1.05613985856687e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SNRPB2,U2 small nuclear ribonucleoprotein B'',37388,-0.0201859480837729,0.00379847784299813,-0.0276309646560493,-0.0127409315114966,1.08815029392253e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SAMD9L,Sterile alpha motif domain-containing protein 9-like,39866,-0.0365371810656908,0.00687610590732779,-0.0500143486440533,-0.0230600134873284,1.08893617032195e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ENTPD2,Ectonucleoside triphosphate diphosphohydrolase 2,39477,-0.021682748569906,0.00408266502984706,-0.0296847720284063,-0.0136807251114058,1.10561742834984e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MAP2K1,Dual specificity mitogen-activated protein kinase kinase 1,37382,-0.032454215017796,0.00611405151759768,-0.0444377559922875,-0.0204706740433046,1.12502928176206e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LGALS3BP,Galectin-3-binding protein,37453,-0.0150216324385721,0.00283060586915169,-0.0205696199421094,-0.0094736449350348,1.13281152817695e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SERPINI2,Serpin I2,37382,-0.0285200042891906,0.00537663544341098,-0.0390582097582761,-0.0179817988201051,1.14805327547496e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MMP9,Matrix metalloproteinase-9,39843,-0.0301520474607936,0.00568634363132216,-0.0412972809781851,-0.0190068139434022,1.15723867890208e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NEXN,Nexilin,37445,-0.034293954638838,0.00646788846263487,-0.0469710160256023,-0.0216168932520736,1.1621597288291e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GAPDH,Glyceraldehyde-3-phosphate dehydrogenase,36846,-0.0164216334185703,0.00309820909168781,-0.0224941232382784,-0.0103491435988622,1.17464557240352e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CLIP2,CAP-Gly domain-containing linker protein 2,39866,-0.05631165398993,0.010631126853855,-0.0771486626234858,-0.0354746453563742,1.19365821838656e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CRKL,Crk-like protein,39881,-0.0531556678713921,0.0100387348672823,-0.0728315882112653,-0.0334797475315188,1.20550306579671e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MMP8,Neutrophil collagenase,39985,-0.0354808077992233,0.00672503585779804,-0.0486618780805075,-0.0222997375179392,1.33793778175506e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LPP,Lipoma-preferred partner,37021,-0.0332538072645031,0.00630581096011093,-0.0456131967463205,-0.0208944177826857,1.35952430066237e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LRRC59,Leucine-rich repeat-containing protein 59,37437,-0.0231173548018226,0.00438536746177113,-0.031712675026894,-0.0145220345767512,1.37405540981235e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RHOC,Rho-related GTP-binding protein RhoC,39672,-0.0583491268020167,0.011080905090576,-0.0800677007795456,-0.0366305528244878,1.41456218255894e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PLG,Plasminogen,37162,-0.0112130430736914,0.00212953702970125,-0.0153869356519059,-0.00703915049547697,1.41998015836505e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MYL3,Myosin light chain 3,37043,-0.0360432267949799,0.0068494501078498,-0.0494681490063655,-0.0226183045835943,1.44567485937843e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TBC1D23,TBC1 domain family member 23,39788,-0.0444774717160566,0.00845857890633699,-0.0610562863724771,-0.0278986570596361,1.47298041194853e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MYDGF,Myeloid-derived growth factor,37437,-0.0499661748223943,0.00951153490351754,-0.0686087832332887,-0.0313235664114999,1.51723336407375e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MPIG6B,Megakaryocyte and platelet inhibitory receptor G6b,39908,-0.0378182546947159,0.00719971641408678,-0.051929698866326,-0.0237068105231058,1.51765303769875e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CST5,Cystatin-D,39559,-0.0267070851655149,0.00509486991284418,-0.0366930301946895,-0.0167211401363403,1.60941392418853e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CETN2,Centrin-2,39489,-0.0333567916425729,0.00636507024189963,-0.0458323293166962,-0.0208812539684497,1.62135467869338e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PGLYRP1,Peptidoglycan recognition protein 1,39962,-0.0206278614391769,0.00393700829058516,-0.0283443976887238,-0.01291132518963,1.63062939445818e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SYAP1,Synapse-associated protein 1,37124,-0.0283380194141186,0.00540853240049998,-0.0389387429190986,-0.0177372959091387,1.63476729343754e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TNFSF13,Tumor necrosis factor ligand superfamily member 13,39931,-0.0129089200688931,0.00246416087742575,-0.0177386753886476,-0.00807916474913862,1.63781549909218e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GFRAL,GDNF family receptor alpha-like,36942,0.0306422439762382,0.00585063675606036,0.0191749959343599,0.0421094920181165,1.65362264206791e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IL32,Interleukin-32,39866,0.0210234579454769,0.00402068035647959,0.0131429244467769,0.0289039914441769,1.72731547262258e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SMOC2,SPARC-related modular calcium-binding protein 2,39931,-0.0186058624481774,0.00355873920433802,-0.0255809912886799,-0.0116307336076748,1.7329584113015e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,QDPR,Dihydropteridine reductase,39790,-0.0213271698010322,0.00408099932662785,-0.0293259284812228,-0.0133284111208416,1.75432389309093e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SESTD1,SEC14 domain and spectrin repeat-containing protein 1,39489,-0.0316131580310458,0.0060508813848755,-0.0434728855454018,-0.0197534305166898,1.76817767842772e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DEFA1_DEFA1B,Neutrophil defensin 1,39537,-0.0246037387521803,0.00471218594574575,-0.0338396232058419,-0.0153678542985186,1.79940842758177e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DPT,Dermatopontin,40052,0.0131267222488043,0.00251638446896019,0.00819460868964228,0.0180588358079662,1.84581462746543e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ALDH2,"Aldehyde dehydrogenase, mitochondrial",37368,-0.0249178568496433,0.0047844961141845,-0.0342954692334449,-0.0155402444658416,1.93647837834819e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,BNIP3L,BCL2/adenovirus E1B 19 kDa protein-interacting protein 3-like,37056,-0.0221159734827543,0.00425388365508088,-0.0304535854467128,-0.0137783615187958,2.03348952565682e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,STK11,Serine/threonine-protein kinase STK11,39585,-0.0356645731628951,0.00687363227651744,-0.0491368924248693,-0.022192253900921,2.14506984111312e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GET3,ATPase GET3,37437,-0.0272076301610614,0.0052585946967782,-0.0375144757667467,-0.0169007845553761,2.32480032735956e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ATG4A,Cysteine protease ATG4A,39477,-0.028585260680141,0.005527192530953,-0.0394185580408089,-0.0177519633194731,2.34777149055447e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MMP7,Matrilysin,39563,-0.0239579374496362,0.00463706480737152,-0.0330465844720843,-0.014869290427188,2.41287467870734e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,KDR,Vascular endothelial growth factor receptor 2,39913,-0.012336415068032,0.00239364512310455,-0.0170279595093169,-0.00764487062674709,2.58260589070916e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NIT1,Deaminated glutathione amidase,37043,-0.0228402724954913,0.00443408109951213,-0.0315310714505351,-0.0141494735404475,2.62737893615332e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IMPACT,Protein IMPACT,37388,-0.026747011710246,0.0051999682407557,-0.0369389494621271,-0.0165550739583648,2.73163375464982e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SNCA,Alpha-synuclein,37124,-0.0560534914343899,0.0109127417811335,-0.0774424653254115,-0.0346645175433684,2.83845079560203e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,BAG4,BAG family molecular chaperone regulator 4,37056,-0.0240462971728394,0.00469018787589753,-0.0332390654095986,-0.0148535289360803,2.98661896956148e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CLSTN2,Calsyntenin-2,40058,0.0189511140815942,0.00369869059594155,0.0117016805135488,0.0262005476496396,3.02981793377699e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,EDN1,Endothelin-1,37043,-0.0135369999198752,0.00264181697695385,-0.0187149611947048,-0.00835903864504567,3.03148478377342e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ALDH3A1,"Aldehyde dehydrogenase, dimeric NADP-preferring",39842,-0.0304660354446053,0.00594694750020155,-0.0421220525450003,-0.0188100183442103,3.04260080253918e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ACHE,Acetylcholinesterase,37124,-0.0157289956904036,0.00307345089982144,-0.0217529594540537,-0.00970503192675362,3.13610201663559e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DFFA,DNA fragmentation factor subunit alpha,40058,-0.0325339822480872,0.00636432951117993,-0.0450080680899999,-0.0200598964061746,3.225216492482e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SIGLEC6,Sialic acid-binding Ig-like lectin 6,40030,-0.0158519994693191,0.00310431028469157,-0.0219364476273146,-0.0097675513113236,3.3199951283272e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SCARF1,Scavenger receptor class F member 1,40052,-0.0205110939587868,0.00401671509085929,-0.028383855536871,-0.0126383323807026,3.32017703422155e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TSNAX,Translin-associated protein X,37021,-0.0187883617933381,0.0036840301139844,-0.0260090608167475,-0.0115676627699287,3.44470021084658e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,VPS28,Vacuolar protein sorting-associated protein 28 homolog,37169,-0.0322141528766401,0.00632317731803365,-0.044607580419986,-0.0198207253332941,3.54235201690806e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NSFL1C,NSFL1 cofactor p47,40009,-0.0310242412108223,0.00609718103106181,-0.0429747160317034,-0.0190737663899412,3.65354613595051e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,VAMP5,Vesicle-associated membrane protein 5,39585,-0.0251840478512716,0.00495272135309618,-0.0348913817033401,-0.0154767139992031,3.72064536347807e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IRAK4,Interleukin-1 receptor-associated kinase 4,39866,-0.0499476811157267,0.00984113699324386,-0.0692363096224847,-0.0306590526089688,3.91020813727474e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GTPBP2,GTP-binding protein 2,37039,-0.0385908962201846,0.0076139845212775,-0.0535143058818885,-0.0236674865584807,4.06560864821807e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,HBQ1,Hemoglobin subunit theta-1,40030,0.0284908165121078,0.00562748644669037,0.0174609430765947,0.039520689947621,4.17690940216097e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CLEC5A,C-type lectin domain family 5 member A,39818,-0.0134674676367354,0.00266182735864438,-0.0186846492596784,-0.00825028601379244,4.25065612308194e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MARS1,"Methionine--tRNA ligase, cytoplasmic",37088,-0.0410946309854882,0.00812390993807573,-0.0570174944641166,-0.0251717675068598,4.2827567979718e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ASAH1,Acid ceramidase,37340,-0.0224311200695717,0.00443887347748091,-0.0311313120854343,-0.0137309280537091,4.39844300010927e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,AHSP,Alpha-hemoglobin-stabilizing protein,39836,-0.040439595119722,0.00800707894508003,-0.0561334698520788,-0.0247457203873651,4.45555351739315e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FCAR,Immunoglobulin alpha Fc receptor,39866,-0.0221771660685879,0.00439361660355885,-0.0307886546115632,-0.0135656775256125,4.52331744768521e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CLEC4A,C-type lectin domain family 4 member A,39866,0.0164693283112095,0.00326324418009011,0.0100733697182329,0.0228652869041861,4.53915648226154e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DKK3,Dickkopf-related protein 3,40052,0.0135991836018938,0.00269701067790291,0.00831304267320414,0.0188853245305836,4.64895466655412e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ANGPTL2,Angiopoietin-related protein 2,39877,-0.0186055270720657,0.00369057789809261,-0.0258390597523272,-0.0113719943918042,4.67281731745646e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RGCC,Regulator of cell cycle RGCC,37411,-0.0359257029090162,0.00712696454240175,-0.0498945534121236,-0.0219568524059088,4.69536551280075e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ESYT2,Extended synaptotagmin-2,37388,-0.0389788247811957,0.00773373586691861,-0.0541369470803562,-0.0238207024820352,4.71291568949143e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,BIN2,Bridging integrator 2,39858,-0.0423828931238569,0.00842188941487924,-0.0588897963770202,-0.0258759898706936,4.89457805688874e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CDH3,Cadherin-3,40009,-0.0163540746540025,0.00325002332730581,-0.0227241203755219,-0.00998402893248309,4.9063798541418e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,BID,BH3-interacting domain death agonist,39866,-0.0311954217455822,0.00621025182860469,-0.0433675153296474,-0.019023328161517,5.13610998774336e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,EGF,Pro-epidermal growth factor,39808,-0.0488570639771203,0.00972909315375028,-0.0679260865584708,-0.0297880413957698,5.17557781590739e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CD80,T-lymphocyte activation antigen CD80,37437,-0.015798615657281,0.00315044918515902,-0.0219734960601927,-0.00962373525436933,5.37814688159879e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CRACR2A,EF-hand calcium-binding domain-containing protein 4B,39477,-0.0401500890569349,0.00801085697726991,-0.0558513687323839,-0.0244488093814858,5.44681059352234e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SCG3,Secretogranin-3,39885,0.0152204954977001,0.00304039710623218,0.009261317169485,0.0211796738259152,5.61369041209372e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CRISP2,Cysteine-rich secretory protein 2,40030,0.0263051248699667,0.00526051148705249,0.0159945223553438,0.0366157273845896,5.77842241856764e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DOK1,Docking protein 1,37388,-0.0644198153312075,0.0128882204868265,-0.0896807274853874,-0.0391589031770276,5.85466515585867e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CSNK2A1,Casein kinase II subunit alpha,37411,0.021109107494906,0.00422723334052835,0.0128237301474705,0.0293944848423416,6.00016594820871e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DECR1,"2,4-dienoyl-CoA reductase, mitochondrial",39866,-0.0452105394085683,0.00905624288633878,-0.0629607754657923,-0.0274603033513443,6.03241701345229e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CMC1,COX assembly mitochondrial protein homolog,37437,-0.0424435824516878,0.00851011010943882,-0.0591233982661879,-0.0257637666371877,6.1943682806291e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ANXA10,Annexin A10,39489,-0.0365746320068608,0.00736202523189502,-0.051004201461375,-0.0221450625523466,6.83573927540616e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SMTN,Smoothelin,37342,-0.0449347013519517,0.00904570746270927,-0.0626642879788618,-0.0272051147250415,6.86466811597587e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LRPAP1,Alpha-2-macroglobulin receptor-associated protein,40009,-0.0260778559440383,0.00525104050946347,-0.0363698953425867,-0.0157858165454899,6.89652978301415e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,POLR2F,"DNA-directed RNA polymerases I, II, and III subunit RPABC2",39788,-0.0151989332970225,0.00306160071120034,-0.0211996706909752,-0.00919819590306988,6.96352433934141e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TTF2,Transcription termination factor 2,37039,-0.0229792186535784,0.00463005515044434,-0.0320541267484493,-0.0139043105587074,7.02597460217434e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,APBB1IP,Amyloid beta A4 precursor protein-binding family B member 1-interacting protein,39788,-0.0209419340314172,0.00422121780143168,-0.0292155209222233,-0.0126683471406111,7.08135150809592e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PIKFYVE,1-phosphatidylinositol 3-phosphate 5-kinase,37056,-0.0267233518983376,0.00539311956626997,-0.0372938662482268,-0.0161528375484485,7.3196026703565e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ATRAID,All-trans retinoic acid-induced differentiation factor,37382,-0.0126095540877393,0.00254580131974698,-0.0175993246744434,-0.00761978350103521,7.39307904505298e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TALDO1,Transaldolase,37415,-0.0207669835921069,0.00419639341506997,-0.028991914685644,-0.0125420524985697,7.55810107228729e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ABO,Histo-blood group ABO system transferase,37445,0.066637300324887,0.0134804622935012,0.0402155942296247,0.0930590064201493,7.77473365280062e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PODXL2,Podocalyxin-like protein 2,39913,0.0127258308187049,0.00257612488944452,0.00767662603539369,0.0177750356020162,7.89442166131641e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,37169,-0.04941290232155,0.0100080581380828,-0.0690286962721923,-0.0297971083709077,8.01670192531766e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TP53I3,Quinone oxidoreductase PIG3,36874,-0.0248719912946372,0.00503786068124479,-0.034746198229877,-0.0149977843593974,8.03108994462814e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CCT5,T-complex protein 1 subunit epsilon,39477,-0.0207568282465664,0.00420534497992712,-0.0289993044072235,-0.0125143520859092,8.06374738317751e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PRKAB1,5'-AMP-activated protein kinase subunit beta-1,39587,-0.0258536040490504,0.00524911173135258,-0.0361418630425015,-0.0155653450555994,8.50736364553713e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SCRIB,Protein scribble homolog,37043,-0.0417802491514322,0.00849083631202302,-0.0584222883229973,-0.0251382099798671,8.73089112927804e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NELL2,Protein kinase C-binding protein NELL2,39931,0.0129574120505096,0.00264040277697177,0.00778222260764497,0.0181326014933743,9.32139977364322e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ARSB,Arylsulfatase B,39788,-0.0254709773007266,0.00519224479491965,-0.0356477770987691,-0.0152941775026841,9.40707779946212e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SLAMF6,SLAM family member 6,39477,-0.0173879194020672,0.00354462301091749,-0.0243353805034655,-0.010440458300669,9.41588445499205e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CD300C,CMRF35-like molecule 6,40009,-0.0153013771970173,0.00312045966709631,-0.0214174781445261,-0.00918527624950855,9.50275732452796e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PAGR1,PAXIP1-associated glutamate-rich protein 1,37043,-0.0200666527618752,0.00409346831986023,-0.0280898506688013,-0.0120434548549491,9.59389448771536e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CPXM1,Probable carboxypeptidase X1,39913,-0.0311512739306321,0.00636684179416756,-0.0436302838472005,-0.0186722640140637,1.004081297736e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IL10,Interleukin-10,39587,-0.0363760272531193,0.00743523906753114,-0.0509490958254804,-0.0218029586807583,1.0060878100567e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MAP3K5,Mitogen-activated protein kinase kinase kinase 5,39477,-0.0451723300796905,0.00923783378068647,-0.063278484289836,-0.027066175869545,1.01876778112035e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PCYT2,Ethanolamine-phosphate cytidylyltransferase,37382,-0.0352533406312763,0.00721047018492042,-0.0493858621937204,-0.0211208190688323,1.02416096823391e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IGBP1,Immunoglobulin-binding protein 1,37411,-0.0277388703824516,0.00567934386084501,-0.0388703843497079,-0.0166073564151954,1.0505221692892e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TBCC,Tubulin-specific chaperone C,39749,-0.0372391038857419,0.00763283252406969,-0.0521994556329185,-0.0222787521385653,1.07764459839514e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SGSH,N-sulphoglucosamine sulphohydrolase,37265,-0.0252932570898582,0.00518904647591395,-0.0354637881826495,-0.0151227259970668,1.10414429844689e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DLG4,Disks large homolog 4,37388,-0.0327605477618163,0.00673303022424747,-0.0459572870013414,-0.0195638085222913,1.15368661940052e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LRG1,Leucine-rich alpha-2-glycoprotein,37453,0.0116162787398276,0.00238770320449262,0.00693638045902201,0.0162961770206331,1.15714688188962e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ADGRF5,Adhesion G protein-coupled receptor F5,37437,-0.0130316911202535,0.00268149447031275,-0.0182874202820664,-0.00777596195844048,1.1878096715914e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CD99L2,CD99 antigen-like protein 2,39858,-0.0109809278859194,0.00226198343103541,-0.0154144154107488,-0.00654744036109004,1.21794956910115e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CD302,CD302 antigen,39788,-0.0132481743551142,0.0027292488495275,-0.0185975021001881,-0.00789884661004033,1.22052118038221e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CHAC2,Glutathione-specific gamma-glutamylcyclotransferase 2,39477,-0.0268044406547958,0.0055646755913855,-0.0377112048139114,-0.0158976764956802,1.47179907935278e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DDT,D-dopachrome decarboxylase,37437,-0.0181449716256482,0.00376690821789629,-0.0255281117327249,-0.0107618315185715,1.47350756548899e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NECAP2,Adaptin ear-binding coat-associated protein 2,37021,-0.0293775118124114,0.00609993317958196,-0.0413333808443921,-0.0174216427804308,1.48066991296469e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DBNL,Drebrin-like protein,39931,-0.0420172826267754,0.00872641092390385,-0.0591210480376269,-0.0249135172159238,1.48572839723405e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GLO1,Lactoylglutathione lyase,39585,-0.0261008894285208,0.00542576280580049,-0.0367353845278898,-0.0154663943291518,1.5191302804842e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GMPR,GMP reductase 1,40058,-0.022413829002295,0.00465937078044378,-0.0315461957319648,-0.0132814622726252,1.51920216969561e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PKD2,Polycystin-2,37021,-0.0269179582517999,0.0055978836682808,-0.0378898102416303,-0.0159461062619696,1.53676772694599e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SIL1,Nucleotide exchange factor SIL1,37043,-0.0150611527225292,0.00313936698464146,-0.0212143120124265,-0.00890799343263192,1.62407506303277e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NUB1,NEDD8 ultimate buster 1,39866,-0.0379432530583105,0.00791331422387719,-0.0534533489371098,-0.0224331571795112,1.64250657680582e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SLAMF1,Signaling lymphocytic activation molecule,39587,-0.0263232094312761,0.00550159530298627,-0.0371063362251292,-0.015540082637423,1.72840485862315e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PPP1R2,Protein phosphatase inhibitor 2,39868,-0.0362589047665766,0.0075827254884608,-0.0511210467239597,-0.0213967628091934,1.75298282968251e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ITPA,Inosine triphosphate pyrophosphatase,37021,-0.030420163043502,0.0063677404784912,-0.0429009343813448,-0.0179393917056593,1.79644222017212e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RILP,Rab-interacting lysosomal protein,39984,-0.026589017109652,0.00557070200972977,-0.0375075930487223,-0.0156704411705816,1.83084762571127e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NPDC1,Neural proliferation differentiation and control protein 1,39868,-0.0132148666238832,0.00277003027353925,-0.0186441259600201,-0.00778560728774624,1.85244675781593e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IL19,Interleukin-19,39419,-0.0307539597757151,0.00644672693349041,-0.0433895445653563,-0.0181183749860739,1.85458161662139e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ALDH5A1,"Succinate-semialdehyde dehydrogenase, mitochondrial",37411,-0.0210694847058491,0.00442546024582612,-0.0297433867876683,-0.0123955826240299,1.94657226770027e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NOTCH1,Neurogenic locus notch homolog protein 1,40052,0.00700221371338596,0.00147130471682822,0.00411845646840265,0.00988597095836926,1.96053694504125e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FKBP1B,Peptidyl-prolyl cis-trans isomerase FKBP1B,39932,-0.0500720536256195,0.0105421838487798,-0.0707347339692279,-0.029409373282011,2.05493083826994e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ITIH4,Inter-alpha-trypsin inhibitor heavy chain H4,37453,0.0116262728654464,0.00245357016020956,0.0068172753514357,0.0164352703794572,2.17472567785256e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,HS1BP3,HCLS1-binding protein 3,37043,-0.0407970475674442,0.00861955856220281,-0.0576913823493617,-0.0239027127855267,2.23438615394706e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TCOF1,Treacle protein,37437,-0.01352158398505,0.0028600847332125,-0.0191273500621465,-0.00791581790795354,2.29374228308829e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,YJU2,Splicing factor YJU2,37368,-0.0143765169137158,0.00304844154410375,-0.0203514623401592,-0.00840157148727247,2.42906490475215e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GOLM2,Protein GOLM2,40009,-0.00978771603395617,0.00207733145533113,-0.0138592856864052,-0.00571614638150715,2.47733083115598e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ECI2,Enoyl-CoA delta isomerase 2,37021,-0.0273832374681138,0.00581376891936875,-0.0387782245500766,-0.0159882503861511,2.50166597766494e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PAFAH2,"Platelet-activating factor acetylhydrolase 2, cytoplasmic",37169,-0.0220734392076485,0.00469081897644383,-0.0312674444014784,-0.0128794340138186,2.55582949657922e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MINDY1,Ubiquitin carboxyl-terminal hydrolase MINDY-1,37368,-0.0475546969407146,0.0101393395628047,-0.0674278024838118,-0.0276815913976174,2.75721870091095e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,EDIL3,EGF-like repeat and discoidin I-like domain-containing protein 3,39585,-0.016100187710972,0.00343411483518359,-0.0228310527879319,-0.00936932263401219,2.77786111282133e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FKBP5,Peptidyl-prolyl cis-trans isomerase FKBP5,39749,-0.0417242686533262,0.00891125214368953,-0.0591903228549577,-0.0242582144516948,2.86158067634462e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,AZU1,Azurocidin,39344,-0.0336775413437992,0.00719562378205625,-0.0477809639566295,-0.019574118730969,2.88908663016117e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ITGAM,Integrin alpha-M,39858,0.0138363019886314,0.00296082728754399,0.00803308050504522,0.0196395234722177,2.99075536752696e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MTUS1,Microtubule-associated tumor suppressor 1,37169,-0.024583532727057,0.00526130631047297,-0.0348956930955841,-0.01427137235853,3.00448807693248e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PHYKPL,5-phosphohydroxy-L-lysine phospho-lyase,37124,-0.0185079253606058,0.00396397917668667,-0.0262773245469117,-0.0107385261743,3.05596297057929e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FGF2,Fibroblast growth factor 2,39866,-0.0292231028580169,0.00626081663929701,-0.041494303471039,-0.0169519022449947,3.07181929394618e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SIGLEC10,Sialic acid-binding Ig-like lectin 10,39866,-0.014371903172633,0.00308096398749878,-0.0204105925881306,-0.0083332137571354,3.11503588509033e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NOS1,"Nitric oxide synthase, brain",39489,-0.0236516162557173,0.00507167421027567,-0.0335920977078576,-0.013711134803577,3.13490100694729e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,STK24,Serine/threonine-protein kinase 24,39489,-0.0271949258108055,0.00584845324531277,-0.0386578941716186,-0.0157319574499925,3.34757603541427e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PSMG3,Proteasome assembly chaperone 3,39866,-0.0217005705224342,0.00466713911476233,-0.0308481631873683,-0.0125529778575,3.35152639075649e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GIPC2,PDZ domain-containing protein GIPC2,37388,-0.0125265720208635,0.00269509566794294,-0.0178089595300317,-0.00724418451169537,3.38475879673091e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,EHD3,EH domain-containing protein 3,37043,-0.0513780725876659,0.0110628121607937,-0.0730611844228216,-0.0296949607525102,3.4467129590284e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PPP1CC,Serine/threonine-protein phosphatase PP1-gamma catalytic subunit,37368,-0.036431525022983,0.00786560341811869,-0.0518481077224957,-0.0210149423234704,3.65967873073959e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SOST,Sclerostin,39846,-0.0166423640914271,0.00359344632262366,-0.0236855188837695,-0.0095992092990847,3.66221900818245e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NT5E,5'-nucleotidase,39913,-0.024014601451026,0.00518537832528043,-0.0341779429685757,-0.0138512599334764,3.66378033001612e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CASC3,Protein CASC3,37039,-0.0182768779332969,0.00394751487913743,-0.0260140070964063,-0.0105397487701876,3.69210891016074e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CD1C,T-cell surface glycoprotein CD1c,39913,0.010181754996672,0.00219987286476584,0.00587000418173096,0.014493505811613,3.71496934693912e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,BTN2A1,Butyrophilin subfamily 2 member A1,39931,-0.0108311629560142,0.00234152039699105,-0.0154205429341167,-0.00624178297791173,3.76253533523554e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MICALL2,MICAL-like protein 2,37039,-0.0296051069374031,0.00640283574913525,-0.0421546650057082,-0.017055548869098,3.80446595923618e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,APOC1,Apolipoprotein C-I,37424,0.0162472948659076,0.00351932288943866,0.0093494220026078,0.0231451677292074,3.93663875071577e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DPP7,Dipeptidyl peptidase 2,39754,-0.026092409320926,0.00565226728993827,-0.037170853209205,-0.015013965432647,3.9375015715913e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FUCA1,Tissue alpha-L-fucosidase,39928,-0.034936862805244,0.00757745781543895,-0.0497886801235043,-0.0200850454869837,4.04541176657592e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MCFD2,Multiple coagulation factor deficiency protein 2,39788,-0.0194151620388504,0.00421193298338483,-0.0276705506862846,-0.0111597733914161,4.06653523291594e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CHCHD6,MICOS complex subunit MIC25,37368,-0.0125713160256683,0.00272717196558187,-0.0179165730782088,-0.00722605897312785,4.07037302414053e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,BMP10,Bone morphogenetic protein 10,37124,0.0122236434991436,0.00265834433314923,0.00701328860617108,0.0174339983921161,4.30060873620397e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,VAMP8,Vesicle-associated membrane protein 8,37056,-0.038191586276962,0.00831397453808584,-0.0544869763716103,-0.0218961961823138,4.39566061830502e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,REG1A,Lithostathine-1-alpha,39804,-0.0200246100645588,0.0043631516601259,-0.0285763873184056,-0.0114728328107121,4.47734910016325e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GNE,Bifunctional UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase,39477,-0.0282821796506964,0.00616407052013079,-0.0403637578701528,-0.0162006014312401,4.50495698650349e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SMAD3,Mothers against decapentaplegic homolog 3,37368,-0.0219643413805265,0.00478970791152427,-0.031352168887114,-0.0125765138739389,4.56450147179943e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MMP10,Stromelysin-2,39857,0.0252617074149622,0.00550978315444682,0.0144625324322465,0.036060882397678,4.57682455226315e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,YARS1,"Tyrosine--tRNA ligase, cytoplasmic",37382,-0.0634663429784761,0.0138585460185686,-0.0906290931748705,-0.0363035927820816,4.70065059216182e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TNF,Tumor necrosis factor,39555,-0.0163142056513478,0.00356272437423752,-0.0232971454248534,-0.0093312658778423,4.70483689928347e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,KYAT1,Kynurenine--oxoglutarate transaminase 1,39850,-0.0243478233780269,0.00531888148654878,-0.0347728310916625,-0.0139228156643913,4.73835616258925e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,KIAA0319,Dyslexia-associated protein KIAA0319,37388,0.013015660693738,0.00284455583469183,0.00744033125774203,0.018590990129734,4.7898991458139e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DIPK2B,Divergent protein kinase domain 2B,37124,0.0122012473859447,0.00266688648402812,0.00697414987724961,0.0174283448946399,4.80328840442005e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ADAM15,Disintegrin and metalloproteinase domain-containing protein 15,39585,-0.013113218501585,0.00286929250194279,-0.0187370318053929,-0.00748940519777716,4.90985344716025e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RALY,RNA-binding protein Raly,37368,-0.0208596006343443,0.00456860958044874,-0.0298140754120239,-0.0119051258566648,5.01860277914841e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DKK4,Dickkopf-related protein 4,39718,-0.0194135405248971,0.00425467753236927,-0.0277527084883409,-0.0110743725614533,5.08375119394822e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,UBAC1,Ubiquitin-associated domain-containing protein 1,39788,-0.0147172855550446,0.00323211038222384,-0.0210522219042033,-0.00838234920588587,5.31616272213514e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CIT,Citron Rho-interacting kinase,37039,-0.0194019243304335,0.00426313708946836,-0.0277576730257915,-0.0110461756350755,5.38456480612727e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DDR1,Epithelial discoidin domain-containing receptor 1,40009,-0.00993062468811391,0.00218556843933746,-0.0142143388292153,-0.00564691054701248,5.5668938075773e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MFAP4,Microfibril-associated glycoprotein 4,37124,-0.0136068894932706,0.0029945337073753,-0.0194761755597262,-0.00773760342681504,5.57080062170499e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,WFIKKN1,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 1",39699,0.0171683637284707,0.00377998291927482,0.00975959720669203,0.0245771302502493,5.6156604904959e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LZTFL1,Leucine zipper transcription factor-like protein 1,37124,-0.0308239426595319,0.00678616082931679,-0.0441248178849928,-0.017523067434071,5.61671809220708e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TXNDC9,Thioredoxin domain-containing protein 9,37388,-0.022908332856152,0.00504861665258247,-0.0328036214952136,-0.0130130442170903,5.74025119882285e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,UROS,Uroporphyrinogen-III synthase,37039,-0.0292314547574819,0.00644806797542381,-0.0418696679893126,-0.0165932415256512,5.85622863380421e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,P4HB,Protein disulfide-isomerase,39776,-0.0165471465889368,0.003650991839975,-0.0237030905952878,-0.00939120258258584,5.87883520716358e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GAL,Galanin peptides,39931,0.0273492474468272,0.00603585666265952,0.0155189683880146,0.0391795265056399,5.90918897878641e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CHMP1A,Charged multivesicular body protein 1a,39749,-0.0338439630689675,0.00747847909281207,-0.0485017820908792,-0.0191861440470559,6.06858242743638e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CSF2,Granulocyte-macrophage colony-stimulating factor,37021,-0.0149099783933519,0.00329632356510498,-0.0213707725809577,-0.00844918420574615,6.14400598737017e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NID2,Nidogen-2,39858,-0.0308525391750267,0.00682377347775086,-0.0442271351914184,-0.017477943158635,6.18930754778203e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PKN3,Serine/threonine-protein kinase N3,37169,-0.032313436245762,0.0071618252160573,-0.0463506136692343,-0.0182762588222897,6.47998301131331e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GPIHBP1,Glycosylphosphatidylinositol-anchored high density lipoprotein-binding protein 1,37382,0.0298241942310946,0.00661242171441798,0.0168638476708353,0.0427845407913538,6.52721349404422e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",37124,-0.0443738033456132,0.00984141481792189,-0.0636629763887401,-0.0250846303024863,6.57279205100435e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CD300E,CMRF35-like molecule 2,39991,-0.0162637282393423,0.00360853833709137,-0.0233364633800414,-0.00919099309864322,6.62090421362277e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DSC2,Desmocollin-2,39673,-0.0140773193020384,0.0031260860537699,-0.0202044479674274,-0.00795019063664943,6.7423740728452e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SART1,U4/U6.U5 tri-snRNP-associated protein 1,37021,-0.0151375095345629,0.00336157415255325,-0.0217261948735673,-0.00854882419555859,6.75445390119498e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SEMA4C,Semaphorin-4C,39788,0.0119858229241258,0.00266211951566927,0.00676806867341402,0.0172035771748375,6.7679464251869e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MCEMP1,Mast cell-expressed membrane protein 1,37056,-0.0381408815627009,0.0084732566543262,-0.0547484646051802,-0.0215332985202215,6.81092352818724e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,APOBR,Apolipoprotein B receptor,37043,0.0179952671128478,0.00400201487986771,0.0101513179483071,0.0258392162773885,6.9653735670268e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CES2,Cocaine esterase,39788,-0.0228575380624185,0.00508667503118847,-0.0328274211235479,-0.0128876550012892,7.05186166842818e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ICA1,Islet cell autoantigen 1,39587,-0.0338730289479882,0.00753846930654166,-0.0486484287888099,-0.0190976291071665,7.0609196815364e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GUK1,Guanylate kinase,37021,0.017476093592474,0.00389103625021409,0.00984966254205438,0.0251025246428936,7.13678549027606e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CDK5RAP3,CDK5 regulatory subunit-associated protein 3,37411,-0.025069376872929,0.0055817799834166,-0.0360096656404255,-0.0141290881054325,7.13790519292057e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NTproBNP,N-terminal prohormone of brain natriuretic peptide,39868,-0.0390846050232304,0.00870643182094512,-0.0561492113922828,-0.022019998654178,7.20021035813312e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,OLFM4,Olfactomedin-4,36654,-0.0519991646637618,0.0115850050258498,-0.0747057745144275,-0.0292925548130962,7.23566726201613e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CRIM1,Cysteine-rich motor neuron 1 protein,39931,0.00848122061654561,0.00188994457392439,0.0047769292516538,0.0121855119814374,7.2547115320986e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TWF2,Twinfilin-2,37437,-0.0355919919204587,0.00793437480786187,-0.051143366543868,-0.0200406172970495,7.32383446482831e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GSTP1,Glutathione S-transferase P,39393,0.0292274609596994,0.00651771591038,0.0164527377753546,0.0420021841440442,7.36741529522461e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DNLZ,DNL-type zinc finger protein,36991,0.0378898961586521,0.00845232702780591,0.0213233351841526,0.0544564571331517,7.43017996825875e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NPPB,Natriuretic peptides B,39585,-0.0531981951330851,0.0118718532183658,-0.076467027441082,-0.0299293628250881,7.48059148780283e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SPAG1,Sperm-associated antigen 1,37411,-0.0245819889988659,0.0054880781554248,-0.0353386221834985,-0.0138253558142332,7.55496596132199e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ATP5IF1,"ATPase inhibitor, mitochondrial",39931,-0.0461802560485134,0.010323592283447,-0.0664144969240695,-0.0259460151729572,7.75592851535136e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,AMPD3,AMP deaminase 3,37388,-0.0297190886301436,0.00664973215301731,-0.0427525636500575,-0.0166856136102297,7.91445667025493e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CD164,Sialomucin core protein 24,39858,-0.0109913324773449,0.00246123684782852,-0.0158153566990887,-0.00616730825560096,8.03251552743989e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TP53,Cellular tumor antigen p53,39477,-0.0185001743767642,0.00414802985627324,-0.0266303128950597,-0.0103700358584686,8.2535165832944e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CXCL16,C-X-C motif chemokine 16,40034,-0.00972045175744982,0.00218156403277177,-0.0139963172616825,-0.00544458625321716,8.41709533535011e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DNAJB6,DnaJ homolog subfamily B member 6,37013,-0.0358749443425691,0.00805291664916985,-0.051658660974942,-0.0200912277101962,8.46247135439019e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ART3,Ecto-ADP-ribosyltransferase 3,39931,0.0137935575466834,0.00310294171377392,0.0077117917876865,0.0198753233056803,8.83502148349046e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,EBI3_IL27,Interleukin-27,40011,-0.0128233617175648,0.00288958336410515,-0.0184869451112109,-0.0071597783239187,9.14891534388798e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FKBPL,FK506-binding protein-like,37382,-0.0248259209676405,0.00559439967615923,-0.0357909443329125,-0.0138608976023684,9.16706746079888e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TPR,Nucleoprotein TPR,37021,-0.0196152401865772,0.00442201510528745,-0.0282823897929406,-0.0109480905802137,9.24688616750397e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LAMB1,Laminin subunit beta-1,37043,-0.012672637570505,0.00286130921645779,-0.0182808036347622,-0.00706447150624769,9.54489158259959e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PRKAR1A,cAMP-dependent protein kinase type I-alpha regulatory subunit,39868,-0.0346985306508581,0.00783684433663505,-0.0500587455506628,-0.0193383157510534,9.5911437959272e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FABP5,Fatty acid-binding protein 5,39972,-0.028272072282951,0.0063988727363197,-0.0408138628461376,-0.0157302817197644,1.00134135734963e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,BCL2L1,Bcl-2-like protein 1,37388,-0.0415208370063281,0.00940130320995173,-0.0599473912978335,-0.0230942827148227,1.01091411784492e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LEPR,Leptin receptor,39868,0.0128124949707897,0.00290243941989145,0.0071237137078025,0.018501276233777,1.01958847461002e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PGLYRP2,N-acetylmuramoyl-L-alanine amidase,37306,-0.012620573591178,0.00286007347231074,-0.0182263175969071,-0.00701482958544898,1.02896070121759e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CRLF1,Cytokine receptor-like factor 1,39931,-0.0107785025420356,0.00244688189394537,-0.0155743910541686,-0.00598261402990272,1.06470277765491e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,COLEC12,Collectin-12,39862,-0.0102282313208219,0.0023295165362202,-0.0147940837318135,-0.00566237890983028,1.13705767435882e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ATXN2L,Ataxin-2-like protein,37411,-0.0198500317676714,0.00452115761703521,-0.0287115006970604,-0.0109885628382824,1.13959809631053e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RWDD1,RWD domain-containing protein 1,40009,-0.0262993910059673,0.00599078905448645,-0.0380413375527608,-0.0145574444591739,1.14085653610461e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PTPRH,Receptor-type tyrosine-protein phosphatase H,37382,-0.0201105894204912,0.00458245418048609,-0.0290921996142439,-0.0111289792267384,1.14943721488708e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CETN3,Centrin-3,37382,-0.0325638900841779,0.00742157108444967,-0.0471101694096992,-0.0180176107586565,1.15404409510588e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SCGB3A2,Secretoglobin family 3A member 2,39908,0.0317195045453537,0.00723844378222483,0.017532154732193,0.0459068543585143,1.18292850404147e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,HNRNPK,Heterogeneous nuclear ribonucleoprotein K,39506,-0.0324311372312183,0.00740317457975323,-0.0469413594075346,-0.017920915054902,1.19064173453806e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,39931,0.0175074896705467,0.00400022125438429,0.00966705601195351,0.0253479233291399,1.21288380070971e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ARHGAP25,Rho GTPase-activating protein 25,39477,-0.0248133686364141,0.00567053070968344,-0.0359276088273937,-0.0136991284454346,1.21747126182831e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,BHMT2,S-methylmethionine--homocysteine S-methyltransferase BHMT2,37021,0.0106421154113288,0.0024342167573553,0.00587105056691242,0.0154131802557452,1.24123796988168e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,COL15A1,Collagen alpha-1(XV) chain,37437,0.0102545930020555,0.00234655565488184,0.00565534391848713,0.0148538420856239,1.25133915067067e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DYNLT3,Dynein light chain Tctex-type 3,37368,-0.0178967145948596,0.0041065557452693,-0.0259455638555874,-0.00984786533413174,1.32175256583421e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PRDX6,Peroxiredoxin-6,40030,0.0241766142879549,0.00554911279116075,0.0133003532172798,0.03505287535863,1.32764705532759e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,HS6ST2,Heparan-sulfate 6-O-sulfotransferase 2,37056,-0.0133754246725258,0.00307466773765834,-0.0194017734383362,-0.00734907590671547,1.3703380388577e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MINK1,Misshapen-like kinase 1,37388,-0.037949018024952,0.00872756957732158,-0.0550550543965023,-0.0208429816534017,1.38277471058816e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CD93,Complement component C1q receptor,39238,0.0125746751771657,0.00289570974039474,0.00689908408599203,0.0182502662683394,1.41759395607813e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CARHSP1,Calcium-regulated heat-stable protein 1,39489,-0.0206008715893853,0.00475253545701613,-0.0299158410851369,-0.0112859020936337,1.46863682573026e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GPI,Glucose-6-phosphate isomerase,37445,-0.0193382263432255,0.00446309473451189,-0.0280858920228688,-0.0105905606635822,1.48202567398251e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TNFRSF19,Tumor necrosis factor receptor superfamily member 19,40030,-0.0120926744624111,0.00279118323929005,-0.0175633936114196,-0.0066219553134026,1.48345332440755e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PIK3AP1,Phosphoinositide 3-kinase adapter protein 1,39866,-0.0247721004125279,0.00571929163430052,-0.0359819120157569,-0.0135622888092988,1.49118015954492e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SMS,Spermine synthase,36991,-0.0261539020412055,0.0060382262082696,-0.0379888254094139,-0.0143189786729971,1.49272002784142e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CKAP4,Cytoskeleton-associated protein 4,39991,-0.0103177994100012,0.00238404751754461,-0.0149905325443886,-0.00564506627561373,1.51478643304593e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CCL17,C-C motif chemokine 17,39836,-0.0364537829750139,0.00845611950259823,-0.0530277772001064,-0.0198797887499213,1.63539112368909e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SPRY2,Protein sprouty homolog 2,39587,-0.0375037398499762,0.00870592573083554,-0.0545673542824139,-0.0204401254175386,1.6585634175776e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NCR1,Natural cytotoxicity triggering receptor 1,39835,-0.0143468803181271,0.00333300586845436,-0.0208795718202977,-0.00781418881595657,1.68369829635084e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,UROD,Uroporphyrinogen decarboxylase,37124,-0.0280835951794895,0.00652600620737238,-0.0408745673459394,-0.0152926230130396,1.69451627111312e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SNX15,Sorting nexin-15,37124,-0.0218110531287417,0.00506864156392055,-0.031745590594026,-0.0118765156634574,1.69604375790186e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SEZ6,Seizure protein 6 homolog,37039,0.0125836277154577,0.00292475959859637,0.00685109890220882,0.0183161565287066,1.70138572772695e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CFH,Complement factor H,36763,-0.00954201944410266,0.00221871964809146,-0.0138907099543619,-0.00519332893384341,1.71520934839747e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ERBB2,Receptor tyrosine-protein kinase erbB-2,39913,-0.0101010273489616,0.00235155052854271,-0.0147100663849053,-0.00549198831301793,1.75344156575691e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GOT1,"Aspartate aminotransferase, cytoplasmic",37437,-0.0169691038389649,0.00395447211142725,-0.0247198691773623,-0.00921833850056748,1.79007713405432e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SPART,Spartin,37124,-0.0314322316624344,0.00734150110642972,-0.0458215738310367,-0.0170428894938322,1.86989064417905e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TRIM58,E3 ubiquitin-protein ligase TRIM58,37368,-0.0343313636900353,0.00802005231943993,-0.0500506662361376,-0.0186120611439331,1.87599239188903e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CRNN,Cornulin,39397,0.0259831787103451,0.00607250028107585,0.0140810781594364,0.0378852792612537,1.89005179641085e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ERI1,3'-5' exoribonuclease 1,37169,-0.0134822697333229,0.00315403843796974,-0.0196641850717436,-0.00730035439490221,1.92809366763982e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SCT,Secretin,37039,-0.0177456185339769,0.00415597712755783,-0.0258913337039903,-0.00959990336396355,1.96927516511615e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,STX8,Syntaxin-8,39866,-0.0195416266317401,0.00458166800594363,-0.0285216959233896,-0.0105615573400906,2.00889734001257e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LEFTY2,Left-right determination factor 2,40011,-0.0213496421771756,0.00500835245069853,-0.0311660129805447,-0.0115332713738065,2.03020092878581e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,F11,Coagulation factor XI,37249,0.0125069411832547,0.00294237212050229,0.00673989182707023,0.0182739905394392,2.14612188580196e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TMED8,Protein TMED8,37382,-0.0410578683567459,0.00972665794340103,-0.060122117925812,-0.0219936187876799,2.44625952150843e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,POLR2A,DNA-directed RNA polymerase II subunit RPB1,37056,0.0118042313543571,0.00279767776701919,0.00632078293099952,0.0172876797777148,2.46703645993627e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CRISP3,Cysteine-rich secretory protein 3,37325,0.0106515402928164,0.00252666258358078,0.00569928162899811,0.0156037989566348,2.50678688018154e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PPCDC,Phosphopantothenoylcysteine decarboxylase,40009,-0.0186549068534868,0.00443155300673668,-0.0273407507466907,-0.00996906296028295,2.5724796694904e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DMD,Dystrophin,37043,-0.0205166133266853,0.00487482707355503,-0.0300712743908532,-0.0109619522625175,2.58562440768739e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SYT1,Synaptotagmin-1,37388,0.0146197756478726,0.00347718416682213,0.00780449468090124,0.021435056614844,2.63357800584117e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ANGPTL4,Angiopoietin-related protein 4,39908,0.0178227962297225,0.00424215048746443,0.00950818127429224,0.0261374111851528,2.66751440749475e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LY96,Lymphocyte antigen 96,39749,-0.0139299825268296,0.00331665028193312,-0.0204306170794185,-0.00742934797424067,2.68351671738272e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,B3GAT3,Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 3,37021,0.00795480666542112,0.00189431055620715,0.0042419579752551,0.0116676553555871,2.69485275024523e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SLC9A3R1,Na(+)/H(+) exchange regulatory cofactor NHE-RF1,37124,-0.0339527126497014,0.00809718785183865,-0.0498232008393052,-0.0180822244600977,2.76895025085916e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,THY1,Thy-1 membrane glycoprotein,40009,-0.0106157019590684,0.00253436911560402,-0.0155830654256522,-0.00564833849248449,2.82051211524285e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MYCBP2,E3 ubiquitin-protein ligase MYCBP2,37411,-0.0265035701961032,0.00633022753151541,-0.0389108161578734,-0.014096324234333,2.84667951450545e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LIF,Leukemia inhibitory factor,39489,-0.0201854427759323,0.0048259108432594,-0.0296442280287207,-0.0107266575231438,2.89611170349315e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FRZB,Secreted frizzled-related protein 3,39695,0.0103497301575954,0.00247485399722029,0.00549901632304358,0.0152004439921471,2.90567231666913e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NDUFA5,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 5,37027,-0.014305455920444,0.00342546933168145,-0.0210193758105396,-0.00759153603034832,2.98323958691022e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RNASEH2A,Ribonuclease H2 subunit A,37411,-0.0193768968106541,0.00464085447835632,-0.0284729715882325,-0.0102808220330757,2.99471916581765e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,S100A12,Protein S100-A12,39615,-0.0291724943577431,0.00703004972036482,-0.0429513918096582,-0.0153935969058281,3.34680840142045e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,BCL2,Apoptosis regulator Bcl-2,37382,-0.0196927581710126,0.00475210803025481,-0.029006889910312,-0.0103786264317132,3.4337057104068e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CR1,Complement receptor type 1,37420,0.0138867171097875,0.00335116161944507,0.00731844033567521,0.0204549938838999,3.43593629423168e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CCL8,C-C motif chemokine 8,40003,-0.0234652666256677,0.00566462756799719,-0.0345679366589422,-0.0123625965923932,3.45409641663578e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IDO1,"Indoleamine 2,3-dioxygenase 1",37043,-0.0246944598038976,0.00597642311811404,-0.0364082491154011,-0.0129806704923941,3.61873354723508e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CXCL8,Interleukin-8,39750,-0.0256297703663494,0.00620411232567223,-0.037789830524667,-0.0134697102080318,3.62888959413611e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CSTB,Cystatin-B,39619,-0.0164404624153572,0.00398422427714161,-0.0242495419985547,-0.00863138283215964,3.70395979246978e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PDGFC,Platelet-derived growth factor C,39477,-0.0112632683734539,0.00273933308178268,-0.016632361213748,-0.00589417553315985,3.94795121685139e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SPINK6,Serine protease inhibitor Kazal-type 6,40030,-0.0208554652154429,0.00507404366548845,-0.0308005907998002,-0.0109103396310855,3.97222418142759e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,BCAT1,"Branched-chain-amino-acid aminotransferase, cytosolic",37437,-0.0115224381407416,0.00281167918244173,-0.0170333293383274,-0.00601154694315582,4.19043359019193e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TACC3,Transforming acidic coiled-coil-containing protein 3,39788,-0.0450440865649009,0.010994379164064,-0.0665930697264663,-0.0234951034033355,4.20590607587648e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GDNF,Glial cell line-derived neurotrophic factor,39489,-0.0147569166468007,0.00360221398988401,-0.0218172560669733,-0.00769657722662801,4.21331877547984e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,F13B,Coagulation factor XIII B chain,37380,-0.00981302600410542,0.0023982015342179,-0.0145135010111725,-0.00511255099703834,4.30471148121666e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CD58,Lymphocyte function-associated antigen 3,39835,0.00667922429354669,0.00163269631455701,0.00347913951701495,0.00987930907007843,4.31779400536418e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CX3CL1,Fractalkine,39749,0.0127404293853808,0.00311514763877345,0.0066347400133848,0.0188461187573767,4.33813214058406e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,VWC2L,von Willebrand factor C domain-containing protein 2-like,37411,0.018297998702031,0.00447871591176225,0.00951971551497703,0.027076281889085,4.42264263612953e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,INPP5J,"Phosphatidylinositol 4,5-bisphosphate 5-phosphatase A",37411,-0.0160299567130171,0.0039235780612032,-0.0237201697129754,-0.00833974371305888,4.42264704894201e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GLYR1,Putative oxidoreductase GLYR1,37368,-0.0228647208545735,0.00560302656158927,-0.0338466529152885,-0.0118827887938586,4.51427621318442e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GRAP2,GRB2-related adapter protein 2,39868,-0.0492026319388864,0.0120649643320227,-0.0728499620296509,-0.025555301848122,4.56167240153048e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CFHR5,Complement factor H-related protein 5,37267,0.015832677103523,0.00388338056775525,0.00822125119072267,0.0234441030163232,4.58769598676947e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PON2,Serum paraoxonase/arylesterase 2,39585,-0.0131479691620752,0.00322755615677753,-0.0194739792293592,-0.00682195909479127,4.65068091086576e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ANPEP,Aminopeptidase N,39891,0.010686343353506,0.0026253813847174,0.00554059583945991,0.0158320908675521,4.71582412983279e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PLB1,"Phospholipase B1, membrane-associated",37388,0.022876731486848,0.00562130069102017,0.0118589821324484,0.0338944808412475,4.73510930742883e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DNAJB14,DnaJ homolog subfamily B member 14,37382,-0.0248106887182478,0.0061045693284645,-0.0367756446020382,-0.0128457328344574,4.84530743574893e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IL22,Interleukin-22,37368,-0.0248494715387305,0.00614374518187144,-0.0368912120951985,-0.0128077309822624,5.26862506670972e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,HSDL2,Hydroxysteroid dehydrogenase-like protein 2,37043,-0.0179505911616889,0.00444084404359478,-0.0266546454871347,-0.00924653683624315,5.32625232177606e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,BAX,Apoptosis regulator BAX,39456,-0.034762033485465,0.00860449156710894,-0.0516268369569985,-0.0178972300139314,5.37102786830771e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NPTXR,Neuronal pentraxin receptor,39868,0.0129010345879756,0.00319361950700022,0.00664154035425513,0.019160528821696,5.37858534047156e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PDZD2,PDZ domain-containing protein 2,37021,-0.0227396871824316,0.00563584667836317,-0.0337859466720234,-0.0116934276928398,5.49505026313333e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MSR1,Macrophage scavenger receptor types I and II,40009,-0.0172958103789843,0.00428736610708248,-0.0256990479488659,-0.00889257280910262,5.50561525108396e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,37021,0.0138804305123089,0.00344492306952708,0.00712838129603583,0.020632479728582,5.62714607127016e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ASPSCR1,Tether containing UBX domain for GLUT4,37411,-0.0257026666239889,0.00638001179377444,-0.0382074897397868,-0.013197843508191,5.64104898183064e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",37388,-0.0370567462893192,0.00920699584501739,-0.0551024581455533,-0.0190110344330851,5.73229836584618e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SPRR3,Small proline-rich protein 3,37388,-0.0247588341193685,0.00615301545050477,-0.0368187444023578,-0.0126989238363791,5.75650331632846e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ASS1,Argininosuccinate synthase,37021,-0.0301930704018171,0.00751139206720232,-0.0449153988535337,-0.0154707419501006,5.86125918803022e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RBM17,Splicing factor 45,37411,-0.028946554280586,0.00720961339281389,-0.0430773965305012,-0.0148157120306708,5.97675597023838e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LPO,Lactoperoxidase,39344,-0.022555448407853,0.00562580644012823,-0.0335820290305043,-0.0115288677852016,6.11889861545899e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TIMM10,Mitochondrial import inner membrane translocase subunit Tim10,37437,-0.0150474025585278,0.0037534804218193,-0.0224042241852936,-0.00769058093176192,6.13231707022664e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TGFBI,Transforming growth factor-beta-induced protein ig-h3,39805,-0.0100876370529555,0.00251643296107643,-0.0150198456566653,-0.00515542844924571,6.13304365475036e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PI16,Peptidase inhibitor 16,37445,0.00899575523736269,0.00224411130325273,0.00459729708298735,0.013394213391738,6.1404773913552e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DENR,Density-regulated protein,37056,-0.0217807569284529,0.00543373182578044,-0.0324308713069826,-0.0111306425499233,6.14586959169894e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GMPR2,GMP reductase 2,37124,-0.0252678514613957,0.00630535617725855,-0.0376263495688225,-0.012909353353969,6.17359452143189e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CD48,CD48 antigen,39908,-0.0108715331505296,0.00271569104968451,-0.0161942876079113,-0.00554877869314801,6.27647668735168e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CLIC5,Chloride intracellular channel protein 5,37039,0.0120757714389418,0.00301644630282793,0.00616353668539904,0.0179880061924845,6.28044091010684e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ATRN,"Attractin, Isoform 2",37453,-0.00611916212276714,0.0015307986028486,-0.0091195273843504,-0.00311879686118388,6.43895399648241e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TRIM21,E3 ubiquitin-protein ligase TRIM21,39866,-0.0282004424102994,0.00705797432628062,-0.0420340720898094,-0.0143668127307894,6.48349660192848e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,VSTM1,V-set and transmembrane domain-containing protein 1,39489,-0.0181230485384443,0.00453747431283258,-0.0270164981915962,-0.00922959888529243,6.52424612007923e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,VCAN,Versican core protein,40009,0.0110643567655484,0.00277463165623022,0.00562607871933717,0.0165026348117596,6.70150082880927e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TIA1,Nucleolysin TIA-1 isoform p40,39374,-0.0459888481040029,0.0115472319936573,-0.0686214228115713,-0.0233562733964346,6.84554045624376e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,HARS1,"Histidine--tRNA ligase, cytoplasmic",39858,-0.0290140983890568,0.00729355681114568,-0.0433094697389023,-0.0147187270392112,6.9790224195669e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MYO9B,Unconventional myosin-IXb,39587,-0.0246855289003946,0.00621210422176746,-0.0368612531750588,-0.0125098046257304,7.10569010081387e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DCLRE1C,Protein artemis,36962,0.0115766424309413,0.00291629848338332,0.00586069740350994,0.0172925874583726,7.23667884996503e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CD72,B-cell differentiation antigen CD72,37124,-0.0154867131610318,0.00390501630727754,-0.0231405451232958,-0.00783288119876786,7.35186660800969e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GCHFR,GTP cyclohydrolase 1 feedback regulatory protein,36764,-0.0185026055103399,0.00466803355538032,-0.0276519512788853,-0.00935325974179445,7.41998923711435e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,VNN2,Vascular non-inflammatory molecule 2,39788,-0.0172138360502616,0.00434519422089717,-0.0257304167232201,-0.00869725537730315,7.47795687161264e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PHOSPHO1,Phosphoethanolamine/phosphocholine phosphatase,39749,-0.0108422352877511,0.00273938116627912,-0.0162114223736582,-0.00547304820184407,7.59360647417012e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ADAMTS8,A disintegrin and metalloproteinase with thrombospondin motifs 8,39913,0.0168465836714073,0.00425729072592792,0.00850229384858854,0.025190873494226,7.61872102574158e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CASP7,Caspase-7,37388,-0.0313248558293667,0.00792538417799055,-0.0468586088182282,-0.0157911028405052,7.77413869707533e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CLU,Clusterin,37453,0.011812741645619,0.00299359226167043,0.00594530081274498,0.0176801824784931,7.98642825753947e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,C1QA,Complement C1q subcomponent subunit A,39971,-0.00849271818440836,0.00215376685362748,-0.0127141012175182,-0.0042713351512985,8.07440575236851e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,QPCT,Glutaminyl-peptide cyclotransferase,39862,-0.00979805370965108,0.00248630568651232,-0.0146712128552152,-0.00492489456408694,8.15526377921274e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NEDD4L,E3 ubiquitin-protein ligase NEDD4-like,37056,-0.0177424005665361,0.00450719504713336,-0.0265765028589175,-0.00890829827415474,8.31162836061693e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ACADSB,"Short/branched chain specific acyl-CoA dehydrogenase, mitochondrial",37437,-0.0324877563489098,0.00825335250252066,-0.0486643272538502,-0.0163111854439693,8.31567081693063e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ANKMY2,Ankyrin repeat and MYND domain-containing protein 2,37056,-0.0296868051542226,0.00755030454622265,-0.044485402064819,-0.0148882082436262,8.47188955908245e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ADAM8,Disintegrin and metalloproteinase domain-containing protein 8,39985,-0.0103528505956738,0.00263353087139732,-0.0155145711036126,-0.00519113008773507,8.48875827154671e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,UBE2L6,Ubiquitin/ISG15-conjugating enzyme E2 L6,37437,-0.0230028532509007,0.00585464304332592,-0.0344779536158195,-0.0115277528859819,8.57247247097748e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LIFR,Leukemia inhibitory factor receptor,39866,-0.00899254122270162,0.00229141334183398,-0.0134837113726962,-0.00450137107270702,8.72909860196762e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,OSCAR,Osteoclast-associated immunoglobulin-like receptor,39885,-0.0121900699672944,0.00310657727591472,-0.0182789614280873,-0.00610117850650156,8.74706213773499e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CACYBP,Calcyclin-binding protein,37088,-0.0383076059954135,0.00976238928372596,-0.0574418889915164,-0.0191733229993107,8.75317299982199e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NAGK,N-acetyl-D-glucosamine kinase,37026,-0.0212390175358274,0.0054166220980014,-0.0318555968479101,-0.0106224382237446,8.85992382508817e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,UNC79,Protein unc-79 homolog,36962,-0.0208129507363686,0.0053095452828119,-0.03121965949068,-0.0104062419820573,8.90319923374868e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CPPED1,Serine/threonine-protein phosphatase CPPED1,40009,-0.0240915147511902,0.0061552292697755,-0.0361557641199501,-0.0120272653824302,9.11553524412554e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PCDH12,Protocadherin-12,37411,-0.00931767832216368,0.00238126553390945,-0.0139849587686262,-0.00465039787570115,9.16360002086096e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GIMAP8,GTPase IMAP family member 8,36962,-0.0182080092167713,0.00465762160547336,-0.0273369475634991,-0.00907907087004354,9.30326821677241e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NPTX2,Neuronal pentraxin-2,37437,0.0123579613162113,0.00316248147212968,0.00615949763083713,0.0185564250015855,9.36392912860517e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PBK,Lymphokine-activated killer T-cell-originated protein kinase,36962,0.0111744718260425,0.00286209834708741,0.00556475906575122,0.0167841845863339,9.49746893868869e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CA12,Carbonic anhydrase 12,39788,-0.0116681210143063,0.00299422179301085,-0.0175367957286076,-0.00579944630000505,9.78388496699252e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SIRT2,NAD-dependent protein deacetylase sirtuin-2,39788,-0.0324895676490686,0.00833883085564496,-0.0488336761261327,-0.0161454591720044,9.81222571118601e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CLGN,Calmegin,37039,-0.0159815270147949,0.00410749352827096,-0.0240322143302059,-0.00793083969938381,0.000100396436299864
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,STC2,Stanniocalcin-2,39831,-0.0096653508542732,0.00248563744582968,-0.0145372002480994,-0.00479350146044702,0.00010128239338539
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CELA2A,Chymotrypsin-like elastase family member 2A,37437,-0.0216188027829943,0.00556780201970702,-0.03253169474162,-0.0107059108243685,0.000103738768614084
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IGFBP6,Insulin-like growth factor-binding protein 6,39825,-0.0100639967942229,0.00259289455074583,-0.0151460701136848,-0.00498192347476112,0.000104285101302237
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FLT3,Receptor-type tyrosine-protein kinase FLT3,39477,0.0111031733610697,0.00286132108362035,0.00549498403717382,0.0167113626849656,0.000104697640829519
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CXCL1,Growth-regulated alpha protein,39839,-0.0344933904443303,0.00889446224491657,-0.0519265364443668,-0.0170602444442939,0.000105707980675127
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PHACTR2,Phosphatase and actin regulator 2,37411,-0.0418001744274932,0.0107842033226,-0.0629372129397892,-0.0206631359151972,0.000106663813903884
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NDUFB7,NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 7,37382,-0.0324530355404142,0.00837436238228933,-0.0488667858097013,-0.0160392852711271,0.000107003036925649
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CLC,Galectin-10,39841,0.0242431928684172,0.00625615546288961,0.0119811281611535,0.0365052575756808,0.000107008943787862
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PCDH9,Protocadherin-9,37382,-0.0120822600090196,0.00312370675873766,-0.0182047252561455,-0.00595979476189384,0.000110280394688877
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,VSNL1,Visinin-like protein 1,37388,-0.0137212571725107,0.00354812564920841,-0.0206755834449592,-0.00676693090006223,0.000110614492141666
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SUSD5,Sushi domain-containing protein 5,37064,0.0123141244003346,0.00318436670458298,0.00607276565935191,0.0185554831413172,0.000110685460981808
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DKKL1,Dickkopf-like protein 1,39788,-0.0305361354105411,0.00790938015664479,-0.0460385205175649,-0.0150337503035173,0.000113486295679331
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IGFBP3,Insulin-like growth factor-binding protein 3,39931,-0.0100437742349154,0.00260192747316619,-0.0151435520823211,-0.00494399638750965,0.000113770863928716
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DHPS,Deoxyhypusine synthase,37368,-0.0148280256343261,0.00384663299154596,-0.0223674262977562,-0.00728862497089603,0.000116357726505663
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SORBS1,Sorbin and SH3 domain-containing protein 1,37411,-0.0137394649958209,0.00356504646523929,-0.0207269560676899,-0.00675197392395191,0.000116769687980452
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DAND5,DAN domain family member 5,37056,0.0194293339974559,0.0050446216553673,0.00954187555293597,0.0293167924419758,0.000117953913183779
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,HSPA2,Heat shock-related 70 kDa protein 2,37368,-0.0122150902183759,0.00317462159213288,-0.0184373485389564,-0.00599283189779548,0.000119765212673806
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ABRAXAS2,BRISC complex subunit Abraxas 2,37021,-0.0241144763501586,0.00626985499443982,-0.0364033921392606,-0.0118255605610566,0.00012057955669918
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,37382,-0.0119171906655866,0.00310477894387919,-0.0180025573955899,-0.00583182393558343,0.000124433944830843
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ACP5,Tartrate-resistant acid phosphatase type 5,39919,-0.0119649302765934,0.00311822540415247,-0.0180766520687322,-0.00585320848445456,0.000124974405166532
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TBCB,Tubulin-folding cofactor B,39749,-0.0364766519914125,0.00951746786251751,-0.0551308890019468,-0.0178224149808782,0.000127284210282276
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DGCR6,Protein DGCR6,36991,-0.0155960683253291,0.00407950191397411,-0.0235918920767184,-0.00760024457393983,0.000132429247516719
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TNC,Tenascin,39931,0.0169103352105636,0.00442465143971771,0.00823801838871692,0.0255826520324104,0.000132955678734133
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NID1,Nidogen-1,39892,-0.0134953029323692,0.0035325719185519,-0.0204191438927309,-0.00657146197200749,0.000133820035773077
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ITGA5,Integrin alpha-5,39858,-0.00888508969716069,0.00232857573798903,-0.0134490981436192,-0.00432108125070218,0.000136321801512172
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DSG4,Desmoglein-4,39725,0.0175797135745387,0.00461553354894096,0.00853326781861447,0.026626159330463,0.000140160556723724
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IL13RA2,Interleukin-13 receptor subunit alpha-2,36991,0.0103167493457872,0.00271060811745057,0.0050039574355841,0.0156295412559904,0.000141836858735113
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CFP,Properdin,37453,0.00827484556899956,0.00217571715096387,0.00401043995311038,0.0125392511848887,0.000143421787553375
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CLEC11A,C-type lectin domain family 11 member A,39822,0.0168414686826751,0.00444368695757571,0.00813184224582669,0.0255510951195235,0.000151215446785218
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NAMPT,Nicotinamide phosphoribosyltransferase,39477,-0.0181760721476938,0.00479591159455331,-0.0275760588730183,-0.00877608542236933,0.000151268235912858
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CSDE1,Cold shock domain-containing protein E1,37021,-0.0425883416342838,0.0112566596040433,-0.0646513944582087,-0.0205252888103589,0.00015539168474129
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CST1,Cystatin-SN,35640,-0.0359039992414228,0.00950116841474221,-0.0545262893343176,-0.0172817091485281,0.000158296771333776
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TIMP3,Metalloproteinase inhibitor 3,39931,-0.0459220339914825,0.0121551641017167,-0.0697461556308472,-0.0220979123521177,0.000158672466784382
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CRYM,Ketimine reductase mu-crystallin,36991,-0.0272706289053667,0.00722130696162808,-0.0414243905501577,-0.0131168672605757,0.000159805479372423
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LRIG3,Leucine-rich repeats and immunoglobulin-like domains protein 3,37031,-0.00992621021534528,0.00262935480910429,-0.0150797456411897,-0.00477267478950087,0.000160613218540239
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IL17C,Interleukin-17C,39587,-0.0235222528988797,0.00624175600678788,-0.0357560946721839,-0.0112884111255754,0.000164810619750138
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SERPINB8,Serpin B8,40058,-0.0194696814208326,0.00517158881051729,-0.0296059954894465,-0.00933336735221872,0.000167312157800917
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,KLHL41,Kelch-like protein 41,37411,-0.0181045354467445,0.00480938947409509,-0.0275309388159709,-0.00867813207751816,0.000167644604844642
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LBP,Lipopolysaccharide-binding protein,39931,0.0204941077960951,0.00544531180277137,0.00982129666266317,0.0311669189295269,0.00016806401337595
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SPINK5,Serine protease inhibitor Kazal-type 5,39858,0.0117373683507316,0.00312331559076504,0.00561566979283216,0.0178590669086311,0.000171896701205426
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PROC,Vitamin K-dependent protein C,39908,-0.00909348699072559,0.00242262502206743,-0.0138418320339777,-0.00434514194747343,0.000174950102965088
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,OGN,Mimecan,39858,-0.0138974613504998,0.00370751632941419,-0.0211641933561516,-0.00663072934484796,0.000178552711311716
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SIGLEC1,Sialoadhesin,39931,-0.0146539954626704,0.00391835433138095,-0.0223339699521771,-0.00697402097316374,0.000184781120912146
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DNAJB2,DnaJ homolog subfamily B member 2,37124,-0.0187429720283465,0.00501375391349577,-0.0285699296987982,-0.0089160143578948,0.000186039054411106
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PSMC3,26S proteasome regulatory subunit 6A,36962,0.010528802214762,0.00281695621571006,0.00500756803197027,0.0160500363975537,0.000186536391167033
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DUT,"Deoxyuridine 5'-triphosphate nucleotidohydrolase, mitochondrial",37382,-0.0359791238257967,0.00962798216344307,-0.0548499688661451,-0.0171082787854483,0.000187045283638975
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PADI4,Protein-arginine deiminase type-4,39456,-0.0246750368711803,0.00660772355999006,-0.0376261750487609,-0.0117238986935998,0.000188928873421971
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SLC12A2,Solute carrier family 12 member 2,37021,0.00974946548541707,0.00261653207656153,0.00462106261535647,0.0148778683554777,0.000195277169530516
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DDX1,ATP-dependent RNA helicase DDX1,37382,-0.0175119601480774,0.00470265803736232,-0.0267291699013076,-0.00829475039484729,0.000197009994251846
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LGALS3,Galectin-3,39901,-0.0102985876982301,0.00276629948454962,-0.0157205346879473,-0.00487664070851284,0.000197640538256305
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RAB6A,Ras-related protein Rab-6A,39866,0.0161665028759512,0.00434668118265798,0.00764700775794153,0.0246859979939608,0.000200477705348981
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,AARSD1,Alanyl-tRNA editing protein Aarsd1,39788,-0.0190356526168738,0.00512985597743401,-0.0290901703326445,-0.00898113490110319,0.000207342869852601
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,COL2A1,Collagen alpha-1(II) chain,37043,-0.0280894151843291,0.00757267216850225,-0.0429318526345936,-0.0132469777340647,0.000208675228144753
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CTSL,Cathepsin L1,39868,-0.00832039366601211,0.00224367969442109,-0.0127180058670774,-0.00392278146494677,0.00020930246297842
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ENOX2,Ecto-NOX disulfide-thiol exchanger 2,37021,-0.00962764113652257,0.00259672701126084,-0.0147172260785938,-0.00453805619445133,0.000210086675644592
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,EVPL,Envoplakin,37169,0.0114963765334277,0.00310132316365027,0.0054177831326732,0.0175749699341823,0.000210641039859199
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PHLDB1,Pleckstrin homology-like domain family B member 1,37382,-0.0185183635797717,0.00500423700581154,-0.0283266681111623,-0.00871005904838104,0.000215997323209179
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GBP1,Guanylate-binding protein 1,37376,-0.0220832897502623,0.00597034061599357,-0.0337851573576097,-0.0103814221429149,0.000217451654635441
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CD7,T-cell antigen CD7,37037,-0.0148673482726522,0.00402032046873647,-0.0227471763913756,-0.00698752015392867,0.000218143918844365
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CA4,Carbonic anhydrase 4,40052,0.00812750837505178,0.00219972754736928,0.00381604238220798,0.0124389743678956,0.000220802343424576
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,EGFLAM,Pikachurin,37382,-0.0106337792860016,0.00287920506453263,-0.0162770212124855,-0.00499053735951765,0.000222230960053924
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,JAM2,Junctional adhesion molecule B,40009,-0.00867867582071885,0.00235344235799365,-0.0132914228423864,-0.0040659287990513,0.000227075010043304
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RAB10,Ras-related protein Rab-10,37437,-0.0185420375289973,0.0050298359141126,-0.028400515920658,-0.00868355913733663,0.000228325609926807
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DCN,Decorin,39585,0.00750443231386342,0.00203781677262287,0.00351031143952259,0.0114985531882042,0.000231654587326791
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PDAP1,28 kDa heat- and acid-stable phosphoprotein,37437,-0.0341085101251647,0.00927734373357727,-0.0522921038429762,-0.0159249164073533,0.00023733186899045
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,AKAP12,A-kinase anchor protein 12,37124,0.00729030882856687,0.00198302179048851,0.00340358611920939,0.0111770315379243,0.000237515962669683
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CASP3,Caspase-3,40052,-0.0307164959461569,0.00835674833433253,-0.0470957226814486,-0.0143372692108651,0.000238009189823732
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,BMP6,Bone morphogenetic protein 6,39568,-0.0144052581453912,0.00392011752344326,-0.02208868849134,-0.00672182779944246,0.000238920460774726
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CRH,Corticoliberin,39455,-0.0300171531407886,0.00817044214837327,-0.0460312197516002,-0.014003086529977,0.000239702688365233
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,USP28,Ubiquitin carboxyl-terminal hydrolase 28,37388,-0.0124572011384493,0.00339151392962833,-0.0191045684405208,-0.00580983383637778,0.000240596456145172
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,HMBS,Porphobilinogen deaminase,40030,-0.0148104667727205,0.00403431114376803,-0.0227177166145058,-0.00690321693093517,0.00024226101996371
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PLXNB3,Plexin-B3,39812,-0.016405101394918,0.00447530176312328,-0.0251766928506396,-0.00763350993919632,0.000247465973037467
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SERPINB1,Leukocyte elastase inhibitor,39811,-0.0308088307423676,0.00840774356790216,-0.0472880081354558,-0.0143296533492793,0.000248780800935665
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,YWHAQ,14-3-3 protein theta,37124,-0.0255666962515914,0.00698522256174481,-0.0392577324726112,-0.0118756600305716,0.000253083525160426
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SLIT2,Slit homolog 2 protein,39489,-0.0177431051322928,0.00485037170006469,-0.0272498336644196,-0.00823637660016604,0.000254935025303573
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CD46,Membrane cofactor protein,39777,-0.00973769696206431,0.0026627500374796,-0.0149566870355243,-0.0045187068886043,0.000255999335284703
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,KLRD1,Natural killer cells antigen CD94,40058,-0.0156587934506576,0.00429076014213803,-0.0240686833292482,-0.00724890357206711,0.000263657224997953
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LCN2,Neutrophil gelatinase-associated lipocalin,39372,-0.0124826712250751,0.00342286626144608,-0.0191914890975095,-0.00577385335264081,0.000266346287882251
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TOR1AIP1,Torsin-1A-interacting protein 1,37043,-0.0172950016266692,0.0047500176761882,-0.0266050362719981,-0.00798496698134034,0.000272579263086064
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NUDC,Nuclear migration protein nudC,40058,-0.0219729319781655,0.00604567373515739,-0.033822452499074,-0.010123411457257,0.000279394560429832
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PRTG,Protogenin,40030,-0.00849047341708206,0.00233697802701086,-0.0130709503500233,-0.00390999648414077,0.000280903950299988
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,HRC,Sarcoplasmic reticulum histidine-rich calcium-binding protein,37043,0.0119727329972437,0.00329584217861993,0.00551288232714862,0.0184325836673388,0.000281559862183684
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IGLC2,Immunoglobulin lambda constant 2,37422,-0.0083261813494677,0.00229344169352297,-0.0128213270687727,-0.00383103563016269,0.000283990188023504
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PPP1R14A,Protein phosphatase 1 regulatory subunit 14A,37411,-0.0265863669206488,0.0073477785241629,-0.0409880128280081,-0.0121847210132895,0.000297639116858494
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FRMD4B,FERM domain-containing protein 4B,37021,-0.0239008438919325,0.00661059669205199,-0.0368576134083544,-0.0109440743755105,0.000300847597852477
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IL3RA,Interleukin-3 receptor subunit alpha,39587,-0.0103800369228242,0.00288132464005076,-0.0160274332173237,-0.00473264062832472,0.000316115830618666
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CA9,Carbonic anhydrase 9,40030,-0.0146313997331271,0.00406296520929783,-0.0225948115433508,-0.00666798792290335,0.000317745662899465
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GYS1,"Glycogen [starch] synthase, muscle",39585,-0.0315181163250653,0.00875409241817308,-0.0486761374646845,-0.014360095185446,0.000318722204884322
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,AOC3,Membrane primary amine oxidase,39931,0.0101648297760858,0.0028246912286484,0.00462843496793496,0.0157012245842367,0.000320941706151225
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FSTL1,Follistatin-related protein 1,37043,-0.00775809080139314,0.00215743705032132,-0.0119866674200229,-0.00352951418276335,0.000324359184762478
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,KLRF1,Killer cell lectin-like receptor subfamily F member 1,37056,-0.0143382004106793,0.00398917809671043,-0.0221569894802317,-0.00651941134112684,0.000326482409145648
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,40034,-0.00895610884250315,0.00249475052139075,-0.013845819864429,-0.00406639782057729,0.000331679758489909
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,THTPA,Thiamine-triphosphatase,37345,-0.029772471416933,0.00829426567182134,-0.0460292321337028,-0.0135157107001631,0.000332456971427398
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CA6,Carbonic anhydrase 6,39817,0.0214021292430827,0.00597254785774205,0.00969593544190827,0.0331083230442571,0.000340138916136682
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RRM2B,Ribonucleoside-diphosphate reductase subunit M2 B,39477,-0.0229331081332875,0.00641011048253916,-0.0354969246790643,-0.0103692915875108,0.000347751172902621
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DHRS4L2,Dehydrogenase/reductase SDR family member 4-like 2,37388,-0.0162288893810988,0.00454270240794925,-0.0251325861006794,-0.00732519266151831,0.000354792753477153
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,VAV3,Guanine nucleotide exchange factor VAV3,36991,-0.0334138779171311,0.00937094605887753,-0.0517809321925311,-0.0150468236417311,0.000364191613314317
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FBLN2,Fibulin-2,37437,0.0101133707245085,0.00284016212392344,0.00454665296161852,0.0156800884873984,0.000370930695049646
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CLSTN3,Calsyntenin-3,37388,0.0101123302369171,0.00284076947559848,0.0045444220647441,0.0156802384090902,0.000372530031749357
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FUT8,"Alpha-(1,6)-fucosyltransferase",39749,-0.0192639758708933,0.00542031581335747,-0.0298877948650739,-0.00864015687671264,0.000380473634368665
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SCGB1A1,Uteroglobin,39903,0.0182339419158716,0.00513268134508151,0.00817388647951185,0.0282939973522314,0.000382657742705242
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CRYZL1,Quinone oxidoreductase-like protein 1,37043,-0.0309011149658524,0.00870702432457995,-0.0479668826420291,-0.0138353472896757,0.000388061638550871
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LGALS7_LGALS7B,Galectin-7,39822,-0.0135464921236888,0.0038177621387359,-0.0210293059156111,-0.0060636783317664,0.000388867580937496
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,COMMD9,COMM domain-containing protein 9,37368,-0.0130716507650831,0.00368452988946757,-0.0202933293484395,-0.00584997218172664,0.00038991040047422
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LAMP3,Lysosome-associated membrane glycoprotein 3,40040,-0.0167129042751854,0.00471248490959277,-0.0259493746979873,-0.00747643385238359,0.00039146398753612
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CLEC4C,C-type lectin domain family 4 member C,39866,0.0153206870202946,0.00432116673383336,0.00685120022198122,0.023790173818608,0.000392990734816064
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,BCL2L11,"Bcl-2-like protein 11, Isoform BimL ",39866,-0.0146432235454637,0.00413170980648243,-0.0227413747661693,-0.00654507232475814,0.000395067344041278
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,BDNF,Brain-derived neurotrophic factor,37437,-0.0274155574795563,0.007745710565572,-0.0425971501880774,-0.0122339647710351,0.000402302025421331
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ARL13B,ADP-ribosylation factor-like protein 13B,37021,-0.0230849284114059,0.00652575736056981,-0.0358754128381227,-0.0102944439846891,0.000405310231440917
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,XRCC4,DNA repair protein XRCC4,39489,-0.0123218803081956,0.00349344072878894,-0.0191690241366219,-0.00547473647976922,0.000421267124999525
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,S100A16,Protein S100-A16,39456,-0.0205965065262716,0.0058394644054321,-0.0320418567609185,-0.0091511562916247,0.000421309166628227
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DDX58,Antiviral innate immune response receptor RIG-I,39477,-0.0189120796668849,0.00536623991117868,-0.0294299098927951,-0.00839424944097472,0.000425865530267587
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ARAF,Serine/threonine-protein kinase A-Raf,37169,-0.0221997628256798,0.00630662901809014,-0.0345607557011365,-0.00983876995022312,0.000432878044013784
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RNF43,E3 ubiquitin-protein ligase RNF43,37169,-0.019517897533321,0.00555259403745065,-0.0304009818467242,-0.00863481321991771,0.000441057466585477
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,STX16,Syntaxin-16,39477,-0.0191903661798524,0.00547424004470177,-0.0299198766674679,-0.00846085569223691,0.000456897460250123
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SERPINB6,Serpin B6,39970,-0.0197964778386037,0.00564806026454145,-0.0308666759571049,-0.00872627972010242,0.000457839556381694
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NFAT5,Nuclear factor of activated T-cells 5,37056,-0.0284130389552121,0.0081184870433376,-0.0443252735601538,-0.0125008043502704,0.000467152287209181
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RAB37,Ras-related protein Rab-37,39587,-0.0273934644909321,0.00783197641718054,-0.042744138268606,-0.0120427907132583,0.000470683384718212
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ITGB2,Integrin beta-2,39731,0.00944314190063365,0.00270001787902291,0.00415110685774875,0.0147351769435186,0.000471036901163622
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ATOX1,Copper transport protein ATOX1,39913,-0.0238800929573031,0.00682923823435582,-0.0372653998966405,-0.0104947860179657,0.000472247510166808
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ITGB1BP2,Integrin beta-1-binding protein 2,39585,-0.0368474553811527,0.0105409350402887,-0.0575076880601184,-0.0161872227021869,0.000474205605868285
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,STX4,Syntaxin-4,39788,-0.0194409132384784,0.00557081802654844,-0.0303597165705133,-0.00852210990644341,0.000484730392215972
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PSAPL1,Proactivator polypeptide-like 1,37382,0.0162905614864823,0.00467241507653934,0.00713262793646516,0.0254484950364994,0.000490865384844677
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CENPF,Centromere protein F,37169,-0.0177250428859769,0.00508461336885643,-0.0276908850889355,-0.00775920068301827,0.000491851965912835
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NPR1,Atrial natriuretic peptide receptor 1,37021,0.0135677325442833,0.00390033770099559,0.00592307065033198,0.0212123944382347,0.000505661426251288
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FCGR3B,Low affinity immunoglobulin gamma Fc region receptor III-B,39881,0.0160848932363463,0.00462687789016078,0.0070162125716312,0.0251535739010615,0.000509533956237502
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GRK5,G protein-coupled receptor kinase 5,39585,-0.0172044495108274,0.00497026211217602,-0.0269461632506924,-0.00746273577096243,0.000538646426297433
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,KLKB1,Plasma kallikrein,37187,-0.00813174135819102,0.00235223936082062,-0.0127421305053994,-0.0035213522109826,0.000547885794376924
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MIF,Macrophage migration inhibitory factor,39826,-0.0221312668356238,0.00640481024728833,-0.0346846949203089,-0.00957783875093863,0.00055087785870441
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ANK2,Ankyrin-2,37021,0.0230206365334942,0.00667293644735115,0.00994168109668598,0.0360995919703025,0.000562654292778884
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,L3HYPDH,Trans-3-hydroxy-L-proline dehydratase,37437,-0.028870482658862,0.00837120265849647,-0.0452780398695151,-0.0124629254482089,0.000564822866630377
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MAGED1,Melanoma-associated antigen D1,39477,-0.0156638098470702,0.00454843990549581,-0.024578752061842,-0.0067488676322984,0.000575155278937504
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,APOA2,Apolipoprotein A-II,37445,0.0154107142231057,0.0044775198979019,0.00663477522321801,0.0241866532229935,0.000579603534580512
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PRELP,Prolargin,39862,0.00716042441074984,0.00208060687150265,0.00308243494260464,0.011238413878895,0.000579959965109402
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,EDF1,Endothelial differentiation-related factor 1,37411,-0.0222979537315215,0.00648340111989494,-0.0350054199265155,-0.00959048753652737,0.000585111777664377
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CDC37,Hsp90 co-chaperone Cdc37,39913,-0.0269514633314382,0.00785384293054999,-0.0423449954753161,-0.0115579311875602,0.000601482590521494
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SNX18,Sorting nexin-18,37382,-0.0145635835092026,0.00424852675287272,-0.0228906959448331,-0.00623647107357207,0.000610050690757775
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GIMAP7,GTPase IMAP family member 7,37124,0.0105116196357975,0.00306807806786306,0.00449818662278591,0.0165250526488091,0.000614114083848208
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NRGN,Neurogranin,37445,-0.0295272715670133,0.00862351953535445,-0.046429369856308,-0.0126251732777186,0.000618798471408659
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CTF1,Cardiotrophin-1,39585,-0.0272512395576451,0.00795935065854924,-0.0428515668484016,-0.0116509122668886,0.00061909106691506
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ELAC1,Zinc phosphodiesterase ELAC protein 1,37411,-0.027523124670212,0.0080470052068081,-0.0432952548755559,-0.0117509944648682,0.000627378962917948
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,AIF1,Allograft inflammatory factor 1,39477,-0.0169202372652559,0.00495624594740532,-0.0266344793221703,-0.00720599520834144,0.000641975690618079
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ROR1,Inactive tyrosine-protein kinase transmembrane receptor ROR1,39868,0.00984120533452202,0.00288697571251842,0.00418273293798591,0.0154996777310581,0.000654032540868436
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DEFB103A_DEFB103B,Beta-defensin 103,37000,-0.0128800808336868,0.00377853430107602,-0.0202860080637958,-0.00547415360357779,0.000654570887268744
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ICAM1,Intercellular adhesion molecule 1,39822,-0.00908874443022481,0.00267127383936041,-0.0143244411553712,-0.00385304770507841,0.000669605260073654
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GNAS,Neuroendocrine secretory protein 55,37411,-0.0289450747160608,0.00850914699244935,-0.0456230028212616,-0.0122671466108601,0.00067175750074429
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CD40LG,CD40 ligand,40058,-0.0248480819472379,0.00730755264483647,-0.0391708851311174,-0.0105252787633584,0.000674672735356831
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MSRA,Mitochondrial peptide methionine sulfoxide reductase,39913,-0.0231590905064205,0.00681831222895349,-0.0365229824751694,-0.00979519853767169,0.000683936671457411
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,JPT2,Jupiter microtubule associated homolog 2,37382,-0.0281168286992761,0.00829841039444835,-0.0443817130723949,-0.0118519443261573,0.000705488671709676
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SEMA7A,Semaphorin-7A,40002,-0.00854966722181061,0.00252808458779528,-0.0135047130138894,-0.00359462142973186,0.000721636140689587
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DRG2,Developmentally-regulated GTP-binding protein 2,39788,-0.017934033574034,0.00531806087008523,-0.0283574328794011,-0.00751063426866694,0.00074723810691338
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TNFRSF17,Tumor necrosis factor receptor superfamily member 17,37124,0.0123360735781375,0.00365882205664422,0.00516478234711481,0.0195073648091601,0.000749471361825381
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PLPBP,Pyridoxal phosphate homeostasis protein,39868,-0.0215544991366175,0.00639630794134283,-0.0340912627016495,-0.00901773557158556,0.000753909500808421
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PRTFDC1,Phosphoribosyltransferase domain-containing protein 1,39489,-0.0356290036239281,0.0105990591741959,-0.056403159605352,-0.0148548476425041,0.000776990748556464
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PTGES2,Prostaglandin E synthase 2,36961,-0.0175655185691175,0.00522725057008846,-0.0278109296864909,-0.00732010745174413,0.000780592243903895
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,VPS4B,Vacuolar protein sorting-associated protein 4B,37368,-0.029820510425348,0.00889206540321826,-0.0472489586156558,-0.0123920622350402,0.000799842727296945
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RTBDN,Retbindin,39788,-0.00923110014241873,0.0027554704915167,-0.0146318223057915,-0.00383037797904601,0.000809701351681489
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ELOB,Elongin-B,37021,-0.0123439712972472,0.0036897580383528,-0.0195758970524187,-0.00511204554207577,0.000823732223813182
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SLC39A14,Zinc transporter ZIP14,39489,-0.0101970961027305,0.00306928022031958,-0.0162128853345569,-0.00418130687090415,0.000894807359744831
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SELENOP,Selenoprotein P,37453,0.00693540774038469,0.00208852933348559,0.00284189024675295,0.0110289252340164,0.000900241043976954
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FCRL6,Fc receptor-like protein 6,39866,-0.0205570510736508,0.00619615437032021,-0.0327015136394784,-0.00841258850782315,0.00090960549576568
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SLITRK2,SLIT and NTRK-like protein 2,40030,-0.0120162041420347,0.00362388981278641,-0.0191190281750961,-0.00491338010897334,0.000915724204196497
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,UBXN1,UBX domain-containing protein 1,37124,-0.021651452147795,0.00653080248954351,-0.0344518250273003,-0.00885107926828972,0.000917963186598767
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GBP4,Guanylate-binding protein 4,39489,-0.0152322015963944,0.00459472519693172,-0.0242378629823806,-0.00622654021040824,0.000918025659826646
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SUSD1,Sushi domain-containing protein 1,39585,-0.0150965701433711,0.00456226047887064,-0.0240386006819576,-0.00615453960478467,0.000938365178169082
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TPD52L2,Tumor protein D54,37124,-0.0339847942650963,0.0102714433797646,-0.054116823289435,-0.0138527652407576,0.000939906157820029
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,BEX3,Protein BEX3,36962,0.0145544719262469,0.00439894440355693,0.00593254089527527,0.0231764029572184,0.000940069652399401
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,EIF4E,Eukaryotic translation initiation factor 4E,37056,-0.0283271742352648,0.00856991288881907,-0.0451242034973501,-0.0115301449731794,0.000950865920840743
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PAEP,Glycodelin,39749,-0.0448703489825708,0.013600520655537,-0.0715273694674233,-0.0182133284977184,0.000971864820565072
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MYL4,Myosin light chain 4,37043,-0.0160950772261429,0.00488479524101671,-0.0256692758985356,-0.0065208785537501,0.000987045865619079
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DBI,Acyl-CoA-binding protein,39793,-0.0247485479937102,0.00751191513123012,-0.0394719016509212,-0.0100251943364991,0.000987866290685024
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IL17A,Interleukin-17A,39558,-0.0130870623086291,0.00398076067105342,-0.0208893532238938,-0.00528477139336436,0.0010127512301322
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,COX5B,"Cytochrome c oxidase subunit 5B, mitochondrial",39788,-0.0216094121589849,0.00657540717689403,-0.0344972102256972,-0.00872161409227263,0.00101696575217691
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ST13,Hsc70-interacting protein,37124,-0.0170041254513624,0.00520092693963681,-0.0271979422530506,-0.00681030864967429,0.00108034654719236
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,REST,RE1-silencing transcription factor,36962,0.0109483960556348,0.00335451635519696,0.00437354399944877,0.0175232481118208,0.00110219113714857
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ZFYVE19,Abscission/NoCut checkpoint regulator,37382,-0.027873032636715,0.00854409070552684,-0.0446194504195476,-0.0111266148538824,0.00110802306706573
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CUZD1,CUB and zona pellucida-like domain-containing protein 1,37039,-0.0111860265513805,0.00343087150950319,-0.0179105347100068,-0.00446151839275426,0.00111536090112457
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,KIF1C,Kinesin-like protein KIF1C,37021,-0.0112057123228181,0.00343783356794226,-0.017943866115985,-0.00446755852965131,0.00111881419713916
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CD83,CD83 antigen,39866,-0.010037709916171,0.00308251073028726,-0.016079430947534,-0.00399598888480797,0.0011309237964885
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SMPD1,Sphingomyelin phosphodiesterase,39912,-0.014978307341275,0.0046039628359625,-0.0240020744997615,-0.00595454018278854,0.00114288257416039
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SERPINA11,Serpin A11,40052,-0.0125004815093942,0.00384254772303785,-0.0200318750465484,-0.00496908797224001,0.00114356867692963
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MCEE,"Methylmalonyl-CoA epimerase, mitochondrial",37411,0.0132541594608941,0.00407756422280108,0.00526213358420403,0.0212461853375843,0.00115479794260578
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,BAP18,Chromatin complexes subunit BAP18,37388,-0.0198720607781545,0.0061165102576419,-0.0318604208831326,-0.0078837006731764,0.0011612624396567
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PRSS27,Serine protease 27,39818,-0.0122399082733657,0.00377083700535982,-0.0196307488038709,-0.00484906774286042,0.00117305135473025
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SERPINB9,Serpin B9,39749,-0.0101879352860745,0.0031403584981723,-0.0163430379424922,-0.00403283262965679,0.0011802650869586
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,REG3G,Regenerating islet-derived protein 3-gamma,37368,-0.0119149218310852,0.00367296141568981,-0.0191139262058372,-0.00471591745633318,0.00118168856488369
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TBC1D5,TBC1 domain family member 5,39866,-0.0237045002339072,0.00732127955921453,-0.0380542081699677,-0.00935479229784671,0.00120720108346203
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LGMN,Legumain,39931,-0.010907107159926,0.00336902587017392,-0.0175103978654669,-0.00430381645438517,0.00120840778819178
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SPINK8,Serine protease inhibitor Kazal-type 8,37021,0.0113278829532093,0.00350567563813322,0.00445675870246822,0.0181990072039504,0.00123532367954998
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,BOLA2_BOLA2B,BolA-like protein 2,37043,-0.0166529489946066,0.00516685566221395,-0.0267799860925459,-0.00652591189666728,0.00127149148908272
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MAPKAPK2,MAP kinase-activated protein kinase 2,37169,-0.0222997058189757,0.00691923584406437,-0.0358614080733418,-0.0087380035646095,0.0012722466120498
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,L1CAM,Neural cell adhesion molecule L1,39913,0.00864143379695852,0.00268144878174853,0.0033857941847314,0.0138970734091857,0.00127253725749726
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SMARCA2,Probable global transcription activator SNF2L2,39489,-0.0223200861270821,0.0069293700347775,-0.035901651395246,-0.00873852085891824,0.00127967837625423
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CEP350,Centrosome-associated protein 350,36962,0.0109318235518756,0.00340227431194721,0.00426336590045912,0.0176002812032922,0.00131631442122661
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CDH22,Cadherin-22,37169,0.00874649881444513,0.00273120652770702,0.00339333402013937,0.0140996636087509,0.00136593786185542
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NXPE4,NXPE family member 4,37021,0.0104899528946314,0.00328314291252902,0.00405499278607456,0.0169249130031883,0.00140114630910676
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FCN2,Ficolin-2,39810,-0.0121761993936865,0.00381241811286154,-0.0196485388948951,-0.00470385989247785,0.00140673635807548
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,AMFR,E3 ubiquitin-protein ligase AMFR,39489,-0.0194066778425968,0.00608168930282404,-0.0313267888761319,-0.00748656680906165,0.00142060953708314
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PPL,Periplakin,37056,-0.00960016921284206,0.00301680061066708,-0.0155130984097495,-0.00368724001593459,0.00146481796015355
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NEFL,Neurofilament light polypeptide,39438,-0.0130070862490161,0.00408789041900229,-0.0210193514702606,-0.00499482102777157,0.00146620773144441
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CPQ,Carboxypeptidase Q,37430,-0.0112674616259562,0.00354311017664786,-0.018211957572186,-0.00432296567972635,0.00147552808682608
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FKBP14,Peptidyl-prolyl cis-trans isomerase FKBP14,37411,-0.0298005440839188,0.00937174953979342,-0.0481691731819139,-0.0114319149859237,0.00147694577034734
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PSG1,Pregnancy-specific beta-1-glycoprotein 1,39749,0.0329883808613279,0.0103801091380926,0.0126433669506664,0.0533333947719894,0.00148559344631438
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NMI,N-myc-interactor,37311,0.0215126286078581,0.00677170687193797,0.00824008313885966,0.0347851740768565,0.0014922564103101
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LYAR,Cell growth-regulating nucleolar protein,39477,-0.0153581594243494,0.00484267195624225,-0.0248497964585843,-0.00586652239011464,0.00151987631011436
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SLC9A3R2,Na(+)/H(+) exchange regulatory cofactor NHE-RF2,37382,-0.0149936798548903,0.00472880883752114,-0.0242621451764318,-0.00572521453334891,0.00152406442328047
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SCGB2A2,Mammaglobin-A,37021,0.00933388644422868,0.00295113439155628,0.00354966303677836,0.015118109851679,0.00156607653342613
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CNTN2,Contactin-2,40030,0.0131527998184418,0.00416001116740382,0.00499917793033032,0.0213064217065533,0.00157128734133474
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ANXA11,Annexin A11,39829,-0.019852758245185,0.0062802149471157,-0.0321619795415318,-0.00754353694883826,0.0015743634110418
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ENO1,Alpha-enolase,39830,0.023397425903588,0.00741493097551186,0.00886416119158477,0.0379306906155913,0.00160549541002811
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RNF5,E3 ubiquitin-protein ligase RNF5,37043,-0.0218281809106465,0.00692296194319288,-0.0353971863193045,-0.00825917550198844,0.00161957649219322
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,OTUD6B,Deubiquitinase OTUD6B,37382,-0.0172812189253158,0.00548252427445795,-0.0280269665032534,-0.00653547134737825,0.00162479708550735
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CACNA1H,Voltage-dependent T-type calcium channel subunit alpha-1H,37021,0.0170622564338064,0.00541382122433186,0.00645116683411594,0.0276733460334968,0.00162736795919444
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MILR1,Allergin-1,39587,-0.0146547101175612,0.00465195103479367,-0.0237725341457568,-0.00553688608936563,0.00163448298149604
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ARHGAP45,Rho GTPase-activating protein 45,37124,-0.0245156041716298,0.00778934286265632,-0.0397827161824362,-0.00924849216082344,0.00165135759425183
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,STAU1,Double-stranded RNA-binding protein Staufen homolog 1,36962,-0.020059595573352,0.00637988956456777,-0.0325641791199048,-0.00755501202679916,0.00166918272239619
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PER3,Period circadian protein homolog 3,37056,-0.0346879452878086,0.0110444798729526,-0.0563351258387957,-0.0130407647368215,0.00168888233361918
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ITGB7,Integrin beta-7,40030,0.013410026552535,0.00427134804146495,0.00503818439126371,0.0217818687138063,0.00169523433519904
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,AHSG,Alpha-2-HS-glycoprotein,37445,-0.00783817771691385,0.00250670033243786,-0.0127513103684921,-0.00292504506533565,0.00177038524161111
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CHM,Rab proteins geranylgeranyltransferase component A 1,37039,-0.0180349449804583,0.00576790613852044,-0.0293400410119583,-0.00672984894895822,0.00177119567387389
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LMNB2,Lamin-B2,37388,-0.00802377458110316,0.00256927315838094,-0.0130595499715298,-0.00298799919067652,0.00179410972785857
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LAP3,Cytosol aminopeptidase,39587,-0.0142584706737012,0.00457245628697522,-0.0232204849961726,-0.00529645635122977,0.00182201457344482
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,KIRREL1,Kin of IRRE-like protein 1,36991,0.0176745186882469,0.00567066456155723,0.00656001614759478,0.0287890212288991,0.00183199110769676
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ECM1,Extracellular matrix protein 1,37106,0.0106162477360271,0.00340666438120402,0.00393918554886722,0.017293309923187,0.00183516508339304
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PEPD,Xaa-Pro dipeptidase,37445,0.00752713883777304,0.00241616434671508,0.00279145671821148,0.0122628209573346,0.00184124480216879
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,HSPB1,Heat shock protein beta-1,39617,-0.0203615327459231,0.00653909670146036,-0.0331781622807854,-0.00754490321106082,0.00185016603091898
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CCDC134,Coiled-coil domain-containing protein 134,37368,-0.0142232581019039,0.00456945292022964,-0.023179385825554,-0.00526713037825384,0.00185782078605102
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TNFAIP2,Tumor necrosis factor alpha-induced protein 2,37382,-0.0139995657398814,0.00450067879090882,-0.0228208961700627,-0.00517823530970011,0.00187130609054992
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CSNK1D,Casein kinase I isoform delta,37056,-0.0188881745625527,0.00607810715853489,-0.0308012645932811,-0.00697508453182428,0.00189029683652432
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SLAMF8,SLAM family member 8,39477,-0.0151737872680111,0.0048872478078686,-0.0247527929714336,-0.00559478156458868,0.00190766726598479
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,C1QTNF6,Complement C1q tumor necrosis factor-related protein 6,37411,-0.0093026009050909,0.00299965493913927,-0.0151819245858039,-0.00342327722437793,0.00193118278371397
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PTPRR,Receptor-type tyrosine-protein phosphatase R,37388,0.010387140032389,0.00335308633060788,0.0038150908243975,0.0169591892403804,0.00195372216560761
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,HDDC2,5'-deoxynucleotidase HDDC2,37382,0.0125711146045993,0.0040628972700237,0.00460783595535282,0.0205343932538457,0.00197796558294528
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PODXL,Podocalyxin,39788,0.00436604073075111,0.00141351022719992,0.00159556068543926,0.00713652077606296,0.0020131712587771
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MAX,Protein max,39489,-0.0305768603497967,0.00991339934518428,-0.0500071230663579,-0.0111465976332355,0.00204320973700721
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",39788,-0.00984979680148331,0.00319355217954999,-0.0161091590734013,-0.00359043452956534,0.0020439734385157
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,HMOX2,Heme oxygenase 2,39489,-0.0137097616502126,0.00444507447169867,-0.022422107614742,-0.00499741568568325,0.00204415692263374
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NARS1,"Asparagine--tRNA ligase, cytoplasmic",37411,-0.0136358969338189,0.00443101078977225,-0.0223206780817725,-0.00495111578586525,0.00209246735862002
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,THAP12,52 kDa repressor of the inhibitor of the protein kinase,36931,-0.0253182162450322,0.00825449543044682,-0.041497027288708,-0.00913940520135643,0.00216513412610934
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ORM1,Alpha-1-acid glycoprotein 1,37389,-0.00571905651544977,0.00186697665516089,-0.00937833075956511,-0.00205978227133443,0.00219361559116317
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,UXS1,UDP-glucuronic acid decarboxylase 1,39477,-0.0150165769572676,0.00491008186979219,-0.0246403374220603,-0.00539281649247492,0.00222962184271466
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CREBZF,CREB/ATF bZIP transcription factor,36962,0.0075410697745242,0.00246793422931169,0.00270391868507329,0.0123782208639751,0.00225047180975287
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IL7,Interleukin-7,39866,-0.0186803274173141,0.00612708134075646,-0.0306894068451968,-0.00667124798943144,0.00230122245899667
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DPP6,Dipeptidyl aminopeptidase-like protein 6,39788,0.00947650193406423,0.00311032501101678,0.00338026491247135,0.0155727389556571,0.0023167906815099
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TXNL1,Thioredoxin-like protein 1,36971,-0.0280348577239693,0.00920635336600961,-0.0460793103213481,-0.00999040512659046,0.00233014808467977
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MED18,Mediator of RNA polymerase II transcription subunit 18,39477,-0.0219911115573352,0.00722385227449643,-0.0361498620153482,-0.00783236109932217,0.00233660202918232
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CCL22,C-C motif chemokine 22,39686,-0.0143790306041949,0.00472386763316216,-0.0236378111651928,-0.00512025004319711,0.00233907865741793
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,C1QL2,Complement C1q-like protein 2,37056,0.0120033422383996,0.00394427490121176,0.00427256343202459,0.0197341210447747,0.00234512495053733
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FGFR4,Fibroblast growth factor receptor 4,37124,-0.0150992401611038,0.00496276810967408,-0.024826265656065,-0.00537221466614258,0.00235077719951427
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MYH4,Myosin-4,37021,0.0136541876577873,0.00448932327889006,0.00485511403116281,0.0224532612844119,0.00235881439714329
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PDIA5,Protein disulfide-isomerase A5,36962,-0.0175182047050276,0.00577317765157926,-0.028833632902123,-0.00620277650793228,0.00241476789043917
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TNFRSF21,Tumor necrosis factor receptor superfamily member 21,40009,0.00762949331892044,0.00251567128076559,0.00269877760861988,0.012560209029221,0.00242691735749852
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TBL1X,F-box-like/WD repeat-containing protein TBL1X,39477,-0.0242259776081769,0.00799554352545546,-0.0398972429180696,-0.00855471229828417,0.00245006418744824
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,BOLA1,BolA-like protein 1,36991,-0.0156778776654806,0.00517444915301449,-0.025819798005389,-0.00553595732557219,0.00245139755292822
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FCRL5,Fc receptor-like protein 5,39858,-0.0158892258115435,0.00524769238995561,-0.0261747028958565,-0.00560374872723047,0.00246692518124912
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,C1QTNF9,Complement C1q and tumor necrosis factor-related protein 9A,37093,0.0139692584247619,0.00461450050267923,0.00492483743951061,0.0230136794100132,0.00247262548207995
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CERT,Ceramide transfer protein,39489,-0.0175365125530918,0.00579347384396345,-0.0288917212872601,-0.00618130381892341,0.0024744319924382
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CWC15,Spliceosome-associated protein CWC15 homolog,37324,-0.0173898526244844,0.00575652160197749,-0.0286726349643602,-0.00610707028460848,0.00252500957559617
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GALNT2,Polypeptide N-acetylgalactosaminyltransferase 2,40030,0.00713823824207481,0.0023656922360697,0.0025014814593782,0.0117749950247714,0.0025535036791608
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NPHS1,Nephrin,37056,0.00971016345512467,0.00321964983056343,0.00339964978722035,0.016020677123029,0.00256699744374299
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SNU13,NHP2-like protein 1,37021,-0.0175283396273097,0.0058162183681156,-0.0289281276288162,-0.0061285516258031,0.0025857373098486
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PSPN,Persephin,39866,-0.0266603375981001,0.00885320038068653,-0.0440126103442457,-0.00930806485195455,0.00260470239259486
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IFIT3,Interferon-induced protein with tetratricopeptide repeats 3,37169,-0.0107888632929659,0.00358323891450769,-0.017812011565401,-0.00376571502053083,0.00260941807055415
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ANXA3,Annexin A3,39985,-0.0197394111095481,0.00655748090563143,-0.0325920736845857,-0.00688674853451046,0.00261468749858761
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RANBP2,E3 SUMO-protein ligase RanBP2,36991,0.00956854463196326,0.00317920654880767,0.00333729979630022,0.0157997894676263,0.00261978784912837
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PRL,Prolactin,40009,-0.0213645340782802,0.00711689591260257,-0.0353136500669812,-0.00741541808957916,0.00268670312070205
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CCDC80,Coiled-coil domain-containing protein 80,39868,-0.0092099513532316,0.00306816937007232,-0.0152235633185733,-0.00319633938788985,0.00268825202189063
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CLPP,"ATP-dependent Clp protease proteolytic subunit, mitochondrial",39713,-0.0272088030270806,0.009072156590841,-0.0449902299451289,-0.0094273761090322,0.00271149859082589
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GLRX,Glutaredoxin-1,39771,-0.0158015706974434,0.005271040724609,-0.026132810517677,-0.00547033087720976,0.00272348359073408
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,C1RL,Complement C1r subcomponent-like protein,37432,-0.00541894426628353,0.00180799297525474,-0.00896261049778282,-0.00187527803478423,0.00272951063158158
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CD28,T-cell-specific surface glycoprotein CD28,39477,-0.00991197353767744,0.00330818719719074,-0.0163960204441713,-0.00342792663118358,0.00273800877280651
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CILP,Cartilage intermediate layer protein 1,37437,-0.0151044351722855,0.00504609221137556,-0.0249947759065816,-0.0052140944379894,0.00276480865200098
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,AHNAK,Neuroblast differentiation-associated protein AHNAK,37043,-0.00880441329455539,0.00294497763728452,-0.014576569463633,-0.00303225712547773,0.00279824815768959
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CA7,Carbonic anhydrase 7,37169,0.00948326765569649,0.00317339581393915,0.00326341186037576,0.0157031234510172,0.00280985456668907
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MMP3,Stromelysin-1,39858,0.0133702324919772,0.00447745206742987,0.00459442643981463,0.0221460385441397,0.00282964678129504
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,REXO2,"Oligoribonuclease, mitochondrial",37021,0.013395973170395,0.00448818642934315,0.00459912776888243,0.0221928185719076,0.00284360874147251
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ARNTL,Aryl hydrocarbon receptor nuclear translocator-like protein 1,37021,0.0145269668581211,0.00486974479739975,0.00498226705521761,0.0240716666610246,0.0028586199885703
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DBH,Dopamine beta-hydroxylase,37430,0.0304286379566672,0.0102447213320875,0.0103489841457757,0.0505082917675588,0.00298148968195954
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MSTN,Growth/differentiation factor 8,39585,-0.0144331980177842,0.00486475470076128,-0.0239681172312763,-0.00489827880429213,0.00301279923474896
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PROS1,Vitamin K-dependent protein S,37453,-0.00682793803444137,0.0023027913684536,-0.0113414091166104,-0.00231446695227231,0.00303139378361378
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TMEM106A,Transmembrane protein 106A,37368,-0.0197349469543285,0.00669040630638627,-0.0328481433148456,-0.00662175059381142,0.00318588688388797
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DNAJC21,DnaJ homolog subfamily C member 21,37388,-0.0106552724126019,0.00361296578656801,-0.0177366853542752,-0.00357385947092858,0.00319167522906032
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CCND2,G1/S-specific cyclin-D2,37169,0.0102233852628199,0.00346688610367769,0.00342828849961167,0.0170184820260282,0.00319495922867046
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PAM,Peptidyl-glycine alpha-amidating monooxygenase,39956,-0.00769557668717693,0.00260978924683663,-0.0128107636109767,-0.00258038976337713,0.0031953610025763
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SOD2,"Superoxide dismutase [Mn], mitochondrial",39858,-0.0103281687027132,0.00350462404371396,-0.0171972318283925,-0.00345910557703381,0.00321323845600397
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PRTN3,Myeloblastin,39421,-0.0127869702503978,0.00434455609431413,-0.0213023001952535,-0.00427164030554209,0.00325300514397181
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FDX1,"Adrenodoxin, mitochondrial",37021,-0.0175305236396737,0.00596566179460183,-0.0292232207570933,-0.0058378265222541,0.00330300973660443
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FGF9,Fibroblast growth factor 9,36931,0.0111483017163605,0.0038075098901787,0.00368558233161026,0.0186110211011108,0.00341763715371243
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CD300LF,CMRF35-like molecule 1,40030,-0.0164021256521824,0.00560544937792106,-0.0273888064329077,-0.0054154448714571,0.00343714062373946
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SIGLEC8,Sialic acid-binding Ig-like lectin 8,37043,-0.0126616056701957,0.00433066080938365,-0.0211497008565877,-0.00417351048380377,0.00346472877858198
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PTPRM,Receptor-type tyrosine-protein phosphatase mu,39845,-0.00667053637235301,0.00228174916598478,-0.0111427647376832,-0.00219830800702284,0.00346682418281639
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,BLVRB,Flavin reductase,39858,-0.0176986444940161,0.00605569599162042,-0.0295678086375921,-0.00582948035044007,0.00347558810606968
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ENAH,Protein enabled homolog,39587,-0.0131630581002767,0.00451071753094572,-0.0220040644609303,-0.00432205173962305,0.00352586576407452
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MESD,LRP chaperone MESD,39858,-0.0334518463396686,0.0114703041562371,-0.0559336424858933,-0.0109700501934439,0.00354602825169756
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GHRL,Appetite-regulating hormone,39868,-0.0210092783562656,0.00720809884934821,-0.0351371521009881,-0.00688140461154315,0.00356550327703731
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SFRP1,Secreted frizzled-related protein 1,39689,0.0116263409586548,0.00398998990666557,0.00380596074159033,0.0194467211757194,0.00357469797426308
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,C2CD2L,Phospholipid transfer protein C2CD2L,39453,-0.0114490590299659,0.00393334497108708,-0.0191584151732965,-0.00373970288663519,0.0036105059347161
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IL20RB,Interleukin-20 receptor subunit beta,37056,0.0117993538631466,0.0040598650735832,0.00384201831892352,0.0197566894073697,0.0036629045344655
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RLN2,Prorelaxin H2,37095,-0.0388002125494441,0.0133543728068902,-0.064974783250949,-0.0126256418479393,0.00367354853020253
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ADA,Adenosine deaminase,40058,-0.00948629441734064,0.00326606938175019,-0.015887790405571,-0.00308479842911026,0.00368338904586912
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,UPK3A,Uroplakin-3a,36991,0.0130474024789752,0.00449393234941434,0.00423929507412308,0.0218555098838273,0.0036982327147035
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TMSB10,Thymosin beta-10,39858,-0.021054006487863,0.00725838118185146,-0.0352804336042919,-0.00682757937143418,0.00372899546247131
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ATP1B2,Sodium/potassium-transporting ATPase subunit beta-2,37021,0.00837744889132436,0.00288942051319583,0.00271418468546053,0.0140407130971882,0.00374552266682489
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SERPINI1,Neuroserpin,37088,0.00835435137136204,0.00289786134274138,0.00267454313958894,0.0140341596031351,0.00394621149432961
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NEK7,Serine/threonine-protein kinase Nek7,37169,-0.0201054648572952,0.0069767957299205,-0.0337799844879393,-0.00643094522665099,0.00396090645292032
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,APOB,Apolipoprotein B-100,37445,0.00613765509195175,0.00213064411206123,0.00196159263231174,0.0103137175515918,0.00397467923832901
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CD99,CD99 antigen,39858,0.00517512532535316,0.00179788358461068,0.00165127349951622,0.0086989771511901,0.0040015882465166
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,KLK13,Kallikrein-13,39490,-0.0114327112798957,0.00397312889602093,-0.0192200439160968,-0.00364537864369471,0.004013722017342
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PRG2,Bone marrow proteoglycan,37437,0.0136768484229751,0.0047589760017356,0.00434925545957335,0.0230044413863769,0.00406059174416119
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LILRA5,Leukocyte immunoglobulin-like receptor subfamily A member 5,39846,-0.008529411712311,0.00297028170489618,-0.0143511638539075,-0.00270765957071449,0.00408957702012396
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PMS1,PMS1 protein homolog 1,37039,-0.0134203109487607,0.0046819640734512,-0.022596960532725,-0.00424366136479632,0.00415846716928597
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LACTB2,Endoribonuclease LACTB2,39868,-0.0179287066702217,0.00625874483059126,-0.0301958465381805,-0.00566156680226281,0.00418099214652878
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SV2A,Synaptic vesicle glycoprotein 2A,37039,-0.0165504201852636,0.00578047790583487,-0.0278801568806999,-0.00522068348982723,0.00420103252742882
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NPTN,Neuroplastin,39477,0.022555583262974,0.00788665572897902,0.00709773803417512,0.0380134284917729,0.00424245362144005
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SCRG1,Scrapie-responsive protein 1,37437,-0.00710322940680766,0.00248477117211509,-0.0119733809041532,-0.00223307790946209,0.00426020887029603
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RCOR1,REST corepressor 1,39585,-0.0120511466885524,0.00421603232955678,-0.0203145700544837,-0.00378772332262111,0.00426330025341747
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IFNW1,Interferon omega-1,37021,0.00950504282846667,0.00332719976757774,0.00298373128401429,0.016026354372919,0.00428647031410208
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ERP29,Endoplasmic reticulum resident protein 29,37124,-0.0320822293817586,0.0112383116787268,-0.0541093202720632,-0.010055138491454,0.00431416204731125
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FABP6,Gastrotropin,39564,0.0144799360085963,0.00507386618609275,0.00453515828385453,0.0244247137333381,0.00432525583400315
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PAPPA,Pappalysin-1,39587,0.0127103133408337,0.00445960631240946,0.00396948496851118,0.0214511417131563,0.00437626288984704
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SRC,Proto-oncogene tyrosine-protein kinase Src,39887,-0.0320174179462797,0.0112573931651793,-0.0540819085500311,-0.00995292734252833,0.00445901430683874
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PALM,Paralemmin-1,37299,0.00758809449562477,0.0026715552521234,0.0023518462014629,0.0128243427897866,0.0045134816996283
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NAA10,N-alpha-acetyltransferase 10,37021,-0.0134985616554587,0.0047526640403791,-0.0228137831746018,-0.00418334013631571,0.00451530753191017
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PKD1,Polycystin-1,37437,-0.00698706185328168,0.00246168938713494,-0.0118119730520662,-0.00216215065449719,0.00454189913685368
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TUBB3,Tubulin beta-3 chain,36991,0.00749489281942621,0.00265018137372996,0.00230053732691548,0.0126892483119369,0.00469007746018724
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CEP170,Centrosomal protein of 170 kDa,37043,-0.0205015243877988,0.00726450291769385,-0.0347399501064787,-0.00626309866911887,0.00477740993109678
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PARD3,Partitioning defective 3 homolog,37169,-0.0196570217808782,0.00697116252930642,-0.0333205003383188,-0.00599354322343763,0.00481302518304963
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CLPS,Colipase,39836,0.0181984888163577,0.0065003872659211,0.00545772977515232,0.030939247857563,0.00512272327992431
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PDCD1LG2,Programmed cell death 1 ligand 2,39788,-0.00809351521958812,0.00289181229261627,-0.013761467313116,-0.00242556312606024,0.00513594446379805
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PMVK,Phosphomevalonate kinase,39480,-0.0291817197607611,0.0104434550860842,-0.0496508917294862,-0.00871254779203608,0.00520821637212056
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GCLM,Glutamate--cysteine ligase regulatory subunit,37021,-0.0116082969969213,0.00415515289385369,-0.0197523966688745,-0.00346419732496804,0.00521823068783053
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,HCG22,Protein PBMUCL2,37021,0.0142129888582884,0.00509108329959929,0.00423446559107379,0.024191512125503,0.00525007856714974
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CNPY4,Protein canopy homolog 4,39788,-0.0198522612561584,0.00711179508957353,-0.0337913796317225,-0.00591314288059426,0.00525340083293247
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TNFRSF4,Tumor necrosis factor receptor superfamily member 4,40040,-0.0094092915142936,0.00337663376225248,-0.0160274936883085,-0.00279108934027875,0.00533279813869638
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MEGF10,Multiple epidermal growth factor-like domains protein 10,39862,0.0104781827464587,0.00376348655257923,0.00310174910340339,0.017854616389514,0.00537280619508635
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,COQ7,"5-demethoxyubiquinone hydroxylase, mitochondrial",37043,-0.0120186846609363,0.00431797293579479,-0.020481911615094,-0.00355545770677846,0.00538675379907602
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CIAPIN1,Anamorsin,39913,-0.0164813947277089,0.0059242032991168,-0.0280928331939778,-0.00486995626143996,0.00540807456491235
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ARHGAP5,Rho GTPase-activating protein 5,36962,-0.0193558867698829,0.00695737175726946,-0.032992335414131,-0.00571943812563476,0.00540908353776085
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MMP12,Macrophage metalloelastase,39900,-0.013108771029822,0.00471595516649911,-0.0223520431561602,-0.00386549890348374,0.00544785236946503
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GC,Vitamin D-binding protein,37453,-0.00675132817985707,0.00243026707728594,-0.0115146516513375,-0.00198800470837663,0.00547664080387815
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RTKN2,Rhotekin-2,37021,0.013556701304408,0.00488279587133517,0.00398642139659103,0.0231269812122249,0.00550385158103198
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PPIB,Peptidyl-prolyl cis-trans isomerase B,39837,-0.02508619535355,0.00903807780352024,-0.0428008278484496,-0.00737156285865029,0.00551620262218188
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,BCHE,Cholinesterase,37208,-0.00720145543736091,0.00259592504723259,-0.0122894685299368,-0.00211344234478504,0.00554250188140074
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GAS2,Growth arrest-specific protein 2,37169,-0.013812898642273,0.00499156116562974,-0.0235963585269073,-0.00402943875763873,0.0056609419965108
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FOSB,Protein fosB,39489,-0.0101579032755344,0.00367224327540445,-0.0173555000953271,-0.00296030645574169,0.00567924788253654
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FAP,Prolyl endopeptidase FAP,40052,0.00708641775269025,0.00256324085861055,0.00206246566981356,0.0121103698355669,0.00570515044163923
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ATP6V1F,V-type proton ATPase subunit F,39453,-0.0171740162155115,0.00622235213232976,-0.0293698263948778,-0.00497820603614513,0.00578596213534882
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,EFCAB2,Dynein regulatory complex protein 8,37169,-0.00910861648901665,0.00330120992043204,-0.0155789879330635,-0.00263824504496985,0.00580266492614597
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SDK2,Protein sidekick-2,37124,-0.00963459380868473,0.00349526325229286,-0.0164853097831787,-0.00278387783419072,0.00585085244543765
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,F2R,Proteinase-activated receptor 1,39908,-0.0150574213855393,0.00548296809905826,-0.0258040388596935,-0.00431080391138513,0.00603540058252674
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MAP2K6,Dual specificity mitogen-activated protein kinase kinase 6,39866,-0.0259532360790178,0.00946418328879294,-0.044503035325052,-0.00740343683298365,0.0061086133055254
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,KLK11,Kallikrein-11,39779,-0.00747973504222832,0.00272953334555355,-0.0128296203995133,-0.00212984968494336,0.00614518978938503
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GBP6,Guanylate-binding protein 6,37021,0.0118853785593357,0.00433907711431993,0.00338078741526868,0.0203899697034028,0.00616813792121553
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PRSS53,Serine protease 53,37388,0.0095812684728776,0.00350376980509108,0.00271387965489908,0.0164486572908561,0.00625450387077544
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PI3,Elafin,39594,-0.0136109967800698,0.00497771544161076,-0.0233673190456269,-0.00385467451451271,0.00625666107649006
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TFRC,Transferrin receptor protein 1,39918,0.0100455439579779,0.00367474563137524,0.00284304252048247,0.0172480453954734,0.00627012785634668
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GAD1,Glutamate decarboxylase 1,36962,0.0066423565128575,0.002437808807909,0.00186425124935585,0.0114204617763591,0.00644406189912004
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SDC4,Syndecan-4,39868,0.0116124985902832,0.00426244989646373,0.00325809679321431,0.0199669003873521,0.00644938476756968
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CSF2RA,Granulocyte-macrophage colony-stimulating factor receptor subunit alpha,39749,-0.0154111473871927,0.0056574567442787,-0.026499762605979,-0.00432253216840647,0.00645588762427596
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GMFG,Glia maturation factor gamma,37437,-0.018441088065968,0.00676971032524669,-0.0317097203034515,-0.00517245582848444,0.00645675440993944
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DBN1,Drebrin,37056,-0.0134022534753316,0.00492762219125371,-0.0230603929701888,-0.00374411398047432,0.0065402628381947
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SCN4B,Sodium channel subunit beta-4,37043,-0.0105834153341317,0.00390119296490314,-0.0182297535453419,-0.00293707712292154,0.00667905855658991
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GP6,Platelet glycoprotein VI,39836,-0.0225817541603514,0.00833159228824569,-0.038911675045313,-0.00625183327538987,0.00672785703359373
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,HPGDS,Hematopoietic prostaglandin D synthase,39477,0.00945208298403574,0.0034913574821393,0.00260902231904272,0.0162951436490288,0.00679107623239018
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,KLRK1,NKG2-D type II integral membrane protein,37388,-0.0112872183362443,0.00417182560650049,-0.0194639965249853,-0.00311044014750338,0.00682701393587
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NGF,Beta-nerve growth factor,39749,0.00311687183536092,0.00115455754603052,0.000853939045141101,0.00537980462558075,0.00694912415183764
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RABEPK,Rab9 effector protein with kelch motifs,39477,-0.0152434293292512,0.00564693472031643,-0.0263114213810715,-0.00417543727743104,0.00695359330918848
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MDH1,"Malate dehydrogenase, cytoplasmic",37397,-0.0102176033257815,0.00378664037728702,-0.017639418465264,-0.00279578818629889,0.00697748509122568
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TACSTD2,Tumor-associated calcium signal transducer 2,38022,0.00780179902223338,0.00289447078887213,0.00212863627604399,0.0134749617684228,0.00703840899381629
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ENTPD6,Ectonucleoside triphosphate diphosphohydrolase 6,39585,-0.00679626067542813,0.00252298461652663,-0.0117413105238203,-0.00185121082703593,0.00707305502008833
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,EPHA4,Ephrin type-A receptor 4,37124,-0.00712526135634971,0.00264828775088,-0.0123159053480745,-0.00193461736462491,0.00714309070360379
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TPSAB1,Tryptase alpha/beta-1,40038,-0.0132078738614309,0.00491131920089848,-0.0228340594951919,-0.00358168822766984,0.00716814268130173
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GLOD4,Glyoxalase domain-containing protein 4,39832,-0.00899453607769026,0.00335683910380073,-0.0155739407211397,-0.00241513143424083,0.00738152777991298
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PDGFRB,Platelet-derived growth factor receptor beta,40052,0.00876922616197164,0.00327544675834455,0.00234935051561633,0.0151891018083269,0.00743015875739276
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,KIAA1549L,UPF0606 protein KIAA1549L,37169,0.00697482160229252,0.00260555605399711,0.00186793173645819,0.0120817114681269,0.00743971623847877
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RYR1,Ryanodine receptor 1,37021,0.00850912978432178,0.00318038246213792,0.00227558015853145,0.0147426794101121,0.00747090398920571
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,C3,Complement C3,36816,-0.0116230095789074,0.00434740497312729,-0.0201439233262369,-0.00310209583157793,0.00751469139636808
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IST1,IST1 homolog,37287,-0.0250320868426621,0.00938345475058122,-0.0434236581538013,-0.00664051553152292,0.00764678436671602
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IL36A,Interleukin-36 alpha,37056,0.014745706620749,0.00553016914618489,0.00390657509422665,0.0255848381472714,0.00767592481261075
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PADI2,Protein-arginine deiminase type-2,39587,-0.014182418267905,0.0053562664040261,-0.0246807004197962,-0.00368413611601385,0.00810939565696406
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PROCR,Endothelial protein C receptor,37021,0.00907812645949701,0.00343393759521872,0.00234760877286831,0.0158086441461257,0.00821148284093876
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,YY1,Transcriptional repressor protein YY1,37056,0.00689787188729431,0.00260923416146278,0.00178377293082727,0.0120119708437614,0.00821171702342061
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,VASH1,Tubulinyl-Tyr carboxypeptidase 1,39866,-0.0203608754089504,0.00770346313698881,-0.0354596631574485,-0.00526208766045232,0.00822354429178166
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,BRSK2,Serine/threonine-protein kinase BRSK2,37411,-0.00959292795368113,0.00363010133574597,-0.0167079265717432,-0.00247792933561903,0.00823652666804796
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NT5C,"5'(3')-deoxyribonucleotidase, cytosolic type",37437,-0.0183991422373076,0.0069630558466481,-0.0320467316967379,-0.00475155277787735,0.00824164803066325
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TRIAP1,TP53-regulated inhibitor of apoptosis 1,40030,-0.0157836688458329,0.00597685653633209,-0.0274983076570437,-0.00406903003462196,0.00827905876513541
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CFHR2,Complement factor H-related protein 2,37364,-0.0139765873593875,0.0052977872964769,-0.0243602504604822,-0.00359292425829274,0.00834446225041585
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PDIA4,Protein disulfide-isomerase A4,37437,-0.0152084010429982,0.00577138923051427,-0.0265203239348062,-0.00389647815119025,0.00841988761368405
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ATP6V1G2,V-type proton ATPase subunit G 2,37021,-0.024399517114884,0.00926733836105821,-0.0425635003025581,-0.00623553392720989,0.00847705043900021
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MAMDC2,MAM domain-containing protein 2,37437,0.00817299987544408,0.00310559035465361,0.002086042780323,0.0142599569705652,0.0085053474898678
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MYH7B,Myosin-7B,36962,0.010882647637835,0.00413576717426533,0.00277654397627496,0.018988751299395,0.00851461982756393
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PNLIPRP2,Pancreatic lipase-related protein 2,39862,-0.0724642074686891,0.0275868163362758,-0.12653436748779,-0.0183940474495886,0.00862818427941394
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CREB3,Cyclic AMP-responsive element-binding protein 3,36962,0.0138542570491964,0.00528036269084422,0.00350474617514173,0.0242037679232511,0.00870729707484795
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NPTX1,Neuronal pentraxin-1,39858,0.0100591544511702,0.00383688615237769,0.00253885759250989,0.0175794513098304,0.00875758946120784
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CD200R1,Cell surface glycoprotein CD200 receptor 1,39809,-0.00852310203368907,0.00325371829692359,-0.0149003898956593,-0.00214581417171884,0.00881431680558356
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,KIFBP,KIF-binding protein,39788,-0.0204135845201686,0.0078044137128908,-0.0357102353974345,-0.00511693364290258,0.00891427793577992
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ACRBP,Acrosin-binding protein,37368,-0.00942495881223073,0.00360582134747042,-0.0164923686532727,-0.00235754897118871,0.0089636165577507
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,INSL4,Early placenta insulin-like peptide,37368,-0.0130947669910795,0.00501882412930854,-0.0229316622845242,-0.00325787169763475,0.00908726605492704
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IL2RA,Interleukin-2 receptor subunit alpha,39732,-0.00960785625132929,0.0036854842022072,-0.0168314052876554,-0.00238430721500317,0.0091439337846037
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CRTAM,Cytotoxic and regulatory T-cell molecule,39749,0.0120964076988679,0.00464509652675381,0.00299201850643044,0.0212007968913054,0.00921951116087293
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,HMOX1,Heme oxygenase 1,39691,-0.0116519305554131,0.00447551234205431,-0.0204239347458396,-0.0028799263649867,0.00923673331553249
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,COX6B1,Cytochrome c oxidase subunit 6B1,37437,-0.00782344728240267,0.00300736838278823,-0.0137178893126676,-0.00192900525213774,0.00929377281762948
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ENOPH1,Enolase-phosphatase E1,37368,0.0136148361854464,0.00523894472518412,0.00334650452408554,0.0238831678468073,0.00936588531476441
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LYZL2,Lysozyme-like protein 2,36962,-0.00879363698226747,0.0033889566995483,-0.0154359921133821,-0.00215128185115279,0.00947536899886761
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PARK7,Parkinson disease protein 7,39858,-0.0127493389125414,0.00492871806720914,-0.0224096263242713,-0.00308905150081147,0.00969745744814623
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,39755,-0.00584608897336764,0.00226290065661355,-0.0102813742603302,-0.00141080368640507,0.00979063007353068
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PITHD1,PITH domain-containing protein 1,36931,0.0191885551207179,0.00743296205658266,0.00461994948981589,0.0337571607516199,0.00984659150222943
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GPC1,Glypican-1,40030,0.0070183919539264,0.0027223610225441,0.00168256434973997,0.0123542195581128,0.00994463074606459
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CA2,Carbonic anhydrase 2,39821,-0.0164158426561378,0.00637714545983949,-0.0289150477574232,-0.00391663755485244,0.0100570842934221
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MEPE,Matrix extracellular phosphoglycoprotein,39862,0.00595398387214913,0.00231506049235684,0.00141646530712973,0.0104915024371685,0.0101246677174147
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,STXBP3,Syntaxin-binding protein 3,39477,-0.0106664330159543,0.00415241259114698,-0.0188051616946024,-0.00252770433730623,0.0102163551290649
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CDKN2D,Cyclin-dependent kinase 4 inhibitor D,39788,-0.022899267020906,0.00892437996987885,-0.0403910517618686,-0.00540748227994347,0.0102992452903398
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CAPG,Macrophage-capping protein,39739,-0.0139920016229877,0.00545597314665879,-0.0246857089904389,-0.00329829425553648,0.0103407025291296
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PLA2G4A,Cytosolic phospholipase A2,39931,-0.0211537106323506,0.00827692779164898,-0.0373764891039826,-0.00493093216071864,0.0106052158663115
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LRRC37A2,Leucine-rich repeat-containing protein 37A2,37382,-0.0101398465465543,0.00397786264503132,-0.0179364573308157,-0.00234323576229292,0.0108120376483714
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RAB44,Ras-related protein Rab-44,37368,-0.0100886662641565,0.00396573434922722,-0.0178615055886418,-0.00231582693967114,0.0109714300527542
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PPP3R1,Calcineurin subunit B type 1,39749,-0.00985452984657032,0.0039008022382938,-0.0175001022336262,-0.00220895745951447,0.0115372931709096
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ATXN10,Ataxin-10,39489,-0.0173481636931901,0.00687790563101974,-0.0308288587299888,-0.00386746865639144,0.0116687626382605
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,AKT2,RAC-beta serine/threonine-protein kinase,37411,-0.030161260427387,0.0119685390973778,-0.0536195970582474,-0.00670292379652657,0.0117453686447793
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ASRGL1,Isoaspartyl peptidase/L-asparaginase,37043,-0.0242854158332851,0.00964144724776736,-0.0431826524389091,-0.00538817922766111,0.011785417400167
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CXCL3,C-X-C motif chemokine 3,39859,-0.0223701973409043,0.00888457161484384,-0.0397839577059983,-0.00495643697581041,0.0118163662216284
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PALLD,Palladin,37056,0.00963375410841151,0.00382803693263814,0.00213080172044075,0.0171367064963823,0.0118600635156229
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MUCL3,Mucin-like protein 3,36962,0.0106337138379563,0.00422788969467673,0.0023470500363899,0.0189203776395227,0.0119105458025719
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CD22,B-cell receptor CD22,40058,0.00946321784891291,0.00376819461204758,0.00207755640929967,0.0168488792885262,0.0120370313244372
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LILRA4,Leukocyte immunoglobulin-like receptor subfamily A member 4,37021,0.0119776673214117,0.00477038895328692,0.00262770497296935,0.0213276296698541,0.0120564303778149
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CD82,CD82 antigen,37169,0.00995514188830481,0.00397160801538658,0.00217079017814712,0.0177394935984625,0.0122024723642239
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LCN15,Lipocalin-15,37411,-0.014603153447468,0.00583537961881889,-0.026040497500353,-0.00316580939458301,0.0123429531988135
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IL13RA1,Interleukin-13 receptor subunit alpha-1,39597,-0.00530171691020037,0.00212189823363618,-0.00946063744812728,-0.00114279637227347,0.0124795737160987
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RGL2,Ral guanine nucleotide dissociation stimulator-like 2,37169,-0.0151966701200988,0.00608956707111447,-0.0271322215794832,-0.00326111866071448,0.0125890834065981
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GP1BB,Platelet glycoprotein Ib beta chain,37021,-0.0158757160832414,0.00636704991606709,-0.0283551339187329,-0.00339629824774986,0.0126641689927714
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SYNGAP1,Ras/Rap GTPase-activating protein SynGAP,36991,0.0132102599975801,0.00531136658040395,0.0027999814999884,0.0236205384951719,0.0128887835360503
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NAAA,N-acylethanolamine-hydrolyzing acid amidase,39674,0.0137892435549712,0.00555218158368474,0.00290696765094909,0.0246715194589933,0.0130174781694281
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DPP10,Inactive dipeptidyl peptidase 10,39866,0.00807790606631324,0.0032552876059629,0.00169754235862594,0.0144582697740005,0.0130942737093822
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PCNA,Proliferating cell nuclear antigen,36962,0.0148924642445474,0.00600964816409238,0.00311355384292638,0.0266713746461685,0.0132211911177862
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,BTC,Probetacellulin,39477,-0.0172347895993149,0.0069553732405174,-0.030867321150729,-0.00360225804790081,0.013225935457659
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GALNT3,Polypeptide N-acetylgalactosaminyltransferase 3,39587,-0.00980733555119614,0.00396484517235431,-0.0175784320890106,-0.0020362390133817,0.013387412823802
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PPME1,Protein phosphatase methylesterase 1,39788,-0.0138885367783526,0.00563093183194932,-0.0249251631689733,-0.00285191038773195,0.0136555817043296
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CALY,Neuron-specific vesicular protein calcyon,37021,0.00876538175987908,0.0035590868339915,0.00178957156525574,0.0157411919545024,0.0137977114529821
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MASP1,Mannan-binding lectin serine protease 1,39713,-0.0054464865380702,0.00221197986673313,-0.00978196707686714,-0.00111100599927326,0.0138167174298871
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,C7orf50,Uncharacterized protein C7orf50,37388,-0.00506603408416817,0.00205950558696702,-0.00910266503462353,-0.00102940313371281,0.0139126906629798
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ICAM3,Intercellular adhesion molecule 3,40052,0.00584927065498553,0.00237910943967377,0.00118621615322495,0.0105123251567461,0.013958509752532
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IRAG2,"Inositol 1,4,5-triphosphate receptor associated 2",39585,-0.0204298593543769,0.00831873082644101,-0.0367345717742013,-0.0041251469345525,0.0140644881926462
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TSPAN15,Tetraspanin-15,37021,0.0113704804705109,0.0046394978885825,0.00227706460888922,0.0204638963321326,0.0142668387606261
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TPSD1,Tryptase delta,37411,-0.00843130408836731,0.00344299604960477,-0.0151795763455927,-0.00168303183114196,0.0143447782972798
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GGCT,Gamma-glutamylcyclotransferase,37430,-0.0110573273761,0.00452690137459874,-0.0199300540703136,-0.00218460068188651,0.0145952871278344
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SAT2,Thialysine N-epsilon-acetyltransferase,37169,-0.0163823206636682,0.00670811726066404,-0.0295302304945697,-0.0032344108327667,0.0146124461672106
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PRKD2,Serine/threonine-protein kinase D2,37021,-0.0104920011686705,0.004296905234023,-0.0189139354273556,-0.00207006690998546,0.0146290301253204
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PCSK7,Proprotein convertase subtilisin/kexin type 7,37368,-0.0101476853632985,0.00416658745987843,-0.0183141967846602,-0.00198117394193673,0.0148844486565513
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NDUFS6,"NADH dehydrogenase [ubiquinone] iron-sulfur protein 6, mitochondrial",39477,-0.0184855777353986,0.0076040660650911,-0.0333895472229772,-0.00358160824782004,0.0150678817450937
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SERPINA7,Thyroxine-binding globulin,37453,-0.00423764267263229,0.00174356736127205,-0.0076550347007255,-0.000820250644539078,0.0150931902193486
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IDI2,Isopentenyl-diphosphate delta-isomerase 2,39489,-0.0106880881997234,0.00440604249111313,-0.0193239314823052,-0.0020522449171417,0.0152867865005207
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DCTD,Deoxycytidylate deaminase,37124,-0.0218157698645875,0.00901088743819164,-0.0394771092434431,-0.0041544304857319,0.0154892654116969
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SFTPD,Pulmonary surfactant-associated protein D,39868,-0.0149883841790298,0.00619226065754036,-0.0271252150678089,-0.00285155329025071,0.015510114596573
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RP2,Protein XRP2,39788,-0.00949667014489762,0.00392589437815748,-0.0171914231260863,-0.00180191716370897,0.0155751167930186
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IL3,Interleukin-3,36962,0.0135403874507793,0.00560506896685042,0.00255445227575245,0.0245263226258061,0.0157168741860906
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PTN,Pleiotrophin,39585,-0.0114121221132589,0.00472556865141904,-0.0206742366700402,-0.00215000755647758,0.0157476973404176
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NINJ1,Ninjurin-1,39477,0.0128025293615324,0.00530185588119923,0.00241089183438194,0.0231941668886829,0.0157584657194201
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CSF2RB,Cytokine receptor common subunit beta,37056,0.0098233741900371,0.00407566843930168,0.0018350640490058,0.0178116843310684,0.0159552425582212
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TNFRSF13C,Tumor necrosis factor receptor superfamily member 13C,39587,0.00943363409974444,0.00391512828083462,0.00175998266930858,0.0171072855301803,0.0159843269275202
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CASP2,Caspase-2,39866,-0.0154312550310159,0.00642143318940894,-0.0280172640822574,-0.00284524597977436,0.0162686782397262
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ODAM,Odontogenic ameloblast-associated protein,39456,-0.0115556986292757,0.00481351598035864,-0.0209901899507786,-0.00212120730777272,0.0163763996232355
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DCTPP1,dCTP pyrophosphatase 1,39868,-0.00714697469431292,0.00297839063683564,-0.0129846203425108,-0.00130932904611506,0.0164239220965248
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CDHR1,Cadherin-related family member 1,39489,-0.00962403194596185,0.00401441606173124,-0.0174922874269551,-0.00175577646496862,0.0165250009587524
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SCP2,Non-specific lipid-transfer protein,39477,-0.0175543057979391,0.00732490308552132,-0.0319111158455609,-0.00319749575031731,0.0165630964179049
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ARID4B,AT-rich interactive domain-containing protein 4B,39489,-0.00914009169420005,0.00381390480678372,-0.0166153451154961,-0.00166483827290397,0.0165633549468108
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CD3D,T-cell surface glycoprotein CD3 delta chain,36991,0.00779055697435618,0.00325262876252075,0.0014154045998155,0.0141657093488969,0.0166271661177379
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LILRB1,Leukocyte immunoglobulin-like receptor subfamily B member 1,40052,0.00616057880168356,0.00257304978164019,0.0011174012296688,0.0112037563736983,0.0166647359208756
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CLEC14A,C-type lectin domain family 14 member A,39858,-0.00679366753470094,0.0028382445188307,-0.0123566267916091,-0.00123070827779277,0.0166946534193533
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CADPS,Calcium-dependent secretion activator 1,37039,0.00972803302832001,0.00407863589493792,0.00173390667424168,0.0177221593823983,0.0170876332681791
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CLTA,Clathrin light chain A,39585,-0.0104044219824841,0.00436693390411024,-0.0189636124345402,-0.00184523153042803,0.0172051833180752
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ADAMTS16,A disintegrin and metalloproteinase with thrombospondin motifs 16,39585,0.00712489598784296,0.00299284555174904,0.00125891870641484,0.0129908732692711,0.0172943038388684
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,KIF22,Kinesin-like protein KIF22,37021,-0.0271000291401647,0.0113980387825391,-0.0494401851539415,-0.00475987312638801,0.0174397007329826
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,EIF2S2,Eukaryotic translation initiation factor 2 subunit 2,37043,-0.00953187201055297,0.00401565222094771,-0.0174025503636105,-0.00166119365749546,0.0176260674772042
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GPC5,Glypican-5,39749,0.0124674923031957,0.00525252480832924,0.00217254367887041,0.022762440927521,0.0176265389510353
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,HBZ,Hemoglobin subunit zeta,37437,0.0235013870932036,0.00991110262502873,0.00407562594814725,0.0429271482382599,0.0177434335942695
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CHRDL1,Chordin-like protein 1,39908,0.00681618985918357,0.00287707169433157,0.00117712933829369,0.0124552503800734,0.0178411994693264
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PSAP,Prosaposin,37347,-0.00622146057679795,0.00262757202613796,-0.0113715017480283,-0.00107141940556755,0.0179101547557055
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LILRA2,Leukocyte immunoglobulin-like receptor subfamily A member 2,39858,0.00802564153936966,0.00339155553676009,0.00137819268731988,0.0146730903914194,0.0179758088531156
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TAGLN3,Transgelin-3,36962,0.013302255196414,0.00562181606874222,0.00228349570167924,0.0243210146911487,0.0179869413268272
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RPS10,40S ribosomal protein S10,37021,0.00953527669415316,0.00403358147755097,0.00162945699815325,0.0174410963901531,0.0180945825504118
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SNX9,Sorting nexin-9,39868,-0.0153497539225246,0.00651539814735269,-0.0281199342913359,-0.00257957355371334,0.0184889070483826
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ADAMTS1,A disintegrin and metalloproteinase with thrombospondin motifs 1,37056,-0.00693620519079491,0.00294476530741641,-0.0127079451933311,-0.00116446518825875,0.0185155532629748
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CD8A,T-cell surface glycoprotein CD8 alpha chain,40009,-0.0104133926296224,0.00442257531128779,-0.0190816402397465,-0.00174514501949831,0.0185545927982061
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,KLRC1,NKG2-A/NKG2-B type II integral membrane protein,36991,0.0135678004697302,0.00576603505709048,0.0022663717578329,0.0248692291816276,0.0186345214377861
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MYOM2,Myomesin-2,37021,-0.0113890278372855,0.00484097346968801,-0.020877335837874,-0.00190071983669704,0.0186557257032203
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DNPEP,Aspartyl aminopeptidase,37388,-0.0130284847078105,0.00555138839671338,-0.0239092059653687,-0.00214776345025225,0.0189453056213512
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GGH,Gamma-glutamyl hydrolase,39573,0.00747397947021111,0.00319032370950882,0.00122094499957383,0.0137270139408484,0.0191570489251119
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LRRC38,Leucine-rich repeat-containing protein 38,37039,-0.0106414096148455,0.00454495254140349,-0.0195495165959964,-0.00173330263369469,0.0192280020705794
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,AXL,Tyrosine-protein kinase receptor UFO,39931,0.00599197133699027,0.00256306113761464,0.000968371507265583,0.011015571166715,0.019408877436123
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SEMA6C,Semaphorin-6C,37056,0.00574912388226302,0.00246025999854348,0.000927014285117803,0.0105712334794082,0.0194647137271412
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,APRT,Adenine phosphoribosyltransferase,39738,-0.0105589417189529,0.00451998814304281,-0.0194181184793168,-0.00169976495858895,0.0195007436758198
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PAIP2B,Polyadenylate-binding protein-interacting protein 2B,36931,0.011552635195856,0.00495248494996236,0.00184576469392981,0.0212595056977823,0.0196792728734349
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ELAVL4,ELAV-like protein 4,36991,-0.0185184174518128,0.00795656844200109,-0.034113291598135,-0.00292354330549071,0.0199571009249964
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SERPINA6,Corticosteroid-binding globulin,37453,-0.00383623831773059,0.00165459790502257,-0.00707925021157483,-0.000593226423886355,0.020435180566411
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DIABLO,"Diablo homolog, mitochondrial",39818,-0.0239130816787144,0.0103173101287528,-0.0441350095310699,-0.00369115382635896,0.0204747770024744
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CLINT1,Clathrin interactor 1,36962,0.0106556977209804,0.00459887978219969,0.001641893347869,0.0196695020940918,0.0205179659024686
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,AMOTL2,Angiomotin-like protein 2,37333,-0.0105060249201527,0.00454604951056118,-0.0194162819608526,-0.00159576787945278,0.0208466051597623
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PEBP1,Phosphatidylethanolamine-binding protein 1,39858,-0.0124961349851264,0.00541548237061025,-0.0231104804315225,-0.00188178953873033,0.0210405942116877
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,EDDM3B,Epididymal secretory protein E3-beta,37368,0.0111268258929362,0.00483406965307772,0.00165204937290381,0.0206016024129685,0.0213643444469373
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,KCNC4,Potassium voltage-gated channel subfamily C member 4,36991,0.0121512801096224,0.00528045460347709,0.00180158908680727,0.0225009711324374,0.0213970059290297
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NMT1,Glycylpeptide N-tetradecanoyltransferase 1,37411,-0.0143222025687001,0.00623306825518067,-0.0265390163488542,-0.002105388788546,0.0215896296391308
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MANF,Mesencephalic astrocyte-derived neurotrophic factor,39931,-0.0260111383815818,0.0113204177561014,-0.0481991571835406,-0.00382311957962304,0.0215905744129089
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,XG,Glycoprotein Xg,39985,0.00648460295140016,0.00282288941108542,0.000951739705672748,0.0120174661971276,0.0216229123525426
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MAEA,E3 ubiquitin-protein transferase MAEA,39477,-0.00861932032260952,0.0037644350837757,-0.0159976130868099,-0.00124102755840916,0.0220536328347154
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,BAG3,BAG family molecular chaperone regulator 3,39720,-0.00847969996003806,0.00371392711243091,-0.0157589971004026,-0.00120040281967347,0.0224307802320841
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MICB_MICA,MHC class I polypeptide-related sequence A_MHC class I polypeptide-related sequence B,39866,-0.0320192912336303,0.0140265065843676,-0.0595112441389908,-0.00452733832826992,0.0224569608587551
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GLP1R,Glucagon-like peptide 1 receptor,36991,0.00813492825156049,0.00356882577423515,0.0011400297340596,0.0151298267690614,0.0226568253058386
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TPSG1,Tryptase gamma,37056,0.00574659885780908,0.00252820435262462,0.000791318326664825,0.0107018793889533,0.0230424135331997
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TBCA,Tubulin-specific chaperone A,37124,-0.0184834719695928,0.00813565712401383,-0.0344293599326599,-0.0025375840065257,0.0231079530156226
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MARCO,Macrophage receptor MARCO,39868,0.00559254283249478,0.00246363192960745,0.000763824250464191,0.0104212614145254,0.0232183960653958
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GSTT2B,Glutathione S-transferase theta-2B,37388,-0.0509160367982819,0.0224577217291529,-0.0949331713874216,-0.0068989022091421,0.0233940199373685
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DXO,Decapping and exoribonuclease protein,37388,-0.00967351961765702,0.00427385831933177,-0.0180502819235473,-0.00129675731176675,0.0236258276085581
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CNTNAP2,Contactin-associated protein-like 2,39866,0.00869698218119535,0.00384966681208774,0.00115163522950338,0.0162423291328873,0.0238873301263937
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TP73,Tumor protein p73,37039,0.00735561723483378,0.00325805814298548,0.000969823274582227,0.0137414111950853,0.0239825895215808
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LAMTOR5,Ragulator complex protein LAMTOR5,37368,0.00876892179842029,0.00388570894564063,0.00115293226496466,0.0163849113318759,0.0240420569237817
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MSMB,Beta-microseminoprotein,39780,0.0142046796384012,0.00630055097709261,0.00185559972329969,0.0265537595535027,0.0241773917950375
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PRDX3,"Thioredoxin-dependent peroxide reductase, mitochondrial",39587,-0.0153255310814035,0.00680096221894639,-0.0286554170305384,-0.00199564513226858,0.0242454057850134
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ZBP1,Z-DNA-binding protein 1,37056,-0.00873022486101731,0.00387467853205616,-0.0163245947838474,-0.00113585493818724,0.0242661590030548
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PPP1R14D,Protein phosphatase 1 regulatory subunit 14D,37411,0.00778736605177705,0.00346204444797319,0.0010017589337496,0.0145729731698045,0.0245059236126405
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ADGRV1,Adhesion G-protein coupled receptor V1,36991,0.0146693560036067,0.00652827859677097,0.00187392995393558,0.0274647820532778,0.0246534924154697
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,OSMR,Oncostatin-M-specific receptor subunit beta,39949,0.00426187875346874,0.00189967550053899,0.000538514772412316,0.00798524273452517,0.0248796048495044
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GALNT7,N-acetylgalactosaminyltransferase 7,39788,-0.00436453616049377,0.00194690391074633,-0.00818046782555657,-0.000548604495430966,0.0249891085810838
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TP53INP1,Tumor protein p53-inducible nuclear protein 1,39585,0.00668418099076962,0.00298489030402471,0.000833795994881184,0.0125345659866581,0.0251477963131802
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,EPHX2,Bifunctional epoxide hydrolase 2,39585,-0.0128912765955398,0.00575763499749253,-0.0241762411906251,-0.00160631200045442,0.0251706147319649
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LILRA6,Leukocyte immunoglobulin-like receptor subfamily A member 6,37437,-0.01543002995827,0.00689390437150958,-0.0289420825264288,-0.00191797739011126,0.0252232796284486
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SOX2,Transcription factor SOX-2,37391,0.0049867450179063,0.00223571833647378,0.000604737078417694,0.00936875295739491,0.0257313317998405
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ERCC1,DNA excision repair protein ERCC-1,36962,0.00689041590943263,0.00309199789773338,0.000830100029875199,0.0129507317889901,0.0258662768007805
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CD33,Myeloid cell surface antigen CD33,39913,-0.0163799433203115,0.00736327805714485,-0.0308119683123154,-0.00194791832830761,0.0261256485445986
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FMR1,Synaptic functional regulator FMR1,39477,-0.00742145907110114,0.00334488335278007,-0.0139774304425501,-0.000865487699652214,0.0265180758790395
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GLI2,Zinc finger protein GLI2,37056,0.00713939197347507,0.00323314353841663,0.000802430638178473,0.0134763533087717,0.0272482317910197
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SLAMF7,SLAM family member 7,39866,-0.0119176822797453,0.00542242412393356,-0.022545633562655,-0.00128973099683549,0.0279739684374681
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ITGB5,Integrin beta-5,39913,-0.0078228410105583,0.00356010204022911,-0.0148006410094074,-0.00084504101170924,0.0280086751937207
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CASP9,Caspase-9,37056,-0.0130837870273469,0.00595455558608614,-0.0247547159760757,-0.00141285807861806,0.0280182386582689
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PTPN9,Tyrosine-protein phosphatase non-receptor type 9,37022,0.00803862011328274,0.00366013643496751,0.000864752700746423,0.015212487525819,0.0280905453910712
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RANGAP1,Ran GTPase-activating protein 1,39477,0.0101832540822546,0.0046514277933109,0.00106645560736523,0.019300052557144,0.0285916142901286
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CD244,Natural killer cell receptor 2B4,40058,-0.00548522282487068,0.00250922188747179,-0.0104032977243154,-0.00056714792542597,0.0288280100244172
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NFYA,Nuclear transcription factor Y subunit alpha,37021,-0.00776409022873328,0.00355712280013669,-0.0147360509170012,-0.000792129540465376,0.0290763869244996
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FNDC1,Fibronectin type III domain-containing protein 1,37388,-0.00943320495229016,0.00432654450644642,-0.0179132321849251,-0.000953177719655177,0.0292517213168482
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MAP1LC3A,Microtubule-associated proteins 1A/1B light chain 3A,36991,0.00661130674000533,0.00303345254227569,0.000665739757144975,0.0125568737228657,0.0293147744405279
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GAD2,Glutamate decarboxylase 2,37056,0.00953341005539308,0.00437819501294237,0.000952147830026033,0.0181146722807601,0.029462802017955
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SERPINC1,Antithrombin-III,37424,0.00298149495744402,0.00136925751770083,0.000297750222750385,0.00566523969213765,0.029463902807858
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PREB,Prolactin regulatory element-binding protein,39587,-0.00585518367660552,0.00268961291178968,-0.0111268249837133,-0.000583542369497744,0.0294982629626092
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CCL28,C-C motif chemokine 28,39815,-0.0121803860247126,0.00559954345302432,-0.0231554911926403,-0.00120528085678499,0.0296262990999647
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PAMR1,Inactive serine protease PAMR1,39858,0.00565703848952207,0.00260317477588713,0.000554815928783284,0.0107592610502609,0.0297851200701547
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NACC1,Nucleus accumbens-associated protein 1,37368,-0.0112290178046957,0.00516764844462519,-0.021357608756161,-0.0011004268532303,0.0298017502867288
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DARS1,"Aspartate--tRNA ligase, cytoplasmic",39713,-0.0149771337530319,0.00689422052265246,-0.0284898059774307,-0.00146446152863307,0.0298388606651231
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ITGB1BP1,Integrin beta-1-binding protein 1,39477,-0.00827061912321667,0.00381315337487549,-0.0157443997379726,-0.000796838508460717,0.0300999240224495
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CHRM1,Muscarinic acetylcholine receptor M1,37039,0.00749198353811877,0.0034562671567741,0.000717699910841529,0.014266267165396,0.0302030370479596
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,EDA2R,Tumor necrosis factor receptor superfamily member 27,40030,-0.00721054136171563,0.00333580775244694,-0.0137487245565116,-0.000672358166919631,0.0306669014704662
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TDP1,Tyrosyl-DNA phosphodiesterase 1,37368,-0.0140052879117298,0.00648654112219427,-0.0267189085112306,-0.00129166731222906,0.0308576032305846
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RLN1,Prorelaxin H1,37411,-0.0163858952590981,0.00759244668083111,-0.0312670907535271,-0.00150469976466914,0.0309310547741507
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PTK7,Inactive tyrosine-protein kinase 7,39489,-0.00780219199055202,0.00361621754369743,-0.014889978376199,-0.000714405604905064,0.0309775553751988
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ATP1B4,Protein ATP1B4,36962,0.00848492662138028,0.00393718276802166,0.000768048396057824,0.0162018048467027,0.0311740777155729
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,HLA_DRA,,39799,0.00715745866444923,0.00333457426893142,0.000621693097343642,0.0136932242315548,0.0318530563238861
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,INPP1,Inositol polyphosphate 1-phosphatase,39788,-0.0108850486382231,0.00507368004866183,-0.0208294615336002,-0.000940635742845863,0.031936337816163
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CD160,CD160 antigen,40058,-0.00899880760107488,0.00421323642911827,-0.0172567510021467,-0.000740864200003074,0.0327072390133432
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SNX5,Sorting nexin-5,37043,-0.00612173749811866,0.00286796196132645,-0.0117429429423185,-0.000500532053918814,0.0328181922011141
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ADRA2A,Alpha-2A adrenergic receptor,37021,0.0143659927288683,0.00673306741190655,0.00116918060153143,0.0275628048562051,0.0328900795447748
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SUGT1,Protein SGT1 homolog,39477,-0.0162452779514971,0.00761821799914878,-0.0311769852298287,-0.00131357067316545,0.0329874838983138
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PRG3,Proteoglycan 3,37437,0.00999077147291765,0.00468914349363757,0.000800050225388017,0.0191814927204473,0.033138581508991
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TG,Thyroglobulin,37368,0.0217235995850643,0.0102026909276855,0.0017263253668007,0.0417208738033279,0.0332555073586649
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,STX6,Syntaxin-6,39477,-0.0136429806368001,0.00640863511007359,-0.0262039054525444,-0.0010820558210559,0.0332828213999184
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,KLK8,Kallikrein-8,39315,-0.00693341197726201,0.00325897369238401,-0.0133210004143347,-0.000545823540189357,0.0333957368868256
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MPO,Myeloperoxidase,39858,-0.00904809645352055,0.00425740435231162,-0.0173926089840513,-0.000703583922989779,0.0335801009434332
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FCGR2B,Low affinity immunoglobulin gamma Fc region receptor II-b,39477,-0.0115218331726263,0.00542565131737725,-0.0221561097546857,-0.000887556590566899,0.033720515407088
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,C1GALT1C1,C1GALT1-specific chaperone 1,37021,0.00652088551688577,0.00307629268757609,0.000491351849236638,0.0125504191845349,0.0340481555010753
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CDC26,Anaphase-promoting complex subunit CDC26,37362,-0.0141497410526122,0.00668203076291177,-0.0272465213479193,-0.00105296075730513,0.0342288007945217
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DLL4,Delta-like protein 4,37043,-0.0171584604674772,0.00810405864971775,-0.033042415420924,-0.00127450551403044,0.0342558206875862
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CASP1,Caspase-1,39489,-0.0133087696321269,0.00628638340320765,-0.0256300811024139,-0.000987458161839944,0.0342689064602984
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SWAP70,Switch-associated protein 70,37382,-0.00714302714491906,0.00337439243980437,-0.0137568363269356,-0.000529217962902492,0.0342921892236917
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CDK1,Cyclin-dependent kinase 1,36962,-0.00719562641710984,0.00340323092422325,-0.0138659590285874,-0.000525293805632282,0.0345040938687028
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,STK4,Serine/threonine-protein kinase 4,39868,-0.0173293309462737,0.00819721336573881,-0.0333958691431217,-0.00126279274942559,0.0345262932187695
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PRR5,Proline-rich protein 5,37056,0.00944431855614884,0.00447441642710726,0.000674462359018607,0.0182141747532791,0.034813642281702
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FGF5,Fibroblast growth factor 5,39587,0.00656742336390834,0.00311244428705071,0.000467032561288945,0.0126678141665277,0.0348695159055723
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PLCB1,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1",37056,0.00907948125877172,0.00431331774336985,0.000625378481766808,0.0175335840357766,0.0353112239679415
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,KAZALD1,Kazal-type serine protease inhibitor domain-containing protein 1,39788,-0.00876682175492284,0.0041654457503061,-0.0169310954255228,-0.000602548084322883,0.0353370686606309
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CCN3,CCN family member 3,40042,-0.00639833561594054,0.00304088308023822,-0.0123584664532075,-0.000438204778673626,0.0353847237498517
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GIPC3,PDZ domain-containing protein GIPC3,37382,-0.0195862835038091,0.00930862948020455,-0.03783119728501,-0.00134136972260818,0.0353881742505678
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GPHA2,Glycoprotein hormone alpha-2,37382,0.00919051760244509,0.00437232913767906,0.000620752492594127,0.0177602827122961,0.0355740921798009
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SCARA5,Scavenger receptor class A member 5,40009,-0.00575513580681127,0.00274036420376302,-0.0111262496461868,-0.000384021967435751,0.0357324045992838
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PDE4D,"cAMP-specific 3',5'-cyclic phosphodiesterase 4D",37021,0.0121896724763904,0.00581341313626131,0.00079538272931827,0.0235839622234626,0.0360286774527919
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,AMIGO2,Amphoterin-induced protein 2,39788,-0.00442623388066196,0.00211234439024331,-0.00856642888553884,-0.000286038875785079,0.0361500432364622
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CBLN1,Cerebellin-1,36991,0.0189718196517023,0.00905410046565816,0.00122578273901231,0.0367178565643923,0.036155949857881
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NAGA,Alpha-N-acetylgalactosaminidase,37037,-0.0118617938415101,0.00567069957432327,-0.0229763650071837,-0.000747222675836537,0.0364782743541231
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,AK2,"Adenylate kinase 2, mitochondrial",37388,-0.0209141342526228,0.0100223466521455,-0.040557933690828,-0.00127033481441767,0.0369293936742963
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DTD1,D-aminoacyl-tRNA deacylase 1,37124,-0.0172789666824478,0.00830243656928006,-0.0335517423582367,-0.00100619100665883,0.0374354475156157
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ADGRE5,Adhesion G protein-coupled receptor E5,39962,-0.00580155284699297,0.00279343376511309,-0.0112766830266146,-0.000326422667371323,0.0378308959797876
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,AHSA1,Activator of 90 kDa heat shock protein ATPase homolog 1,37368,-0.0131498611222931,0.00634277855095323,-0.0255817070821614,-0.000718015162424803,0.0381723973787167
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GAMT,Guanidinoacetate N-methyltransferase,37021,0.00717405445590307,0.00346162107201208,0.000389277154759404,0.0139588317570467,0.03824243631229
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TNFRSF10C,Tumor necrosis factor receptor superfamily member 10C,39881,-0.00948446891115727,0.00458383204080259,-0.0184687797111303,-0.0005001581111842,0.0385514322092139
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,AMDHD2,N-acetylglucosamine-6-phosphate deacetylase,37437,0.00492514511283686,0.0023954416307894,0.000230079516489645,0.00962021070918408,0.0397968782851631
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SPRED2,"Sprouty-related, EVH1 domain-containing protein 2",37056,-0.00880649595053096,0.0042848788772855,-0.0172048585500105,-0.000408133351051386,0.0398745322983613
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LTA,Lymphotoxin-alpha,39866,-0.00762433265590192,0.00371034814651668,-0.0148966150230746,-0.000352050288729226,0.0399064668787751
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DTX2,Probable E3 ubiquitin-protein ligase DTX2,37039,0.0121304563867218,0.00590543620195961,0.000555801430880968,0.0237051113425626,0.0399840577496376
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TRAF3,"TNF receptor-associated factor 3, Isoform 2",37056,-0.00692474868581175,0.00337493567504934,-0.0135396226089084,-0.000309874762715052,0.0402071899015115
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MYBPC2,"Myosin-binding protein C, fast-type",37043,-0.0164083548509597,0.00801478770392309,-0.032117338750649,-0.000699370951270473,0.0406523352299024
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FGF6,Fibroblast growth factor 6,37056,0.00787914965828527,0.00385188864105573,0.000329447921816032,0.0154288513947545,0.0408225258747723
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,BNIP2,BCL2/adenovirus E1B 19 kDa protein-interacting protein 2,37437,0.00652612870330614,0.00320314260435294,0.000247969198774379,0.0128042882078379,0.0416278870942861
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FHIT,Bis(5'-adenosyl)-triphosphatase,39489,-0.0142332921613522,0.00699779803373767,-0.027948976307478,-0.000517608015226325,0.0419717485649065
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IFNLR1,Interferon lambda receptor 1,39866,-0.00714267012773236,0.00351462965832157,-0.0140313442580427,-0.000253995997422079,0.0421429877874579
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CRADD,Death domain-containing protein CRADD,39713,-0.014565335703488,0.0071727830699108,-0.0286239905205131,-0.000506680886462781,0.0423082470052289
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RCC1,Regulator of chromosome condensation,37368,-0.00963320041573896,0.00475557755613493,-0.0189541324257634,-0.000312268405714498,0.0428188880303648
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MERTK,Tyrosine-protein kinase Mer,40058,-0.00482048101430761,0.00238167210994212,-0.00948855834979416,-0.000152403678821051,0.0429875418398497
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FXYD5,FXYD domain-containing ion transport regulator 5,39587,-0.0124239248031604,0.00615024320231271,-0.0244784014796933,-0.000369448126627456,0.0433929973401587
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,APPL2,DCC-interacting protein 13-beta,37124,-0.0214869885146125,0.0106388853498316,-0.0423392038002825,-0.000634773228942537,0.0434381767662825
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SATB1,DNA-binding protein SATB1,37411,-0.00570307287044615,0.00282405013894064,-0.0112382111427698,-0.000167934598122496,0.0434584682316537
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CFB,Complement factor B,37220,-0.00627344851545507,0.00310845032403616,-0.012366011150566,-0.000180885880344193,0.0435912509211221
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PRKG1,cGMP-dependent protein kinase 1,37124,-0.0240268637220276,0.0119115693250488,-0.0473735395991233,-0.000680187844931932,0.0437048591273422
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CLEC1A,C-type lectin domain family 1 member A,39585,-0.00605094339728277,0.00300516581929034,-0.0119410684030918,-0.000160818391473708,0.0440775893179518
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CIRBP,Cold-inducible RNA-binding protein,37382,-0.0182250754337782,0.00906300738629257,-0.0359885699109116,-0.000461580956644777,0.0443526387751222
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,BRME1,Break repair meiotic recombinase recruitment factor 1,36991,0.00769186795389907,0.00383381828914529,0.000177584107174308,0.0152061518006238,0.0448425397875289
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,M6PR,Cation-dependent mannose-6-phosphate receptor,37043,-0.00777996402138758,0.0038801818114616,-0.0153851203718523,-0.000174807670922835,0.0449779566007439
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GFRA2,GDNF family receptor alpha-2,39788,0.00391809355688698,0.00195708523826123,8.22064898949684e-05,0.007753980623879,0.0453011670289123
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TTN,Titin,37021,-0.012831754666136,0.00642749384674591,-0.025429642605758,-0.000233866726514062,0.0459125565042841
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TJP3,Tight junction protein ZO-3,36991,0.0081660932372048,0.00409186079222174,0.000146046084450195,0.0161861403899594,0.0459880957931567
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MYOM3,Myomesin-3,37124,-0.0175840708124132,0.00881151933485293,-0.0348546487087249,-0.000313492916101415,0.0460003331597057
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,KLK10,Kallikrein-10,39856,-0.00737397171604101,0.00369608851755046,-0.0146183052104399,-0.000129638221642099,0.0460516968697452
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,EVI2B,Protein EVI2B,36962,0.00772793244370588,0.00387664710929371,0.000129704109490199,0.0153261607779216,0.0462320381041106
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RAP1A,Ras-related protein Rap-1A,37056,0.0127345744403754,0.00639059099412378,0.000209016091892762,0.025260132788858,0.0463141189475805
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TK1,"Thymidine kinase, cytosolic",37169,-0.00864854687799194,0.00434286340553836,-0.0171605591528471,-0.00013653460313676,0.0464530675417743
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CBX2,Chromobox protein homolog 2,37021,0.00754788451536279,0.00380131783102093,9.73015665617638e-05,0.0149984674641638,0.0470988293007569
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CGB3_CGB5_CGB8,Choriogonadotropin subunit beta 3,37445,0.00872417571563137,0.00439697255506308,0.00010610950770774,0.017342241923555,0.0472611722332517
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ACYP1,Acylphosphatase-1,37073,-0.0122551292816867,0.00618066846417694,-0.0243692394714735,-0.00014101909189991,0.0474086431555939
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TEX33,Testis-expressed protein 33,37169,0.00741465702024382,0.00374266969711253,7.90244139032559e-05,0.0147502896265844,0.0475989888687507
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MYL1,"Myosin light chain 1/3, skeletal muscle isoform",37021,-0.00758641123564757,0.00383598303182554,-0.0151049379780256,-6.78844932695041e-05,0.047983752761967
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ITGA6,Integrin alpha-6,39866,-0.00985821342998268,0.00498579188073519,-0.0196303655162237,-8.60613437417019e-05,0.0480292298798368
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CBLN4,Cerebellin-4,40030,0.00574084628508298,0.00291163258402241,3.4046420399063e-05,0.0114476461497669,0.0486616548908242
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DDX39A,ATP-dependent RNA helicase DDX39A,37056,0.00416412635114008,0.00211746723549422,1.38905695714168e-05,0.00831436213270875,0.0492548845779324
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TST,Thiosulfate sulfurtransferase,39455,-0.0141392047526417,0.00719193547130304,-0.0282353982763957,-4.30112288877394e-05,0.0493185780830705
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PPM1F,Protein phosphatase 1F,37437,-0.00983909013070172,0.00500551408588515,-0.0196498977390366,-2.82825223668227e-05,0.0493593723858094
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PECR,Peroxisomal trans-2-enoyl-CoA reductase,37043,-0.0051711268770346,0.00263448448131716,-0.0103347164604162,-7.53729365295976e-06,0.0496833218329085
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,VCAM1,Vascular cell adhesion protein 1,39908,-0.00491959821841181,0.00250875409993082,-0.00983675625427622,-2.44018254739412e-06,0.0498994798037086
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DAPK2,Death-associated protein kinase 2,37056,-0.00981297205391074,0.00500650117989106,-0.0196257143664972,-2.29741324275431e-07,0.0500114400739798
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,VSIG10L,V-set and immunoglobulin domain-containing protein 10-like,37021,0.00616089024800813,0.00314387160133577,-1.09809060997758e-06,0.0123228785866262,0.0500577030395653
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FGF20,Fibroblast growth factor 20,37056,0.00789763601897037,0.0040389303331727,-1.86674340481238e-05,0.0158139394719889,0.0505595318028105
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LPCAT2,Lysophosphatidylcholine acyltransferase 2,39788,-0.00703660306169862,0.00360009733311522,-0.0140927938346044,1.95877112072066e-05,0.0506526005147456
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,VCPKMT,Protein-lysine methyltransferase METTL21D,36962,-0.0158849581852639,0.00812826986629102,-0.0318163671231943,4.64507526665506e-05,0.0506887296931934
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MRPL52,"39S ribosomal protein L52, mitochondrial",36942,0.00464215286758219,0.00237844741767975,-1.96040710701154e-05,0.0093039098062345,0.0509882960701044
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,INSL3,Insulin-like 3,37388,0.0132815096248105,0.00681058175855775,-6.7230621962679e-05,0.0266302498715837,0.051181430865294
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CRYBB1,Beta-crystallin B1,37437,-0.0121795296223518,0.00625618069078259,-0.0244416437762857,8.25845315820528e-05,0.0515793680292931
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PMCH,Pro-MCH,37021,0.0151612226100215,0.00778813658797552,-0.000103525102410537,0.0304259703224535,0.0515910786882421
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LTO1,Protein LTO1 homolog,39587,0.00735346834610473,0.00379246635827888,-7.97657161218639e-05,0.0147867024083313,0.0525231819302016
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,EFNA1,Ephrin-A1,39826,-0.0047955007557072,0.00247519684168885,-0.00964688656541734,5.58850540029448e-05,0.0527113963685397
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SDHB,Succinate dehydrogenase,37382,-0.0127204778935174,0.00659604909918664,-0.0256487341279232,0.000207778340888379,0.0538139259433491
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PRAME,Melanoma antigen preferentially expressed in tumors,36962,0.00464538029878531,0.00240942860344091,-7.70997639588638e-05,0.00936786036152949,0.0538766111494551
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ART5,Ecto-ADP-ribosyltransferase 5,36991,0.011144904555403,0.0058004572702416,-0.00022399169427058,0.0225138008050765,0.054704962834492
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CD14,Monocyte differentiation antigen CD14,39564,-0.00739013285847214,0.00385864781097946,-0.0149530825679919,0.000172816851047609,0.0554834754173672
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TLR3,Toll-like receptor 3,40058,-0.0109425691189307,0.00572556033454337,-0.0221646673746357,0.000279529136774285,0.0559992472685757
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RAB6B,Ras-related protein Rab-6B,39489,-0.00844718061935162,0.0044214794791769,-0.0171132803985384,0.000218919159835108,0.0560887732159413
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CLMP,CXADR-like membrane protein,40030,-0.00366783883503192,0.00192300381737502,-0.00743692631708696,0.000101248647023111,0.0564931468917026
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,BSND,Barttin,36962,0.0060415018394283,0.00317005294300076,-0.000171801928853193,0.0122548056077098,0.0566974101682429
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LONP1,"Lon protease homolog, mitochondrial",37043,-0.0156510218215546,0.00822684109936463,-0.0317756303763093,0.000473586733200075,0.0571362152591586
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ARG2,"Arginase-2, mitochondrial",37368,0.00783024141621101,0.0041182801398702,-0.000241587657934571,0.0159020704903566,0.0572790484001637
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CD101,Immunoglobulin superfamily member 2,37382,-0.0075297805781186,0.00396050041394672,-0.0152923613894542,0.000232800233216961,0.0572945070202806
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ACVRL1,Serine/threonine-protein kinase receptor R3,39720,-0.0041445478675014,0.00218065058652067,-0.0084186230170819,0.000129527282079111,0.0573723365087276
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MRC1,Macrophage mannose receptor 1,37445,-0.00491630349509816,0.00258985777886317,-0.00999242474166997,0.000159817751473653,0.0576789432610246
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RICTOR,Rapamycin-insensitive companion of mTOR,37056,0.0085385506815652,0.00450236001001597,-0.000286074938066108,0.0173631763011965,0.0579209164580448
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,HMGCL,"Hydroxymethylglutaryl-CoA lyase, mitochondrial",37043,-0.00897101228812193,0.00473331199958471,-0.018248303807308,0.000306279231064095,0.0580754723418165
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IL18RAP,Interleukin-18 receptor accessory protein,39639,0.0305158932878088,0.0161151910552903,-0.00106988118056025,0.0621016677561778,0.0582950184115789
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SIRT5,"NAD-dependent protein deacylase sirtuin-5, mitochondrial",39489,-0.00970610121344789,0.00514318887666525,-0.0197867514117118,0.000374548984815998,0.059155208348919
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IL5RA,Interleukin-5 receptor subunit alpha,39866,-0.00962265475738883,0.00509988771023274,-0.019618434669445,0.000373125154667336,0.0592003892022852
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CCER2,Coiled-coil domain-containing glutamate-rich protein 2,37043,-0.0108250786228766,0.00574309617097988,-0.0220815471179971,0.000431389872244003,0.059467276359846
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LIPF,Gastric triacylglycerol lipase,37043,-0.0106154513013141,0.00563686059850558,-0.0216636980743851,0.000432795471756807,0.0596924908494605
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,AHCY,Adenosylhomocysteinase,39868,-0.0119919412578241,0.00636848629131895,-0.0244741743888093,0.000490291873161025,0.0597167480560708
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ACOX1,Peroxisomal acyl-coenzyme A oxidase 1,39868,-0.00863969285641308,0.00458942131124476,-0.0176349586264528,0.000355572913626654,0.0597831108903904
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,AIF1L,Allograft inflammatory factor 1-like,37043,0.010388232473404,0.00551873826639285,-0.000428494528725962,0.021204959475534,0.0598096427334437
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CEND1,Cell cycle exit and neuronal differentiation protein 1,36991,0.0104048515679278,0.00553038853715784,-0.000434709964901542,0.0212444131007572,0.0599401572942273
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,HSBP1,Heat shock factor-binding protein 1,37043,-0.0170665478560463,0.00909492062809754,-0.0348925922871175,0.000759496575024821,0.0606097936863934
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IL15RA,Interleukin-15 receptor subunit alpha,39587,-0.00604588296952844,0.0032237543084934,-0.0123644414141755,0.000272675475118621,0.0607539187481384
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ADAMTSL5,ADAMTS-like protein 5,37437,-0.00690507098696573,0.00368472210498804,-0.0141271263127423,0.000316984338810835,0.0609555594819719
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GGACT,Gamma-glutamylaminecyclotransferase,37437,-0.0125710677337101,0.00671017298294529,-0.0257230067802829,0.000580871312862628,0.0610299128568893
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DNAJA1,DnaJ homolog subfamily A member 1,36962,0.0081311598125639,0.00434215104035373,-0.000379456226529412,0.0166417758516572,0.0611443739118712
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PNMA1,Paraneoplastic antigen Ma1,37043,-0.00999975276992436,0.00536901181036342,-0.0205230159182367,0.00052351037838794,0.0625557059804346
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,STX7,Syntaxin-7,37056,-0.008639556727415,0.00464213617895966,-0.0177381436381759,0.000459030183345921,0.0627499332011354
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,KLK6,Kallikrein-6,39889,0.00515607977921964,0.00277401757041604,-0.000280994658795788,0.0105931542172351,0.0630873079413084
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,WAS,Wiskott-Aldrich syndrome protein,39587,-0.0117711977475641,0.00633866295048384,-0.0241949771305124,0.000652581635384225,0.0633230885245307
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,AKT3,RAC-gamma serine/threonine-protein kinase,39391,-0.0101890691440748,0.00548723288674002,-0.0209440456020852,0.000565907313935642,0.0633488043378561
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SCN3B,Sodium channel subunit beta-3,36991,0.00777202991922401,0.00418861182407271,-0.000437649255958496,0.0159817090944065,0.0635451847480361
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TARS1,"Threonine--tRNA ligase 1, cytoplasmic",37368,-0.00635538444923619,0.00343637558975592,-0.0130906806051578,0.000379911706685416,0.0644155475715645
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,APOL1,Apolipoprotein L1,37445,0.0106463468251917,0.0057719562477159,-0.000666687420331481,0.0219593810707148,0.0651327306430128
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CLASP1,CLIP-associating protein 1,36962,-0.0126955891565361,0.00688588009094079,-0.0261919141347801,0.000800735821707796,0.0652474914091849
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PKLR,Pyruvate kinase PKLR,39881,-0.0110303454594072,0.00599912150720012,-0.0227886236135194,0.000727932694705049,0.0659836912147368
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TERF1,Telomeric repeat-binding factor 1,37056,0.00504584967524228,0.00274641053391026,-0.000337114971221832,0.0104288143217064,0.0661950984653326
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IL1RL2,Interleukin-1 receptor-like 2,39587,0.00686231668000307,0.0037357125943345,-0.000459680004892562,0.0141843133648987,0.06623615834844
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CEACAM16,Carcinoembryonic antigen-related cell adhesion molecule 16,37382,0.0145146152629216,0.00790402165974658,-0.000977267190181654,0.0300064977160249,0.0663266322001828
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IGF1R,Insulin-like growth factor 1 receptor,39788,-0.00373609579367034,0.00204096593059943,-0.00773638901764523,0.000264197430304549,0.0671860009900764
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,APCS,Serum amyloid P-component,37333,-0.0059932638882773,0.00327573691817828,-0.0124137082479067,0.000427180471352116,0.06733297372656
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ANXA1,Annexin A1,37072,-0.00752352108728267,0.0041137547029577,-0.0155864803050798,0.000539438130514422,0.0674416690267021
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DLL1,Delta-like protein 1,39913,-0.00487148259015807,0.00266600245013983,-0.0100968473924321,0.000353882212115985,0.0676790755764146
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CCL18,C-C motif chemokine 18,39715,-0.0121048706560914,0.00663117519406891,-0.0251019740364665,0.00089223272428368,0.0679521363927086
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IL12RB2,Interleukin-12 receptor subunit beta-2,37056,0.00714557721833121,0.00391525827267593,-0.000528328996113603,0.014819483432776,0.0680147262000079
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PPP2R5A,Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit alpha isoform,37382,-0.0203216194251771,0.0111467476981628,-0.0421692449135762,0.00152600606322191,0.0683105368532659
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ATF4,Cyclic AMP-dependent transcription factor ATF-4,36962,0.00575406563743962,0.00315820322052301,-0.000436012674785487,0.0119441439496647,0.0684864518587681
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,BCAM,Basal cell adhesion molecule,39858,0.00402556891890421,0.00221153787294676,-0.000309045312071449,0.00836018314987987,0.0687384404759911
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SKIV2L,Helicase SKI2W,37021,0.00687858948533456,0.00378331908886229,-0.00053671592883552,0.0142938948995046,0.0690660367837873
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,KEL,Kell blood group glycoprotein,39489,-0.00602916682185549,0.00333607146292083,-0.0125678668891803,0.000509533245469327,0.0707401149531668
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SAT1,Diamine acetyltransferase 1,37021,0.00839621442598136,0.00466794139029097,-0.000752950698988942,0.0175453795509517,0.0720894507447184
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CGN,Cingulin,37039,-0.00657297814217437,0.00365832688430427,-0.0137432988354107,0.000597342551062004,0.0724034468901235
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SLURP1,Secreted Ly-6/uPAR-related protein 1,37370,-0.00620736593885889,0.00345581546712054,-0.0129807642544151,0.000566032376697356,0.0724836589647683
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PPIF,"Peptidyl-prolyl cis-trans isomerase F, mitochondrial",37437,-0.0104010905073637,0.00579537587017247,-0.0217600272129018,0.000957846198174296,0.0727201863732171
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FGF3,Fibroblast growth factor 3,37056,0.00518673870999288,0.00289308110966187,-0.000483700264944389,0.0108571776849302,0.0730265385143531
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LAMA1,Laminin subunit alpha-1,37021,0.00913067425601539,0.00509539312677431,-0.000856296272462262,0.019117644784493,0.0731644250163754
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ADGRE2,Adhesion G protein-coupled receptor E2,39931,-0.00471647506051989,0.00263213579621224,-0.00987546122109589,0.000442511100056101,0.0731707788435804
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,METAP1D,"Methionine aminopeptidase 1D, mitochondrial",39866,-0.0140005523315176,0.00781506067202858,-0.0293180712486936,0.00131696658565843,0.0732346233716857
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RASGRF1,Ras-specific guanine nucleotide-releasing factor 1,36962,0.00731868430705419,0.00409099279080677,-0.000699661562927071,0.0153370301770355,0.0736419158758552
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ITGA2,Integrin alpha-2,37124,-0.00565604079069325,0.00316493989975174,-0.0118593229942067,0.000547241412820161,0.0739453444011227
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GRN,Progranulin,39787,-0.00414422271844568,0.00231952439451354,-0.00869049053169222,0.000402045094800864,0.0740099885814536
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NRTN,Neurturin,39587,-0.0083056884239422,0.00466611847155999,-0.0174512806281998,0.000839903780315386,0.075095349428782
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SSBP1,"Single-stranded DNA-binding protein, mitochondrial",37056,0.00589240909163116,0.00332881622086732,-0.000632070701268788,0.0124168888845311,0.0767299921773028
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CD177,CD177 antigen,39844,-0.0207210171985557,0.0117232701316416,-0.0436986266565732,0.00225659225946179,0.0771616466771671
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SLC4A1,Band 3 anion transport protein,37437,-0.00773418224946309,0.00437853423819589,-0.016316109356327,0.000847744857400852,0.0773535536986138
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CNTF,Ciliary neurotrophic factor,36991,0.00564370790716245,0.003195549772949,-0.000619569647817582,0.0119069854621425,0.0773998150361303
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FLRT2,Leucine-rich repeat transmembrane protein FLRT2,39749,0.00466530658577533,0.00264353256594421,-0.000516017243475319,0.00984663041502599,0.0776165730824938
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,AMY1A_AMY1B_AMY1C,Alpha-amylase 1A_Alpha-amylase 1B_Alpha-amylase 1C,36675,-0.00811324839051185,0.00459794018806513,-0.0171252111591195,0.000898714378095798,0.0776649613031732
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TNFAIP8,Tumor necrosis factor alpha-induced protein 8,39587,0.00593982964633739,0.00336923407251075,-0.000663869135783683,0.0125435284284585,0.077926416978706
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IL10RA,Interleukin-10 receptor subunit alpha,39587,-0.00967449580560692,0.00549135851061782,-0.0204375584864178,0.001088566875204,0.0781280494168217
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PRKAG3,5'-AMP-activated protein kinase subunit gamma-3,37039,0.00526326016437473,0.00298905753982187,-0.000595292613676144,0.0111218129424256,0.0782882186312249
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TREML2,Trem-like transcript 2 protein,39858,-0.00547776828415339,0.00311315993155904,-0.0115795617500091,0.000624025181702324,0.078502825525324
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LTBR,Tumor necrosis factor receptor superfamily member 3,39786,-0.0043871676554958,0.00250926445635288,-0.00930532598994744,0.000530990678955845,0.0804161457449903
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CXCL12,Stromal cell-derived factor 1,39587,0.00654164407078758,0.00374709911444699,-0.000802670193528521,0.0138859583351037,0.0808671656859499
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,AMBN,Ameloblastin,39587,0.00468063103954786,0.00268214668603744,-0.00057637646508552,0.00993763854418124,0.0809859004511372
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GNGT1,Guanine nucleotide-binding protein G(T) subunit gamma-T1,37039,-0.00847134774868813,0.00485913098003556,-0.0179952444695578,0.00105254897218156,0.0812892859890099
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NAP1L4,Nucleosome assembly protein 1-like 4,37362,-0.00664985991981039,0.00381538712202802,-0.0141280186789853,0.000828298839364524,0.08137285478675
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MYLPF,"Myosin regulatory light chain 2, skeletal muscle isoform",37039,-0.00792013214399711,0.00454469775183959,-0.0168277397376027,0.000987475449608491,0.081405995651913
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SIGLEC9,Sialic acid-binding Ig-like lectin 9,40003,-0.00494971562762509,0.00284165796275065,-0.0105193652346164,0.000619933979366174,0.0815553610407579
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CEACAM3,Carcinoembryonic antigen-related cell adhesion molecule 3,39477,-0.00770891221369431,0.00442601005383534,-0.0163838919192116,0.000966067491822958,0.081575479191871
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PTX3,Pentraxin-related protein PTX3,39866,0.00813202128274956,0.00467097687645117,-0.00102309339509474,0.0172871359605939,0.0817084019940929
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IGHMBP2,DNA-binding protein SMUBP-2,37021,-0.00921578970400116,0.00529693368235637,-0.0195977797214196,0.00116620031341733,0.0819114011580553
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CSF3R,Granulocyte colony-stimulating factor receptor,37056,-0.00509876914638683,0.00294448089757268,-0.0108699517056293,0.000672413412855619,0.0833617614129809
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LTBP3,Latent-transforming growth factor beta-binding protein 3,39477,0.00893424283365996,0.00516775383388171,-0.00119455468074818,0.0190630403480681,0.0838566912612339
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MANSC1,MANSC domain-containing protein 1,39913,0.00436849409534844,0.00253500184366614,-0.000600109518237186,0.00933709770893407,0.0848588620232622
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,VTA1,Vacuolar protein sorting-associated protein VTA1 homolog,40009,0.0114545405354625,0.00665951587259746,-0.00159811057482855,0.0245071916457535,0.0854468720927342
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ACTA2,"Actin, aortic smooth muscle",39585,-0.00696410984725904,0.00405189184180008,-0.0149058178571872,0.000977598162669106,0.0856831489924002
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LCP1,Plastin-2,37437,0.00757038069877981,0.00440591765079975,-0.00106521789678771,0.0162059792943473,0.0857774372016502
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,F3,Tissue factor,39931,0.0043816915992551,0.00255119759861857,-0.000618655694037292,0.0093820388925475,0.0859064235347387
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RBPMS,RNA-binding protein with multiple splicing,37056,-0.010452905181703,0.00610215232038554,-0.0224131237296587,0.00150731336625263,0.0867384939419844
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SOD1,Superoxide dismutase [Cu-Zn],39487,-0.00780557282466476,0.00455702496049905,-0.0167373417472429,0.00112619609791338,0.086757042655121
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PPIE,Peptidyl-prolyl cis-trans isomerase E,37169,0.010058477849015,0.00588903037077874,-0.00148402167771137,0.0216009773757413,0.0876592221193404
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,OTOA,Otoancorin,36991,0.00850672701728341,0.00498922006068906,-0.00127214430166714,0.018285598336234,0.0882140852395925
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GRSF1,G-rich sequence factor 1,36874,-0.0129430517125945,0.00759930304530414,-0.0278376856813906,0.00195158225620157,0.0885565234175591
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IL1RL1,Interleukin-1 receptor-like 1,40002,-0.0074889246129599,0.00439818163029826,-0.0161093606083445,0.0011315113824247,0.0886374852888471
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NPHS2,Podocin,37056,0.016306733849695,0.00959111953319966,-0.00249186043537632,0.0351053281347663,0.0891185939017089
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MZT1,Mitotic-spindle organizing protein 1,39477,-0.00852497590133864,0.00501508658749843,-0.0183545456128356,0.00130459381015828,0.0891760194427453
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,UNG,Uracil-DNA glycosylase,37368,0.0055334861958465,0.00325683758765437,-0.00084991547595606,0.0119168878676491,0.0893353181403593
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ESPL1,Separin,36962,0.00858918920476857,0.00505843513173719,-0.00132534365343633,0.0185037220629735,0.0895327633080572
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TCN2,Transcobalamin-2,40012,0.0046552764141331,0.00274749690054666,-0.000729817510938357,0.0100403703392045,0.0902142684089619
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TSPYL1,Testis-specific Y-encoded-like protein 1,37056,-0.00645992022317226,0.00382366935179704,-0.0139543121526945,0.00103447170634994,0.0911557451047815
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ADGRB3,Adhesion G protein-coupled receptor B3,39720,0.00522243964438468,0.0031016548947735,-0.000856803949371387,0.0113016832381408,0.0922479141270684
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,KIAA2013,Uncharacterized protein KIAA2013,37368,0.0090344673234716,0.00538184549575336,-0.00151394984820499,0.0195828844951482,0.0932349858403597
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MRI1,Methylthioribose-1-phosphate isomerase,37039,-0.0106217453680215,0.00634766497712744,-0.0230631687231913,0.00181967798714828,0.0942858612544565
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ARHGAP1,Rho GTPase-activating protein 1,39477,-0.00737254829781877,0.00440857137521115,-0.0160133481932326,0.00126825159759508,0.0944809915957433
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ITGAL,Integrin alpha-L,37056,-0.00672043703927471,0.0040196380495347,-0.0145989276163627,0.00115805353781331,0.0945675460734648
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,HADH,"Hydroxyacyl-coenzyme A dehydrogenase, mitochondrial",37021,0.0101484862112594,0.00607165748541873,-0.0017519624601613,0.0220489348826801,0.0946561354888774
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FABP9,Fatty acid-binding protein 9,39866,0.00868623177642962,0.00519835741566409,-0.001502548758272,0.0188750123111312,0.0947497189381118
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DNPH1,2'-deoxynucleoside 5'-phosphate N-hydrolase 1,39904,-0.00794780296033524,0.00476224900711243,-0.0172818110142756,0.00138620509360513,0.0951531482483945
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TNNI3,"Troponin I, cardiac muscle",39585,-0.013133383673546,0.00789293345694378,-0.0286035332491558,0.00233676590206382,0.0961439409455549
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NUP50,Nuclear pore complex protein Nup50,37021,0.00516567583479892,0.00310714674344888,-0.00092433178236089,0.0112556834519587,0.0964335152655775
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CD3E,T-cell surface glycoprotein CD3 epsilon chain,37169,0.00536388179878978,0.00322996987988301,-0.00096685916578092,0.0116946227633605,0.0968053059628627
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PDIA3,Protein disulfide-isomerase A3,37124,-0.00395562011144117,0.00238400038698399,-0.00862826086992979,0.000717020647047449,0.097091816163014
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CSRP3,Cysteine and glycine-rich protein 3,37021,-0.0151828597254085,0.00915264930100822,-0.0331220523553846,0.00275633290456766,0.0971701270576586
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FASLG,Tumor necrosis factor ligand superfamily member 6,40058,0.00571581006274034,0.00344757984622779,-0.00104144643586612,0.0124730665613468,0.0973530672091901
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,OBP2B,Odorant-binding protein 2b,39701,0.0097461357599918,0.00591727635218175,-0.00185172589028443,0.021343997410268,0.0995646257222949
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ACTN2,Alpha-actinin-2,37021,-0.00909238079384027,0.00555083113816891,-0.0199720098246513,0.00178724823697079,0.10144111227084
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FLT1,Vascular endothelial growth factor receptor 1,39755,0.00356024464414864,0.00217455169498501,-0.000701876678021972,0.00782236596631926,0.101601892484208
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,QSOX1,Sulfhydryl oxidase 1,37186,-0.00646317897217549,0.00395275176627815,-0.0142105724340807,0.00128421448972968,0.102049872182773
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LSM8,U6 snRNA-associated Sm-like protein LSm8,37169,0.0132509565559835,0.0081557295382947,-0.00273427333907412,0.0292361864510411,0.104241217277576
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PCDHB15,Protocadherin beta-15,37368,-0.00603659423027841,0.00373156589330109,-0.0133504633811485,0.00127727492059172,0.105748298529858
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ITM2A,Integral membrane protein 2A,39866,0.00896400291450204,0.00555508063020466,-0.0019239551206991,0.0198519609497032,0.106621239433133
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ERVV_1,,37021,0.00726429449723547,0.00452101700402749,-0.00159689883065842,0.0161254878251294,0.108125908309379
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CHGB,Secretogranin-1,39952,0.00594942759528537,0.00370686217629101,-0.00131602227024501,0.0132148774608157,0.10851854524267
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,BLMH,Bleomycin hydrolase,40052,0.00481083620174555,0.00300645480693709,-0.00108181521985114,0.0107034876233422,0.109580575638304
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SPON2,Spondin-2,39775,-0.00503452693007674,0.00315314529600937,-0.0112146917102551,0.00114563785010163,0.110359534267023
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CYP24A1,"1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial",37021,0.0127510600513599,0.00799035878885656,-0.00291004317479893,0.0284121632775188,0.110556191671766
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LAIR2,Leukocyte-associated immunoglobulin-like receptor 2,39749,-0.0152931769954946,0.00960725098421873,-0.0341233889245633,0.00353703493357408,0.111441240877058
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CD276,CD276 antigen,39862,-0.00525583600430156,0.00330186556363563,-0.0117274925090274,0.00121582050042427,0.111454412867252
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SAFB2,Scaffold attachment factor B2,37411,-0.0041043247932185,0.0025798439076863,-0.00916081885228364,0.000952169265846654,0.111650948915187
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MTR,Methionine synthase,37021,0.00962435975477402,0.006052425529677,-0.0022383942833929,0.0214871137929409,0.111821468265242
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,HDGF,Hepatoma-derived growth factor,40014,-0.0139923118343885,0.00881495963718304,-0.0312696327232672,0.00328500905449029,0.112455904945911
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TCL1A,T-cell leukemia/lymphoma protein 1A,39730,-0.0141436898542213,0.00891745056388036,-0.0316218929594268,0.0033345132509842,0.11274363353533
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SNED1,"Sushi, nidogen and EGF-like domain-containing protein 1",37043,0.00484343020252297,0.00305597640138401,-0.00114628354418968,0.0108331439492356,0.113012060385322
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TMPRSS11D,Transmembrane protease serine 11D,37357,-0.00538634714563404,0.0033996160404641,-0.0120495945849437,0.0012769002936756,0.113126451833168
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GPR15L,Protein GPR15L,37382,-0.00913712408444712,0.00576997080273399,-0.0204462668578057,0.00217201868891151,0.113316119251768
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RILPL2,RILP-like protein 2,37437,-0.0146792960135152,0.00928075912670607,-0.0328695839018591,0.00351099187482871,0.113743351933039
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MTPN,Myotrophin,39585,0.0047891047906323,0.00304363716616843,-0.00117642405505783,0.0107546336363224,0.115627637435088
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CDHR5,Cadherin-related family member 5,39868,-0.00571782555587715,0.00364411993077526,-0.0128603006201967,0.00142464950844237,0.116654827600843
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RPE,Ribulose-phosphate 3-epimerase,37169,-0.0105207646116353,0.0067082238347803,-0.0236688833278047,0.00262735410453408,0.116825966969514
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PRRT3,Proline-rich transmembrane protein 3,37043,0.00535304588066356,0.00341327334301588,-0.00133696987164757,0.0120430616329747,0.116834501267818
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MMUT,"Methylmalonyl-CoA mutase, mitochondrial",37021,0.00739115277182982,0.00471317932570711,-0.00184667870655612,0.0166289842502158,0.116861230128422
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PRKCQ,Protein kinase C theta type,39587,-0.00639080058671281,0.00407661008355942,-0.0143809563504893,0.00159935517706365,0.116977067559989
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IGF2BP3,Insulin-like growth factor 2 mRNA-binding protein 3,37021,-0.00686794662312905,0.00438839292728869,-0.0154691967606149,0.00173330351435679,0.117600984107844
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CTLA4,Cytotoxic T-lymphocyte protein 4,37437,0.00434104793763402,0.00277927665289927,-0.00110633430204854,0.00978843017731659,0.118326739826982
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TGFB2,Transforming growth factor beta-2 proprotein,37368,-0.00771514868777727,0.0049401612656755,-0.0173978647685013,0.00196756739294672,0.118377389492474
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LY75,Lymphocyte antigen 75,39866,0.00566744175835837,0.00363181174927598,-0.00145090927022255,0.0127857927869393,0.118661571335259
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IL17RA,Interleukin-17 receptor A,39858,-0.00644960620471746,0.00413917708934335,-0.0145623932998304,0.0016631808903955,0.119209034318732
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ACP6,Lysophosphatidic acid phosphatase type 6,40011,-0.00953934330209716,0.00613546983651177,-0.0215648641816602,0.00248617757746591,0.120016611045544
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NGFR,Tumor necrosis factor receptor superfamily member 16,37437,-0.0043589512380579,0.00280407656218413,-0.00985494129993878,0.00113703882382299,0.120087296021374
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CCL20,C-C motif chemokine 20,40058,-0.0123024005035207,0.00791433147811422,-0.0278144902006246,0.00320968919358314,0.12009761693525
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DDX4,Probable ATP-dependent RNA helicase DDX4,37056,0.00805316245213992,0.00518229206659486,-0.00210412999838602,0.0182104549026659,0.120213894611808
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,S100A13,Protein S100-A13,37056,0.00504261309194031,0.00326810058397861,-0.00136286405265776,0.0114480902365384,0.12285966294683
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TMCO5A,Transmembrane and coiled-coil domain-containing protein 5A,37039,-0.00764378488972507,0.00495556623767831,-0.0173566947155745,0.00206912493612442,0.122984773135031
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DNAJC9,DnaJ homolog subfamily C member 9,37382,-0.0109794513929963,0.00713468540527875,-0.0249634347873426,0.0030045320013501,0.123856079019241
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TIE1,Tyrosine-protein kinase receptor Tie-1,40052,0.00593848142832973,0.00385908082172331,-0.00162531698224796,0.0135022798389074,0.123864579400415
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,BRK1,Protein BRICK1,39489,0.00642883383274094,0.00418568867124282,-0.00177511596289499,0.0146327836283769,0.124581122992104
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,EIF5,Eukaryotic translation initiation factor 5,37021,-0.00634582455032944,0.0041432943424797,-0.0144666814615896,0.00177503236093078,0.12564789331299
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DYNC1H1,Cytoplasmic dynein 1 heavy chain 1,37368,-0.00689646345761964,0.00450818015208216,-0.0157324965557007,0.00193956964046139,0.126097925910215
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MANSC4,MANSC domain-containing protein 4,37021,0.0089306428948738,0.00585472541960454,-0.0025446189275511,0.0204059047172987,0.127189998112033
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MST1,Hepatocyte growth factor-like protein,37271,-0.00904768625506801,0.00593753848573074,-0.0206852616871003,0.00258988917696425,0.127579518561634
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SH3GL3,Endophilin-A3,37083,-0.0118535716895437,0.00778211388929818,-0.0271065149125681,0.00339937153348076,0.127737223775415
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ACSL1,Long-chain-fatty-acid--CoA ligase 1,37021,0.00522966077012556,0.00343448297390577,-0.00150192585872976,0.0119612473989809,0.127859731585713
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,COL4A4,Collagen alpha-4(IV) chain,37147,0.00751844716892797,0.00493839243477419,-0.00216080200322946,0.0171976963410854,0.12792058774563
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PDP1,"[Pyruvate dehydrogenase [acetyl-transferring]]-phosphatase 1, mitochondrial",39477,-0.00731976586246977,0.00481443608722395,-0.0167560605934287,0.00211652886848918,0.128436080757988
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,C2orf69,UPF0565 protein C2orf69,37039,-0.0083622982965877,0.00550356041623019,-0.0191492767123989,0.00242468011922347,0.128677210184779
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CAT,Catalase,37252,-0.0075448936197752,0.00496894872978038,-0.0172840331301448,0.00219424589059435,0.128935074481774
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,STEAP4,Metalloreductase STEAP4,36991,0.0107401011545421,0.00707700816235942,-0.00313083484368241,0.0246110371527665,0.129138144111845
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FCRL1,Fc receptor-like protein 1,39868,0.00624986311872854,0.00412492128484652,-0.00183498259957064,0.0143347088370277,0.129754863675764
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SERPINB5,Serpin B5,39585,-0.00691221989941127,0.00456340896536445,-0.0158565014715256,0.00203206167270305,0.129867141987597
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PTRHD1,Putative peptidyl-tRNA hydrolase PTRHD1,37124,-0.00864671519878013,0.00570928573661824,-0.0198369152425519,0.00254348484499163,0.129922814880005
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FKBP7,Peptidyl-prolyl cis-trans isomerase FKBP7,39453,-0.00676590890188394,0.00446977536935979,-0.0155266686258291,0.00199485082206125,0.130121649200474
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GSTM4,Glutathione S-transferase Mu 4,37021,0.0101674863152165,0.00673059750962608,-0.00302448480365064,0.0233594574340836,0.130905094957543
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TPRKB,EKC/KEOPS complex subunit TPRKB,36962,0.00928870985225714,0.00619498341871881,-0.00285345764843174,0.021430877352946,0.133796008243912
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CDAN1,Codanin-1,37388,0.00317487932836402,0.00211757007324342,-0.000975558015193089,0.00732531667192112,0.133818359186673
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CCAR2,Cell cycle and apoptosis regulator protein 2,37388,-0.00806937366661144,0.00539892135746103,-0.0186512595272351,0.00251251219401218,0.135035138440075
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ZNF830,Zinc finger protein 830,37368,-0.0113039830400008,0.00756729451718686,-0.0261358802936871,0.00352791421368545,0.135252692876566
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,AFAP1,Actin filament-associated protein 1,37124,-0.0119199640775216,0.00798365879361186,-0.0275679353130009,0.00372800715795761,0.13544911974058
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CD84,SLAM family member 5,39866,-0.00437083597806703,0.00292752984422586,-0.0101087944727497,0.00136712251661564,0.135453864312395
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ATF2,Cyclic AMP-dependent transcription factor ATF-2,39489,-0.00965296286073746,0.00648503022515758,-0.0223636221020463,0.00305769638057141,0.136639446497692
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CEACAM5,Carcinoembryonic antigen-related cell adhesion molecule 5,39247,-0.00859937588353761,0.00578622170956112,-0.0199403704342774,0.0027416186672022,0.137251597574225
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CTSH,Pro-cathepsin H,39546,-0.0100716995935065,0.00678818808236321,-0.0233765482349384,0.00323314904792536,0.137906079404456
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RANBP1,Ran-specific GTPase-activating protein,37043,-0.0072905556446379,0.0049257958867621,-0.0169451155826916,0.00236400429341582,0.138876679282172
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,WASL,Neural Wiskott-Aldrich syndrome protein,37056,0.00836300433173941,0.00565414169801315,-0.00271911339636638,0.0194451220598452,0.139139192394919
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TNFRSF9,Tumor necrosis factor receptor superfamily member 9,39749,-0.00534928387644976,0.00362015909227652,-0.0124447956973117,0.00174622794441223,0.139524574646665
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,AGBL2,Cytosolic carboxypeptidase 2,36991,0.01274054121661,0.00863304617217208,-0.00418022928084727,0.0296613117140673,0.140024938096829
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,THSD1,Thrombospondin type-1 domain-containing protein 1,36975,0.00478617953514251,0.00324436778520738,-0.00157278132386395,0.011145140394149,0.140175482085671
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CALCB,Calcitonin gene-related peptide 2,37388,0.00544099122433183,0.00369791136835899,-0.0018069150576518,0.0126888975063155,0.141214680483438
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CORO1A,Coronin-1A,39520,-0.012342416282468,0.00840225130120134,-0.0288108288328226,0.00412599626788665,0.141868722905927
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RSPO3,R-spondin-3,40030,-0.0037115089878917,0.00253047703735413,-0.0086712439811058,0.00124822600532239,0.14247085811433
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IL20,Interleukin-20,39587,0.00671480220602099,0.00458938187331539,-0.00228038626567717,0.0157099906777192,0.143455376818056
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MORC3,MORC family CW-type zinc finger protein 3,37388,-0.00384046494572376,0.00262900366339278,-0.00899331212597362,0.0013123822345261,0.14409184830658
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ARFIP1,Arfaptin-1,37411,-0.00951901941692361,0.00652283166717672,-0.02230376948459,0.00326573065074276,0.144495141821162
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PNMA2,Paraneoplastic antigen Ma2,36991,-0.00592649163792183,0.00408925832611473,-0.0139414379571067,0.00208845468126304,0.147282511308992
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TMED1,Transmembrane emp24 domain-containing protein 1,37169,0.00736358452604309,0.0050918920714666,-0.00261652393403145,0.0173436929861176,0.14816172201174
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SFTPA2,Pulmonary surfactant-associated protein A2,39477,0.00666340763586045,0.00463095664402801,-0.00241326738643444,0.0157400826581553,0.150203541496448
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TCN1,Transcobalamin-1,37235,0.00461972951091197,0.0032155162743052,-0.00168268238672621,0.0109221414085502,0.150826885656162
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GH2,Growth hormone variant,39477,0.0221111671364434,0.0154414512381294,-0.00815407729029012,0.052376411563177,0.152182202955955
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DEFB104A_DEFB104B,Beta-defensin 104,36991,0.00787209583303422,0.00549951636610941,-0.00290695624454022,0.0186511479106087,0.152334818997565
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,INSR,Insulin receptor,37056,-0.0022395162274943,0.00156454760610738,-0.00530602953546476,0.000826997080476157,0.152335119387005
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MDGA1,MAM domain-containing glycosylphosphatidylinositol anchor protein 1,39749,0.00942165260485257,0.00658465791597334,-0.00348427691045517,0.0223275821201603,0.152493100943566
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,UHRF2,E3 ubiquitin-protein ligase UHRF2,37021,0.0046428203546265,0.0032478268942859,-0.00172292035817387,0.0110085610674269,0.152879729174056
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SERPINF2,Alpha-2-antiplasmin,37224,0.00181388545155598,0.0012691560943189,-0.000673660493309069,0.00430143139642103,0.152968419545021
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,OMP,Olfactory marker protein,36991,0.00654231436961265,0.00457813559159226,-0.00243083138990817,0.0155154601291335,0.153018063694429
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RSPO1,R-spondin-1,39749,0.00471659871436958,0.00331430169027062,-0.00177943259856083,0.0112126300273,0.154725404540097
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CSPG5,Chondroitin sulfate proteoglycan 5,36991,0.00654644227273366,0.00460475569816826,-0.00247887889567613,0.0155717634411434,0.155145870812855
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SCARF2,Scavenger receptor class F member 2,40009,0.00374780461067149,0.00264188033294532,-0.00143028084190133,0.00892589006324431,0.156031301392317
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SCGB3A1,Secretoglobin family 3A member 1,37124,0.00326569300248754,0.0023031920824456,-0.00124856347910584,0.00777994948408092,0.156243840794251
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,AK1,Adenylate kinase isoenzyme 1,39868,-0.008315328596406,0.00588535585157873,-0.0198506260655003,0.00321996887268831,0.157709102469024
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CPVL,Probable serine carboxypeptidase CPVL,39990,0.00532615267957808,0.00377657007303911,-0.00207592466357858,0.0127282300227347,0.158466032444121
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TDGF1,Teratocarcinoma-derived growth factor 1,39489,-0.0187453321380599,0.01329918852428,-0.0448117416456487,0.00732107736952892,0.158704473208753
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NFIC,Nuclear factor 1 C-type,37411,-0.00556461991693217,0.00394953224563942,-0.0133057031183854,0.0021764632845211,0.158878404816157
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CD2,T-cell surface antigen CD2,37021,-0.00508121004565562,0.00360701108942698,-0.0121509517809325,0.00198853168962126,0.158946409603727
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,KLK4,Kallikrein-4,40030,0.00795020998802896,0.00565005444751507,-0.00312389672910057,0.0190243167051585,0.159415994141434
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ANKRA2,Ankyrin repeat family A protein 2,36962,0.0071821884624734,0.00511076451980697,-0.00283490999634826,0.0171992869212951,0.159953990808208
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CRHR1,Corticotropin-releasing factor receptor 1,39585,-0.00816824935533986,0.00582014043344447,-0.019575724604891,0.00323922589421129,0.160503806931143
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CD163,Scavenger receptor cysteine-rich type 1 protein M130,39931,-0.00560872587848139,0.00399779172062543,-0.0134443976509072,0.00222694589394445,0.160649278753447
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PPP1R12B,Protein phosphatase 1 regulatory subunit 12B,37169,-0.00947691038159989,0.0067650973974538,-0.0227365012806093,0.00378268051740956,0.161281200641613
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,EIF5A,Eukaryotic translation initiation factor 5A-1,39587,0.00396304106223941,0.0028327248779642,-0.00158909969857042,0.00951518182304923,0.161826462764803
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PTPN6,Tyrosine-protein phosphatase non-receptor type 6,39908,0.0117707132748019,0.00841524634971798,-0.00472316957064532,0.0282645961202492,0.16191130215833
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CPLX2,Complexin-2,36962,0.00393828609073404,0.0028203305248577,-0.00158956173798705,0.00946613391945513,0.162620233531597
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,HMGCS1,"Hydroxymethylglutaryl-CoA synthase, cytoplasmic",37021,0.00569692840671322,0.00408092018907955,-0.0023016751638827,0.0136955319773091,0.162740711693533
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CENPJ,Centromere protein J,37169,-0.00954347924805587,0.00684532047269154,-0.0229603073745313,0.00387334887841956,0.163292247535164
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MMP13,Collagenase 3,39489,0.00420409192385514,0.00301689990747505,-0.00170903189479596,0.0101172157425062,0.163484263370818
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CLEC10A,C-type lectin domain family 10 member A,39749,0.00471305710871516,0.00338391845275253,-0.00191942305867979,0.0113455372761101,0.163705532451348
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TYMP,Thymidine phosphorylase,39764,-0.00886268026096519,0.00636526699882575,-0.0213386035786637,0.00361324305673329,0.163835868237546
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TEK,Angiopoietin-1 receptor,39913,-0.00282265925650624,0.00203257893523013,-0.00680651396955729,0.00116119545654481,0.164940733033453
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ATP2B4,Plasma membrane calcium-transporting ATPase 4,37021,0.00829416195253385,0.00598287659403518,-0.0034322761717751,0.0200206000768428,0.165673692924978
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,HEBP1,Heme-binding protein 1,39585,0.00695826109726919,0.00503977946257494,-0.0029197066493777,0.0168362288439161,0.167400757036344
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TBC1D17,TBC1 domain family member 17,39489,-0.00570823550650603,0.00413509674164104,-0.0138130251201225,0.0023965541071104,0.167472251529979
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,THBD,Thrombomodulin,39868,-0.00352708519044675,0.00255531684541519,-0.00853550620746053,0.00148133582656703,0.167515815496306
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IGDCC3,Immunoglobulin superfamily DCC subclass member 3,36991,0.00625778991666746,0.00453795731151572,-0.00263660641390334,0.0151521862472383,0.167921857480565
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FCER1A,High affinity immunoglobulin epsilon receptor subunit alpha,37411,-0.00309698121266508,0.00224846537850597,-0.00750397335453678,0.00131001092920662,0.168418920519479
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RBP7,Retinoid-binding protein 7,37382,-0.00778362025907995,0.00566548470816204,-0.0188879702870776,0.00332072976891765,0.169505871467477
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,VWA5A,von Willebrand factor A domain-containing protein 5A,36962,-0.0105139356514494,0.00765528213819428,-0.0255182886423102,0.00449041733941139,0.169644583284037
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,HSD17B3,Testosterone 17-beta-dehydrogenase 3,37021,-0.00614833389344508,0.00448066470283662,-0.0149304367110049,0.0026337689241147,0.170026947964626
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DDA1,DET1- and DDB1-associated protein 1,37021,0.00512280566302472,0.00373387118792013,-0.00219558186529872,0.0124411931913482,0.170092292439736
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,EIF2AK3,Eukaryotic translation initiation factor 2-alpha kinase 3,37021,-0.00841014852180367,0.00616639319438236,-0.0204962791827931,0.00367598213918577,0.172632327935332
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DAPP1,Dual adapter for phosphotyrosine and 3-phosphotyrosine and 3-phosphoinositide,39866,-0.0154852127035671,0.0113563648597092,-0.0377436878285972,0.00677326242146294,0.172721720773984
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TPK1,Thiamin pyrophosphokinase 1,37437,0.00351552062394911,0.00259265275967142,-0.00156607878500687,0.0085971200329051,0.175136018934435
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SNAP25,Synaptosomal-associated protein 25,36991,0.00603412261113586,0.00445276692748693,-0.00269330056673852,0.0147615457890102,0.17539626468151
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TEX101,Testis-expressed protein 101,37039,0.00620082341508298,0.00457722735180759,-0.0027705421944599,0.0151721890246259,0.175532653429523
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CXCL14,C-X-C motif chemokine 14,39587,-0.00785824859365051,0.00580777783991835,-0.0192414931598905,0.00352499597258947,0.176057193259028
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RAB2B,Ras-related protein Rab-2B,37368,-0.00796984247108623,0.00589190005600644,-0.0195179665808589,0.0035782816386864,0.176181223265707
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SFTPA1,Pulmonary surfactant-associated protein A1,39477,0.0073448381627055,0.00543244179205347,-0.00330274774971929,0.0179924240751303,0.17638448004375
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CD109,CD109 antigen,39858,0.00428144028082468,0.00316910179856554,-0.00192999924436377,0.0104928798060131,0.176716181345368
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MATN2,Matrilin-2,39885,-0.00377038459105661,0.00279334999167306,-0.00924535057473582,0.00170458139262259,0.177108311303388
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ST6GAL1,"Beta-galactoside alpha-2,6-sialyltransferase 1",40052,-0.00366533828261453,0.00272062993848317,-0.00899777296204155,0.00166709639681249,0.177922179847198
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CSH1,Chorionic somatomammotropin hormone 1,37445,-0.0044034439446027,0.00327356259759312,-0.0108196266358852,0.00201273874667982,0.178598146677714
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CDC25A,M-phase inducer phosphatase 1,36962,0.00526705132796262,0.00391812507934564,-0.00241247382755483,0.0129465764834801,0.17888161761711
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SIGLEC15,Sialic acid-binding Ig-like lectin 15,39489,-0.00999958145055657,0.00747463575105562,-0.0246498675226256,0.00465070462151244,0.180980507720956
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MAN1A2,"Mannosyl-oligosaccharide 1,2-alpha-mannosidase IB",37043,-0.00326939860100767,0.00244696856037579,-0.00806545697934423,0.00152665977732888,0.181539130508769
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GNLY,Granulysin,39858,0.00637947535643083,0.00478652167678546,-0.00300210713006867,0.0157610578429303,0.18261647699946
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TOP1,DNA topoisomerase 1,37382,-0.0142490210270609,0.010697175876385,-0.0352154857447756,0.00671744369065373,0.1828708808216
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,OXCT1,"Succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial",37043,0.00878786801751692,0.00660836424202523,-0.00416452589685253,0.0217402619318864,0.183603929635213
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NLGN2,Neuroligin-2,36991,0.00590053167719248,0.00443893297021156,-0.00279977694442218,0.0146008402988071,0.183782652314395
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ACE,Angiotensin-converting enzyme,37445,-0.00318354282423073,0.0024118285654694,-0.00791072681255075,0.00154364116408929,0.186867071539798
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GPR158,Probable G-protein coupled receptor 158,37411,0.00442666405661032,0.00335844303467981,-0.00215588429136211,0.0110092124045828,0.18750239161271
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CTNNA1,Catenin alpha-1,36991,0.00435961371596859,0.00330777542631888,-0.00212362611961642,0.0108428535515536,0.187530110422275
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FCRL2,Fc receptor-like protein 2,39990,-0.00570928304412799,0.00435050619243665,-0.0142362751813038,0.00281770909304785,0.189428786085143
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PGR,Progesterone receptor,37056,0.012908075764558,0.0098727967626138,-0.00644260589016504,0.0322587574192811,0.191086567488551
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TIGAR,"Fructose-2,6-bisphosphatase TIGAR",39453,-0.00576308832860041,0.00441636851093096,-0.0144191706100251,0.00289299395282427,0.191933121890487
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FRMD7,FERM domain-containing protein 7,37039,0.00412815516313276,0.00316429026794946,-0.00207385376204818,0.0103301640883137,0.192049491876094
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NFU1,"NFU1 iron-sulfur cluster scaffold homolog, mitochondrial",37382,0.0126708564545422,0.00971477498633502,-0.00637010251867441,0.0317118154277589,0.192157885242874
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,HMCN2,Hemicentin-2,37100,-0.00695950885716861,0.00534318771921076,-0.0174321567868217,0.00351313907248448,0.1927677351887
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MLLT1,Protein ENL,36962,0.00871785071904882,0.00671072732227198,-0.00443517483260426,0.0218708762707019,0.193935292978185
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ITPRIP,"Inositol 1,4,5-trisphosphate receptor-interacting protein",36991,-0.00567125745905136,0.00436579607100606,-0.0142282177582232,0.00288570284012051,0.19395979222693
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DUSP29,Dual specificity phosphatase 29,37039,-0.00810722333979416,0.00625542204433678,-0.0203678505466942,0.00415340386710592,0.194987365851043
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NUDT2,Bis(5'-nucleosyl)-tetraphosphatase [asymmetrical],39788,0.00701590552069323,0.00541397639406626,-0.00359548821167664,0.0176272992530631,0.195032948612341
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IL36G,Interleukin-36 gamma,37021,-0.0081800659432406,0.00633547353625631,-0.020597594074303,0.00423746218782176,0.196673291098677
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,S100A3,Protein S100-A3,37368,0.00547133984341481,0.00423818590671201,-0.00283550453374073,0.0137781842205704,0.196738711250669
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MATN3,Matrilin-3,39720,0.00377995292844262,0.00294251414353598,-0.00198737479288789,0.00954728064977314,0.198950948690311
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FAM171A2,Protein FAM171A2,37411,-0.0189916424964999,0.0147915840525035,-0.0479831472394068,0.00999986224640693,0.199181683329883
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TEF,Thyrotroph embryonic factor,37021,0.00511419870725765,0.00398605144258659,-0.00269846212021206,0.0129268595347274,0.199506345228218
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ATP1B3,Sodium/potassium-transporting ATPase subunit beta-3,37021,0.00495959603532629,0.00386879758132207,-0.00262324722406497,0.0125424392947175,0.199883586514606
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RNASE10,Inactive ribonuclease-like protein 10,37043,-0.00565696935495138,0.00441297455994369,-0.014306399492441,0.00299246078253826,0.199902078776342
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ROBO4,Roundabout homolog 4,37043,-0.00215200638414808,0.00167921736257277,-0.0054432724147907,0.00113925964649455,0.200021966223896
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,KRT6C,"Keratin, type II cytoskeletal 6C",37021,-0.00485078923459638,0.00378706704167914,-0.0122734406362875,0.00257186216709473,0.200257387079312
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CDNF,Cerebral dopamine neurotrophic factor,39788,-0.00380014586100569,0.00296758813819977,-0.00961661861187723,0.00201632688986586,0.200370315356023
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PCDH1,Protocadherin-1,40018,-0.00249650844252102,0.00195361596152055,-0.00632559572710131,0.00133257884205926,0.201306186088042
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,EIF1AX,"Eukaryotic translation initiation factor 1A, X-chromosomal",37388,-0.00663776839678632,0.0051958742456167,-0.0168216819181951,0.00354614512462241,0.201445052003164
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TGOLN2,Trans-Golgi network integral membrane protein 2,37445,-0.00297916060324455,0.00233220619464616,-0.00755028474475103,0.00159196353826192,0.201482832698024
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FAM172A,Cotranscriptional regulator FAM172A,37043,-0.00743291801919899,0.00582485606200817,-0.018849635900735,0.00398379986233703,0.201953624231212
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ID4,DNA-binding protein inhibitor ID-4,37169,0.00531656964648679,0.00417257127257381,-0.00286167004775789,0.0134948093407315,0.202625040135464
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MEGF11,Multiple epidermal growth factor-like domains protein 11,37021,0.00379130009484304,0.00297630356276778,-0.00204225488818182,0.00962485507786789,0.202746721878445
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,HTR1B,5-hydroxytryptamine receptor 1B,36991,0.00513043582760674,0.00403295936344411,-0.00277416452474372,0.0130350361799572,0.203350585806683
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ENPP6,Glycerophosphocholine cholinephosphodiesterase ENPP6,37043,-0.00431222433821651,0.00339859192168743,-0.0109734645047239,0.00234901582829084,0.204525265197474
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MMP15,Matrix metalloproteinase-15,37437,0.00590456373057036,0.00465464400794975,-0.00321853852501115,0.0150276659861519,0.204629867411808
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SCN2B,Sodium channel subunit beta-2,37039,0.00344027213413847,0.00271347859943426,-0.00187814592075268,0.00875869018902962,0.204875462254773
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IKZF2,Zinc finger protein Helios,39477,0.0111269972009838,0.00883504948062546,-0.00618969978104208,0.0284436941830097,0.207899159238283
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SERPINA1,Alpha-1-antitrypsin,37247,0.000956831239495414,0.00076036861930532,-0.000533491254343014,0.00244715373333384,0.208276984162188
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GNPDA2,Glucosamine-6-phosphate isomerase 2,37124,-0.00438100519942036,0.00348183767292758,-0.0112054070383584,0.0024433966395177,0.208325276123009
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,BHLHE40,Class E basic helix-loop-helix protein 40,36991,0.00844840769757076,0.00672399739954712,-0.0047306272055416,0.0216274426006831,0.208972996623415
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TARM1,"T-cell-interacting, activating receptor on myeloid cells protein 1",37039,0.009090516340595,0.00723764843912486,-0.00509527460008973,0.0232763072812797,0.209136737424036
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FADD,FAS-associated death domain protein,39868,-0.00905471482197705,0.00722568158107225,-0.0232170507208787,0.00510762107692457,0.210176881125156
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,WASF3,Wiskott-Aldrich syndrome protein family member 3,39489,-0.00989677302218208,0.00790715173203972,-0.0253947904169799,0.00560124437261576,0.210725999706107
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PDE1C,"Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C",36962,0.00643854835980257,0.00514547681053928,-0.00364658618885442,0.0165236829084596,0.210846449449942
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,BLNK,B-cell linker protein,37056,-0.00458827691984241,0.00367825651215844,-0.0117976596836729,0.00262110584398813,0.21227103592951
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CALB1,Calbindin,39788,-0.00491281072111111,0.00394033093143071,-0.0126358593467153,0.00281023790449308,0.212488605320728
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SCIN,Adseverin,36991,-0.00867626968910097,0.00696200640807219,-0.0223218022489225,0.00496926287072052,0.212701755657114
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MSLNL,Mesothelin-like protein,37039,0.00424749790593916,0.00341535260876993,-0.00244659320724991,0.0109415890191282,0.213651104999618
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PCSK9,Proprotein convertase subtilisin/kexin type 9,40052,-0.00455094051775744,0.00368431104966604,-0.0117721901751029,0.00267030913958799,0.216765972076559
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,F2,Prothrombin,37453,0.00170295707588483,0.00138082797230342,-0.00100346574982989,0.00440937990159954,0.217490062599061
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,KDM3A,Lysine-specific demethylase 3A,37056,0.0107906024002331,0.0087519431414226,-0.00636320615695518,0.0279444109574214,0.217620897295207
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MYL6B,Myosin light chain 6B,37039,-0.0107304757687577,0.0087032157947556,-0.0277887787264787,0.00632782718896326,0.217623019357161
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ISLR2,Immunoglobulin superfamily containing leucine-rich repeat protein 2,39214,0.00438247388933632,0.00355476546055161,-0.00258486641334483,0.0113498141920175,0.217652572350367
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DCTN6,Dynactin subunit 6,39489,-0.00819450909342572,0.00667793161435244,-0.0212832550575565,0.00489423687070506,0.219802410561278
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RAD23B,UV excision repair protein RAD23 homolog B,39477,-0.00540671399101121,0.00443110513015877,-0.0140916800461224,0.00327825206409997,0.222417797035884
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LUZP2,Leucine zipper protein 2,37368,-0.00500824798788928,0.00410482332111428,-0.0130537016972733,0.0030372057214947,0.222452603683408
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CSF3,Granulocyte colony-stimulating factor,39587,-0.00548523879922187,0.00450807359482303,-0.014321063045075,0.00335058544663127,0.223714209988158
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MNAT1,CDK-activating kinase assembly factor MAT1,37169,-0.00502048202377995,0.00412611750745398,-0.0131076723383897,0.00306670829082985,0.223718292449454
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IL34,Interleukin-34,39456,-0.00409069144611412,0.00336368414743124,-0.0106835123750794,0.00250212948285112,0.223952197067719
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CABP2,Calcium-binding protein 2,37039,-0.00751967125578163,0.00619374964057663,-0.0196594205513118,0.00462007803974857,0.224741169788744
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CEACAM21,Carcinoembryonic antigen-related cell adhesion molecule 21,39866,-0.00952055926501201,0.00784819900678108,-0.0249030293183029,0.00586191078827891,0.22511392241754
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TSPAN7,Tetraspanin-7,36991,0.0107217354826196,0.00887359139425716,-0.00667050365012446,0.0281139746153636,0.226963397428237
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TNFRSF11B,Tumor necrosis factor receptor superfamily member 11B,39862,-0.00336247353609683,0.00278474223097735,-0.00882056830881243,0.00209562123661877,0.227271687293096
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ARMCX2,Armadillo repeat-containing X-linked protein 2,36991,0.00709546034631765,0.00589379443495536,-0.00445637674619485,0.0186472974388302,0.228655099781942
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TYRO3,Tyrosine-protein kinase receptor TYRO3,39868,0.00317833666848022,0.00264611871011759,-0.00200805600335026,0.00836472934031071,0.229717947427599
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TPMT,Thiopurine S-methyltransferase,39477,-0.00820291266633758,0.00683835906102763,-0.0216060964259517,0.00520027109327658,0.230334680101014
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LELP1,Late cornified envelope-like proline-rich protein 1,36991,0.0082717728161514,0.00690337096915063,-0.00525883428338384,0.0218023799156866,0.230852124682576
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,AKR1B1,Aldo-keto reductase family 1 member B1,39477,-0.00865482571713198,0.00722603557115093,-0.0228178554365878,0.00550820400232384,0.231041071448867
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NTF4,Neurotrophin-4,39477,0.00446201651743878,0.00373650124103255,-0.00286152591498501,0.0117855589498626,0.232429735609194
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CORO6,Coronin-6,36991,-0.00425798780672271,0.0035695887481726,-0.011254381753141,0.00273840613969559,0.23294925302329
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LMNB1,Lamin-B1,37348,0.00649003732038218,0.00544831236288005,-0.00418865491086271,0.0171687295516271,0.233595490768416
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CEP164,Centrosomal protein of 164 kDa,39587,-0.00676993016947182,0.00569193939157849,-0.0179261313769657,0.00438627103802202,0.234304579009293
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TGM2,Protein-glutamine gamma-glutamyltransferase 2,39835,-0.0081329967286806,0.00683939362543113,-0.0215382082345256,0.00527221477716442,0.234402243962233
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,STX3,Syntaxin-3,37388,-0.00424504376725848,0.0035716401338136,-0.0112454584295331,0.00275537089501618,0.2346408664771
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,WFDC12,WAP four-disulfide core domain protein 12,39990,-0.00689059357629119,0.00584071309636682,-0.0183383912451702,0.00455720409258778,0.238116222407613
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ENO2,Gamma-enolase,40009,-0.00732670412486019,0.00621513263074293,-0.0195083640811163,0.00485495583139595,0.238475597780995
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,BABAM1,BRISC and BRCA1-A complex member 1,37056,-0.00328789235075132,0.0027919681323943,-0.00876014989024414,0.00218436518874151,0.238967251082958
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GGA1,ADP-ribosylation factor-binding protein GGA1,39489,-0.00774434437597553,0.00658584473516134,-0.0206526000568918,0.00516391130494069,0.239649743434545
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CAPN3,Calpain-3,37368,-0.00415004942792112,0.00353514225215711,-0.0110789282421491,0.00277882938630683,0.240439242474046
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IFNL1,Interferon lambda-1,39489,-0.00493647026186393,0.0042209085303143,-0.01320945098128,0.00333651045755209,0.242208845195983
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,VSTM2B,V-set and transmembrane domain-containing protein 2B,37169,0.00456836728575885,0.0039120160808489,-0.003099184232705,0.0122359188042227,0.242917143960927
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GM2A,Ganglioside GM2 activator,37178,-0.00396058612597333,0.00339663566644559,-0.0106179920322067,0.00269681978026003,0.243622359182101
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CRYGD,Gamma-crystallin D,37388,-0.0105359646005694,0.00905127023643389,-0.0282764542639799,0.007204525062841,0.244431733460732
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TRAF3IP2,E3 ubiquitin ligase TRAF3IP2,37021,0.00516969949150006,0.00444610582427127,-0.00354466792407163,0.0138840669070718,0.244952949225957
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FZD8,Frizzled-8,36991,-0.00465842494504035,0.00400877855477374,-0.0125156309123969,0.00319878102231619,0.245233862234862
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TXK,Tyrosine-protein kinase TXK,37169,0.00812752525416147,0.0069941650662635,-0.005581038275715,0.0218360887840379,0.245238564009768
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CEACAM19,Carcinoembryonic antigen-related cell adhesion molecule 19,37382,-0.00421891490954169,0.00363362090764035,-0.0113408118885168,0.00290298206943339,0.245630943804558
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IGLON5,IgLON family member 5,36962,0.0100457526474279,0.00867082906262302,-0.00694907231531322,0.027040577610169,0.246653079693803
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NME1,Nucleoside diphosphate kinase A,37056,0.00237622382357431,0.0020521826358727,-0.00164605414273619,0.00639850178988481,0.246925495728663
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SSH3,Protein phosphatase Slingshot homolog 3,36962,-0.00322323999927668,0.0027871561922338,-0.00868606613605494,0.00223958613750157,0.247513352761269
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,BRD2,Bromodomain-containing protein 2,36991,0.00368050461326785,0.00318817327994593,-0.00256831501542617,0.00992932424196187,0.24834727848835
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FN1,Fibronectin,37453,-0.00287868722785817,0.00250441161879378,-0.00778733400069397,0.00202995954497763,0.250392129479403
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RELB,Transcription factor RelB,37056,0.00529252477064914,0.00462333216920352,-0.00376920628098977,0.014354255822288,0.252336607655998
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MPI,Mannose-6-phosphate isomerase,39788,-0.00928280806454404,0.00811784485941821,-0.0251937839890037,0.00662816785991565,0.252845558528115
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TSC1,Hamartin,37056,0.00820955568210334,0.00718329845277362,-0.00586970928533296,0.0222888206495396,0.253114496098123
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ICAM5,Intercellular adhesion molecule 5,39868,-0.00473805107342669,0.00414613526432701,-0.0128644761915076,0.00338837404465426,0.25315398520402
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CCDC50,Coiled-coil domain-containing protein 50,37411,0.00826631888803849,0.00727491682091687,-0.00599251808095858,0.0225251558570356,0.255860849567029
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PFDN6,Prefoldin subunit 6,37039,0.00704506212859552,0.00621218022408419,-0.0051308111106095,0.0192209353678005,0.256784808027681
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,WNT9A,Protein Wnt-9a,39587,0.00299799974613042,0.00264377873990163,-0.00218380658407677,0.00817980607633761,0.25681902724062
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LYPD3,Ly6/PLAUR domain-containing protein 3,39794,0.00363478248024507,0.00323322382788599,-0.00270233622241146,0.00997190118290161,0.26094614121051
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MIA,Melanoma-derived growth regulatory protein,39913,0.00380163423126707,0.00339268687241355,-0.00284803203866349,0.0104513005011976,0.26250137348
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,EXTL1,Exostosin-like 1,37021,-0.00502678796069062,0.00448704403844856,-0.0138213942760498,0.00376781835466856,0.262610892080122
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RBM19,Probable RNA-binding protein 19,37021,0.00500500070537945,0.00446804656359689,-0.00375237055927046,0.0137623719700293,0.262659002387137
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FH,"Fumarate hydratase, mitochondrial",36991,0.00871944418046361,0.007789553750955,-0.00654808117140818,0.0239869695323354,0.26299998520992
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,S100A11,Protein S100-A11,39703,-0.0047593642731695,0.00426844067505076,-0.013125507996269,0.00360677944993,0.264862022006743
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TLR4,Toll-like receptor 4,37056,0.00288382271599562,0.00259158073538294,-0.00219567552535493,0.00796332095734618,0.265829246805969
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SULT1A1,Sulfotransferase 1A1,40009,0.0134511661934568,0.0121138076090621,-0.0102918967203049,0.0371942291072186,0.266843436635147
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IL11,Interleukin-11,39587,-0.0064875977753325,0.00584906989479787,-0.0179517747691363,0.00497657921847132,0.267374924043019
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CCDC28A,Coiled-coil domain-containing protein 28A,37039,-0.00307484400254523,0.0027724529340168,-0.00850885175321816,0.00235916374812771,0.267420281241313
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GFOD2,Glucose-fructose oxidoreductase domain-containing protein 2,39477,0.0131814219665649,0.0119269296993849,-0.0101953602442296,0.0365582041773593,0.269097980585642
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TPT1,Translationally-controlled tumor protein,39587,0.00675893725989366,0.00613280245450523,-0.00526135555093658,0.0187792300707239,0.270436788910808
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CTSV,Cathepsin L2,39967,0.00423757814530708,0.00384548617993006,-0.00329957476735584,0.01177473105797,0.270494827148578
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,INHBB,Inhibin beta B chain,37124,0.00512649252404782,0.00465600743132033,-0.00399928204134002,0.0142522670894357,0.270895293415677
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ESR1,Estrogen receptor,37056,0.00613845978952705,0.00558765876322552,-0.00481335138639498,0.0170902709654491,0.271973720720805
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CYB5A,Cytochrome b5,36962,-0.00740215677165727,0.00673816152853848,-0.0206089533675927,0.00580463982427814,0.271987859114626
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,OLR1,Oxidized low-density lipoprotein receptor 1,39721,-0.00605383773546893,0.00551188567556782,-0.0168571336595819,0.004749458188644,0.272079595897075
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TMEM132A,Transmembrane protein 132A,37043,-0.00645194026516471,0.00590319048283537,-0.018022193611522,0.00511831308119262,0.274432137863813
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,VWF,von Willebrand factor,40052,0.00749829236320201,0.00686586156581482,-0.00595879630579505,0.0209553810321991,0.27479996091548
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,KIF20B,Kinesin-like protein KIF20B,36991,0.00770339088565435,0.0070736138810179,-0.00616089232114073,0.0215676740924494,0.276159822100175
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MORN4,MORN repeat-containing protein 4,36962,-0.00816504956943254,0.00749869314648982,-0.0228624881365526,0.0065323889976875,0.276234329054537
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CDON,Cell adhesion molecule-related/down-regulated by oncogenes,39885,-0.00271802969389758,0.00250520348647336,-0.00762822852738537,0.00219216913959021,0.277958501031608
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,37437,-0.00272063218683083,0.00251397924393047,-0.00764803150493456,0.00220676713127289,0.27918220834768
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CLEC12A,C-type lectin domain family 12 member A,37056,-0.00204633016850726,0.00189358491129632,-0.00575775659464805,0.00166509625763354,0.279866087638775
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CCL24,C-C motif chemokine 24,39908,0.00832063051723596,0.00773881180321298,-0.00684744061706148,0.0234887016515334,0.282309453770159
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FCRL3,Fc receptor-like protein 3,39587,0.00526321404074168,0.00490116127341758,-0.00434306205515677,0.0148694901366401,0.282897062347558
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,EPHB6,Ephrin type-B receptor 6,39713,-0.00304839634954271,0.00284057438670594,-0.00861592214748635,0.00251912944840093,0.283214794276765
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GADD45B,Growth arrest and DNA damage-inducible protein GADD45 beta,37169,0.00514638060474136,0.00479750971684593,-0.00425673844027666,0.0145494996497594,0.283416590066119
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GFRA3,GDNF family receptor alpha-3,39709,0.00278347260873459,0.00259708085982514,-0.00230680587652269,0.00787375109399187,0.28383979937285
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GBA,Lysosomal acid glucosylceramidase,37039,0.00528590661611205,0.00495916838563964,-0.00443406341974165,0.0150058766519658,0.286494844882688
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CPB2,Carboxypeptidase B2,37424,0.00225260855775602,0.00212352103715601,-0.00190949267506977,0.0064147097905818,0.288804518689152
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DUSP13,Dual specificity protein phosphatase 13 isoform A,37368,0.00418465357510689,0.00394794316459412,-0.00355331502749758,0.0119226221777114,0.289182701415188
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CACNA1C,Voltage-dependent L-type calcium channel subunit alpha-1C,36991,0.00323364692540475,0.00305266214090144,-0.00274957087076208,0.00921686472157159,0.289488339005663
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LEO1,RNA polymerase-associated protein LEO1,37411,-0.00278886444352864,0.00263389241363192,-0.00795129357424721,0.00237356468718993,0.289692598754236
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GDF2,Growth/differentiation factor 2,39868,0.00348054818792606,0.003315963576712,-0.00301874042242947,0.00997983679828158,0.293902254167439
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GP1BA,Platelet glycoprotein Ib alpha chain,39817,0.00320552148819467,0.0030637254589992,-0.00279938041144377,0.0092104233878331,0.295446598094041
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GTF2IRD1,General transcription factor II-I repeat domain-containing protein 1,37169,0.00713447543061637,0.0068201918582234,-0.0062331006115015,0.0205020514727342,0.295542478109936
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TXNDC15,Thioredoxin domain-containing protein 15,39913,-0.00266308673997075,0.00254658332474663,-0.00765439005647414,0.00232821657653264,0.295692719913434
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LRRC25,Leucine-rich repeat-containing protein 25,39788,0.00381434647519087,0.00364887827132204,-0.00333745493660033,0.0109661478869821,0.295878167050359
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TNPO1,Transportin-1,37169,0.00348731312575666,0.00333803572027328,-0.00305523688597896,0.0100298631374923,0.296171310827315
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,HRAS,GTPase Hras,37161,0.00961496795602687,0.00921236278378365,-0.00844126310018907,0.0276711990122428,0.296641926215317
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CST6,Cystatin-M,39524,0.00459356996846644,0.00440670817433971,-0.0040435780532394,0.0132307179901723,0.29724052771255
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IGFL4,Insulin growth factor-like family member 4,37056,-0.00751471614982051,0.00722245628900699,-0.0216707304762742,0.00664129817663319,0.298142775541759
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,STOML2,"Stomatin-like protein 2, mitochondrial",36962,-0.00902259087540813,0.00871616871231238,-0.0261062815515404,0.00806109980072413,0.300615354214486
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SPACA5_SPACA5B,Sperm acrosome-associated protein 5,37411,-0.00289121444414702,0.0028019894965154,-0.00838311385731721,0.00260068496902316,0.302163886888145
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RPA2,Replication protein A 32 kDa subunit,37056,0.00309535465243981,0.00300212866844532,-0.00278881753771301,0.00897952684259264,0.302534725125083
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CA3,Carbonic anhydrase 3,40017,0.00579001539715288,0.00566045622345937,-0.00530447880082747,0.0168845095951332,0.306375897077415
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SLC1A4,Neutral amino acid transporter A,37039,-0.00492437347013597,0.00483210141778655,-0.0143952922489976,0.00454654530872566,0.308176272656033
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RGS10,Regulator of G-protein signaling 10,37411,-0.00570225776644637,0.00564270639568659,-0.0167619623019921,0.00535744676909935,0.312248133808478
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LSM1,U6 snRNA-associated Sm-like protein LSm1,39477,0.00518669701448069,0.00513791033387304,-0.00488360723991046,0.0152570012688719,0.312752731274166
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MAPT,Microtubule-associated protein tau,39489,0.00498099401452359,0.00495052843871605,-0.00472204172535987,0.0146840297544071,0.314357070556961
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RASA1,Ras GTPase-activating protein 1,39489,-0.00308597574094149,0.00306976284235956,-0.00910271091196624,0.00293075943008325,0.314776892570545
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ACTN4,Alpha-actinin-4,39587,-0.00296120861148721,0.00295133998159201,-0.00874583497540754,0.00282341775243312,0.315710456643152
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,THBS4,Thrombospondin-4,39892,-0.00421273743336695,0.00420459075331441,-0.0124537353098632,0.0040282604431293,0.31638886881049
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DUSP3,Dual specificity protein phosphatase 3,39489,0.007991208083544,0.00797698258910198,-0.00764367779109588,0.0236260939581839,0.316463765518776
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CEACAM1,Carcinoembryonic antigen-related cell adhesion molecule 1,39887,0.00221437624895946,0.00221817107336774,-0.00213323905484131,0.00656199155276024,0.318154209756331
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SOX9,Transcription factor SOX-9,37039,0.00253625915947003,0.00254356384414799,-0.00244912597506002,0.00752164429400009,0.318720608567093
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SLC34A3,Sodium-dependent phosphate transport protein 2C,36962,0.00452180801683933,0.00456472648990347,-0.00442505590337146,0.0134686719370501,0.321900305992539
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TLR1,Toll-like receptor 1,37056,-0.00242757869732724,0.00245287775173146,-0.0072352190907209,0.00238006169606641,0.322345780866219
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IL21R,Interleukin-21 receptor,37056,0.00505640984363999,0.00510983524036535,-0.0049588672274761,0.0150716869147561,0.322414905981605
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TRDMT1,tRNA (cytosine(38)-C(5))-methyltransferase,37169,-0.00781684602391462,0.00790113721897841,-0.0233030749731123,0.00766938292528306,0.322518833500987
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,YAP1,Transcriptional coactivator YAP1,37388,-0.00235866384977349,0.00239672596989853,-0.00705624675077462,0.00233891905122764,0.325074547562129
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PM20D1,N-fatty-acyl-amino acid synthase/hydrolase PM20D1,39801,-0.0172374906133851,0.0175562031659156,-0.0516476488185796,0.0171726675918094,0.326190545730038
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LYPD1,Ly6/PLAUR domain-containing protein 1,39489,-0.0059496607379414,0.00607501525336711,-0.0178566906345409,0.00595736915865813,0.327414545076795
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PTTG1,Securin,37169,0.0038518956328217,0.00393389146604205,-0.00385853164062072,0.0115623229062641,0.327520426886457
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TNFSF8,Tumor necrosis factor ligand superfamily member 8,37437,0.00324543977737874,0.00334261966330863,-0.00330609476270617,0.00979697431746365,0.331601913984985
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MN1,Transcriptional activator MN1,37039,0.00540663636490517,0.00557076624234583,-0.00551206547009265,0.016325338199903,0.331796558900908
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TSLP,Thymic stromal lymphopoietin,39585,-0.00546607572548442,0.0056333988088483,-0.0165075373908271,0.00557538593985826,0.331912886439029
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DOC2B,Double C2-like domain-containing protein beta,37039,0.00331881124830933,0.00342060451515632,-0.00338557360139706,0.0100231960980157,0.331944110976648
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,METAP1,Methionine aminopeptidase 1,39489,-0.0027745472648355,0.00286591205909055,-0.00839173490065298,0.00284264037098198,0.33299933932153
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SLK,STE20-like serine/threonine-protein kinase,37169,0.00698260793059961,0.00723181237706924,-0.00719174432845609,0.0211569601896553,0.334291691398918
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ROBO1,Roundabout homolog 1,39885,-0.00213676659294033,0.00221576490741363,-0.00647966581147104,0.00220613262559038,0.33488645683144
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SH3BGRL2,SH3 domain-binding glutamic acid-rich-like protein 2,36991,-0.00560341753927193,0.0058112760439249,-0.0169935185853647,0.00578668350682088,0.334947448664357
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ECE1,Endothelin-converting enzyme 1,39489,-0.00316703222352557,0.00328798715391861,-0.00961148704520605,0.00327742259815492,0.335455506332976
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CA13,Carbonic anhydrase 13,39657,-0.00954770823823215,0.00992915997136717,-0.0290088617821118,0.0099134453056475,0.336273994126717
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LRP2,Low-density lipoprotein receptor-related protein 2,37039,0.00323865278513234,0.00337040709156296,-0.00336734511433107,0.00984465068459575,0.336615811147087
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GKN1,Gastrokine-1,39123,-0.00252906633764495,0.00263990391473456,-0.00770327801052469,0.00264514533523478,0.338070600523307
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,JMJD1C,Probable JmjC domain-containing histone demethylation protein 2C,36962,-0.00507402330478479,0.00530190868243154,-0.0154657643223506,0.00531771771278102,0.338575707751574
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PRC1,Protein regulator of cytokinesis 1,37368,0.00413443801052487,0.00433343838644781,-0.00435910122691285,0.0126279772479626,0.340061259277758
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SSC4D,Scavenger receptor cysteine-rich domain-containing group B protein,39846,-0.0101382108120879,0.0106567586792424,-0.031025457823403,0.0107490361992272,0.341445713986301
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ECSCR,Endothelial cell-specific chemotaxis regulator,36991,0.0043989582590956,0.00462731214202565,-0.00467057353927468,0.0134684900574659,0.341799138794538
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,KLK7,Kallikrein-7,36818,0.00349147819895841,0.00367590697586338,-0.00371329947373381,0.0106962558716506,0.342217532438629
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GLRX5,"Glutaredoxin-related protein 5, mitochondrial",37124,-0.00799000589946924,0.00842903614291514,-0.0245109167395829,0.00853090494064443,0.343190232513541
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GUCY2C,Heat-stable enterotoxin receptor,37169,0.00764471648861907,0.00807254681443727,-0.00817747526767798,0.0234669082449161,0.343655047236223
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IL31,Interleukin-31,37056,0.00509894281548365,0.00540050989101213,-0.00548605657090012,0.0156839422018674,0.345105424566099
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IL6R,Interleukin-6 receptor subunit alpha,39805,0.00298212217089076,0.00316381445373053,-0.00321895415842108,0.00918319850020261,0.345914268563984
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SPINT3,Kunitz-type protease inhibitor 3,37382,0.0129017647482027,0.0136946062692901,-0.0139396635396058,0.0397431930360112,0.346155427333103
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TINAGL1,Tubulointerstitial nephritis antigen-like,39844,-0.00196932055010916,0.00209090360029958,-0.00606749160669634,0.00212885050647801,0.346282943029786
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,USP47,Ubiquitin carboxyl-terminal hydrolase 47,37021,-0.00770389422005197,0.00818870291570805,-0.0237537519348397,0.00834596349473581,0.346826974048482
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,39477,0.00305529711600236,0.00327753434680682,-0.003368670203739,0.00947926443574371,0.351250802738585
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,VWC2,Brorin,39684,-0.0033662197039649,0.00361835620861346,-0.0104581978728473,0.00372575846491749,0.352220968535013
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ATP5F1D,"ATP synthase subunit delta, mitochondrial",37021,0.00443842922679056,0.00477455700961799,-0.00491970251206069,0.0137965609656418,0.352595165184519
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LEG1,Protein LEG1 homolog,36703,0.00610974011210571,0.00658913281456463,-0.00680496020444098,0.0190244404286524,0.353816795165581
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CLEC4G,C-type lectin domain family 4 member G,39866,-0.00288958379286398,0.00311909520154079,-0.00900301038788393,0.00322384280215598,0.354243118663357
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ADAM22,Disintegrin and metalloproteinase domain-containing protein 22,39749,-0.00300643878233845,0.00325452477230431,-0.0093853073360549,0.003372429771378,0.355619076385323
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DSCAM,Down syndrome cell adhesion molecule,37411,-0.00304976035978049,0.00332071074238629,-0.00955835341485762,0.00345883269529664,0.35842274570113
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,EP300,Histone acetyltransferase p300,37056,0.00255303437689719,0.00278185763351797,-0.00289940658479802,0.00800547533859241,0.358769448634583
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NFKB2,Nuclear factor NF-kappa-B p100 subunit,37169,0.00504435244921189,0.005502365669022,-0.00574028426207124,0.015828989160495,0.359284676525164
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IL13,Interleukin-13,39587,0.00419628025183698,0.00458196404738442,-0.00478436928103649,0.0131769297847104,0.359772384261129
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LMOD1,Leiomodin-1,37411,0.0030333739970614,0.00331610795456557,-0.00346619759388712,0.00953294558800992,0.36034482672248
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,HLA_A,,37411,-0.00276766116441793,0.00303970713822647,-0.00872548715534181,0.00319016482650594,0.362573721486663
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GART,Trifunctional purine biosynthetic protein adenosine-3,37411,0.00229107090262111,0.00251748125157771,-0.00264319235047121,0.00722533415571343,0.36280455886589
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TFAP2A,Transcription factor AP-2-alpha,36991,-0.00506499115290305,0.00558424369312849,-0.0160101087914349,0.00588012648562879,0.364415664350164
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,HMMR,Hyaluronan mediated motility receptor,36942,0.00404470071172487,0.00446406975709166,-0.00470487601217478,0.0127942774356245,0.364922482108349
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DNM1,Dynamin-1,37382,0.00974942454594758,0.0107777102234998,-0.011374887492112,0.0308737365840072,0.36569798125474
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NRCAM,Neuronal cell adhesion molecule,39868,-0.00235049393755198,0.00260132869076955,-0.0074490981714603,0.00274811029635633,0.366234732545387
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MGMT,Methylated-DNA--protein-cysteine methyltransferase,39866,-0.0103835817010041,0.0115179493425638,-0.0329587624124292,0.0121915990104209,0.367329160490232
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,VIPR1,Vasoactive intestinal polypeptide receptor 1,37043,0.00220083463732437,0.00244722149606959,-0.00259571949497204,0.00699738876962078,0.368498793664705
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ITIH1,Inter-alpha-trypsin inhibitor heavy chain H1,37453,0.00157502248484531,0.00175143596358615,-0.00185779200378354,0.00500783697347416,0.368522157699725
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IL2RB,Interleukin-2 receptor subunit beta,39587,0.00306650138487586,0.00341225172840249,-0.00362151200279302,0.00975451477254474,0.368840170052786
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NT5C3A,Cytosolic 5'-nucleotidase 3A,39829,0.00745618386927485,0.00831085714128002,-0.00883309612763399,0.0237454638661837,0.369646090380596
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GRIK2,"Glutamate receptor ionotropic, kainate 2",37411,0.00332389537673544,0.00371455722890005,-0.00395663679190867,0.0106044275453795,0.370894132975904
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GBP2,Guanylate-binding protein 2,39587,-0.00498223513337221,0.00557313267647361,-0.0159055751792605,0.00594110491251607,0.371349537959961
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,HIF1A,Hypoxia-inducible factor 1-alpha,37056,0.00574110087303601,0.00642917183532614,-0.00686007592420323,0.0183422776702752,0.371885915821513
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,C2,Complement C2,39908,-0.0019840216029656,0.00222341038751267,-0.00634190596249043,0.00237386275655924,0.372228057767135
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GADD45GIP1,Growth arrest and DNA damage-inducible proteins-interacting protein 1,37043,-0.00445862543299639,0.00500372290717325,-0.014265922331056,0.00534867146506317,0.372912376131274
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FAM171B,Protein FAM171B,37368,0.0023151890570559,0.00260270458511555,-0.00278611192977058,0.00741649004388238,0.373733065559241
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",36991,0.00469477946935389,0.00528678501407466,-0.00566731915823243,0.0150568780969402,0.374545379559564
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,VASP,Vasodilator-stimulated phosphoprotein,37445,-0.00607993272940099,0.00686524156278775,-0.019535806192465,0.007375940733663,0.375842913518694
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MEP1B,Meprin A subunit beta,39868,-0.00956429996286294,0.0108248191145937,-0.0307809454274666,0.0116523455017407,0.37695090076637
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,EXOSC10,Exosome component 10,37021,0.0050615403609432,0.00572932442294718,-0.00616793550803327,0.0162910162299197,0.377012273579999
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GATD3,"Glutamine amidotransferase-like class 1 domain-containing protein 3B, mitochondrial",37043,0.00647141372742075,0.00732806611937177,-0.00789159586654792,0.0208344233213894,0.377198455106315
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DCUN1D2,DCN1-like protein 2,36962,0.0066663975721933,0.00756052117613893,-0.00815222393303901,0.0214850190774256,0.377934771074285
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NAPRT,Nicotinate phosphoribosyltransferase,37388,-0.00269642489154455,0.00307130278993358,-0.00871617835981437,0.00332332857672527,0.379990932175352
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FZD10,Frizzled-10,37039,-0.00491974477711419,0.00563773107477707,-0.0159696976836773,0.00613020812944887,0.382871831601688
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NXPH1,Neurexophilin-1,39489,0.00307905597009028,0.0035302967687026,-0.00384032569656681,0.00999843763674737,0.383123318822521
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MAP1LC3B2,Microtubule-associated proteins 1A/1B light chain 3 beta 2,37021,-0.00526756098807208,0.00605423824148878,-0.0171338679413901,0.00659874596524594,0.384282539386938
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GZMB,Granzyme B,39866,0.0052387803117268,0.00602203937531974,-0.00656441686389989,0.0170419774873535,0.384349200538785
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IZUMO1,Izumo sperm-egg fusion protein 1,36962,0.0040872749534388,0.00471303137432395,-0.00515026654023614,0.0133248164471137,0.385832726237839
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DNAJA4,DnaJ homolog subfamily A member 4,37388,-0.00566936523208464,0.00654751461825227,-0.0185024938838591,0.0071637634196898,0.386571053285764
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,HEPACAM2,HEPACAM family member 2,37388,0.0033949444738997,0.00393609631068868,-0.00431980429505011,0.0111096932428495,0.388419141448698
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FOLR2,Folate receptor beta,40009,0.00233330861734024,0.00270634286749639,-0.00297112340295268,0.00763774063763316,0.388610643285068
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,AFP,Alpha-fetoprotein,39699,0.00547178926568157,0.00634673634024922,-0.00696781396120689,0.01791139249257,0.388622321102688
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MFAP3,Microfibril-associated glycoprotein 3,39585,-0.00394580514562657,0.00460125020224477,-0.0129642555420263,0.00507264525077317,0.39115369931822
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IL1A,Interleukin-1 alpha,39587,0.00429922845867609,0.00501897159497611,-0.00553795586747708,0.0141364127848293,0.391681527657749
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,HS3ST3B1,Heparan sulfate glucosamine 3-O-sulfotransferase 3B1,39788,0.00305203188579473,0.00359138964352749,-0.00398709181551915,0.0100911555871086,0.395438384616209
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SMPD3,Sphingomyelin phosphodiesterase 3,37056,0.00472421997527052,0.00565076407028491,-0.0063512776024879,0.0157997175530289,0.403152000087869
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SNX2,Sorting nexin-2,37368,-0.00632107513540164,0.007571613352542,-0.021161437306384,0.00851928703558067,0.403823350231954
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,OGT,UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit,37169,0.00497574298725345,0.00596037858321452,-0.00670659903584701,0.0166580850103539,0.403843520209199
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,EPGN,Epigen,37368,0.00390852830434767,0.00468644077840689,-0.00527689562132983,0.0130939522300252,0.404291319318063
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,VIT,Vitrin,37437,-0.00288211285864298,0.0034567257914922,-0.0096572954099677,0.00389306969268173,0.404425500814412
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SLC44A4,Choline transporter-like protein 4,37039,0.00530218506444052,0.00638269592340121,-0.00720789894542587,0.0178122690743069,0.406151131592997
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CA1,Carbonic anhydrase 1,39531,-0.00462107747370154,0.00557987976648905,-0.0155576418160201,0.006315486868617,0.40758801542975
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IL24,Interleukin-24,39587,-0.00364897316256933,0.00443826858143238,-0.0123479795821768,0.00505003325703812,0.410997501777097
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DGKZ,Diacylglycerol kinase zeta,39587,-0.00278068763853946,0.00338342633839387,-0.00941220326179145,0.00385082798471252,0.411171585413091
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CAPS,Calcyphosin,37388,0.00669741642587163,0.00817490655857758,-0.00932540042894043,0.0227202332806837,0.412649557491375
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NEB,Nebulin,37021,-0.00287667778409422,0.00352841797068998,-0.00979237700664659,0.00403902143845814,0.414922074800696
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DCDC2C,Doublecortin domain-containing protein 2C,36962,0.00485140027020868,0.00596774918720202,-0.00684538813670728,0.0165481886771246,0.416269320894022
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NEDD9,Enhancer of filamentation 1,37056,0.00254877957319062,0.00313972678874142,-0.00360508493274256,0.0087026440791238,0.41693029989669
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,C5,Complement C5,37453,-0.00116101420866941,0.00143071302728169,-0.00396521174214152,0.0016431833248027,0.417096578775997
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CACNB1,Voltage-dependent L-type calcium channel subunit beta-1,36991,0.00446717649300878,0.0055366046428401,-0.00638456860695781,0.0153189215929754,0.419770952257769
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,STX1B,Syntaxin-1B,37039,0.00321865886539717,0.00400070386366704,-0.00462272070739024,0.0110600384381846,0.421109418856319
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GPNMB,Transmembrane glycoprotein NMB,39444,0.00213623221282906,0.00265783244403601,-0.00307311937748152,0.00734558380313964,0.421553764240726
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PGLYRP4,Peptidoglycan recognition protein 4,37021,0.00471116266897423,0.0058677009746662,-0.00678953124137153,0.01621185657932,0.422048457767438
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IL9,Interleukin-9,37169,0.00432014196448452,0.00539827853661795,-0.00626048396728666,0.0149007678962557,0.423562055102703
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MUC16,Mucin-16,39788,-0.0139409572648895,0.0174932407324648,-0.0482277091005204,0.0203457945707415,0.425501276742742
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GPR101,Probable G-protein coupled receptor 101,36991,0.00468737118352084,0.0059015724857816,-0.00687971088861109,0.0162544532556528,0.427059600670721
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RNF4,E3 ubiquitin-protein ligase RNF4,37169,0.00487463243517085,0.00618506352065151,-0.0072480920653061,0.0169973569356478,0.430634864298454
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,KLK3,Prostate-specific antigen,37437,0.00581544519703301,0.00738782292913191,-0.00866468774406554,0.0202955781381316,0.431198265932964
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DLGAP5,Disks large-associated protein 5,37411,0.00388542272897877,0.00493914312733556,-0.00579529780059892,0.0135661432585565,0.431495109481489
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TIMP2,Metalloproteinase inhibitor 2,37437,-0.00188484790790569,0.00239606866141463,-0.00658114248427837,0.00281144666846699,0.431505277627142
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,EFHD1,EF-hand domain-containing protein D1,37411,-0.00255211674553167,0.00324933601390272,-0.008920815332781,0.00381658184171766,0.432216895804862
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LHPP,Phospholysine phosphohistidine inorganic pyrophosphate phosphatase,39869,0.00424448958698488,0.00540527209782559,-0.00634984372475328,0.014838822898723,0.432318661228676
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CHGA,Chromogranin-A,37437,-0.00576787740058333,0.0073571513700929,-0.0201878940859654,0.00865213928479875,0.433064097403887
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DDI2,Protein DDI1 homolog 2,37124,-0.00553542916076648,0.00707100050461127,-0.0193945901498046,0.00832373182827161,0.433737781507354
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,HTR1A,5-hydroxytryptamine receptor 1A,36991,0.00559452204837879,0.00715401105101194,-0.00842733961160461,0.0196163837083622,0.434221658150041
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CR2,Complement receptor type 2,39931,0.00333288500212416,0.00426419669273902,-0.00502494051564433,0.0116907105198926,0.43446273576143
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,COL4A1,Collagen alpha-1(IV) chain,39868,-0.00286837271852023,0.00367134082539122,-0.010064200736287,0.00432745529924656,0.434644970675452
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CA8,Carbonic anhydrase-related protein,37056,0.00191489261823667,0.00245185462766879,-0.00289074245199415,0.00672052768846749,0.434817907246308
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ZNF174,Zinc finger protein 174,37056,0.00280192286419027,0.00358938269728342,-0.00423326722248524,0.00983711295086578,0.435043478888869
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MKI67,Proliferation marker protein Ki-67,37056,-0.00287205113211966,0.0036936514710465,-0.0101116080153708,0.00436750575113148,0.436839915531555
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FST,Follistatin,39908,0.00375332696991426,0.00482848387439743,-0.00571050142390469,0.0132171553637332,0.436975362646738
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ENPP2,Ectonucleotide pyrophosphatase/phosphodiesterase family member 2,40052,0.00196410425836558,0.00253254180014579,-0.00299967766992016,0.00692788618665133,0.438028049305462
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PHLDB2,Pleckstrin homology-like domain family B member 2,36962,0.00666286539575629,0.00859272174586721,-0.0101788692261434,0.023504600017656,0.438112589568484
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,COPB2,Coatomer subunit beta',37021,-0.00311486994220359,0.00401902658293686,-0.0109921620447598,0.00476242216035266,0.438335302731705
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CINP,Cyclin-dependent kinase 2-interacting protein,37169,-0.00317440019048284,0.00409941605991313,-0.0112092556679126,0.00486045528694689,0.438735094445686
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NMRK2,Nicotinamide riboside kinase 2,36962,0.00296929127444113,0.00383892301122091,-0.00455499782755185,0.0104935803764341,0.439258309324136
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SLIRP,"SRA stem-loop-interacting RNA-binding protein, mitochondrial",36962,0.00411992503066999,0.00533782225985933,-0.0063422065986543,0.0145820566599943,0.440225304490447
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GABRA4,Gamma-aminobutyric acid receptor subunit alpha-4,36991,0.00479599523110455,0.00621545811514887,-0.00738630267458723,0.0169782931367963,0.440351176406809
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CRYBB2,Beta-crystallin B2,37388,-0.00411151939806134,0.00533511194477252,-0.0145683388098155,0.0063453000136928,0.440926165555746
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SCARB1,Scavenger receptor class B member 1,39489,-0.00411542533113398,0.00535794862039622,-0.0146170046271106,0.00638615396484261,0.442441045311219
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TMEM25,Transmembrane protein 25,37411,0.00323534070743445,0.00421323494060455,-0.00502259977615047,0.0114932811910194,0.442560316738544
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,BRD3,Bromodomain-containing protein 3,37021,0.00334468354338882,0.00436002923076549,-0.00520097374891154,0.0118903408356892,0.443021489179906
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IL4,Interleukin-4,39587,-0.00650786111293441,0.00848533805148647,-0.0231391236938479,0.0101234014679791,0.443120577920809
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RGMB,RGM domain family member B,40009,0.0018310164533967,0.00239321472514649,-0.00285968440789042,0.00652171731468381,0.444231174883684
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,AOC1,Amiloride-sensitive amine oxidase [copper-containing],39587,0.00393197540488685,0.00514135894473314,-0.00614508812679011,0.0140090389365638,0.44441786709654
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CYB5R2,NADH-cytochrome b5 reductase 2,37220,-0.00400491202436525,0.00523884129235182,-0.0142730409573748,0.00626321690864432,0.444603549864611
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MORF4L2,Mortality factor 4-like protein 2,36962,0.00266458851733961,0.0034923289502804,-0.00418037622520998,0.00950955325988919,0.445487117876778
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,VIM,Vimentin,39585,-0.00839007137322162,0.0109985814227337,-0.0299472909617796,0.0131671482153364,0.445574955266936
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SCN3A,Sodium channel protein type 3 subunit alpha,37039,-0.00274327495839329,0.00361188383269468,-0.00982256727047486,0.00433601735368828,0.447558955675978
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ARTN,Artemin,39587,-0.00319733290703485,0.00421209497982778,-0.0114530390674973,0.0050583732534276,0.447813828023564
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,KHDC3L,KH domain-containing protein 3,36962,0.00474428099856335,0.00625101626411462,-0.00750771087910132,0.016996272876228,0.447889210588291
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TNFRSF8,Tumor necrosis factor receptor superfamily member 8,40009,0.00317268518719432,0.00418060600726191,-0.00502130258703903,0.0113666729614277,0.447920122654485
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,EPN1,Epsin-1,37169,-0.00307443615362671,0.00405988358717119,-0.0110318079844822,0.00488293567722882,0.448900330111107
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,EPHA10,Ephrin type-A receptor 10,39489,0.0045472989308776,0.00603126354919203,-0.00727397762553878,0.016368575487294,0.450887838483101
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GZMH,Granzyme H,39585,-0.00527545392660533,0.00706592136865115,-0.0191246598091616,0.00857375195595093,0.455313045748791
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PLXDC1,Plexin domain-containing protein 1,39477,-0.00241378698473898,0.00323314636984379,-0.00875075386963282,0.00392317990015485,0.455331245345139
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,HNF1A,Hepatocyte nuclear factor 1-alpha,37039,-0.00498104276042789,0.00668540561924903,-0.018084437774156,0.00812235225330021,0.456247428641051
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DHODH,Dihydroorotate dehydrogenase,37021,-0.00323226872463977,0.00436243841121143,-0.0117826480106142,0.00531811056133464,0.458748098187045
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CALB2,Calretinin,39489,-0.00203181635254822,0.00274324264938517,-0.00740857194534315,0.0033449392402467,0.458909363023332
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CASP4,Caspase-4,37169,0.0114855564096025,0.0155400208310812,-0.0189728844193167,0.0419439972385216,0.459862163052898
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,BMP4,Bone morphogenetic protein 4,39720,0.00318064237366983,0.00431664174011613,-0.00527997543695778,0.0116412601842974,0.461235052357622
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SPRR1B,Cornifin-B,37169,0.00607519743617877,0.00826316093020193,-0.010120597987017,0.0222709928593746,0.462221699020976
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PNPT1,"Polyribonucleotide nucleotidyltransferase 1, mitochondrial",39587,-0.00835808152681827,0.01139007344309,-0.0306826254752747,0.0139664624216382,0.463079137202598
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TLR2,Toll-like receptor 2,37169,-0.0015613907816561,0.00213954081302192,-0.00575489077517906,0.00263210921186687,0.465538461893566
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GP2,Pancreatic secretory granule membrane major glycoprotein GP2,39351,-0.0058262277884075,0.00799288986584994,-0.0214922919254734,0.00983983634865838,0.466057754131584
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FBN2,Fibrillin-2,37039,-0.00411775508022508,0.00565772831318996,-0.0152069025740774,0.00697139241362724,0.466742416892173
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CPA4,Carboxypeptidase A4,36868,0.00298042840337677,0.00409941931710604,-0.00505443345815106,0.0110152902649046,0.467216540926206
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,C7,Complement component C7,37149,-0.00218924219199321,0.00301881106181487,-0.00810611187315036,0.00372762748916394,0.468342028904532
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SEMA4D,Semaphorin-4D,40009,-0.00203759929851442,0.0028118678442963,-0.00754886027333516,0.00347366167630632,0.468681799997468
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LY9,T-lymphocyte surface antigen Ly-9,39699,-0.00192421503016208,0.00266402669805476,-0.00714570735834942,0.00329727729802525,0.47012335935726
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TGFBR1,TGF-beta receptor type-1,37056,0.00147700126664518,0.00204690191855329,-0.00253492649371928,0.00548892902700963,0.470566190679419
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SMPDL3B,Acid sphingomyelinase-like phosphodiesterase 3b,37368,0.00519025683297253,0.00720157633938887,-0.00892483279222966,0.0193053464581747,0.471099682739775
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,OFD1,Oral-facial-digital syndrome 1 protein,37169,0.00456646531681852,0.00640830069155284,-0.00799380403862504,0.0171267346722621,0.476114473540778
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CCS,Copper chaperone for superoxide dismutase,39749,-0.00315934944401532,0.00443620627004518,-0.0118543137333039,0.00553561484527324,0.476367676062054
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CEBPA,CCAAT/enhancer-binding protein alpha,37056,-0.0025278881136993,0.00355536583192838,-0.00949640514427892,0.00444062891688032,0.477092792452761
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PRR4,Proline-rich protein 4,37031,0.00465607517105661,0.0065716230172445,-0.00822430594274262,0.0175364562848558,0.478639769254056
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TMPRSS11B,Transmembrane protease serine 11B,36991,0.00511244472466962,0.00722875146147136,-0.00905590813981424,0.0192807975891535,0.479431396311668
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,APOH,Beta-2-glycoprotein 1,39858,0.00235516226382611,0.00333527612383298,-0.00418197893888654,0.00889230346653875,0.480113154779541
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RGMA,Repulsive guidance molecule A,40009,0.00204998227644148,0.00290719328246826,-0.0036481165571963,0.00774808111007926,0.480732428654297
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,EPB41L5,Band 4.1-like protein 5,37039,-0.00426057872641377,0.00604554213031343,-0.0161098413018281,0.00758868384900055,0.480980042674836
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,KCNH2,Potassium voltage-gated channel subfamily H member 2,37039,0.00515018880399073,0.00733559572388788,-0.00922757881482952,0.019527956422811,0.482640503427769
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RTN4IP1,"Reticulon-4-interacting protein 1, mitochondrial",37411,0.00602138271376305,0.0085945651367028,-0.0108239649541744,0.0228667303817005,0.48356250071107
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PDXDC1,Pyridoxal-dependent decarboxylase domain-containing protein 1,36962,-0.00378537136174959,0.00541527628006483,-0.0143993128706766,0.00682857014717747,0.484553678513967
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PLXDC2,Plexin domain-containing protein 2,37388,-0.00175695757495148,0.00251897209256265,-0.00669414287637427,0.00318022772647131,0.485508249165509
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MSLN,Mesothelin,39766,-0.00343970754609466,0.00493786143319507,-0.013117915955157,0.00623850086296767,0.486064188304531
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,KIR2DL3,Killer cell immunoglobulin-like receptor 2DL3,39477,-0.0048695865850507,0.00701243998714622,-0.0186139689598573,0.00887479578975589,0.487428468740976
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MDM1,Nuclear protein MDM1,37039,-0.00204287433498145,0.00294562598617321,-0.00781630126788095,0.00373055259791805,0.487990432672426
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IL2,Interleukin-2,39587,0.00202764354749972,0.00292902594574874,-0.00371324730616782,0.00776853440116726,0.48878513298944
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CFD,Complement factor D,37453,0.00118775651792475,0.00171672524015501,-0.00217702495277908,0.00455253798862857,0.489028657830292
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CEP112,Centrosomal protein of 112 kDa,37021,-0.00303007638501878,0.00438509893322615,-0.011624870294142,0.00556471752410449,0.489581594252065
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ACADM,"Medium-chain specific acyl-CoA dehydrogenase, mitochondrial",37169,-0.00456665908695511,0.00662247764625685,-0.0175467152736185,0.00841339709970831,0.490476929332905
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NRN1,Neuritin,37411,-0.00227884645518052,0.0033144530134878,-0.0087751743616166,0.00421748145125556,0.491749057254808
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ITGAX,Integrin alpha-X,37169,-0.00342047632613175,0.00498380474368116,-0.0131887336237468,0.00634778097148333,0.492524376948892
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SEPTIN7,Septin-7,37169,0.00330528043361149,0.00483741906318166,-0.00617606093022456,0.0127866217974475,0.49444590681953
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IL25,Interleukin-25,36903,0.00218139283668027,0.00322645181923034,-0.00414245272901119,0.00850523840237173,0.498991355740391
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NCLN,Nicalin,39587,0.00333803878260743,0.00495480195221386,-0.00637337304373173,0.0130494506089466,0.500513411785836
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SIGLEC5,Sialic acid-binding Ig-like lectin 5,39858,-0.00748747207679722,0.0111436177453709,-0.0293289628577242,0.0143540187041297,0.501652760193089
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NUDT15,Nucleotide triphosphate diphosphatase NUDT15,37021,0.00317668049864994,0.004752105986701,-0.00613744723528401,0.0124908082325839,0.503839949770023
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CRTAP,Cartilage-associated protein,37039,-0.00310264556421513,0.00465171850376499,-0.0122200138315945,0.00601472270316425,0.504790769463023
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IL6ST,Interleukin-6 receptor subunit beta,39868,-0.00109766932348389,0.00165177484685898,-0.0043351480233275,0.00213980937635972,0.506354767721181
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ENG,Endoglin,40052,0.00105503259256519,0.00159192027353037,-0.00206513114355434,0.00417519632868472,0.507505172109678
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TFPI2,Tissue factor pathway inhibitor 2,39864,0.00248241263326756,0.00375980923322167,-0.00488681346384692,0.00985163873038205,0.509103154065947
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TCP11,T-complex protein 11 homolog,37169,-0.00370116446293601,0.00561343133288423,-0.0147034898753891,0.00730116094951708,0.509688338185508
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TET2,Methylcytosine dioxygenase TET2,37161,0.0061091227913772,0.00932112230923046,-0.0121602769347145,0.0243785225174689,0.512217496460573
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TSHB,Thyrotropin subunit beta,39868,-0.00460546115908048,0.00703652782147994,-0.0183970556891812,0.00918613337102019,0.512794215204309
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PSMG4,Proteasome assembly chaperone 4,37056,0.00340928121011045,0.00521136765996716,-0.00680499940342519,0.0136235618236461,0.512993807617435
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CD164L2,CD164 sialomucin-like 2 protein,37039,-0.00226462643847055,0.00346633541047638,-0.00905864384300425,0.00452939096606314,0.513561363762945
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ACRV1,Acrosomal protein SP-10,37056,-0.00448054989170795,0.00685877023179222,-0.0179237395460207,0.00896263976260481,0.513601029146259
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,KLK1,Kallikrein-1,39720,0.00770099066889333,0.0117953001635689,-0.0154177976517017,0.0308197789894884,0.51383900208878
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LRTM1,Leucine-rich repeat and transmembrane domain-containing protein 1,37039,0.00257175630788587,0.00393932755726363,-0.00514932570435085,0.0102928383201226,0.513869887044067
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FES,Tyrosine-protein kinase Fes/Fps,39477,-0.0028964595062677,0.00445025072299534,-0.0116189509233386,0.00582603191080317,0.515150890609046
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,COL24A1,Collagen alpha-1(XXIV) chain,37382,0.00338794690563794,0.00520655413915172,-0.00681689920709943,0.0135927930183753,0.515245995378066
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SLITRK6,SLIT and NTRK-like protein 6,39585,0.00202805216758894,0.00311724873529078,-0.00408175535358098,0.00813785968875887,0.515320420700818
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PDGFRA,Platelet-derived growth factor receptor alpha,39868,0.00170695755496223,0.00263681637724335,-0.00346120254443475,0.00687511765435921,0.517411179527845
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CDH23,Cadherin-23,37388,0.00163342295185495,0.00252333862156822,-0.00331232074641876,0.00657916665012865,0.517431896298118
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MPRIP,Myosin phosphatase Rho-interacting protein,37338,0.00272794812369509,0.00421457702926964,-0.00553262285367341,0.0109885191010636,0.517471484953447
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PROK1,Prokineticin-1,39866,-0.00393589785445712,0.00608556241241301,-0.0158636001827866,0.00799180447387238,0.517796610511983
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,BAMBI,BMP and activin membrane-bound inhibitor homolog,39477,-0.00182333577965118,0.00281927077352972,-0.00734910649576944,0.00370243493646707,0.517809597388854
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PMM2,Phosphomannomutase 2,37021,-0.00364889155896599,0.00565776167123572,-0.014738104434588,0.00744032131665602,0.518980203001876
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MORF4L1,Mortality factor 4-like protein 1,37169,-0.00243623573635129,0.00380205950111028,-0.00988827235852744,0.00501580088582487,0.521684856450102
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GAGE2A,G antigen 2A,36962,0.00367365616631258,0.00573538335477187,-0.00756769520904029,0.0149150075416655,0.521842572236806
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RAC3,Ras-related C3 botulinum toxin substrate 3,37039,0.00409666609303966,0.00641277744565018,-0.00847237770043468,0.016665709886514,0.522945496193413
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,HRG,Histidine-rich glycoprotein,37380,-0.00189455993743961,0.00297796609068614,-0.00773137347518445,0.00394225360030523,0.52466167673718
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PTEN,"Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN",39489,-0.00180561626555803,0.00284880522176566,-0.00738927450021873,0.00377804196910267,0.526210658654363
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LHB,Lutropin subunit beta,39477,0.00524609949097409,0.00831409696309928,-0.0110495305567005,0.0215417295386487,0.528057284235618
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SSB,Lupus La protein,39489,-0.00359205188111211,0.00570764463240368,-0.0147790353606233,0.0075949315983991,0.529135366287318
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CD5L,CD5 antigen-like,37380,0.0027638838474226,0.00439668459400888,-0.0058536179568348,0.01138138565168,0.529602528971475
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DEFB116,Beta-defensin 116,36991,0.0045792286237493,0.0072887424854106,-0.00970670664765546,0.0188651638951541,0.529844263501869
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MRPL24,"39S ribosomal protein L24, mitochondrial",37021,-0.0023417409978224,0.00373077533583426,-0.00965406065605754,0.00497057866041274,0.530223086170601
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MYOM1,Myomesin-1,36991,0.00280043076693266,0.00446357774302432,-0.00594818160939502,0.0115490431432603,0.53041060624913
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PALM3,Paralemmin-3,37021,-0.00445590960979166,0.00711085346428123,-0.0183931823997829,0.00948136318019955,0.530909393774818
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,KIR3DL1,Killer cell immunoglobulin-like receptor 3DL1,39477,0.00706190944105697,0.0113074070809534,-0.0151006084376117,0.0292244273197257,0.532283211834195
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NOS2,"Nitric oxide synthase, inducible",37021,0.00232161566488633,0.00371884077269655,-0.00496731224959892,0.00961054357937157,0.532451403705552
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LGALS1,Galectin-1,39868,-0.00195958556744035,0.00315021794933332,-0.00813401274813365,0.00421484161325295,0.533919417333428
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MAG,Myelin-associated glycoprotein,37039,-0.00269908408474477,0.00434354014928223,-0.011212422777338,0.00581425460784841,0.534345972649684
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ABHD14B,Protein ABHD14B,39687,-0.00334596155884715,0.00540383539478766,-0.013937478932631,0.00724555581493665,0.535804899023821
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ADGRE1,Adhesion G protein-coupled receptor E1,37382,0.00312026915859468,0.00504534792814421,-0.00676861278056798,0.0130091510977573,0.536292595149651
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LTB,Lymphotoxin-beta,37368,0.00198190383991269,0.00320873387545395,-0.00430721455597706,0.00827102223580243,0.536810456777353
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ANP32C,Acidic leucine-rich nuclear phosphoprotein 32 family member C,37043,0.00234514277319784,0.00384050057768463,-0.00518223835906403,0.00987252390545972,0.541451997023753
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ARNT,Aryl hydrocarbon receptor nuclear translocator,39587,-0.00216416028075621,0.00354593332387783,-0.00911418959555675,0.00478586903404433,0.541657501520775
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CNTNAP4,Contactin-associated protein-like 4,37039,0.0059355541197186,0.00973550491627538,-0.0131460355161812,0.0250171437556184,0.542083535140382
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SCRN1,Secernin-1,39866,-0.00321878974568547,0.00528694587500628,-0.0135812036606978,0.00714362416932683,0.542653479161675
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PTPRK,Receptor-type tyrosine-protein phosphatase kappa,37382,-0.00121252306224869,0.00200910758066698,-0.00515037392035597,0.00272532779585859,0.546177421340892
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MED21,Mediator of RNA polymerase II transcription subunit 21,37021,0.00277696435853183,0.00461503550018278,-0.00626850522182641,0.0118224339388901,0.547370149667704
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ANXA5,Annexin A5,39415,-0.00170291780377674,0.00284426802228193,-0.00727768312744932,0.00387184751989585,0.549368886559
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NUDT16,U8 snoRNA-decapping enzyme,37366,-0.00496385691133106,0.00830203317513165,-0.0212358419345891,0.011308128111927,0.549910956165488
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NOP56,Nucleolar protein 56,37021,-0.00619666123799644,0.0103714008864669,-0.0265246069754715,0.0141312844994787,0.550200025973034
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GID8,Glucose-induced degradation protein 8 homolog,37411,0.00187359774146303,0.00315224199817156,-0.00430479657495323,0.00805199205787929,0.552274662956775
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IL2RG,Cytokine receptor common subunit gamma,37368,-0.0020973503121631,0.00353900469200679,-0.00903379950849641,0.00483909888417022,0.553433050827246
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SRPX,Sushi repeat-containing protein SRPX,37437,0.00189614494392526,0.00320724573694998,-0.0043900567004967,0.00818234658834723,0.554391823151808
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,BLOC1S2,Biogenesis of lysosome-related organelles complex 1 subunit 2,36991,0.00401853043122016,0.00679848303546974,-0.00930649631830053,0.0173435571807409,0.554468806503838
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,REPS1,RalBP1-associated Eps domain-containing protein 1,37056,-0.00213351731054349,0.00361065986892779,-0.00921041065364196,0.00494337603255498,0.554601555792984
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TMED4,Transmembrane emp24 domain-containing protein 4,37021,0.0031224453425449,0.00529006161937226,-0.00724607543142474,0.0134909661165145,0.555034903562448
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CD59,CD59 glycoprotein,39173,-0.00116878045104118,0.00198658326226321,-0.00506248364507707,0.00272492274299471,0.556314787384952
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,BRDT,Bromodomain testis-specific protein,37021,-0.00201514975160819,0.00343767597418315,-0.00875299466100716,0.00472269515779077,0.557754283222904
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FDX2,"Ferredoxin-2, mitochondrial",37021,0.00307468244795181,0.00529650743466384,-0.00730647212398933,0.0134558370198929,0.561579803832005
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,EDAR,Tumor necrosis factor receptor superfamily member EDAR,39866,0.00505149552474131,0.00870440368486243,-0.0120091356975891,0.0221121267470717,0.56169493045395
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MTHFD2,"Bifunctional methylenetetrahydrofolate dehydrogenase/cyclohydrolase, mitochondrial",37388,0.00138060204041054,0.00238182575200567,-0.00328777643352056,0.00604898051434164,0.562166906249788
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PEAR1,Platelet endothelial aggregation receptor 1,40052,-0.00122930662054024,0.00212701962139958,-0.00539826507848342,0.00293965183740294,0.563307300821829
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PAFAH1B3,Platelet-activating factor acetylhydrolase IB subunit alpha1,37411,-0.00628132004457356,0.0108887480958992,-0.0276232663125359,0.0150606262233888,0.56404133171183
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PSMA1,Proteasome subunit alpha type-1,39477,-0.0025185476784913,0.00436656157088237,-0.0110770083574207,0.00603991300043815,0.564096039934212
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SPINK2,Serine protease inhibitor Kazal-type 2,37124,-0.00197617043227802,0.00343154780740819,-0.00870200413479807,0.00474966327024203,0.564703961169668
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IFNL2,Interferon lambda-2,36991,-0.00335319972695781,0.00583551394501195,-0.0147908070591812,0.00808440760526561,0.565558548903015
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SMAD5,Mothers against decapentaplegic homolog 5,39788,-0.00110396517896087,0.00192787823175372,-0.00488260651319817,0.00267467615527643,0.566901826321271
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TMED10,Transmembrane emp24 domain-containing protein 10,37021,0.00272755563736222,0.00477461992767541,-0.00663069942088159,0.012085810695606,0.567832278252448
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PVALB,Parvalbumin alpha,39971,0.00608693798785915,0.010720809087283,-0.0149258478232155,0.0270997237989338,0.570200064804326
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CDSN,Corneodesmosin,39992,0.00224317007667878,0.00397324758231253,-0.00554439518465379,0.0100307353380113,0.572375205581956
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,KIR2DS4,Killer cell immunoglobulin-like receptor 2DS4,37382,-0.00902166928158166,0.0160035548970838,-0.040388636879866,0.0223452983167027,0.572947871945385
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IL31RA,Interleukin-31 receptor subunit alpha,37015,0.00211564645128903,0.00375370168558035,-0.00524160885244844,0.00947290175502651,0.573025080414322
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CA11,Carbonic anhydrase-related protein 11,39477,0.00166069822279601,0.00294751251220124,-0.00411642630111841,0.00743782274671044,0.573154534095088
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DTX3,Probable E3 ubiquitin-protein ligase DTX3,39788,0.00122658331896069,0.00219302396276287,-0.00307174364805453,0.00552491028597591,0.575957075528531
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,C1QTNF5,Complement C1q tumor necrosis factor-related protein 5,37124,0.00197295186671176,0.00353096532467931,-0.00494774016965969,0.00889364390308322,0.576336951932041
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TIGIT,T-cell immunoreceptor with Ig and ITIM domains,37169,0.00188015896356835,0.00337842057085775,-0.00474154535531284,0.00850186328244955,0.577864712639836
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ACOT13,Acyl-coenzyme A thioesterase 13,37382,-0.00597463444591008,0.0107374175274464,-0.027019972799705,0.0150707039078849,0.577925302083563
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CTAG1A_CTAG1B,Cancer/testis antigen 1,37135,0.00265237732911036,0.00477598282536588,-0.00670854900860676,0.0120133036668275,0.578659593550318
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PSMD1,26S proteasome non-ATPase regulatory subunit 1,37411,-0.00252329697867466,0.00454379159927852,-0.0114291285132606,0.00638253455591123,0.57867915450052
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,AMY2A,Pancreatic alpha-amylase,39246,-0.00244893626712132,0.00442319757979419,-0.0111184035235179,0.00622053098927529,0.579821350020426
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PRUNE2,Protein prune homolog 2,37169,-0.00148563462034,0.00268686393291553,-0.00675188792885444,0.00378061868817444,0.580323957538175
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,C1QBP,"Complement component 1 Q subcomponent-binding protein, mitochondrial",37411,-0.00334837374587182,0.006103815513159,-0.0153118521516635,0.00861510465991981,0.583309203180269
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FUT1,"Galactoside alpha-(1,2)-fucosyltransferase 1",37139,-0.00331153118518472,0.006075216892498,-0.0152189562944808,0.00859589392411136,0.585701769731752
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IGSF21,Immunoglobulin superfamily member 21,37043,0.00201213754597939,0.00372574822981434,-0.00529032898445671,0.00931460407641549,0.58916293460688
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PFDN2,Prefoldin subunit 2,39489,0.00283004340309773,0.00524819381927938,-0.00745641648268987,0.0131165032888853,0.589727976081698
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LMOD2,Leiomodin-2,36991,-0.00325686710401295,0.00604039397989181,-0.0150960393046009,0.00858230509657499,0.589770946405618
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TBR1,T-box brain protein 1,37039,-0.00242941883166524,0.0045376993966314,-0.0113233096490628,0.0064644719857323,0.592392291922667
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NECTIN4,Nectin-4,39913,-0.00147707911197005,0.00275937896364023,-0.0068854618807049,0.0039313036567648,0.592453962392003
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ZP3,Zona pellucida sperm-binding protein 3,37043,-0.0130112453973429,0.0243092018804262,-0.0606572810829782,0.0346347902882924,0.592493274239578
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,KIAA1549,UPF0606 protein KIAA1549,37169,-0.00344962681161267,0.00647940027427455,-0.0161492513491908,0.00924999772596545,0.594458502934806
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,BCAT2,"Branched-chain-amino-acid aminotransferase, mitochondrial",36991,0.00269900899960622,0.00507753299159157,-0.00725295566391326,0.0126509736631257,0.595040372213485
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,POMC,Pro-opiomelanocortin,37043,0.00353229924336663,0.00668417550112183,-0.00956868473883217,0.0166332832255654,0.597191089687591
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CPTP,Ceramide-1-phosphate transfer protein,37021,-0.00196550131505747,0.003732396688332,-0.0092809988241882,0.00534999619407326,0.598476317885581
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ATXN2,Ataxin-2,36991,-0.00547721964969003,0.0104841215182854,-0.0260260978255294,0.0150716585261493,0.601379783190829
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,KLK15,Kallikrein-15,37351,-0.00247031728323664,0.00473100862189326,-0.0117430941821474,0.00680245961567415,0.601571359172965
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FOLR3,Folate receptor gamma,39858,0.00925609808825827,0.0177484603359192,-0.0255308841701434,0.04404308034666,0.602014893956769
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CCNE1,G1/S-specific cyclin-E1,37056,0.00467372165932617,0.00899234008828535,-0.0129512649137131,0.0222987082323654,0.60325020186922
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PSMD9,26S proteasome non-ATPase regulatory subunit 9,39788,-0.00262448107425541,0.00506049963494363,-0.0125430603587449,0.0072940982102341,0.604032308726677
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,REG3A,Regenerating islet-derived protein 3-alpha,40052,0.00283479942823808,0.00551408154136891,-0.00797280039284498,0.0136423992493211,0.60718781176933
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SHH,Sonic hedgehog protein,37056,-0.0021042262968241,0.00410246791056577,-0.010145063401533,0.00593661080788481,0.608017836890223
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SDC1,Syndecan-1,39868,-0.00189869050630893,0.00373329214409315,-0.0092159431087315,0.00541856209611364,0.61105125803148
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IGFBP7,Insulin-like growth factor-binding protein 7,40052,-0.00138412057690007,0.00275508226309086,-0.00678408181255815,0.00401584065875801,0.615401371646218
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DCUN1D1,DCN1-like protein 1,36991,0.00352914410480774,0.00706105070980407,-0.0103105152864082,0.0173688034960237,0.617221197779671
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FGF16,Fibroblast growth factor 16,37056,0.00226694072586454,0.00454038741937156,-0.00663221861610373,0.0111661000678328,0.61758796936442
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ZNRF4,E3 ubiquitin-protein ligase ZNRF4,37368,-0.00249084648858718,0.0050239347991188,-0.01233775869486,0.00735606571768565,0.620046453978284
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,AMY2B,Alpha-amylase 2B,38832,-0.0022355154509048,0.0045201789617974,-0.0110950662160277,0.00662403531421811,0.620915540937688
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CELA3A,Chymotrypsin-like elastase family member 3A,40034,-0.00258421730027747,0.00523685062055946,-0.012848444516574,0.00768000991601907,0.621688766929144
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IL17D,Interleukin-17D,39587,0.00156402628223368,0.00318476091602117,-0.00467810511316781,0.00780615767763516,0.62336475128694
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PPM1A,Protein phosphatase 1A,39477,-0.00140390757325187,0.00286952001906647,-0.00702816681062216,0.00422035166411841,0.624672843173205
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CEP152,Centrosomal protein of 152 kDa,36962,0.00191539871899839,0.0039244886680708,-0.00577659907042039,0.00960739650841716,0.625513203518539
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GATA3,Trans-acting T-cell-specific transcription factor GATA-3,36962,0.00120095732021708,0.0024675214280085,-0.00363538467867958,0.00603729931911375,0.626474881034732
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SIRPA,Tyrosine-protein phosphatase non-receptor type substrate 1,39877,-0.00260260963366997,0.00536417862734329,-0.0131163997432628,0.00791118047592287,0.627552996568603
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,AGER,Advanced glycosylation end product-specific receptor,39817,-0.00179346693488292,0.00371631560279873,-0.00907744551636844,0.00549051164660259,0.629391553984043
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MAPK13,Mitogen-activated protein kinase 13,36962,-0.00193231477096953,0.00401062218443383,-0.00979313425245984,0.00592850471052078,0.629956607733449
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GNPDA1,Glucosamine-6-phosphate isomerase 1,37043,0.0014808490079938,0.00309042804203493,-0.00457638995439467,0.00753808797038226,0.631823662354138
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,COL9A2,Collagen alpha-2(IX) chain,37169,-0.00208054989681588,0.00434880320182606,-0.010604204172395,0.0064431043787632,0.632359901547019
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GIPR,Gastric inhibitory polypeptide receptor,37056,-0.00203336749170226,0.00429468108228648,-0.0104509424129838,0.00638420742957924,0.6358915710616
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DRAXIN,Draxin,39749,0.00186959075735601,0.00395014302172185,-0.00587268956521881,0.00961187107993083,0.63600781951425
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MRPL28,"39S ribosomal protein L28, mitochondrial",37411,0.00159197791447564,0.00339391877858805,-0.00506010289155694,0.00824405872050822,0.639028741661774
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TREML1,Trem-like transcript 1 protein,37445,0.00231840326564639,0.00498760500932187,-0.00745730255262447,0.0120941090839173,0.642058522836338
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,KRT17,"Keratin, type I cytoskeletal 17",37021,-0.00170125691062849,0.0036653881389536,-0.00888541766297753,0.00548290384172056,0.64255440671732
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NTF3,Neurotrophin-3,39866,0.00146053670226097,0.00316361736391771,-0.00474015333101774,0.00766122673553968,0.644326648253913
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PDRG1,p53 and DNA damage-regulated protein 1,37039,-0.00230183928735469,0.00499680596650095,-0.0120955789816966,0.00749190040698717,0.645048628779036
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,H2AP,Huntingtin-interacting protein M,36962,0.00216485497689312,0.00471039010954461,-0.0070675096378143,0.0113972195916005,0.645817129435814
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,C9orf40,Uncharacterized protein C9orf40,37382,-0.00337740059583916,0.0074545702213657,-0.0179883582297159,0.0112335570380376,0.650509618273487
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ASGR2,Asialoglycoprotein receptor 2,37445,-0.00107647966718277,0.00238288495244584,-0.00574693417397662,0.00359397483961107,0.651452861788986
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PPM1B,Protein phosphatase 1B,37056,0.00269516499520935,0.00599276637881623,-0.00905065710727047,0.0144409870976892,0.652907930591406
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FCGR2A,Low affinity immunoglobulin gamma Fc region receptor II-a,39812,0.00247748544465677,0.00550942466075469,-0.00832098689042242,0.013275957779736,0.652946340576729
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ERC2,ERC protein 2,37039,-0.00316635006232677,0.00705847441583222,-0.0170009599173579,0.0106682597927044,0.65373594597582
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DCC,Netrin receptor DCC,37039,0.000954650451869965,0.00212888210079352,-0.00321795846568534,0.00512725936942527,0.653851673044479
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TPPP2,Tubulin polymerization-promoting protein family member 2,37169,-0.00330772360339606,0.00738432497645178,-0.0177810005572415,0.0111655533504494,0.654204858334638
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,VGF,Neurosecretory protein VGF,37411,-0.00123017020259246,0.00275348016536261,-0.00662699132670317,0.00416665092151825,0.655048832672901
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ZPR1,Zinc finger protein ZPR1,36991,0.00401818073507565,0.00904455755030495,-0.0137091520635221,0.0217455135336734,0.656858294086838
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PPT1,Palmitoyl-protein thioesterase 1,37039,-0.00325055712149773,0.00735502572534608,-0.017666407543176,0.0111652933001806,0.658532294975127
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SOWAHA,Ankyrin repeat domain-containing protein SOWAHA,37039,-0.00196090822501038,0.00444354499664003,-0.0106702564184248,0.00674843996840408,0.659007656456455
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TXN,Thioredoxin,37289,-0.00178827389700677,0.00406564365938053,-0.0097569354693926,0.00618038767537906,0.660052734754181
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SUMF1,Formylglycine-generating enzyme,37056,0.00281474744211022,0.0064266263298278,-0.00978144016435227,0.0154109350485727,0.661406411624706
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,AHNAK2,Protein AHNAK2,37043,-0.0012050026082998,0.00276265310306953,-0.00661980269031608,0.00420979747371649,0.662716279516462
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MUC2,Mucin-2,37437,0.00368713402827313,0.00846813812096631,-0.0129104166888208,0.0202846847453671,0.663269888396469
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CLNS1A,Methylosome subunit pICln,37039,0.00137755303572738,0.0031704557184855,-0.0048365401725042,0.00759164624395896,0.663934792378072
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RUVBL1,RuvB-like 1,39477,0.00409434764481972,0.00954251789656672,-0.0146089874324511,0.0227976827220905,0.667882816629292
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FOS,Proto-oncogene c-Fos,36931,-0.00140556006484241,0.00332203402838301,-0.00791674676047311,0.00510562663078828,0.672227623208029
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CYTH3,Cytohesin-3,36962,-0.00284620220405959,0.00679973615366693,-0.0161736850652468,0.0104812806571276,0.675533340244676
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NEO1,Neogenin,37411,-0.000850401597383069,0.0020341222266362,-0.00483728116159002,0.00313647796682388,0.675903958114253
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CHEK2,Serine/threonine-protein kinase Chk2,39585,-0.0013135611763293,0.00314260840928563,-0.00747307365852912,0.00484595130587053,0.67596425695105
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MRPL46,"39S ribosomal protein L46, mitochondrial",39489,-0.00104232227738065,0.00256334115845252,-0.0060664709479476,0.0039818263931863,0.684287946433425
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,AIDA,"Axin interactor, dorsalization-associated protein",37039,-0.00323522176064232,0.00796995599595539,-0.0188563355127149,0.0123858919914302,0.684802696940948
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GABARAPL1,Gamma-aminobutyric acid receptor-associated protein-like 1,37169,0.00249246998188965,0.0061756719656954,-0.00961184707087334,0.0145967870346526,0.686517088168782
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MTIF3,"Translation initiation factor IF-3, mitochondrial",37382,-0.00331989522182079,0.00823440493999184,-0.0194593289042048,0.0128195384605632,0.68682684582025
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,KRT14,"Keratin, type I cytoskeletal 14",39064,0.00109686677481517,0.0027299405365857,-0.00425381667689281,0.00644755022652315,0.687843160361436
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,C1S,Complement C1s subcomponent,37453,0.000787294811135116,0.0019686420659956,-0.00307124363821626,0.00464583326048649,0.689223417535082
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SEPTIN9,Septin-9,39788,0.00105704167625564,0.00266333551063945,-0.00416309592459768,0.00627717927710895,0.691456541761901
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PINLYP,phospholipase A2 inhibitor and Ly6/PLAUR domain-containing protein,37124,-0.00248101334151948,0.00629189590076858,-0.0148131293070259,0.00985110262398694,0.693351965737504
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,STXBP1,Syntaxin-binding protein 1,37411,-0.00290135118168601,0.00736393498422938,-0.0173346637507756,0.0115319613874036,0.693591169064968
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CNPY2,Protein canopy homolog 2,39585,0.00222523133367125,0.00565408799199262,-0.00885678113063429,0.0133072437979768,0.693910148506967
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TRPV3,Transient receptor potential cation channel subfamily V member 3,37021,0.00191100307337242,0.0048635516106991,-0.00762155808359782,0.0114435642303427,0.694382446440864
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,UBE2B,Ubiquitin-conjugating enzyme E2 B,37368,-0.00104858967543544,0.0026701090947003,-0.00628200350104803,0.00418482415017715,0.694536800808831
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PSMD5,26S proteasome non-ATPase regulatory subunit 5,37039,0.00204626035298102,0.00521503130426948,-0.00817520100338716,0.0122677217093492,0.694785737550962
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TDO2,"Tryptophan 2,3-dioxygenase",37039,-0.0014157410154036,0.00368700865485748,-0.00864227797892426,0.00581079594811705,0.70099877575169
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LRIG1,Leucine-rich repeats and immunoglobulin-like domains protein 1,39984,0.0012247123840985,0.00319122443491203,-0.00503008750832908,0.00747951227652609,0.70115022651811
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,KIR3DL2,Killer cell immunoglobulin-like receptor 3DL2,36962,-0.00300157952422921,0.00784924329202127,-0.0183860963765909,0.0123829373281325,0.702168163459519
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,VSIG10,V-set and immunoglobulin domain-containing protein 10,37368,-0.00130696250571186,0.00341860810976325,-0.00800743440084782,0.00539350938942411,0.702238659088336
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IL33,Interleukin-33,39587,0.00140087167386708,0.00367937119405753,-0.00581069586648568,0.00861243921421984,0.703403770516607
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IFNAR1,Interferon alpha/beta receptor 1,37382,-0.000896456300571912,0.00239755266813083,-0.00559565953010834,0.00380274692896452,0.708481054109635
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,BPIFB2,BPI fold-containing family B member 2,37405,0.00215275384136029,0.00577566025929926,-0.00916754026686625,0.0134730479495868,0.709356270001998
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DEFB118,Beta-defensin 118,36991,-0.00203793245693275,0.00547142415395644,-0.0127619237986874,0.00868605888482188,0.709550166086182
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TNFSF11,Tumor necrosis factor ligand superfamily member 11,39866,0.0021452663126406,0.00578473093081222,-0.00919280631175134,0.0134833389370325,0.710754314220239
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DIPK1C,Divergent protein kinase domain 1C,37039,0.00148382971861649,0.00402754558284985,-0.00641015962376921,0.00937781906100219,0.712565749764269
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PRDX2,Peroxiredoxin-2,37249,-0.00210693887547532,0.00572300823821706,-0.0133240350223808,0.0091101572714301,0.712765465478646
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ITIH5,Inter-alpha-trypsin inhibitor heavy chain H5,37368,0.00152855841565226,0.00416974099431518,-0.00664413393320549,0.00970125076451002,0.713935429365778
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PLA2G2A,"Phospholipase A2, membrane associated",39826,0.00187099543025355,0.00511817772740733,-0.00816063291546481,0.0119026237759719,0.714699089665461
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,BATF,Basic leucine zipper transcriptional factor ATF-like,37039,-0.00288458476071934,0.0079018138506523,-0.0183721399079978,0.0126029703865592,0.715077332510907
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TNN,Tenascin-N,37437,0.00147025288712005,0.00403444353884774,-0.00643725644902152,0.00937776222326162,0.715546197070956
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,UPK3BL1,Uroplakin-3b-like protein 1,37149,0.00186013723795399,0.00511680581495347,-0.00816880215935481,0.0118890766352628,0.716211166778909
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PGD,"6-phosphogluconate dehydrogenase, decarboxylating",37437,-0.00183140818292924,0.00507644107337923,-0.0117812326867525,0.00811841632089406,0.718279870155824
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DENND2B,DENN domain-containing protein 2B,37021,-0.0017451246922432,0.00484613099881682,-0.0112435414499242,0.00775329206543776,0.718773051533708
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SPINT1,Kunitz-type protease inhibitor 1,39794,0.000873883709425274,0.00244115492998705,-0.00391077995334935,0.0056585473721999,0.720363308474286
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MELTF,Melanotransferrin,37437,-0.000971067947823853,0.00273025102042178,-0.00632235994785054,0.00438022405220284,0.722093358634381
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ZNF75D,Zinc finger protein 75D,37169,0.00197740902556686,0.00558024211302885,-0.00895986551596968,0.0129146835671034,0.723075469504437
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FXN,"Frataxin, mitochondrial",40030,0.00244172352397695,0.00689434371125599,-0.0110711901500848,0.0159546371980387,0.723221123268397
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CDC123,Cell division cycle protein 123 homolog,36962,-0.00210678947933368,0.00598245345559826,-0.0138323982523063,0.00961881929363891,0.724722850349707
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ARID3A,AT-rich interactive domain-containing protein 3A,36991,-0.00131715316603593,0.00374973007057395,-0.00866662410436086,0.00603231777228901,0.725394338903061
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CEACAM6,Carcinoembryonic antigen-related cell adhesion molecule 6,37437,0.00130860842736913,0.0037269258042484,-0.00599616614895773,0.00861338300369598,0.725501711350038
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PGM2,Phosphoglucomutase-2,37039,-0.00200023226417794,0.00569964221816904,-0.0131715310117893,0.00917106648343338,0.725638994574844
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,BTN1A1,Butyrophilin subfamily 1 member A1,37348,0.0013477899493369,0.00385222723533742,-0.00620257543192445,0.00889815533059825,0.726439541759678
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TGFBR3,Transforming growth factor beta receptor type 3,40052,0.00103294027871239,0.00296973929805857,-0.00478774874548242,0.0068536293029072,0.727978484706656
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,AMIGO1,Amphoterin-induced protein 1,37039,-0.00162197164160641,0.00470161639142736,-0.010837139768804,0.00759319648559122,0.730113629572501
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IL1B,Interleukin-1 beta,39478,-0.00179726429107823,0.00524745607465035,-0.0120822781973929,0.00848774961523645,0.731977735213129
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,VEGFB,Vascular endothelial growth factor B,37056,0.000907822648706864,0.00266594657262646,-0.00431743263364099,0.00613307793105472,0.733466283178458
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,HDAC8,Histone deacetylase 8,37056,0.00202210977297493,0.00593984889618583,-0.00961999406354929,0.0136642136094992,0.733537259618514
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MAPRE3,Microtubule-associated protein RP/EB family member 3,36962,0.00457822538451148,0.0135380434961807,-0.0219563398680028,0.0311127906370257,0.735236870452689
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,BTLA,B- and T-lymphocyte attenuator,36962,0.00275099742020413,0.00815602748186794,-0.013234816444257,0.0187368112846653,0.735898995320569
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LYVE1,Lymphatic vessel endothelial hyaluronic acid receptor 1,37453,0.000606845978418226,0.00180143859508233,-0.00292397366794313,0.00413766562477958,0.736222044284332
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SCN2A,Sodium channel protein type 2 subunit alpha,36991,-0.00153785321692655,0.00457141257691448,-0.0104978218676789,0.00742211543382583,0.736569672728592
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GSAP,Gamma-secretase-activating protein,39477,-0.00276768943272445,0.00826728228647934,-0.0189715627142239,0.0134361838487751,0.737798403557296
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TP53BP1,TP53-binding protein 1,37056,0.00274895670871933,0.0082686311505057,-0.0134575603462718,0.0189554737637105,0.739550178376918
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IL17F,Interleukin-17F,39587,0.00242185856396815,0.00728485480869146,-0.0118564568610671,0.0167001739890034,0.73955303014479
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PDIA2,Protein disulfide-isomerase A2,36962,-0.00123685996631531,0.00373369096699243,-0.00855489426162048,0.00608117432898986,0.740445815411355
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MECR,"Enoyl-[acyl-carrier-protein] reductase, mitochondrial",37043,0.00284350657439664,0.00862301994325383,-0.0140576125143809,0.0197446256631741,0.741588347831681
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ARHGEF5,Rho guanine nucleotide exchange factor 5,36991,-0.00231167776868476,0.0070382695195625,-0.0161066860270273,0.0114833304896577,0.74258117629159
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ATP5PO,"ATP synthase subunit O, mitochondrial",39489,-0.00134503408544205,0.0040958290277571,-0.00937285897984596,0.00668279080896186,0.742620318109924
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CASP8,Caspase-8,39984,-0.00188409804638342,0.00579210769516905,-0.0132366291289148,0.00946843303614792,0.744967996613858
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RALB,Ras-related protein Ral-B,37056,0.000891885345664598,0.00274956751977181,-0.00449726699308816,0.00628103768441735,0.745660832724585
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,HK2,Hexokinase-2,39585,-0.000824908912920864,0.00256473204515342,-0.00585178372142158,0.00420196589557985,0.74773311006946
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RNASE3,Eosinophil cationic protein,39791,-0.00324276233352475,0.0100973912803721,-0.0230336492430541,0.0165481245760046,0.748102050155318
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SEMA3G,Semaphorin-3G,37124,0.00132319428297954,0.00412265130249845,-0.00675720226991742,0.0094035908358765,0.748247944056539
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DDX53,Probable ATP-dependent RNA helicase DDX53,37039,0.00104081236539624,0.00331274252383267,-0.0054521629813158,0.00753378771210828,0.753385884652497
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,KLK12,Kallikrein-12,39477,0.00404403262522793,0.0129416794095395,-0.0213216590174695,0.0294097242679254,0.754678955286704
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,HDAC9,Histone deacetylase 9,36991,0.00186715095808667,0.00604916223430928,-0.0099892070211595,0.0137235089373329,0.757582990478344
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PSTPIP2,Proline-serine-threonine phosphatase-interacting protein 2,36709,-0.00317892933573819,0.0103089367733293,-0.0233844454114636,0.0170265867399873,0.757808573262178
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PRDX5,"Peroxiredoxin-5, mitochondrial",40058,-0.00200443741938668,0.00650291117468635,-0.0147501433217719,0.0107412684829986,0.757906012034894
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ATP6V1D,V-type proton ATPase subunit D,39788,-0.000746481992930301,0.00244853560724411,-0.00554561178312876,0.00405264779726815,0.760470099679724
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LYSMD3,LysM and putative peptidoglycan-binding domain-containing protein 3,37039,-0.00286868322522274,0.00944448436669334,-0.0213798725839417,0.0156425061334962,0.761329522272168
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ENPEP,Glutamyl aminopeptidase,37021,0.00118987815833833,0.00393699745776508,-0.00652663685888123,0.00890639317555788,0.762481625016398
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,HIP1,Huntingtin-interacting protein 1,37021,0.000950600594360229,0.00315250106086799,-0.00522830148494104,0.00712950267366149,0.763008623596884
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MYO6,Unconventional myosin-VI,37411,0.00108010757055272,0.00359263680938759,-0.00596146057584696,0.00812167571695241,0.763689978683814
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CHP1,Calcineurin B homologous protein 1,36991,0.0020547736848414,0.00683527025158991,-0.0113423560082748,0.0154519033779576,0.76371408757474
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TPBGL,Trophoblast glycoprotein-like,37039,0.0011452378777113,0.00381618386357419,-0.00633448249489411,0.00862495825031671,0.764105392480424
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MCTS1,Malignant T-cell-amplified sequence 1,37382,-0.000703238078826888,0.00234476327862518,-0.00529897410493224,0.00389249794727846,0.764243869788188
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SHD,SH2 domain-containing adapter protein D,37002,-0.00233376467469235,0.0078166218554011,-0.0176543435112785,0.0129868141618938,0.765277185341704
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RIPK4,Receptor-interacting serine/threonine-protein kinase 4,37021,0.00188510002855156,0.00634829549238376,-0.0105575591365206,0.0143277591936237,0.766512533614206
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,BGLAP,Osteocalcin,37437,-0.00240494435092001,0.00811897555737388,-0.0183181364433728,0.0135082477415328,0.767072117210393
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,BCL7B,B-cell CLL/lymphoma 7 protein family member B,37368,-0.00125989725684295,0.00425555755502939,-0.00960079006470055,0.00708099555101466,0.767189370433352
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SMC3,Structural maintenance of chromosomes protein 3,36962,-0.00145445181304719,0.00497398307681953,-0.0112034586436135,0.00829455501751909,0.769976345395523
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CNGB3,Cyclic nucleotide-gated cation channel beta-3,36991,-0.00149718209089233,0.00515148671269082,-0.0115940960477663,0.00859973186598167,0.771338085344463
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DNAJB8,DnaJ homolog subfamily B member 8,39585,-0.00155148035005559,0.00534484948899558,-0.0120273853484869,0.00892442464837576,0.771609094584864
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ZCCHC8,Zinc finger CCHC domain-containing protein 8,37021,0.00160330729472041,0.00553259401270118,-0.00924057697017389,0.0124471915596147,0.771979130145702
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PTPRC,Receptor-type tyrosine-protein phosphatase C,37437,0.000590693764249776,0.0020932360119788,-0.00351204881922867,0.00469343634772822,0.777800847174688
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,OSBPL2,Oxysterol-binding protein-related protein 2,37388,-0.00101836949261895,0.00361825235912071,-0.00811014411649555,0.00607340513125765,0.778366956611895
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ISM2,Isthmin-2,37437,0.00117550303656136,0.00417670648976354,-0.00701084168337518,0.0093618477564979,0.778375254886806
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,HAGH,"Hydroxyacylglutathione hydrolase, mitochondrial",39984,-0.00185491229003489,0.00663768386245912,-0.0148647726604548,0.011154948080385,0.779901755188383
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,BTNL10,Butyrophilin-like protein 10,36962,0.00102200804978771,0.00371195740401188,-0.00625342846207556,0.00829744456165099,0.783068132350606
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PCARE,Photoreceptor cilium actin regulator,36991,0.00220128518234398,0.00803150797325492,-0.0135404704452357,0.0179430408099236,0.784026547686961
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,JUN,Transcription factor AP-1,39587,-0.00132464752385931,0.00487935583928532,-0.0108881849688585,0.00823888992113991,0.78602544317079
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ANGPTL3,Angiopoietin-related protein 3,39892,-0.00089462614675922,0.00331422565178898,-0.00739050842426562,0.00560125613074718,0.787213584689408
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GABARAP,Gamma-aminobutyric acid receptor-associated protein,37368,-0.00122647264348123,0.00458740340993431,-0.0102177833269525,0.00776483803999003,0.789198682452741
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IMPG1,Interphotoreceptor matrix proteoglycan 1,36991,0.000752946135556673,0.00282773509800398,-0.00478941465653114,0.00629530692764448,0.79003406471936
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GLT8D2,Glycosyltransferase 8 domain-containing protein 2,39489,-0.00122299891101124,0.00460673750731473,-0.0102522044253481,0.00780620660332563,0.79064284230808
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LILRB5,Leukocyte immunoglobulin-like receptor subfamily B member 5,40052,0.0017079190286095,0.00655580083879592,-0.0111414506154305,0.0145572886726495,0.794465791781498
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,OSTN,Osteocrin,37039,-0.00102425784865048,0.00393694403350341,-0.00874066815431715,0.0066921524570162,0.794740015747366
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GSR,"Glutathione reductase, mitochondrial",37403,-0.000549197754877516,0.00211903141439139,-0.00470249932708465,0.00360410381732961,0.795504963832842
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CEACAM18,Carcinoembryonic antigen-related cell adhesion molecule 18,37169,0.00163557982769672,0.00640474375789848,-0.0109177179377843,0.0141888775931777,0.798441235552712
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LRP2BP,LRP2-binding protein,37039,-0.00189137991602973,0.0075062844745999,-0.0166036974862455,0.0128209376541861,0.801065976044405
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SF3B4,Splicing factor 3B subunit 4,39788,0.00172274539128376,0.00685892389850294,-0.011720745449782,0.0151662362323495,0.801687104053224
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RRP15,RRP15-like protein,36991,-0.00213787976112338,0.00851499765742705,-0.0188272751696804,0.0145515156474336,0.80176216597806
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MFAP3L,Microfibrillar-associated protein 3-like,37039,0.00151831858733559,0.00606722715382135,-0.0103734466341543,0.0134100838088254,0.802398559634177
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,JCHAIN,Immunoglobulin J chain,39587,0.0014096273709867,0.00569117999157297,-0.00974508541249632,0.0125643401544697,0.804380358483453
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RNF168,E3 ubiquitin-protein ligase RNF168,37056,0.00094494940647211,0.00389501387828456,-0.00668927779496562,0.00857917660790984,0.808315264519074
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DUOX2,Dual oxidase 2,39585,-0.00161752402135926,0.00668812756247046,-0.0147262540438014,0.0114912060010828,0.808899505059067
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PYDC1,Pyrin domain-containing protein 1,37043,-0.000938836263756682,0.00388785631196929,-0.00855903463521649,0.00668136210770312,0.809187524788982
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SLC13A1,Solute carrier family 13 member 1,37368,-0.00135276562863802,0.00561562301550836,-0.0123593867390344,0.00965385548175838,0.809641516783921
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RNF31,E3 ubiquitin-protein ligase RNF31,37056,-0.000831020356038149,0.00352324077251131,-0.00773657227016031,0.00607453155808401,0.813538627996573
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TAP1,Antigen peptide transporter 1,37169,-0.00126878947602354,0.00554536929451714,-0.0121377132932771,0.00960013434123007,0.819026623358601
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TRIM26,Tripartite motif-containing protein 26,36962,0.00118517892835281,0.00525232648339737,-0.00910938097910604,0.0114797388358117,0.821478433854572
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ACP1,Low molecular weight phosphotyrosine protein phosphatase,37056,-0.00092077720573809,0.00408100842664471,-0.00891955372196171,0.00707799931048553,0.821496650146358
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MRPL58,"Peptidyl-tRNA hydrolase ICT1, mitochondrial",37411,0.00148205458476573,0.00661984446744731,-0.011492840571431,0.0144569497409625,0.822853606153526
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NENF,Neudesin,37368,0.00229232452686535,0.0103107544136911,-0.0179167541239692,0.0225014031776999,0.82406530604834
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IL20RA,Interleukin-20 receptor subunit alpha,39587,-0.000952538956830987,0.00428448754339487,-0.00935013454188492,0.00744505662822295,0.824065547670727
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RAB39B,Ras-related protein Rab-39B,37021,-0.00183551298430187,0.00833863737370974,-0.018179242236773,0.0145082162681692,0.825779980670328
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MAGEA3,Melanoma-associated antigen 3,37169,0.00173352238613566,0.00789672051375615,-0.0137440498208264,0.0172110945930977,0.826244985555455
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SMPDL3A,Acid sphingomyelinase-like phosphodiesterase 3a,39904,-0.00131915507074689,0.00603756875036435,-0.013152789821461,0.0105144796799672,0.827049266686064
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,XPNPEP2,Xaa-Pro aminopeptidase 2,39913,0.0020273580626014,0.00928857482811143,-0.016178248600497,0.0202329647256998,0.827226484494509
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,VTCN1,V-set domain-containing T-cell activation inhibitor 1,39477,0.000661335385500582,0.00303681374373761,-0.00529081955222514,0.0066134903232263,0.82760899550263
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TCL1B,T-cell leukemia/lymphoma protein 1B,39585,-0.00157782479555389,0.00735677189828691,-0.0159970977161962,0.0128414481250884,0.830181440160338
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CD55,Complement decay-accelerating factor,39315,0.000511651512980819,0.00239187280218587,-0.00417641917930349,0.00519972220526513,0.830618106908551
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IFNGR1,Interferon gamma receptor 1,39931,0.000405050413588237,0.00189439610367182,-0.00330796594960852,0.004118066776785,0.830693994007397
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CRX,Cone-rod homeobox protein,39585,-0.00214370912465088,0.0101491261919227,-0.0220359964608194,0.0177485782115176,0.832717520261524
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,UGDH,UDP-glucose 6-dehydrogenase,37021,-0.00196140567616031,0.00941245452734935,-0.020409816549765,0.0164870051974444,0.83493231054991
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,EDNRB,Endothelin receptor type B,37056,-0.000912845892401128,0.00438430102189373,-0.00950607589531283,0.00768038411051057,0.835069892249189
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ADA2,Adenosine deaminase 2,39782,0.000801047115670407,0.00387758651222982,-0.00679902244830004,0.00840111667964085,0.836337441999783
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ARHGAP30,Rho GTPase-activating protein 30,37169,0.000761222828441778,0.003708094147893,-0.00650664170142851,0.00802908735831207,0.837351186223842
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,HPCAL1,Hippocalcin-like protein 1,40058,-0.0014261279980006,0.00696974760365549,-0.0150868333011653,0.0122345773051642,0.837874038197213
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DSG3,Desmoglein-3,39964,0.000633083655085726,0.00313079312953615,-0.00550327087880513,0.00676943818897659,0.839753617805299
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,HSP90B1,Endoplasmin,39405,0.00125886143162219,0.00633298787915787,-0.0111537948115272,0.0136715176747716,0.842438663826305
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FOLH1,Glutamate carboxypeptidase 2,37056,-0.00201705738499178,0.0103025342871689,-0.0222100245878428,0.0181759098178593,0.844783311131022
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SAP18,Histone deacetylase complex subunit SAP18,37169,0.00132854300341699,0.0068851370976481,-0.0121663257079733,0.0148234117148073,0.846994723517635
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CDH6,Cadherin-6,39868,0.000689054858575409,0.00357430714644744,-0.00631658714846157,0.00769469686561238,0.847133728944644
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LYPLA2,Acyl-protein thioesterase 2,36991,-0.0019091977682363,0.00990386054662664,-0.0213207644396245,0.0175023689031519,0.847139663063864
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LILRA3,Leukocyte immunoglobulin-like receptor subfamily A member 3,37437,0.00241248888082462,0.0126253836876444,-0.0223332631469585,0.0271582409086077,0.848463877092497
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LY6D,Lymphocyte antigen 6D,39761,-0.000618450319386202,0.00339034857172394,-0.00726353351996513,0.00602663288119273,0.855259407118326
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SUSD4,Sushi domain-containing protein 4,37368,-0.000707203996613237,0.0039205017907961,-0.0083913875065736,0.00697697951334712,0.856852178234292
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SHPK,Sedoheptulokinase,37169,-0.00069941336658713,0.00394780546811306,-0.00843711208408873,0.00703828535091447,0.859381400926518
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,STAM,Signal transducing adapter molecule 1,37368,-0.000595449429432581,0.00341986706916898,-0.00729838888500378,0.00610749002613862,0.86177786084354
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GAS6,Growth arrest-specific protein 6,39947,0.000414159653016531,0.00239654010120311,-0.00428305894534157,0.00511137825137463,0.862798503514445
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NECTIN1,Nectin-1,37056,-0.000514982856117327,0.00301625831671458,-0.0064268491568779,0.00539688344464325,0.864434239059827
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CDKL5,Cyclin-dependent kinase-like 5,36991,0.000836305024046376,0.00496220931665139,-0.00888962523659035,0.0105622352846831,0.866165153525828
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ZP4,Zona pellucida sperm-binding protein 4,36962,-0.000496016204154222,0.00302680057247518,-0.00642854532620557,0.00543651291789713,0.86983226821644
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ARL2BP,ADP-ribosylation factor-like protein 2-binding protein,37021,-0.000616418316533212,0.00380366289270236,-0.00807159758622984,0.00683876095316342,0.871261774433397
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RPGR,X-linked retinitis pigmentosa GTPase regulator,37039,0.000612306513871151,0.00384650188360776,-0.00692683717800005,0.00815145020574235,0.873525333053409
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,BRD1,Bromodomain-containing protein 1,37169,-0.000461472410160421,0.00290089367882587,-0.00614722402065913,0.00522427920033828,0.873608736034513
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TAFA5,Chemokine-like protein TAFA-5,39788,0.000507468962685596,0.00320032375489642,-0.0057651655969114,0.00678010352228259,0.874011246050855
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,KCNIP4,Kv channel-interacting protein 4,39489,0.000778039229673289,0.00493307414839278,-0.00889078610117656,0.0104468645605231,0.874680312188478
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IFIT1,Interferon-induced protein with tetratricopeptide repeats 1,37169,0.000768676268840566,0.00490883180127048,-0.00885263406164957,0.0103899865993307,0.875569990494583
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FGF12,Fibroblast growth factor 12,37056,0.000689221006373763,0.00440488925997468,-0.00794436194317661,0.00932280395592414,0.875667108132605
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TYRP1,"5,6-dihydroxyindole-2-carboxylic acid oxidase",37056,-0.000876691011984492,0.00563018402122823,-0.0119118516935918,0.0101584696696228,0.876261887970556
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NDRG1,Protein NDRG1,39489,-0.000986114469099213,0.0065130017178567,-0.0137515978360983,0.0117793688978999,0.879656571441285
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IMPA1,Inositol monophosphatase 1,39749,0.000865773639081146,0.00576265750193316,-0.0104290350647078,0.0121605823428701,0.880578274123307
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FGF7,Fibroblast growth factor 7,36962,0.00112063227233944,0.00748311794872999,-0.0135462789071714,0.0157875434518502,0.880960435518648
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NLGN1,Neuroligin-1,37039,0.000921568094193544,0.00633323054804452,-0.0114915637799737,0.0133346999683608,0.884307988385099
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SAG,S-arrestin,36991,0.000720315208666456,0.00500517066953341,-0.00908981930361902,0.0105304497209519,0.885570418913668
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,STX5,Syntaxin-5,37056,0.000544069296638166,0.00382784406057224,-0.00695850506208342,0.00804664365535975,0.886975814834048
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CAMLG,Guided entry of tail-anchored proteins factor CAMLG,37039,0.000725819228790607,0.00512044734936991,-0.00931025757597442,0.0107618960335556,0.887280291314838
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CEP290,Centrosomal protein of 290 kDa,37169,-0.000691149231218815,0.00489135773987457,-0.010278210401373,0.00889591193893533,0.887635026396306
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SETMAR,Histone-lysine N-methyltransferase SETMAR,39699,-0.000388645898362933,0.00279550846618881,-0.005867842492093,0.00509055069536713,0.889432066867828
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SEPTIN3,Neuronal-specific septin-3,37411,-0.000990957375003719,0.00718501297325079,-0.0150735828025753,0.0130916680525678,0.890305650523043
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PSCA,Prostate stem cell antigen,37382,-0.00323545874075074,0.0238501877273554,-0.0499818266863674,0.0435109092048659,0.892094003482998
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ST8SIA1,"Alpha-N-acetylneuraminide alpha-2,8-sialyltransferase",37056,-0.00063848954852711,0.00473317449424025,-0.009915511557238,0.00863853246018378,0.892695618010721
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RBM25,RNA-binding protein 25,36962,0.00057397516095056,0.00429434043086118,-0.00784293208353735,0.00899088240543847,0.893674664490764
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,THRAP3,Thyroid hormone receptor-associated protein 3,37021,-0.00145205880839196,0.010887602940285,-0.0227917605713506,0.0198876429545667,0.893904319528925
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SPRING1,SREBP regulating gene protein,36962,-0.00072913323198364,0.00563029164316092,-0.011764504852579,0.0103062383886118,0.896962542328925
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CLSTN1,Calsyntenin-1,39489,0.00060954248512376,0.00473442544215643,-0.00866993138150283,0.00988901635175035,0.897559599014104
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ANXA4,Annexin A4,39783,-0.000869120915685414,0.00681562521105112,-0.0142277463293456,0.0124895044979748,0.898531338776282
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MB,Myoglobin,40052,0.000620647398472558,0.00487189026698392,-0.00892825752481593,0.010169552321761,0.898630502597314
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CSF1R,Macrophage colony-stimulating factor 1 receptor,37445,-0.000469743077928137,0.00371322467860538,-0.00774766344799468,0.00680817729213841,0.899333724666827
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,COL28A1,Collagen alpha-1(XXVIII) chain,37039,0.000906802442269696,0.00730222650611011,-0.0134055615097061,0.0152191663942455,0.901173354994157
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CLSPN,Claspin,39453,-0.000396271371413788,0.00323855023826498,-0.00674382983841315,0.00595128709558557,0.902614914505117
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NDST1,Bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 1,37368,0.000691840460002275,0.00574890572202414,-0.010576014755165,0.0119596956751696,0.904213246292796
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ICOSLG,ICOS ligand,39788,-0.000210402114251738,0.00177275918887183,-0.00368501012444052,0.00326420589593705,0.905525438776238
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,KIRREL2,Kin of IRRE-like protein 2,39489,-0.000432059243852141,0.00372336493097477,-0.00772985450856268,0.0068657360208584,0.907622336197028
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TPPP3,Tubulin polymerization-promoting protein family member 3,39489,-0.0004210926450332,0.0036550409440943,-0.00758497289545802,0.00674278760539162,0.908281154974901
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TPM3,Tropomyosin alpha-3 chain,37021,-0.000474590844009018,0.00417113648874588,-0.00865001836195094,0.00770083667393291,0.90941413135289
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SHC1,SHC-transforming protein 1,36962,0.00123293719444255,0.0108678659924343,-0.0200680801507287,0.0225339545396138,0.909677159036399
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CLEC7A,C-type lectin domain family 7 member A,40058,-0.00060039105159335,0.00537893294397745,-0.0111430996217892,0.00994231751860246,0.911126898888544
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ALCAM,CD166 antigen,40052,0.000188652023030179,0.00182367108490851,-0.0033857433033905,0.00376304734945086,0.917610049616626
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ITGB6,Integrin beta-6,39587,0.000280751199546906,0.00278878922577539,-0.00518527568297286,0.00574677808206667,0.919812631813809
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,KIR2DL2,Killer cell immunoglobulin-like receptor 2DL2,37368,-0.000790003842600644,0.0078626381900512,-0.016200774695101,0.0146207670098997,0.919968188485842
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,UBQLN3,Ubiquilin-3,37021,0.000442936718525262,0.00441654641690544,-0.00821349425860941,0.00909936769565993,0.920115394114877
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ENDOU,Poly(U)-specific endoribonuclease,36430,0.000483707893237747,0.00486198342216767,-0.00904577961421089,0.0100131954006864,0.920752583561759
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,APOA1,Apolipoprotein A-I,37453,0.000254028761272583,0.00256831760266223,-0.00477987373994539,0.00528793126249056,0.921212279626813
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CASQ2,Calsequestrin-2,37021,0.000441657181532964,0.00458305159685716,-0.00854112394830707,0.009424438311373,0.923230177983444
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RGS8,Regulator of G-protein signaling 8,39587,-0.000595134534842408,0.00618333195363633,-0.0127144651639696,0.0115241960942848,0.923324681352439
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MANEAL,"Glycoprotein endo-alpha-1,2-mannosidase-like protein",36962,-0.000453227346977758,0.00477238356428837,-0.00980709913298295,0.00890064443902744,0.924341093353519
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SPESP1,Sperm equatorial segment protein 1,37437,0.000260171591340004,0.0027417670456381,-0.00511369181811068,0.00563403500079069,0.92440205970534
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RBP1,Retinol-binding protein 1,37039,0.000597135181987508,0.00661188123869439,-0.0123621520458535,0.0135564224098285,0.928040300783817
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PXDNL,Peroxidasin-like protein,37368,-0.000501168061331845,0.00558887437562389,-0.0114553618375547,0.010453025714891,0.928548838423916
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PTPRN2,Receptor-type tyrosine-protein phosphatase N2,39682,0.000241462926292771,0.00299484594630581,-0.00562843512846662,0.00611136098105216,0.935740281577349
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SIRT1,NAD-dependent protein deacetylase sirtuin-1,37056,-0.000622288330225576,0.00844947907135715,-0.0171832673100856,0.0159386906496344,0.941291489427907
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,UBE2Z,Ubiquitin-conjugating enzyme E2 Z,37056,-0.00040721759992896,0.00568338312825529,-0.0115466485313093,0.0107322133314514,0.942881085956908
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TMOD4,Tropomodulin-4,36962,-0.000271685082183744,0.00383569474672432,-0.00778964678576341,0.00724627662139592,0.943533550464394
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NUDT10,Diphosphoinositol polyphosphate phosphohydrolase 3-alpha,37043,0.000176908937175234,0.00250124641099584,-0.00472553402837662,0.00507935190272709,0.943615060182534
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TNFAIP8L2,Tumor necrosis factor alpha-induced protein 8-like protein 2,37124,-0.000420880801345156,0.00604716155610785,-0.0122733174513165,0.0114315558486262,0.944513302389986
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IVD,"Isovaleryl-CoA dehydrogenase, mitochondrial",39489,0.000306984214624115,0.00465292127054559,-0.00881274147564524,0.00942670990489347,0.947397249750102
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FCER2,Low affinity immunoglobulin epsilon Fc receptor,39858,-0.000295230281128756,0.00448852823115438,-0.00909274561419134,0.00850228505193383,0.94755825450648
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,BST1,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 2,40009,-0.000285721567996327,0.00436477702897539,-0.00884068454478809,0.00826924140879544,0.947807968332717
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,BPIFA2,BPI fold-containing family A member 2,36593,0.000663854282821508,0.0102336757361374,-0.0193941501600078,0.0207218587256508,0.948278856755363
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ENSA,Alpha-endosulfine,37368,0.000318130770972395,0.00493493489814425,-0.00935434162939034,0.00999060317133513,0.948600897884836
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CLEC2L,C-type lectin domain family 2 member L,37039,-0.000301374314853944,0.00480630519079628,-0.00972173248881464,0.00911898385910676,0.95000320376291
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PRND,Prion-like protein doppel,37388,-0.000283855367457456,0.00477249632704683,-0.00963794816846924,0.00907023743355433,0.95257279532529
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MRPS16,"28S ribosomal protein S16, mitochondrial",37056,-0.000158093036437823,0.00279465790786974,-0.0056356225358625,0.00531943646298686,0.954888806297622
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GJA8,Gap junction alpha-8 protein,36962,0.000311779469865715,0.00561674450083484,-0.0106970397517706,0.011320598691502,0.955733863252935
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DOCK9,Dedicator of cytokinesis protein 9,36991,0.000602651257867439,0.0109722404892754,-0.0209029401011123,0.0221082426168471,0.956198981519437
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,THPO,Thrombopoietin,39585,-0.000194684309789094,0.00357776523028366,-0.00720710416114507,0.00681773554156688,0.956605171728141
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PDCD1,Programmed cell death protein 1,39998,0.000200396247592513,0.00384627537375069,-0.00733830348495884,0.00773909598014386,0.958448559738276
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RAB3GAP1,Rab3 GTPase-activating protein catalytic subunit,36991,0.00027680074663123,0.00543366701334195,-0.010373186599519,0.0109267880927815,0.959372676630732
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SLC28A1,Sodium/nucleoside cotransporter 1,36962,0.000269105176899048,0.00560402015480956,-0.0107147743265277,0.0112529846803258,0.961701016857188
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SPTBN2,"Spectrin beta chain, non-erythrocytic 2",36991,0.000140666177080556,0.00300528448477519,-0.00574969141307882,0.00603102376723993,0.962668338253618
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,COPE,Coatomer subunit epsilon,39489,0.000208208675381018,0.00444858162088455,-0.00851101130155269,0.00892742865231473,0.962670529670854
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TOP1MT,"DNA topoisomerase I, mitochondrial",36962,0.000206413929283252,0.0045873117975697,-0.00878471719395335,0.00919754505251986,0.964110618701914
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CHIT1,Chitotriosidase-1,39906,-0.000619297101604487,0.0141543449345985,-0.0283618131734175,0.0271232189702086,0.965101720846647
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FHIP2A,FHF complex subunit HOOK interacting protein 2A,37021,-0.000190172212401196,0.00435280546154163,-0.00872167091702278,0.00834132649222039,0.965152513536826
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SPON1,Spondin-1,39885,0.000128259429093895,0.00299005250022679,-0.00573224347135061,0.0059887623295384,0.96578546844726
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CCL26,C-C motif chemokine 26,39866,0.000323616978988666,0.00804164362577748,-0.0154380045275352,0.0160852384855125,0.967900184312034
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GP5,Platelet glycoprotein V,37124,-0.000136497932827937,0.00340526985048147,-0.00681082683977161,0.00653783097411574,0.968026504358495
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ARG1,Arginase-1,39754,-0.000187556647562234,0.00485558980868268,-0.00970451267258028,0.00932939937745581,0.969188296714885
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ALMS1,Alstrom syndrome protein 1,37169,0.000156709273022518,0.00422213583303438,-0.00811867695972487,0.00843209550576991,0.970392980784413
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ADAM23,Disintegrin and metalloproteinase domain-containing protein 23,40058,0.000117716662592768,0.00322645461712945,-0.00620613438698096,0.0064415677121665,0.970896220597786
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PFDN4,Prefoldin subunit 4,36962,0.000185835075599298,0.00511605159559908,-0.0098416260517749,0.0102132962029735,0.97102462632774
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PDCL2,Phosducin-like protein 2,36962,0.000160049796375949,0.00499396895643362,-0.00962812935823394,0.00994822895098584,0.974433768522499
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,BCL7A,B-cell CLL/lymphoma 7 protein family member A,36962,-0.000159311952604653,0.00598942304868279,-0.0118985811280229,0.0115799572228136,0.978780070648225
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GHRHR,Growth hormone-releasing hormone receptor,39489,0.000134588567231932,0.00507512250451092,-0.00981265154160948,0.0100818286760733,0.978843498690745
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ADAMTS13,A disintegrin and metalloproteinase with thrombospondin motifs 13,40052,-5.22016489907737e-05,0.0021321863855052,-0.00423128696458097,0.00412688366659942,0.980467896131198
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LRFN2,Leucine-rich repeat and fibronectin type-III domain-containing protein 2,37039,0.000110334611426917,0.00454936218107277,-0.00880641526347571,0.00902708448632955,0.980651357367167
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IL5,Interleukin-5,39587,-0.000278456363298731,0.0135626268414346,-0.0268612049725105,0.026304292245913,0.983619921470335
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RAD51,DNA repair protein RAD51 homolog 1,37169,-8.70634170563012e-05,0.00496955080369992,-0.00982738299230814,0.00965325615819554,0.986022539948517
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CD3G,T-cell surface glycoprotein CD3 gamma chain,37056,-0.000140234895784577,0.0085518880735952,-0.0169019355200312,0.016621465728462,0.986917026643826
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NUBP1,Cytosolic Fe-S cluster assembly factor NUBP1,37368,0.000123405302303144,0.00916471776653039,-0.0178394415200964,0.0180862521247027,0.989256800906344
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LILRB2,Leukocyte immunoglobulin-like receptor subfamily B member 2,39962,-3.25317565302939e-05,0.00323179060433058,-0.00636684134101822,0.00630177782795763,0.99196861799479
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NRXN3,Neurexin-3,37039,3.17527242411589e-05,0.00330272890691074,-0.0064415959333039,0.00650510138178622,0.992329331817923
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,C1R,Complement C1r subcomponent,37453,-1.31822829418381e-05,0.0018185271432422,-0.00357749548369655,0.00355113091781287,0.994216388512626
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CDH4,Cadherin-4,36991,-3.02988366263152e-05,0.00440801107590186,-0.00867000054539396,0.00860940287214133,0.994515820648979
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CPOX,"Oxygen-dependent coproporphyrinogen-III oxidase, mitochondrial",37056,1.23436868635718e-05,0.00261137396648039,-0.00510594928743799,0.00513063666116513,0.996228570080648
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DDX25,ATP-dependent RNA helicase DDX25,37039,-1.62222854341955e-05,0.00352861353062471,-0.00693230480545862,0.00689986023459023,0.99633192474931
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LAMA4,Laminin subunit alpha-4,39931,-1.43034071872612e-05,0.00315585681883992,-0.00619978277211351,0.00617117595773898,0.996383786777495
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,EFNB2,Ephrin-B2,37039,-2.32875897408673e-05,0.00567047991031703,-0.0111374282139623,0.0110908530344805,0.996723310212436
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ATP1B1,Sodium/potassium-transporting ATPase subunit beta-1,37021,1.47951179756869e-05,0.00460267129669923,-0.00900644062355481,0.00903603085950619,0.997435282495638
